0001193125-21-323920.txt : 20211109 0001193125-21-323920.hdr.sgml : 20211109 20211109090107 ACCESSION NUMBER: 0001193125-21-323920 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211109 DATE AS OF CHANGE: 20211109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Palantir Technologies Inc. CENTRAL INDEX KEY: 0001321655 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 680551851 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39540 FILM NUMBER: 211390079 BUSINESS ADDRESS: STREET 1: 1555 BLAKE STREET STREET 2: SUITE 250 CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 720-358-3679 MAIL ADDRESS: STREET 1: 1555 BLAKE STREET STREET 2: SUITE 250 CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: Palantir Technologies Inc DATE OF NAME CHANGE: 20050324 10-Q 1 d178745d10q.htm FORM 10-Q Form 10-Q
falseQ30001321655--12-31P3YP3YDeferred revenue as of September 30, 2021 and December 31, 2020 includes $38.6 million and $68.2 million, respectively, from Palantir Technologies Japan, K.K. See Note 6. Equity Method Investments for more information.No other country represents 10% or more of total revenue for the three months ended September 30, 2021 or 2020.No other country represents 10% or more of total revenue for the nine months ended September 30, 2021 or 2020.On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date.The Company’s investment closed after September 30, 2021. See further discussion in Note 14. Subsequent Events.Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed. Investments are in publicly-traded marketable securities, unless otherwise noted.Investment in privately-held company. Reflected as commitments in Note 8. Commitments and Contingencies - Investment Commitments as of September 30, 2021. 0001321655 2020-12-31 0001321655 2021-09-30 0001321655 2020-01-01 2020-09-30 0001321655 2021-01-01 2021-09-30 0001321655 2020-07-01 2020-09-30 0001321655 2021-07-01 2021-09-30 0001321655 2020-09-30 0001321655 2021-01-01 2021-03-31 0001321655 2020-01-01 2020-12-31 0001321655 2019-12-31 0001321655 2021-06-30 0001321655 2020-06-30 0001321655 us-gaap:CommonClassAMember 2020-12-31 0001321655 us-gaap:CommonClassBMember 2020-12-31 0001321655 pltr:CommonClassFMember 2020-12-31 0001321655 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001321655 us-gaap:FairValueInputsLevel2Member 2020-12-31 0001321655 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001321655 us-gaap:ComputerEquipmentMember 2020-12-31 0001321655 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001321655 us-gaap:ConstructionInProgressMember 2020-12-31 0001321655 pltr:PalantirTechnologiesJapanKKMember 2020-12-31 0001321655 us-gaap:CommonClassAMember 2021-09-30 0001321655 us-gaap:CommonClassBMember 2021-09-30 0001321655 pltr:CommonClassFMember 2021-09-30 0001321655 srt:MinimumMember 2021-09-30 0001321655 us-gaap:FairValueInputsLevel1Member 2021-09-30 0001321655 us-gaap:FairValueInputsLevel2Member 2021-09-30 0001321655 us-gaap:LeaseholdImprovementsMember 2021-09-30 0001321655 us-gaap:ComputerEquipmentMember 2021-09-30 0001321655 us-gaap:FurnitureAndFixturesMember 2021-09-30 0001321655 us-gaap:ConstructionInProgressMember 2021-09-30 0001321655 pltr:PalantirTechnologiesJapanKKMember 2021-09-30 0001321655 us-gaap:RestrictedStockUnitsRSUMember 2021-09-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2021-09-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember pltr:IncrementalCreditFacilityMember 2021-09-30 0001321655 pltr:TelecommunicationsCompanyMember 2021-09-30 0001321655 pltr:RigettiCoInc.Member 2021-09-30 0001321655 pltr:AlternativeInvestmentMember 2021-09-30 0001321655 pltr:CommercialContractMember pltr:InvestmentAgreementMember srt:MaximumMember 2021-09-30 0001321655 pltr:CelularityMember 2021-09-30 0001321655 pltr:FaradayFutureMember 2021-09-30 0001321655 pltr:AstrocastMember 2021-09-30 0001321655 pltr:BlackSkyMember 2021-09-30 0001321655 pltr:LiliumMember 2021-09-30 0001321655 pltr:RoivantSciencesMember 2021-09-30 0001321655 pltr:SarcosRoboticsMember 2021-09-30 0001321655 pltr:AutonomousAerialVehicleCompanyMember 2021-09-30 0001321655 pltr:ConversionOfConvertiblePreferredStockWarrantsIntoCommonStockWarrantsMember 2020-01-01 2020-09-30 0001321655 pltr:ConversionOfRedeemableConvertiblePreferredStockToCommonStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember pltr:SeriesHOneConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:CommonStockMember pltr:SeriesHOneConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001321655 pltr:SeriesHOneConvertiblePreferredStockMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001321655 pltr:SeriesHOneConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001321655 pltr:SeriesKConvertiblePreferredStockMember us-gaap:NonredeemableConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 pltr:SeriesDConvertiblePreferredStockMember us-gaap:NonredeemableConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:TreasuryStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 pltr:CustomerFMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-09-30 0001321655 us-gaap:SalesRevenueNetMember srt:MaximumMember 2020-01-01 2020-09-30 0001321655 pltr:WarrantsToPurchaseRedeemableConvertibleAndConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 pltr:OptionsAndSarsIssuedAndOutstandingMember 2020-01-01 2020-09-30 0001321655 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0001321655 pltr:GrowthUnitsOutstandingMember 2020-01-01 2020-09-30 0001321655 us-gaap:GovernmentMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0001321655 pltr:CommercialMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0001321655 us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0001321655 us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember country:US 2020-01-01 2020-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember country:GB 2020-01-01 2020-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember country:FR 2020-01-01 2020-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember pltr:RestOfWorldMember 2020-01-01 2020-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-09-30 0001321655 srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001321655 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001321655 us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001321655 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-09-30 0001321655 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001321655 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001321655 pltr:AlternativeInvestmentMember 2020-01-01 2020-09-30 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember 2020-07-01 2020-09-30 0001321655 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001321655 pltr:SeriesDConvertiblePreferredStockMember us-gaap:NonredeemableConvertiblePreferredStockMember 2020-07-01 2020-09-30 0001321655 us-gaap:RedeemableConvertiblePreferredStockMember 2020-07-01 2020-09-30 0001321655 us-gaap:SalesRevenueNetMember srt:MaximumMember 2020-07-01 2020-09-30 0001321655 pltr:CustomerAMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0001321655 us-gaap:OperatingSegmentsMember us-gaap:GovernmentMember 2020-07-01 2020-09-30 0001321655 pltr:CommercialMember us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0001321655 us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0001321655 us-gaap:MaterialReconcilingItemsMember 2020-07-01 2020-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember country:US 2020-07-01 2020-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember country:GB 2020-07-01 2020-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember pltr:RestOfWorldMember 2020-07-01 2020-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember 2020-07-01 2020-09-30 0001321655 srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001321655 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001321655 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001321655 us-gaap:SellingAndMarketingExpenseMember 2020-07-01 2020-09-30 0001321655 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2020-09-30 0001321655 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2020-09-30 0001321655 pltr:ConversionOfConvertiblePreferredStockWarrantsIntoCommonStockWarrantsMember 2021-01-01 2021-09-30 0001321655 pltr:ConversionOfRedeemableConvertiblePreferredStockToCommonStockMember 2021-01-01 2021-09-30 0001321655 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001321655 us-gaap:AccountsReceivableMember pltr:CustomerHMember 2021-01-01 2021-09-30 0001321655 srt:MaximumMember us-gaap:AccountsReceivableMember 2021-01-01 2021-09-30 0001321655 us-gaap:SalesRevenueNetMember srt:MaximumMember 2021-01-01 2021-09-30 0001321655 us-gaap:LondonInterbankOfferedRateLIBORMember pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2021-01-01 2021-09-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2021-01-01 2021-09-30 0001321655 srt:MinimumMember pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2021-01-01 2021-09-30 0001321655 pltr:PurchaseCommitmentTwoMember 2021-01-01 2021-09-30 0001321655 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001321655 pltr:OptionsAndSarsIssuedAndOutstandingMember 2021-01-01 2021-09-30 0001321655 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001321655 us-gaap:GovernmentMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0001321655 pltr:CommercialMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0001321655 us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0001321655 us-gaap:MaterialReconcilingItemsMember 2021-01-01 2021-09-30 0001321655 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001321655 country:US us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001321655 country:GB us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001321655 country:FR us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001321655 pltr:RestOfWorldMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001321655 srt:MinimumMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001321655 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001321655 us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0001321655 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-09-30 0001321655 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-09-30 0001321655 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001321655 pltr:PurchaseCommitmentOneMember 2021-01-01 2021-09-30 0001321655 pltr:InvestmentAgreementMember pltr:InvestmentCommitmentsMember 2021-01-01 2021-09-30 0001321655 pltr:MobilityCompanyMember 2021-01-01 2021-09-30 0001321655 pltr:WejoMember 2021-01-01 2021-09-30 0001321655 pltr:BabylonHealthMember 2021-01-01 2021-09-30 0001321655 pltr:BoxedMember 2021-01-01 2021-09-30 0001321655 pltr:PearTherapeuticsMember 2021-01-01 2021-09-30 0001321655 pltr:AutonomousVehicleCompanyMember 2021-01-01 2021-09-30 0001321655 pltr:FastRadiusMember 2021-01-01 2021-09-30 0001321655 pltr:TritiumMember 2021-01-01 2021-09-30 0001321655 pltr:AdtheorentMember 2021-01-01 2021-09-30 0001321655 pltr:FinaccelMember 2021-01-01 2021-09-30 0001321655 pltr:ElectricvehiclechargingcompanyMember 2021-01-01 2021-09-30 0001321655 pltr:EnergyVaultMember 2021-01-01 2021-09-30 0001321655 pltr:TelecommunicationsCompanyMember 2021-01-01 2021-09-30 0001321655 pltr:RigettiCoInc.Member 2021-01-01 2021-09-30 0001321655 srt:MaximumMember pltr:InvestmentAgreementMember pltr:CommercialContractMember 2021-01-01 2021-09-30 0001321655 srt:MinimumMember pltr:InvestmentAgreementMember pltr:CommercialContractMember 2021-01-01 2021-09-30 0001321655 pltr:CommercialContractMember 2021-01-01 2021-09-30 0001321655 pltr:GrowthUnitsMember 2021-01-01 2021-09-30 0001321655 us-gaap:SalesRevenueNetMember srt:MaximumMember 2021-07-01 2021-09-30 0001321655 us-gaap:OperatingSegmentsMember us-gaap:GovernmentMember 2021-07-01 2021-09-30 0001321655 pltr:CommercialMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0001321655 us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0001321655 us-gaap:MaterialReconcilingItemsMember 2021-07-01 2021-09-30 0001321655 country:US us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0001321655 country:GB us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0001321655 pltr:RestOfWorldMember us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0001321655 srt:MinimumMember us-gaap:SalesRevenueNetMember 2021-07-01 2021-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001321655 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001321655 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001321655 us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0001321655 us-gaap:SellingAndMarketingExpenseMember 2021-07-01 2021-09-30 0001321655 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2021-09-30 0001321655 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001321655 srt:MinimumMember 2021-07-01 2021-09-30 0001321655 srt:MaximumMember 2021-07-01 2021-09-30 0001321655 pltr:CommercialContractMember 2021-07-01 2021-09-30 0001321655 us-gaap:CommonClassBMember 2020-09-30 0001321655 us-gaap:AccountsReceivableMember pltr:CustomerGMember 2020-01-01 2020-12-31 0001321655 srt:MaximumMember us-gaap:AccountsReceivableMember 2020-01-01 2020-12-31 0001321655 pltr:PalantirTechnologiesJapanKKMember 2019-11-01 2019-11-30 0001321655 pltr:PalantirTechnologiesJapanKKMember 2019-11-30 0001321655 pltr:SompoHoldingsIncMember 2019-11-30 0001321655 us-gaap:LondonInterbankOfferedRateLIBORMember pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2014-10-30 2014-10-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2014-10-30 2014-10-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2021-04-01 2021-04-01 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember pltr:IncrementalCreditFacilityMember 2021-04-01 2021-04-01 0001321655 pltr:AmendedTwoThousandAndFourteenRevolvingCreditFacilityMember 2021-04-01 0001321655 pltr:AmendedTwoThousandAndFourteenRevolvingCreditFacilityMember pltr:TermLoanMember pltr:IncrementalCreditFacilityMember 2021-04-01 0001321655 pltr:PurchaseCommitmentOneMember 2019-12-01 2019-12-31 0001321655 pltr:PurchaseCommitmentTwoMember 2020-06-01 2020-06-30 0001321655 us-gaap:CommonClassBMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-09-30 2020-09-30 0001321655 us-gaap:CommonClassBMember us-gaap:ConvertiblePreferredStockMember 2020-09-30 2020-09-30 0001321655 pltr:GrowthUnitsMember 2021-01-01 2021-03-31 0001321655 pltr:GrowthUnitsMember 2021-03-31 0001321655 pltr:EquityInvestmentMember us-gaap:SubsequentEventMember 2021-10-01 2021-10-01 0001321655 srt:MaximumMember pltr:AdditionalInvestmentAgreementMember us-gaap:SubsequentEventMember 2021-10-01 2021-10-01 0001321655 srt:MinimumMember us-gaap:SubsequentEventMember pltr:AdditionalInvestmentAgreementMember 2021-10-01 2021-10-01 0001321655 srt:MaximumMember pltr:CommercialContractMember us-gaap:SubsequentEventMember pltr:InvestmentAgreementMember 2021-10-01 0001321655 pltr:CommonClassFMember 2021-11-04 0001321655 us-gaap:CommonClassAMember 2021-11-04 0001321655 us-gaap:CommonClassBMember 2021-11-04 0001321655 pltr:InvestmentAgreementMember srt:ScenarioForecastMember 2021-12-31 0001321655 pltr:BabylonHealthMember srt:ScenarioForecastMember 2021-12-31 0001321655 pltr:MobilityCompanyMember srt:ScenarioForecastMember 2021-12-31 0001321655 us-gaap:RedeemableConvertiblePreferredStockMember 2019-12-31 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember 2019-12-31 0001321655 us-gaap:CommonStockMember 2019-12-31 0001321655 us-gaap:TreasuryStockMember 2019-12-31 0001321655 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001321655 us-gaap:RetainedEarningsMember 2019-12-31 0001321655 us-gaap:CommonStockMember 2020-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001321655 us-gaap:RetainedEarningsMember 2020-09-30 0001321655 us-gaap:RedeemableConvertiblePreferredStockMember 2020-06-30 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember 2020-06-30 0001321655 us-gaap:CommonStockMember 2020-06-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001321655 us-gaap:RetainedEarningsMember 2020-06-30 0001321655 us-gaap:CommonStockMember 2020-12-31 0001321655 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001321655 us-gaap:RetainedEarningsMember 2020-12-31 0001321655 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001321655 us-gaap:CommonStockMember 2021-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001321655 us-gaap:RetainedEarningsMember 2021-09-30 0001321655 us-gaap:CommonStockMember 2021-06-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001321655 us-gaap:RetainedEarningsMember 2021-06-30 iso4217:USD xbrli:shares xbrli:pure utr:Year iso4217:USD xbrli:shares utr:oz
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2021
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
    
    
    
    
to
    
    
    
    
Commission File Number:
001-39540
 
 
Palantir Technologies Inc.
(Exact Name of Registrant as Specified in its Charter)
 
 
 
Delaware
 
68-0551851
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
   
1555 Blake Street, Suite 250
Denver, Colorado
 
80202
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (720)
358-3679
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Class A Common Stock, par value $0.001 per share
 
PLTR
 
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
Large accelerated filer
 
  
Accelerated filer
 
       
Non-accelerated filer
 
  
Smaller reporting company
 
       
Emerging growth company  
        
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☐    No  
As of November 4, 2021, there
were 1,906,589,959 shares of the registrant’s Class A common stock outstanding,
 
97,225,971 shares of the registrant’s Class B common stock outstanding, and 1,005,000 shares of the registrant’s Class F common stock outstanding.
 
 
 

TABLE OF CONTENTS
 
 
 
 
  
Page  
 
 
PART I. FINANCIAL INFORMATION
  
 
     
Item 1.        
 
  
3
     
 
 
  
4
     
 
 
  
5
     
 
 
  
6
     
 
 
  
7
     
 
 
  
10
     
 
 
  
11
     
Item 2.
 
  
26
     
Item 3.
 
  
42
     
Item 4.
 
  
44
 
 
PART II. OTHER INFORMATION
  
 
     
Item 1.
 
  
45
     
Item 1A.
 
  
45
     
Item 2.
 
  
93
     
Item 3.
 
  
93
     
Item 4.
 
  
93
     
Item 5.
 
  
93
     
Item 6.
 
  
9
4
 
2

 
ITEM 1.
FINANCIAL STATEMENTS (UNAUDITED)
 
3

Palantir Technologies Inc.
Condensed Consolidated Balance Sheets
(in thousands, except per share amounts)
(unaudited)
 
                               
                               
 
 
     As of September 30,       
 
 
 
      As of December 31,      
 
 
 
 
 
 
 
 
 
 
 
2021
 
2020
Assets
               
Current assets:
               
Cash and cash equivalents
  $ 2,335,068        $ 2,011,323     
Restricted cash
    41,316          37,285     
Accounts receivable
    174,405          156,932     
Marketable securities
    148,077         
 
 
 
 
Prepaid expenses and other current assets
    112,624          51,889     
   
 
 
 
 
 
 
 
Total current assets
    2,811,490          2,257,429     
Property and equipment, net
    28,778          29,541     
Restricted cash, noncurrent
    46,791          79,538     
Operating lease
right-of-use
assets
    220,846          217,075     
Other assets
    116,422          106,921     
   
 
 
 
 
 
 
 
Total assets
  $     3,224,327        $     2,690,504     
   
 
 
 
 
 
 
 
Liabilities and Stockholders’ Equity
               
Current liabilities:
               
Accounts payable
  $ 17,654        $ 16,358     
Accrued liabilities
    179,467          158,546     
Deferred revenue
(1)
    208,100          189,520     
Customer deposits
    232,707          210,320     
Operating lease liabilities
    43,581          29,079     
   
 
 
 
 
 
 
 
Total current liabilities
    681,509          603,823     
Deferred revenue, noncurrent
(1)
    26,723          50,525     
Customer deposits, noncurrent
    42,734          81,513     
Debt, noncurrent, net
    —          197,977     
Operating lease liabilities, noncurrent
    219,646          229,800     
Other noncurrent liabilities
    5,659          4,316     
   
 
 
 
 
 
 
 
Total liabilities
    976,271          1,167,954     
   
 
 
 
 
 
 
 
Commitments and Contingencies (Note 8)
           
Stockholders’ equity:
               
Preferred stock, par value $0.001: 2,000,000 shares authorized and 0 issued and outstanding as of September 30, 2021 and December 31, 2020
               
Common stock, $0.001 par value: 20,000,000 Class A shares authorized as of September 30, 2021 and December 31, 2020; 1,900,441 shares issued and outstanding as of September 30, 2021, and 1,542,058 shares issued and outstanding as of December 31, 2020; 2,700,000 Class B shares authorized as of September 30, 2021 and December 31, 2020; 89,672 shares issued and outstanding as of September 30, 2021, and 249,077 shares issued and outstanding as of December 31, 2020; and 1,005 Class F shares authorized, issued, and outstanding as of September 30, 2021 and December 31, 2020
    1,991          1,792     
Additional
paid-in
capital
    7,577,305          6,488,857     
Accumulated other comprehensive loss
    (1,695)         (2,745)    
Accumulated deficit
    (5,329,545)         (4,965,354)    
   
 
 
 
 
 
 
 
Total stockholders’ equity
    2,248,056          1,522,550     
   
 
 
 
 
 
 
 
Total liabilities and stockholders’ equity
  $ 3,224,327        $ 2,690,504     
   
 
 
 
 
 
 
 
 
(1)
Deferred revenue as of September 30, 2021 and December 31, 2020 includes $38.6 million and $68.2 million, respectively, from Palantir Technologies Japan, K.K. See
Note 6.
Equity Method Investments
 for more information.
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
4

Palantir Technologies Inc.
Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)
 
   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2021
   
2020
   
2021
   
2020
 
Revenue
   $ 392,146        $ 289,366     $ 1,109,022     $ 770,582  
Cost of revenue
     86,804          149,340       251,841       282,044  
 
 
 
   
 
 
   
 
 
   
 
 
 
Gross profit
     305,342          140,026       857,181       488,538  
Operating expenses:
                                
Sales and marketing
     153,443       334,911       451,919       536,082  
Research and development
     94,316       313,915       303,311       466,530  
General and administrative
     149,524       338,977       454,054       503,033  
 
 
 
   
 
 
   
 
 
   
 
 
 
Total operating expenses
     397,283       987,803       1,209,284       1,505,645  
 
 
 
   
 
 
   
 
 
   
 
 
 
Loss from operations
     (91,941     (847,777     (352,103     (1,017,107
Interest income
     379       494       1,127       4,312  
Interest expense
     (609     (2,085     (3,039     (12,325
Change in fair value of warrants
           (9,201           811  
Other income (expense), net
     (8,528     (3,293     (11,297     1,218  
 
 
 
   
 
 
   
 
 
   
 
 
 
Loss before provision (benefit) for income taxes
     (100,699 )     (861,862     (365,312     (1,023,091
Provision (benefit) for income taxes
     1,438       (8,543     (1,121     (5,043
 
 
 
   
 
 
   
 
 
   
 
 
 
Net loss
   $ (102,137   $ (853,319   $ (364,191   $ (1,018,048
 
 
 
   
 
 
   
 
 
   
 
 
 
Net loss per share attributable to common stockholders, basic
   $ (0.05   $ (0.94   $ (0.19   $ (1.43
 
 
 
   
 
 
   
 
 
   
 
 
 
Net loss per share attributable to common stockholders, diluted
   $ (0.05   $ (0.94   $ (0.19   $ (1.43
 
 
 
   
 
 
   
 
 
   
 
 
 
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, basic
     1,964,395       905,462       1,893,911       713,879  
 
 
 
   
 
 
   
 
 
   
 
 
 
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, diluted
     1,964,395       905,462       1,893,911       716,027  
 
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
5

Palantir Technologies Inc.
Condensed Consolidated Statements of Comprehensive Loss
(in thousands)
(unaudited)
 
 
 
Three Months Ended September 30,
  
Nine Months Ended September 30,
 
 
2021
 
2020
  
2021
 
2020
Net loss
   $ (102,137   $ (853,319   $ (364,191   $ (1,018,048
Other comprehensive income (loss):
                                
Foreign currency translation adjustments
     (1,760     268       1,050       1,871  
    
 
 
   
 
 
   
 
 
   
 
 
 
Comprehensive loss
   $     (103,897   $     (853,051   $     (363,141   $     (1,016,177
    
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
6

Palantir Technologies Inc.
Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders’ Equity (Deficit)
(in thousands)
(unaudited)
 
 
  
Common Stock
 
Additional
Paid-in

Capital
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Accumulated
Deficit
 
Total
Stockholders’
Equity
  
Shares
 
Amount
Balance as of June 30, 2021
     1,936,578     $ 1,937
 
 
 
$ 7,294,369      $ 65   $ (5,227,408    $ 2,068,963  
Issuance of common stock from the exercise of stock options
     41,249       41
 
 
 
  97,954        —      —         97,995  
Issuance of common stock upon vesting of restricted stock units (“RSUs”)
     13,291       13
 
 
 
  (13      —      —         —   
Stock-based compensation
          
 
 
 
  184,995        —      —         184,995  
Other comprehensive loss
          
 
 
 
  —         (1,760   —         (1,760
Net loss
          
 
 
 
  —         —      (102,137      (102,137
    
 
 
    
 
 
 
 
 
 
 
    
 
 
 
 
 
    
 
 
 
Balance as of September 30, 2021
     1,991,118     $ 1,991
 
 
 
$ 7,577,305      $ (1,695 $ (5,329,545    $ 2,248,056  
    
 
 
    
 
 
 
 
 
 
 
    
 
 
 
 
 
    
 
 
 
 
 
 
Common Stock
 
Additional
Paid-in

Capital
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Accumulated
Deficit
 
Total
Stockholders’
Equity
 
Shares
 
Amount
Balance as of December 31, 2020
     1,792,140        $ 1,792  
 
$ 6,488,857   $ (2,745)      $ (4,965,354    $ 1,522,550  
Issuance of common stock from the exercise of stock options
     155,720          155  
 
  474,528     —         —         474,683  
Issuance of common stock upon vesting of RSUs
     37,123          37  
 
  (37   —         —         —   
Issuance of common stock upon vesting of growth units
     1,471          1  
 
  (1   —         —         —   
Issuance of common stock upon net exercise of common stock warrants and other
     4,664          6  
 
  1,706     —         —         1,712  
Stock-based compensation
               
 
  612,252     —         —         612,252  
Other comprehensive income
               
 
  —      1,050        —         1,050  
Net loss
               
 
  —      —         (364,191      (364,191
    
 
 
      
 
 
 
 
 
 
 
 
 
    
 
 
    
 
 
 
Balance as of September 30, 2021
     1,991,118        $         1,991  
 
$     7,577,305   $ (1,695    $ (5,329,545    $ 2,248,056  
    
 
 
      
 
 
 
 
 
 
 
 
 
    
 
 
    
 
 
 
 
7

Palantir Technologies Inc.
Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders’ Equity (Deficit)
(in thousands)
(unaudited)
 
   
Redeemable Convertible
Preferred Stock
   
Convertible Preferred
Stock
   
Common Stock
   
Additional
Paid-in

Capital
   
Accumulated
Other
Comprehensive
Income
   
Accumulated
Deficit
   
Total
Stockholders’
Equity
(Deficit)
 
Shares
   
Amount
   
Shares
   
Amount
   
Shares
   
Amount
 
Balance as of June 30, 2020
    4,017     $ 33,569       742,933     $ 2,094,509       736,635       $ 737       $ 2,563,354     $ 900     $ (3,963,692     $ (1,398,701)  
                     
Issuance of Series D preferred stock upon net exercise of Series D preferred stock warrants
   
 
 
     
 
 
      2,380       10,810      
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
 
                     
Issuance of common stock upon net exercise of common stock warrants
   
 
 
     
 
 
     
 
 
     
 
 
      7,631       8         (8      
 
 
     
 
 
     
 
 
 
                     
Issuance of common stock, net of issuance costs
   
 
 
     
 
 
     
 
 
     
 
 
      88,280       88         404,591      
 
 
     
 
 
      404,679  
                     
Conversion of redeemable convertible preferred stock to common stock
    (4,017       (33,569      
 
 
     
 
 
      4,017       4         33,565      
 
 
     
 
 
      33,569  
                     
Conversion of convertible preferred stock to common stock
   
 
 
     
 
 
      (745,313       (2,105,319       793,726       794         2,104,525      
 
 
     
 
 
      2,105,319  
                     
Conversion of preferred stock warrants to common stock warrants
   
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
      31,007      
 
 
     
 
 
      31,007  
                     
Issuance of common stock from the exercise of stock options
   
 
 
     
 
 
     
 
 
     
 
 
      31,748       32         87,175      
 
 
     
 
 
      87,207  
                     
Issuance of common stock upon vesting of restricted stock units
   
 
 
     
 
 
     
 
 
     
 
 
      68,149       68         (68      
 
 
     
 
 
     
 
 
 
                     
Stock-based compensation
   
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
      841,929      
 
 
     
 
 
      841,929  
                     
Settlement of employee loan accounted for as a modification to stock option
   
 
 
     
 
 
     
 
 
     
 
 
      (3,500       (4       (201      
 
 
     
 
 
      (205)  
                     
Other comprehensive income
   
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
      268      
 
 
      268  
Net loss
   
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
      (853,319)       (853,319)  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of September 30, 2020
   
 
 
    $
 
 
     
 
 
    $
 
 
      1,726,686     $ 1,727     $ 6,065,869     $ 1,168     $ (4,817,011)     $ 1,251,753  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
8

Palantir Technologies Inc.
Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders’ Equity (Deficit)
(in thousands)
(unaudited)
 
   
Redeemable Convertible
Preferred Stock
   
  Convertible Preferred  
Stock
   
Common Stock
   
Additional
Paid-in

Capital
   
Treasury Stock
   
Accumulated
Other
Comprehensive
Income (Loss)
   
Accumulated
Deficit
   
Total
Stockholders’
Equity (Deficit)
 
Shares
   
Amount
   
Shares
   
Amount
   
Shares
   
Amount
   
Shares
   
Amount
 
Balance as of December 31, 2019
    4,017       $ 33,569         742,840     $ 2,093,662         581,497       $ 588       $ 1,857,331         6,393       $ (38,895     $ (703     $ (3,798,963     $ (1,980,642  
                         
Conversion of Series
H-1
convertible preferred stock to common stock
    —         —         (28       (100       28         —         100         —         —         —         —         100    
                         
Issuance of Series K convertible preferred stock
    —         —         121         947         —         —         —         —         —         —         —         —    
                         
Issuance of Series D preferred stock upon net exercise of Series D preferred stock warrants
    —         —         2,380         10,810         —         —         —         —         —         —         —         —    
                         
Repurchase of common stock, held in treasury
    —         —         —         —         (808       —         —         808         (3,777       —         —         (3,777  
                         
Retirement of treasury stock
    —         —         —         —         —         (7       (42,665       (7,201       42,672         —         —         —    
                         
Issuance of common stock upon net exercise of common stock warrants
    —         —         —         —         7,631         8         (8       —         —         —         —         —    
                         
Issuance of common stock, net of issuance costs
    —         —         —         —         206,501         207         942,322         —         —         —         —         942,529    
                         
Conversion of redeemable convertible preferred stock to common stock
    (4,017)       (33,569)       —         —         4,017         4         33,565         —         —         —         —         33,569    
                         
Conversion of convertible preferred stock to common stock
    —         —         (745,313)       (2,105,319)       793,726         794         2,104,525         —         —         —         —         2,105,319    
                         
Conversion of preferred stock warrants to common stock warrants
    —         —         —         —         —         —         31,007         —         —         —         —         31,007    
                         
Issuance of common stock from the exercise of stock options
    —         —         —         —         69,444         69         115,961         —         —         —         —         116,030    
                         
Issuance of common stock upon vesting of RSUs
    —         —         —         —         68,150         68         (68       —         —         —         —         —    
                         
Stock-based compensation
    —         —         —         —         —         —         1,024,000         —         —         —         —         1,024,000    
                         
Settlement of employee loan accounted for as a modification to stock option
    —         —         —         —         (3,500       (4       (201       —         —         —         —         (205  
                         
Other comprehensive income
    —         —         —         —         —         —         —         —         —         1,871         —         1,871    
                         
Net loss
    —         —         —         —         —         —         —         —         —         —         (1,018,048       (1,018,048  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of September 30, 2020
    —       $ —         —       $ —         1,726,686       $ 1,727       $ 6,065,869         —       $ —       $ 1,168       $ (4,817,011     $ 1,251,753    
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
9

Palantir Technologies Inc.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)
 
    
  Nine Months Ended September 30,  
  
2021
 
2020
     
Operating activities
                
     
Net loss
   $ (364,191   $ (1,018,048
     
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
                
     
Depreciation and amortization
     11,057       10,308  
     
Stock-based compensation
     611,308       1,028,914  
     
Non-cash
operating lease expense
     23,417       28,815  
     
Unrealized loss from marketable securities
     7,238        
     
Other operating activities
     3,076       3,621  
     
Changes in operating assets and liabilities:
                
     
Accounts receivable
     (15,412     (112,723
     
Prepaid expenses and other current assets
     (7,872     (11,598
     
Other assets
     (8,155     (20,944
     
Accounts payable
     1,158       (29,372
     
Accrued liabilities
     20,360       42,138  
     
Deferred revenue, current and noncurrent
     (3,781     (30,937
     
Customer deposits, current and noncurrent
     (16,227     (140,162
     
Operating lease liabilities, current and noncurrent
     (22,786     (34,725
     
Other noncurrent liabilities
     1,234       6,393  
    
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
     240,424       (278,320
     
Investing activities
                
     
Purchases of property and equipment
     (6,783     (7,475
     
Purchases of marketable securities
     (155,315      
     
Purchases of alternative investments
     (50,941      
     
Other investing activities
     (3,000     (2,500
    
 
 
 
 
 
 
 
Net cash used in investing activities
     (216,039     (9,975
     
Financing activities
                
     
Proceeds from the issuance of common stock, net of issuance costs
           942,529  
     
Proceeds from issuance of debt, net of issuance costs
           199,369  
     
Principal payments on borrowings
     (200,000     (400,000
     
Proceeds from the exercise of common stock options
     474,683       79,473  
     
Repurchase of common stock
           (3,777
     
Other financing activities
     (401     (250
    
 
 
 
 
 
 
 
     
Net cash provided by financing activities
     274,282       817,344  
     
Effect of foreign exchange on cash, cash equivalents, and restricted cash
     (3,638     (678
    
 
 
 
 
 
 
 
     
Net increase in cash, cash equivalents, and restricted cash
     295,029       528,371  
     
Cash, cash equivalents, and restricted cash - beginning of period
     2,128,146       1,401,962  
    
 
 
 
 
 
 
 
Cash, cash equivalents, and restricted cash - end of period
   $ 2,423,175     $ 1,930,333  
    
 
 
 
 
 
 
 
     
Supplemental disclosures of cash flow information:
                
     
Cash paid for income taxes
   $ 3,588     $ 9,143  
     
Cash paid for interest
     2,774       9,737  
     
Supplemental disclosures of
non-cash
investing and financing information:
                
     
Conversion of redeemable convertible and convertible preferred stock to common stock
   $     $ 2,138,988  
     
Receivable from the exercise of common stock options included in prepaid expenses and other current assets
     396       36,557  
     
Conversion of convertible preferred stock warrants to common stock warrants
           31,007  
     
Cashless net exercise of warrants for convertible preferred stock
           10,810  
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
10

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
1. Organization
Palantir Technologies Inc. (including its subsidiaries, “Palantir,” or “the Company”) was incorporated in Delaware on May 6, 2003. The Company builds and deploys software platforms, Palantir Gotham and Palantir Foundry, that serve as the central operating systems for its customers.
2. Significant Accounting Policies
Basis of Presentation and Consolidation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over the investee, but does not control, are accounted for using the equity method of accounting. The Company’s fiscal year ends on December 31.
The unaudited condensed consolidated balance sheet as of December 31, 2020, included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity (deficit), and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period.
The Company ceased to be an emerging growth company as of December 31, 2020, which accelerated its adoption of Accounting Standards Update (“ASU”)
2016-02,
Leases (Topic 842)
. As a result, certain components of cash flows used in operating activities within the Company’s condensed consolidated statements of cash flows for the nine months ended September 30, 2020, have been presented to conform to the new standard. The impact to the presentation of the other statements was not material.
These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form
10-K
for the year ended December 31, 2020, which was filed with the SEC on February 26, 2021.
Use of Estimates
The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods.
Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts
;
the valuation of deferred tax assets and uncertain tax positions
;
collectability of contract consideration, including accounts receivable
;
useful lives of tangible assets
;
and the incremental borrowing rate for operating leases. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations.
 
11

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
Summary of Significant Accounting Policies
The Company’s significant accounting policies are discussed in
Note 2. Significant Accounting Policies
in the notes to consolidated financial statements in its Annual Report on Form
10-K
for the year ended December 31, 2020, which was filed with the SEC on February 26, 2021. There have been no significant changes to these policies during the nine months ended September 30, 2021.
Cash, Cash Equivalents, and Restricted Cash
The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds.
Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands):
 
 
  
As of September 30,
 
  
2021
  
2020
Cash and cash equivalents
   $ 2,335,068        $ 1,800,190    
Restricted cash
     41,316          43,800    
Restricted cash, noncurrent
     46,791          86,343    
    
 
 
 
  
 
 
 
Total cash, cash equivalents, and restricted cash
   $             2,423,175        $             1,930,333    
    
 
 
 
  
 
 
 
Accounts Receivable and Allowance for Credit Losses
Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses, if any. The Company generally grants
non-collateralized
credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, including the ongoing
COVID-19
pandemic, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are
written-off
and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the assessment as of September 30, 2021, the Company recorded an immaterial allowance for credit losses. As of December 31, 2020, the Company did not record an allowance for credit losses.
Concentrations of Credit Risk and Other Concentrations
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents primarily consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.
The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of September 30, 2021 and December 31, 2020 were $174.4 million and $156.9 million, respectively. Customer H represented 11% of total accounts receivable as of September 30, 2021. Customer G represented 13% of total accounts receivable as of December 31, 2020. No other customer represented more than 10% of total accounts receivable as of September 30, 2021 and December 31, 2020. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of September 30, 2021 and December 31, 2020, the Company had not experienced any significant losses on its accounts receivable.
For the three and nine months ended September 30, 2021, no customer represented more than 10% of total revenue. For the three months ended September 30, 2020, no customer represented more than 10% of total revenue. For the nine months ended September 30, 2020, Customer F, which is in the government operating segment, represented 11% of total revenue. No other customer represented more than 10% of total revenue for the three and nine months ended September 30, 2020.
 
12

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
The Company relies on the technology, infrastructure, and software applications, including
software-as-a-service
offerings, of third parties in order to host or operate certain key products and functions of its business.
Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued ASU
2019-12,
Simplifying the Accounting for Income Taxes (Topic 740),
as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU
2019-12
removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU
2019-12
also amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The Company adopted ASU
2019-12
as of January 1, 2021 using transition methods allowed under each aspect of the guidance. The adoption of the standard did not have a material impact on the Company’s condensed consolidated financial statements.
3. Contract Liabilities and Remaining Performance Obligations
Contract Liabilities
The Company’s contract liabilities consist of deferred revenue and customer deposits. As of September 30, 2021 and December 31, 2020, the Company’s contract liability balances were $510.3 million and $531.9 million, respectively. Revenue of $347.7 million and $406.4 million was recognized during the nine months ended September 30, 2021 and 2020, respectively, that was included in the contract liability balances as of December 31, 2020 and 2019, respectively.
Remaining Performance Obligations
The Company’s arrangements with its customers often have terms that span over multiple years. However, the Company generally allows its customers to terminate contracts for convenience prior to the end of the stated term with less than twelve months’ notice. Revenue allocated to remaining performance obligations represents noncancelable contracted revenue that has not yet been recognized, which includes deferred revenue and, in certain instances, amounts that will be invoiced. The Company has elected the practical expedient allowing the Company to not disclose remaining performance obligations for contracts with original terms of twelve months or less. Cancelable contracted revenue, which includes customer deposits, is not considered a remaining performance obligation.
The Company’s remaining performance obligations were $873.9 million as of September 30, 2021, of which the Company expects to recognize approximately 45% as revenue over the next twelve months.
Disaggregation of Revenue
See
Note 13. Segment and Geographic Information
for disaggregated revenue by customer segment and geographic region.
 
13

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
4. Investments and Fair Value Measurements
Financial instruments consist of money market funds and certificates of deposit included in cash equivalents and restricted cash, accounts receivable, equity securities, other assets accounted for at fair value, accounts payable, and accrued liabilities. Money market funds, certificates of deposit, and marketable securities are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date.
The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation (in thousands):
 
    
As of September 30, 2021
 
    
Total
   
Level 1
   
Level 2
   
Level 3
 
Assets:
                                
Money market funds
   $ 767,372     $ 767,372     $     $  
Certificates of deposit
     60,061             60,061        
Marketable securities
     148,077       148,077              
    
 
 
   
 
 
   
 
 
   
 
 
 
         
Total
   $ 975,510     $ 915,449     $ 60,061     $                 —  
    
 
 
   
 
 
   
 
 
   
 
 
 
   
    
As of December 31, 2020
 
    
Total
   
Level 1
   
Level 2
   
Level 3
 
Assets:
                              
Money market funds
   $ 1,075,783     $ 1,075,783     $     $  
Certificates of deposit
     74,097             74,097        
    
 
 
   
 
 
   
 
 
   
 
 
 
         
Total
   $     1,149,880     $ 1,075,783     $     74,097     $                 —  
    
 
 
   
 
 
   
 
 
   
 
 
 
Certificates of Deposit
The Company’s Level 2 instruments consist of cash equivalents and restricted cash invested in certificates of deposit. The fair value of such instruments is estimated based on valuations obtained from third-party pricing services that utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable either directly or indirectly. These inputs include interest rate curves, foreign exchange rates, and credit ratings. Gross unrealized gains or losses on certificate of deposits as of September 30, 2021 and December 31, 2020 were not material.
Marketable Securities
Marketable securities consist of equity securities in publicly-traded companies and are recorded at fair market value each reporting period. Realized and unrealized gains and losses are recorded in other income (expense), net on the condensed consolidated statements of operations. During the three and nine months ended September 30, 2021, the Company recorded net unrealized losses of 
$7.2 million within other income (expense), net on the condensed consolidated statements of operations.
Investments
The Company approved and entered into certain agreements (“Investment Agreements”) to purchase, or commit to purchase, as further discussed in
Note 8. Commitments and Contingencies—Investment Commitments,
shares of various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities (each, an “Investee,” and such purchases, and commitments to purchase, the “Investments”). In connection with signing the Investment Agreements, each Investee or an associated entity and the Company entered into a commercial contract for access to the Company’s products and services. The maximum potential revenue from all of these commercial contracts is $640.2 million, which is inclusive of $82.9 
million of contractual options. The terms of
such contracts, including such contractual options, range
 
from three to ten years. The majority of these commercial contracts are subject to various termination provisions, including for convenience in the event a proposed business combination is not completed.
 
14

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
During 2021, the Company assessed the concurrent agreements under the
non-monetary
guidance within Accounting Standards Codification (“ASC”) 606 -
Revenue from Contracts with Customers
and the total revenue recognized from the commercial contracts during the three and nine months ended September 30, 2021 was $19.0 million and $22.0 million, respectively.
The following table presents the details of the investments purchased under such Investment Agreements during the nine months ended September 30, 2021 (in thousands):
 
Entity
(1)
     
Share Amount
   
Investment Amount
 
Celularity
                               2,000     $ 20,000  
Faraday Future
        2,500       25,000  
Astrocast
        1,520       5,000  
BlackSky
        800       8,000  
Lilium
        4,100       41,000  
Roivant Sciences
        3,000       30,000  
Sarcos Robotics
        2,100       21,000  
Autonomous aerial vehicle company
(2)
        3,000       3,000  
       
 
 
   
 
 
 
Total
        19,020     $ 153,000  
       
 
 
   
 
 
 
 
 
 
(1)
 
Investments are in publicly-traded marketable securities, unless otherwise noted.
 
(2)
 
Investment in privately-held company.
Privately-Held Securities
Equity investments in private-held companies without readily determinable fair values are recorded using the measurement alternative of cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. As of September 30, 2021, the carrying value of investments without readily determinable fair values were recorded in other assets in the Company’s condensed consolidated balance sheets and were not material.
Alternative Investments
The Company purchased $50.9 million in
100-ounce
gold bars, which are included within prepaid expenses and other current assets on the condensed consolidated balance sheet. The investment is initially recorded as cost and is subsequently remeasured at lower of cost or market each reporting period. The gold bars will initially be kept in a secure third-party facility located in the northeastern United States. The Company is able to take physical possession of the gold bars stored at the facility at any time with reasonable notice.
5. Balance Sheet Components
Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
 
    
 
As of September 30,
2021
 
 
  
 
As of December 31,
2020
Leasehold improvements
       $ 80,215           $ 85,196   
Computer equipment, software, and other
     25,451           22,275   
Furniture and fixtures
     10,021           9,976   
Construction in progress
     5,305           493   
    
 
 
    
 
 
Total property and equipment, gross
                 120,992                   117,940   
Less: accumulated depreciation and amortization
     (92,214)          (88,399)  
    
 
 
    
 
 
Total property and equipment, net
     $ 28,778           $ 29,541   
    
 
 
    
 
 
Depreciation and amortization expense related to property and equipment, net was $3.1 million and $2.5 million for the three months ended September 30, 2021 and 2020, respectively, and $9.3 million and $9.3 million for the nine months ended September 30, 2021 and 2020,
respectively.
 
15

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
Accrued Liabilities
Accrued liabilities consisted of the following (in thousands):
 
    
As of September 30,
2021
    
As of December 31,
2020
Accrued payroll and related expenses
     $ 100,157        $ 85,466
Accrued other liabilities
     79,310        73,080
    
 
 
    
 
 
Total accrued liabilities
     $             179,467        $         158,546
    
 
 
    
 
 
6. Equity Method Investments
Palantir Technologies Japan, K.K.
During November 2019, the Company and SOMPO Holdings, Inc. (“SOMPO”) created a Japanese Kabushiki Kaisha (“K.K.”), Palantir Technologies Japan, K.K. (“Palantir Japan”), to distribute Palantir platforms to the Japanese market. Upon closing of the transaction with SOMPO, the Company purchased a total of 100,000 shares of Palantir Japan common stock for $25.0 million. The shares the Company received in exchange represent a 50% voting interest in Palantir Japan. The remaining 50% of the voting interest is held by SOMPO. The Company’s investment in Palantir Japan is accounted for as an equity method investment as the Company is able to exercise significant influence over, but does not control, the investee.
7. Debt
2014 Credit Facility
In October 2014, the Company entered into an unsecured revolving credit facility which has been subsequently amended (the “2014 Credit Facility”). The 2014 Credit Facility incurred interest at the London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75% per annum, subject to certain adjustments, and incurs a commitment fee of 0.375% assessed on the daily average undrawn portion of revolving commitments. Interest and commitment fees are payable at the end of an interest period or at each three-month interval if the interest period is longer than three months. The 2014 Credit Facility, as amended, matures on June 4, 2023.
During April 2021, the Company entered into an amendment to the 2014 Credit Facility, which provided for an increase of $200.0 million to the revolving commitments of the existing lenders under the 2014 Credit Facility, for total revolving commitments of $400.0 million, and which also provided for an incremental loan facility for additional loans in an aggregate principal amount of up to $100.0 million with one or more existing or new lenders upon mutual agreement between the Company and such lenders. Upon entering into the amendment, the Company repaid its outstanding term loans of $200.0 million. As of September 30, 2021, the Company had no amounts outstanding under the 2014 Credit Facility and a $400.0 million undrawn revolving credit facility.
The 2014 Credit Facility contains customary r
epresentat
ions and warranties, and certain financial and nonfinancial covenants, including but not limited to maintaining minimum liquidity of $50.0 million, and certain limitations on liens and indebtedness. The Company was in compliance with all covenants associated with the 2014 Credit Facility as of September 30, 2021.
8. Commitments and Contingencies
Purchase Commitments
In December 2019, the Company entered into, and subsequently amended during December 2020, a minimum annual commitment to purchase cloud hosting services of at least $1.49 billion over six contract years, with an optional carryover period through June 30, 2029, in exchange for various discounts on such services. I
f the spend does not meet the minimum annual commitment each year or at the end of the term, the Company is obligated to make a return payment. If the difference is greater than $30.0 million for each of the first three contract years or $50.0 million for each of the contract years thereafter (“relief amounts”), the Company has the option to pay the respective relief amount for that year for services to be utilized in the future and the excess amount of the difference above the relief amount would be added to the minimum annual commitment of the following year through the end of the contract.
As of September 30, 2021, the Company had satisfied $34.0 million of its $167.0 million
commitment for the contract year ending June 30, 2022. 
 
16

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
In June 2020, the Company entered into an additional commitment to purchase at least $45.0 million of cloud hosting services over a period of five years commencing on June 1, 2020 and ending on May 31, 2025. If the spend commitment is not met at the end of the term, the Company is obligated to pay the full amount of the outstanding balance (“shortfall payment”). The shortfall payment may be applied as a prepayment against consumption during an additional twelve-month coverage period expiring on May 31, 2026, at which time any unused amount would be forfeited. As of September 30, 2021, the Company had satisfied $8.0 million of its commitment.
Investment Commitments
The Company approved and entered into certain Investment Agreements with Investees, as further discussed in
Note 4. Investments and Fair Value Measurements - Investments
.
As of September 30, 2021, the Company had outstanding investment commitments, subject to the applicable terms and conditions, to purchase a total of 22.7 million shares for an aggregate purchase price of $226.5 million. The closings of certain of such Investments are contingent upon the completion of a proposed business combination between the applicable Investee and other applicable parties.
The following table presents details related to the Company’s investment commitments outstanding as of September 30, 2021 (in thousands):
 
Entity
  
Investment
Agreement Date
 
 
Committed
Share Amount
 
 
Committed
Investment Amount
Mobility company
(1)
     May 11, 2021        2,000   
 
$ 20,000
       
Wejo
     May 28, 2021        3,500   
 
  35,000
       
Babylon Health
(1) (2)
     June 3, 2021        3,500   
 
  35,000
       
Boxed
(
2
)
     June 13, 2021        2,000   
 
  20,000
       
Pear Therapeutics
     June 21, 2021        1,000   
 
  10,000
       
Autonomous vehicle company
(
2
)
     June 22, 2021        1,800   
 
  18,000
       
Fast Radius
(
2
)
     July 18, 2021        2,000   
 
  20,000
       
Tritium
(
2
)
     July 27, 2021        1,500   
 
  15,000
       
AdTheorent
(
2
)
     July 27, 2021        1,500   
 
  15,000
       
FinAccel
     August 2, 2021        1,000   
 
  10,000
       
Energy Vault
(
2
)
     September 8, 2021       
850
  
 
  8,500
       
Electric vehicle charging company
(
2
)
     September 10, 2021        2,000   
 
  20,000
             
 
 
  
 
 
 
Total
              22,650   
 
$ 226,500
             
 
 
  
 
 
 
 
 
(1)
The Company’s investment closed after September 30, 2021. See further discussion in
Note 14. Subsequent Events
.
(2)
 
Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.
Litigation and Legal Proceedings
From time to time, third parties may assert patent infringement claims against the Company. In addition, from time to time, the Company may be subject to other legal proceedings and claims in the ordinary course of business, including claims of alleged infringement of trademarks, copyrights, and other intellectual property rights; employment claims; securities claims; investor claims; corporate claims; class action claims; and general contract, tort, or other claims. The Company may from time to time also be subject to various legal or government claims, disputes, or investigations. Such matters may include, but not be limited to, claims, disputes, allegations, or investigations related to warranty; refund; breach of contract; breach, leak, or misuse of personal data or confidential information; employment; government procurement; intellectual property; government regulation or compliance (including but not limited to anti-corruption requirements, export or other trade controls, data privacy or data protection, cybersecurity requirements, or antitrust/competition law requirements); securities; investor; corporate; or other matters. The Company is unable to predict whether or when any such matters may arise, the outcome of these matters, or the ultimate legal and financial liability, and cannot reasonably estimate the possible loss or range of loss at this time and accordingly has not accrued a related liability.
 
17

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
On December 14, 2017, members of KT4 Partners LLC (Managing Member Marc Abramowitz) and Sandra Martin Clark, as trustee for the Marc Abramowitz Irrevocable Trust Number 7 (together, “KT4 Plaintiffs”), filed an action in the Delaware Superior Court against the Company and Disruptive Technology Advisers LLC. The complaint alleges tortious interference with prospective economic advantage and civil conspiracy in connection with a potential sale of stock by the KT4 Plaintiffs to a third party. The KT4 Plaintiffs seek compensatory and punitive damages, interest, fees, and costs.
The Company believes this lawsuit is without merit and is vigorously defending itself against it. Given the uncertainty of litigation, it may be reasonably possible that the Company will incur a loss with regards to the matter; however, it cannot currently estimate a range of possible losses. Accordingly, the Company is unable, at this time, to estimate the overall effects that may result from the lawsuit on its financial condition, results of operations, or cash flows.
As of September 30, 2021, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that were expected to have a material adverse impact on its condensed consolidated financial statements.
Letters of Credit and Guarantees
The Company had irrevocable standby letters of credit and guarantees, including bank guarantees, outstanding in the amounts of $88.1 million and $116.8 million as of September 30, 2021 and December 31, 2020, respectively, all of which were fully collateralized. The Company is required to maintain these letters of credit and guarantees primarily for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. As of September 30, 2021, these letters of credit and guarantees had expiration dates through August 2028.
Warranties and Indemnification
The Company generally provides a warranty for its software products and services and a service level agreement (“SLA”) for the Company’s performance of software operations via its operations and maintenance (“O&M”) services to its customers. The Company’s products are generally warranted to perform substantially as described in the associated product documentation during the subscription term or for a period of up to 90 days where the software is hosted by the customer; and the Company includes O&M services as part of its subscription and license agreements to support this warranty and maintain the operability of the software. The Company’s services are generally warranted to be performed in a professional manner and by an adequate staff with knowledge about the products. In the event there is a failure of such warranties, the Company generally is obligated to correct the product or service to conform to the warranty provision, as set forth in the applicable SLA, or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product and service (generally prorated over the contract term). Due to the absence of historical warranty claims, the Company’s expectations of future claims related to products under warranty continue to be insignificant. The Company has not recorded warranty expense or related accruals as of September 30, 2021 and December 31, 2020.
The Company generally agrees to indemnify its customers against legal claims that the Company’s software products infringe certain third-party intellectual property rights and accounts for its indemnification obligations. In the event of such a claim, the Company is generally obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of an infringement, the Company generally agrees to secure the right for the customer to continue using the infringing product; to modify or replace the infringing product; or, if those options are not commercially practicable, to refund the cost of the software, as prorated over the period. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers and does not believe that the Company will be liable for such claims in the foreseeable future. As such, the Company has not recorded a liability for infringement costs as of September 30, 2021 and December 31, 2020.
The Company has obligations under certain circumstances to indemnify each of the defendant directors and certain officers against judgments, fines, settlements, and expenses related to claims against such directors and certain officers and otherwise to the fullest extent permitted under the law and the Company’s bylaws and Amended and Restated Certificate of Incorporation.
9. Stockholders’ Equity
The Company’s Class A, Class B, and Class F common stock (collectively, the “common stock”) all have the same rights, except with respect to voting and conversion rights. Class A and Class B common stock have voting rights of 1 and 10 votes per share, respectively. The Class F common stock has the voting rights generally described below and each share of Class F common stock is convertible at any time, at the option of the holder thereof, into one share of Class B common stock. All shares of Class F common stock are held in a voting trust established by Stephen Cohen, Alexander Karp, and Peter Thiel (the “Founders”). The Class F common stock generally gives the Founders the ability to control up to 49.999999% of the total voting power of the Company’s capital stock, so long as the Founders and certain of their affiliates collectively meet a minimum ownership threshold, which was 100 million of the Company’s equity securities as of September 30, 2021.
 
18

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
Holders of common stock are entitled to dividends when, as and if declared by the Company’s Board of Directors, subject to the rights of the holders of all classes of stock outstanding having priority rights to dividends. No dividends have been declared as of September 30, 2021.
In connection with the Company’s direct listing of its Class A common stock on the New York Stock Exchange (“Direct Listing”) in September 2020, all outstanding shares of redeemable convertible preferred stock and convertible preferred stock were converted into 4,017,378 and 793,725,807 shares of Class B common stock, respectively, and 1,005,000 shares of Class B common stock held by the Founders were exchanged for an equal number of shares of Class F common stock.
The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands):
 
 
 
As of September 30, 2021
 
 
As of December 31, 2020
 
 
 
Authorized
 
 
Issued and
Outstanding
 
 
Authorized
 
 
Issued and
Outstanding
 
Common stock:
                       
         
Class A
    20,000,000       1,900,441       20,000,000       1,542,058  
         
Class B
    2,700,000       89,672       2,700,000       249,077  
         
Class F
    1,005       1,005       1,005       1,005  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
    22,701,005       1,991,118       22,701,005       1,792,140  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10. Stock-Based Compensation
Stock Options
The following table summarizes stock option activity for the nine months ended September 30, 2021 (in thousands, except per share amounts):
 
 
 
Options

Outstanding
 
Weighted-

Average

Exercise Price

Per Share
 
 
Weighted-

Average

Remaining

Contractual

Life (years)
 
 
Aggregate

Intrinsic Value
 
Balance as of December 31, 2020
    535,767     $ 6.12       7.99     $ 9,340,245    
         
Options exercised
    (155,720     3.05                  
         
Options canceled and forfeited
    (5,518     5.26                  
   
 
 
 
                       
         
Balance as of September 30, 2021
                  374,529     $ 7.40       8.82     $ 6,230,308    
   
 
 
 
                       
Options vested and exercisable as of September 30, 2021
    182,617     $ 4.48       7.08     $ 3,571,719    
   
 
 
 
                       
As of September 30, 2021, the unrecognized expense related to options outstanding was $940.0 million, which is expected to be recognized over a weighted-average service period of eight years.
 
19

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
RSUs
The following table summarizes the RSU activity for the nine months ended September 30, 2021 (in thousands, except per share amounts):
 
 
  
RSUs
Outstanding
 
 
Weighted Average
Grant Date Fair
Value per Share
Unvested and outstanding as of December 31, 2020
     184,870        $ 6.97   
     
RSUs granted
     25,093        24.01   
     
RSUs vested
     (37,123      8.17   
     
RSUs canceled
     (6,807      8.18   
    
 
 
 
        
Unvested and outstanding as of September 30, 2021
     166,033        $ 9.22   
    
 
 
 
        
As of September 30, 2021, the total unrecognized stock-based compensation expense related to the RSUs outstanding was $985.1 million, which
the
Company expects to recognize over three years.
Growth Units
In May 2019, the Company granted growth units which vest upon the satisfaction of both a performance-based vesting condition, which was satisfied upon the Company’s Direct Listing, and a service-based vesting condition, which was satisfied in March 2021. In March 2021, the 3.6 million outstanding growth units vested and, per the formula applicable to the awards, converted into 1.5 million shares of common stock. During the three months ended March 31, 2021, the Company recognized the remaining stock-based compensation expense related to the growth units of $1.2 million.
Stock-based Compensation Expense
Total stock-based compensation expense was as follows (in thousands):
 
  
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
  
2021
 
2020
 
2021
 
2020
Cost of revenue
    $ 14,860      $ 94,385      $ 54,866      $ 120,285  
         
Sales and marketing
     57,124       263,958       186,418       322,353  
         
Research and development
     34,472       256,769       122,976       309,698  
         
General and administrative
     78,379       231,847       247,048       276,578  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total stock-based compensation expense
(1)
   $ 184,835     $ 846,959     $ 611,308     $ 1,028,914  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
 
On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date.
11. Income Taxes
The Company recorded a provision for income taxes of $1.4 million and a benefit
from
income taxes of $8.5 million for the three months ended September 30, 2021 and 2020, respectively, and
a
benefit 
from
income taxes of $1.1 million and $5.0 million for the nine months ended September 30, 2021 and 2020, respectively. The Company is subject to income tax in the U.S. as well as other tax jurisdictions in which it conducts business. The Company’s effective rate differs from the U.S. statutory rate primarily due to the valuation allowance recorded on its losses from the U.S. and other jurisdictions, foreign income taxed at different rates,
non-deductible
stock-based compensation and the revaluation of its United Kingdom (“UK”) deferred tax assets as a result of a change in the UK corporate tax rate enacted during the second quarter of 2021, which increased the rate from 19% to 25% effective April 1, 2023.
The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. The Company assesses its ability to realize the deferred tax assets on a quarterly basis, and it establishes a valuation allowance if it is
more-likely-than-not
that some portion of the deferred tax assets will not be realized. The Company weighs all available positive and negative evidence, including its earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies. For example, due to the weight of objectively verifiable negative evidence, including its history of losses in certain jurisdictions, the Company believes that it is more likely than not that its U.S. federal and state deferred tax assets will not be fully realized. Accordingly, the Company has maintained a valuation allowance on its U.S. federal and state deferred tax assets.
 
20

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
12. Net Loss Per Share Attributable to Common Stockholders
The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):
 
 
  
Three Months Ended

September 30,
 
Nine Months Ended

September 30,
 
  
2021
 
2020
 
2021
 
2020
Numerator
                                
         
Net loss attributable to common stockholders
   $ (102,137   $ (853,319   $ (364,191   $ (1,018,048
         
Less: Change in fair value attributable to participating securities
                       (5,483
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
Net loss attributable to common stockholders, for diluted net loss per share
   $ (102,137   $ (853,319   $ (364,191   $ (1,023,531
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator
                                
         
Weighted-average shares used in computing net loss per share, basic
     1,964,395       905,462       1,893,911       713,879  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average shares used in computing net loss per share, diluted
     1,964,395       905,462       1,893,911       716,027  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
Net loss per share
                                
         
Net loss per share attributable to common stockholders, basic
   $ (0.05   $ (0.94   $ (0.19   $ (1.43
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
Net loss per share attributable to common stockholders, diluted
   $ (0.05   $ (0.94   $ (0.19   $ (1.43
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands):
 
 
 
As of September 30,
 
 
        2021        
 
        2020        
Warrants to purchase common stock
     13,042        19,068
Options and Stock Appreciation Rights issued and outstanding
     374,555        587,977
RSUs outstanding
     166,033        199,655
Growth units outstanding
            3,583
    
 
 
 
  
 
 
Total
     553,630        810,283
    
 
 
 
  
 
 
13. Segment and Geographic Information
The following tables reflect the results of the Company’s reportable operating segments consistent with the manner in which the chief operating decision maker (“CODM”) evaluates the performance of each segment and allocates the Company’s resources. The CODM does not evaluate the performance of the Company’s assets on a segment basis for internal management reporting and, therefore, such information is not presented.
Contribution is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. A segment’s contribution is calculated as segment revenue less the related costs of revenue and sales and marketing expenses. It excludes certain operating expenses that are not allocated to segments because they are separately managed at the consolidated corporate level. These unallocated costs include stock-based compensation expense, research and development expenses, and general and administrative expenses.
 
21

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
Financial information for each reportable segment was
as
follows (in thousands):
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2021
 
2020
 
2021
 
2020
Revenue:
                                   
Government
   $ 217,836      $ 162,561      $ 658,375      $ 420,257  
Commercial
     174,310        126,805        450,647        350,325  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Total revenue
   $ 392,146      $ 289,366      $ 1,109,022      $   770,582  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2021
 
2020
 
2021
 
2020
Contribution:
                                   
Government
   $ 125,706      $ 93,962      $ 400,705      $ 226,186  
Commercial
     98,177        69,496        245,841        168,908  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Total contribution
   $ 223,883      $ 163,458      $    646,546      $   395,094  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
The reconciliation of contribution to loss from operations is as follows (in thousands):
 
 
  
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
  
2021
 
2020
 
2021
 
2020
Loss from operations
  
$
(91,941)
 
 
$
(847,777)
 
 
$
(352,103)
 
 
$
(1,017,107)
 
Research and development expenses
(1)
  
 
59,844 
   
 
57,146
   
 
180,335
   
 
156,832
 
General and administrative expenses
(1)
  
 
71,145 
   
 
107,130
   
 
207,006
   
 
226,455
 
Stock-based compensation expense
  
 
184,835 
   
 
846,959
   
 
611,308
   
 
1,028,914
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total contribution
  
$
223,883 
   
$
163,458
   
$
646,546
   
$
395,094
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
Excludes stock-based compensation expense.
Geographic Information
Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages):
 
                           
                           
                           
                           
 
  
Three Months Ended September 30,
 
  
2021
 
2020
 
  
Amount
 
%
 
Amount
 
%
Revenue:
                                  
United States
  
 $
227,285
    
 
58
 
 $
156,336
    
 
54
United Kingdom
  
 
47,914
    
 
12
 
 
35,432
    
 
12
Rest of world
(1)
  
 
116,947
    
 
30
 
 
97,598
    
 
34
    
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
Total revenue
  
 $
            392,146
    
 
                100
 
 $
          289,366
    
 
                    100
    
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
(1)
No other country represents 10% or more of total revenue for the three months ended September 30, 2021 or 2020.
 
22

Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
 
                         
                         
                         
                         
 
  
Nine Months Ended September 30,
 
  
2021
 
2020
 
  
Amount
 
%
 
Amount
 
%
Revenue:
                                  
United States
  
 $
625,662
    
 
56
 
 $
391,106
    
 
51
United Kingdom
  
 
122,234
    
 
11
 
 
94,440
    
 
12
France
  
 
61,558
    
 
6
 
 
78,572
    
 
10
Rest of world
(1)
  
 
299,568
    
 
27
 
 
206,464
    
 
27
    
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
Total revenue
  
 $
            1,109,022
    
 
                  100
 
 $
            770,582
    
 
                    100
    
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
(1)
No other country represents 10% or more of total revenue for the nine months ended September 30, 2021 or 2020.
14. Subsequent Events
Investment Commitments and Investments
The Company approved and entered into additional Investment Agreements from October 1, 2021 through the date of this filing. As of the date of this filing, the Company had additional outstanding investment commitments, subject to applicable terms and conditions, to purchase a total of 2.6 million shares for an aggregate purchase price of $26.0 million.
The following table presents details regarding the Company’s additional investment commitments outstanding as of the date of this filing (in thousands):
 
Entity
 
Investment Agreement
Date
 
Committed
Share Amount
 
 
Committed
Investment Amount
Telecommunications company (1)
  October 6, 2021     1,600     $ 16,000
Rigetti & Co, Inc.
(1)
  October 6, 2021     1,000       10,000
       
 
 
   
 
 
Tota
l
        2,600     $ 26,000
       
 
 
   
 
 
 
 
(1)
Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.
In connection with signing each of the Investment Agreements entered into between October 1, 2021 and the date of this filing, each Investee or an associated entity and the Company entered into a commercial contract for the Company’s products and services. The maximum potential revenue from these commercial contracts, including option years, is $26.0 million, and the terms of such agreements range from three to four years.
Additionally, from October 1 to the date of this filing, the Company purchased 5.5 million shares for an aggregate purchase price of $55.0 million, as set forth in the following table (in thousands):
 
Entity
  
Share Amount
 
  
Investment Amount
Babylon Health
(1)
    3,500     $ 35,000
Mobility company
(1)
    2,000       20,000
   
 
 
   
 
 
Total
 
 
5,500
    $ 55,000
   
 
 
   
 
 
 
 
(1)
Reflected as commitments in
Note 8. Commitments and Contingencies
- Investment Commitments
as of September 30, 2021.
23

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form
10-Q
contains forward-looking statements within the meaning of the federal securities laws, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “would,” “intend,” “target,” “goal,” “outlook,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Forward-looking statements contained in this Quarterly Report on Form
10-Q
include, but are not limited to, statements about:
 
   
our expectations regarding financial performance and liquidity, including but not limited to our expectations regarding revenue, cost of revenue, operating expenses, stock-based compensation, our ability to achieve and maintain future profitability, and cash flows;
 
   
our ability to successfully execute our business and growth strategy;
 
   
the sufficiency of our cash and cash equivalents to meet our liquidity needs;
 
   
the demand for our platforms in general;
 
   
our ability to increase our number of customers and revenue generated from customers;
 
   
our expectations regarding the future contribution margin of our existing and future customers;
 
   
our expectations regarding our ability to quickly and effectively integrate our platforms for our existing and future customers;
 
   
our ability to develop new platforms, and enhancements to existing platforms, and bring them to market in a timely manner;
 
   
our market share, category positions, and market trends, including our ability to grow our business in large government and commercial organizations, including our expectations regarding the impact of Federal Acquisition Streamlining Act of 1994 (“FASA”);
 
   
our ability to compete with existing and new competitors in existing and new markets and products;
 
   
our expectations regarding anticipated technology needs and developments and our ability to address those needs and developments with our platforms;
 
   
our expectations regarding litigation and legal and regulatory matters;
 
   
our expectations regarding our ability to meet existing performance obligations and maintain the operability of our products;
 
   
our expectations regarding the effects of existing and developing laws and regulations, including with respect to taxation, privacy data protection, and cybersecurity;
 
   
our expectations regarding new and evolving markets;
 
   
our ability to develop and protect our brand;
 
   
our ability to maintain the security and availability of our platforms;
 
   
our expectations and management of future growth;
 
   
our expectations concerning relationships with third parties, including our customers, equity method investment partners, and vendors;
 
   
our expectations regarding our recent investments in, and enterprise agreements with, various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities;
 
   
our ability to maintain, protect, and enhance our intellectual property;
 
   
our expectations regarding our multi-class stock and governance structure and the benefits thereof;
 
   
the impact of the ongoing
COVID-19
pandemic, including on our and our customers’, vendors’, and partners’ respective businesses and the markets in which we and our customers, vendors, and partners operate; and
 
   
the increased expenses associated with being a public company.
We caution you that the foregoing list may not contain all of the forward-looking statements made in this Quarterly Report on Form
10-Q.
 
24

You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form
10-Q
primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations, and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors, including those described in the section titled “
Risk Factors
” and elsewhere in this Quarterly Report on Form
10-Q.
Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all risks and uncertainties that could have an impact on any forward-looking statements contained in this Quarterly Report on Form
10-Q.
We cannot assure you that the results, events, and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events, or circumstances could differ materially from those described in such forward-looking statements.
Neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Moreover, the forward-looking statements made in this Quarterly Report on Form
10-Q
relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form
10-Q
to reflect events or circumstances after the date of this Quarterly Report on Form
10-Q
or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, restructurings, joint ventures, partnerships, channel sales relationships, or investments we may make.
In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form
10-Q,
and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.
 
25

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the accompanying notes thereto included elsewhere in this Quarterly Report on Form
10-Q.
This discussion contains forward-looking statements based upon current plans, expectations, and beliefs, involving risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements. You should review the section titled “Special Note Regarding Forward-Looking Statements” for a discussion of forward-looking statements and the section titled “Risk Factors” for a discussion of factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis and elsewhere in this Quarterly Report on Form
10-Q.
Our historical results are not necessarily indicative of the results that may be expected for any period in the future.
Overview
We founded the Company in 2003 to build software for use in counterterrorism operations.
In 2008, we released our first platform, Palantir Gotham (“Gotham”), for customers in the intelligence sector. Gotham enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants.
Defense agencies in the United States then began using Gotham to investigate potential threats and to help protect soldiers from improvised explosive devices. Today, the platform is widely used by government agencies in the United States and its allies. Our software is on the front lines, sometimes literally, and that means so are we.
We later began working with leading companies across industries, including companies in the energy, transportation, financial services, and healthcare sectors. In 2016, we released our second software platform, Palantir Foundry (“Foundry”), to address a common set of challenges that we saw at large companies.
Foundry is becoming a central operating system not only for individual institutions but also for entire industries.
In 2017, for example, our partnership with Airbus expanded into a platform for the aviation industry, and today connects data from more than one hundred airlines and 9,000 aircraft around the world.
We believe that every large institution faces challenges that our platforms were designed to address. Our focus in the near term is to build partnerships with institutions that have the leadership necessary to effect structural change within their organizations — to reconstitute their operations around data. Over the long term, we believe that every large institution in the markets we serve is a potential partner.
Our Business
For the three months ended September 30, 2021, we generated $392.1 million in revenue, reflecting a 36% growth rate from the three months ended September 30, 2020, when we generated $289.4 million in revenue. In the nine months ended September 30, 2021, we generated $1.1 billion in revenue, reflecting a 44% growth rate from the nine months ended September 30, 2020, when we generated $770.6 million in revenue.
Our operating results continued to improve when excluding stock-based compensation. In the three months ended September 30, 2021, we incurred losses from operations of $91.9 million, or adjusted income from operations of $116.1 million when excluding stock-based compensation and related employer payroll taxes. In the three months ended September 30, 2020, our losses from operations were $847.8 million, or adjusted income from operations of $73.1 million when excluding stock-based compensation, related employer payroll taxes, and
non-recurring
charges relating to the direct listing of our Class A common stock (“Direct Listing”) on the New York Stock Exchange (“NYSE”). In the nine months ended September 30, 2021, we incurred losses from operations of $352.1 million, or adjusted income from operations of $349.4 million when excluding stock-based compensation and related employer payroll taxes. In the nine months ended September 30, 2020, our losses from operations were $1.0 billion, or adjusted income from operations of $85.7 million when excluding stock-based compensation, related employer payroll taxes, and
non-recurring
charges relating to our Direct Listing.
In the three months ended September 30, 2021, our gross profit was $305.3 million, reflecting a gross margin of 78%, or 82% when excluding stock-based compensation. In the three months ended September 30, 2020, our gross profit was $140.0 million, reflecting a gross margin of 48%, or 81% when excluding stock-based compensation. In the nine months ended September 30, 2021, our gross profit was $857.2 million, reflecting a gross margin of 77%, or 82% when excluding stock-based compensation. In the nine months ended September 30, 2020, our gross profit was $488.5 million, reflecting a gross margin of 63%, or 79% when excluding stock-based compensation.
 
26

For more information about our income from operations, when excluding stock-based compensation, related employer payroll taxes, and non-recurring charges related to our Direct Listing; and gross profit and gross margin, when excluding stock-based compensation, as well as reconciliations from loss from operations and gross profit, see the section titled
“Non-GAAP
Reconciliations
” below.
Our Customers
We define a customer to be an organization from which we have recognized revenue during the trailing twelve month period. During the period ended September 30, 2021, we had 203 customers, including leading companies in various commercial sectors as well as government agencies around the world. During the period ended September 30, 2020, we had 142 customers.
For large government agencies, where a single institution has multiple divisions, units, or subsidiary agencies, each such division, unit, or subsidiary agency that enters into a separate contract with us and is invoiced as a separate entity is treated as a separate customer. For example, while the U.S. Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health are subsidiary agencies of the U.S. Department of Health and Human Services, we treat each of those agencies as a separate customer given that the governing structures and procurement processes of each agency are independent.
We have built lasting and significant customer relationships with some of the world’s leading government institutions and companies. Our average revenue per customer during the trailing twelve months ended September 30, 2021 and 2020 was $7.0 million. Our average revenue for the top twenty customers during the trailing twelve months ended September 30, 2021 was $41.3 million, which grew 35% from an average of $30.7 million from the top twenty customers during the trailing twelve months ended September 30, 2020.
Organizations in the commercial and government sectors face similar challenges when it comes to managing data, and we intend to expand our reach in both markets moving forward. In the nine months ended September 30, 2021, commercial customers accounted for 41% of our revenue while government agencies accounted for 59%. In the nine months ended September 30, 2021, we generated 56% of our revenue from customers in the United States and the remaining 44% from customers abroad.
Expansion of Access to Platforms
We have recently begun to expand access to our platforms to earlier stage companies, including startups, as we continue our outreach efforts to an increasingly broad swath of the potential market.
Our software platforms can now be installed and ready for use within hours. The speed with which our platforms can be deployed has significantly expanded the range of potential customers with which we plan on partnering over the long term. We anticipate that our reach among an increasingly broad set of customers, in both the commercial and government sectors, will accelerate moving forward. We believe that, as these new partners grow, we will grow with them.
We have also made a number of investments in companies whose businesses rely on the ability of their organizations to manage and analyze data effectively at scale. The companies in which we are investing include some of the most innovative organizations in their fields.
Our proximity to these businesses and the industries in which they are operating has enhanced, and is expected to continue enhancing, our own product and business development efforts, as we continue expanding access to our platforms to the broadest possible set of customers.
Coronavirus
(“COVID-19”)
Impact
As a result of
COVID-19,
we continue to take precautionary measures in order to minimize the risk of the virus to our employees, our customers, and the communities in which we operate, which included the suspension of all
non-essential
business travel of employees and the temporary closure of all of our major offices. Although the majority of our workforce worked remotely, there was minimal disruption in our ability to ensure the effective operation of our software platforms. As local situations permit, we continue to open our offices in at least a limited capacity and are allowing business travel to resume, while continuing to closely monitor the pandemic.
The economic consequences of the
COVID-19
pandemic have been challenging for certain of our customers and prospective customers. While the broader implications of the
COVID-19
pandemic on our results of operations and overall financial performance remain uncertain, the
COVID-19
pandemic has, to date, not had a material adverse impact on our results of operations. The economic effects of the pandemic and resulting societal changes are currently not predictable.
 
27

The pandemic has made clear to many of our customers that accommodating the extended timelines ordinarily required to realize results from implementing new software solutions is not an option during a crisis. As a result, customers are increasingly adopting our software, which can be ready in days, over internal software development efforts, which may take months or years.
We saw decreases in our travel and office-related expenditures, including during the temporary closures of our offices globally and reductions in related operating expenses, related to the ongoing pandemic. However, improvement of our contribution metric has also been driven by the expansion of existing customer accounts, improved sales efficiency, and the increasing deployment of centralized hosting and other software deployment infrastructure. While we expect our travel and office-related expenditures to increase moving forward, especially as we continue to open our offices, we do not expect such expenditures to return to their
pre-pandemic
levels, given that we have made significant investments in enabling employees to work with customers remotely.
See the section titled “
Risk Factors
” included elsewhere in this Quarterly Report on Form
10-Q,
and Annual Report on Form
10-K
for the year ended December 31, 2020, which was filed with the SEC on February 26, 2021, for further discussion of the possible impact of the
COVID-19
pandemic on our business.
Our Business Model
Our customers pay us to use the software platforms we have built.
Our business model with respect to acquiring and growing our accounts has three phases: (1) Acquire, (2) Expand, and (3) Scale. We categorize all customers into cohorts on December 31st each year.
Our decisions about which customer relationships require further investment may change over time, based on our assessment of the potential long-term value that our software can generate for them.
As a result, customers may move back and forth through phases, as relationship needs and our assessment of the merits of further investment change. We enter into initial pilots with customers, generally at our own expense and without a guarantee of future returns, in order to access a unique set of opportunities that others may pass over for lack of resources and shorter investment horizons.
Some customers may have a rapid Acquire phase followed by a long Expand phase. Others may skip the Expand phase altogether and move immediately into the Scale phase. We manage customers at the account level, not by industry or sector, so that we can optimize on the specific growth opportunities for each.
In 2020, we generated a total of $1.1 billion in revenue. Acquire phase customers cohorted as of December 31, 2020 generated $0.3 million in revenue in 2020. Expand phase customers cohorted as of December 31, 2020 generated $20.3 million in revenue in 2020. Scale phase customers cohorted as of December 31, 2020 generated $1.1 billion in revenue in 2020.
In the nine months ended September 30, 2021, customers cohorted as of December 31, 2020 generated a total of $1.1 billion in revenue.
New customers acquired during the nine months ended September 30, 2021 generated an additional $37.9 million in revenue and will be assigned a cohort as of December 31, 2021. A more detailed discussion of the three phases, for purposes of illustration of how we manage accounts across the business, follows below.
Acquire
We actively pursue discussions with existing and prospective customers in order to identify ways in which our software platforms can provide long-term value.
In the first phase, we typically acquire new opportunities with minimal risk to our customers through short-term pilot deployments of our software platforms at no or low cost to them. We believe in proving the value of our platforms to our customers. During these short-term pilots, we operate the accounts at a loss. We believe that our investments during this phase will drive future revenue growth.
 
28

We define a customer or potential customer as being in the Acquire phase if, as of the end of a calendar year, we have recognized less than $100,000 in revenue from the customer that respective year. Customers may make nominal payments in connection with the evaluation of our software that we do not consider material in evaluating the performance of our accounts.
We evaluate the success of customer accounts in the Acquire phase based on the revenue such accounts generate in the following year. In 2020, we generated $0.3 million in revenue from customers in the Acquire phase, which yielded a contribution loss of $36.8 million. In the nine months ended September 30, 2021, those same customers generated $15.6 million in revenue, which yielded a contribution loss of $7.1 million.
Expand
Our investment in this second phase is often significant as we seek to understand the principal challenges faced by our customers and ensure that our software delivers value and results.
We define a customer in the Expand phase as any customer from which we have recognized more than $100,000 in revenue in a calendar year and whose account had a negative contribution margin during the year at issue, as determined as of the end of the year. In this phase, we operate at a loss, as measured by contribution margin, in order to drive future revenue growth and margin expansion.
In 2020, we generated $20.3 million in revenue from customers that were in the Expand phase as of the end of that year, with a contribution margin of (159)%. In the nine months ended September 30, 2021, those same customers generated $62.1 million in revenue with a contribution margin of 45%.
Scale
As customer accounts mature, our investment costs relative to revenue generally decrease, while the value our software provides to our customer increases, often significantly, as usage of the platform increases across the customer’s operations. In this third phase, after having installed and configured the software across an entire enterprise, customers become more self-sufficient in their use of our platforms, including developing software and applications that run on top of our platforms, while still continuing to benefit from the support of our operations and maintenance (“O&M”) services.
We define a customer in the Scale phase as any customer from which we recognized more than $100,000 in revenue in a calendar year and whose account had a positive contribution margin during the year at issue, as determined as of the end of the year.
It is in the Scale phase of our partnerships with customers that we generally see contribution margin on particular accounts improve. In 2020, we generated $1.1 billion in revenue from customers in the Scale phase, with a contribution margin of 63%. In the nine months ended September 30, 2021, those same customers generated $993.4 million in revenue with a contribution margin of 64%.
We believe that our customers will move into the Scale phase over the long term. We also believe that contribution margin for Scale phase accounts will increase further as we become more efficient at deploying our software platforms across the entirety of our customers’ operations and at managing and operating our software.
Key Business Measure
In addition to the measures presented in our condensed consolidated financial statements, we use the following key
non-GAAP
business measure to help us evaluate our business, identify trends affecting our business, formulate business plans and financial projections, and make strategic decisions.
Contribution Margin
We believe that the revenue we generate relative to the costs we incur in order to generate such revenue is an important measure of the efficiency of our business. We define contribution margin as revenue less our cost of revenue and sales and marketing expenses, excluding stock-based compensation, divided by revenue. At the end of each year, we categorize each customer account into one of the three phases based on its revenue and contribution margin for that year.
 
29

Revenue is allocated to each customer account directly. The cost of revenue and sales and marketing costs include both the costs associated with the deployment and operation of our software as well as expenses associated with identifying new customers and expanding partnerships with existing ones. Our software engineers working with existing customers often manage the deployment and operation of our platforms as well as identify new ways that those platforms can be used. To calculate the contribution by customer, we allocate cost of revenue and sales and marketing expenses, excluding stock-based compensation, to an account pro rata based on headcount and time spent on the account during the period. To the extent certain costs or personnel are not directly assigned to a specific account, they are allocated pro rata based on total headcount staffed during such period. Direct costs, such as third-party cloud hosting services, are directly allocated to the account to which they relate.
Contribution margin, both across our business and on specific customer accounts, is intended to capture how much we have earned from customers after accounting for the costs associated with deploying and operating our software, as well as any sales and marketing expenses involved in acquiring and expanding our partnerships with those customers, including allocated overhead. We exclude stock-based compensation as it is a
non-cash
expense.
We believe that our contribution margin across the business and on specific customer accounts provides an important measure of the efficiency of our operations over time. We have included contribution margin because it is a key measure used by our management to evaluate our performance, and we believe that it also provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management team. Our calculation of contribution margin may differ from similarly titled measures, if any, reported by other companies. Contribution margin should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP.
For more information about contribution margin, including the limitations of this measure, and a reconciliation to loss from operations, see the section titled “
Non-GAAP
Reconciliations
” below.
Non-GAAP
Reconciliations
We use the
non-GAAP
measures contribution margin; gross profit and gross margin, excluding stock-based compensation; and adjusted income from operations, which excludes stock-based compensation, related employer payroll taxes, and
non-recurring
charges relating to our Direct Listing, to help us evaluate our business, identify trends affecting our business, formulate business plans and financial projections, and make strategic decisions. We exclude stock-based compensation, which is a
non-cash
expense, from these
non-GAAP
financial measures because we believe that excluding this item provides meaningful supplemental information regarding operational performance and provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management team. Additionally, we exclude expenses primarily related to our Direct Listing during the quarter ended September 30, 2020, as they are a
one-time
nonrecurring charge, and employer payroll taxes related to stock-based compensation, as it is difficult to predict and outside of our control.
Our definitions may differ from the definitions used by other companies and therefore comparability may be limited. In addition, other companies may not publish these or similar metrics. Further, these metrics have certain limitations, as they do not include the impact of certain expenses that are reflected in our condensed consolidated statement of operations. Thus, our
non-GAAP
contribution margin; gross profit and gross margin, excluding stock-based compensation; and adjusted income from operations should be considered in addition to, not as a substitute for, or in isolation from, measures prepared in accordance with GAAP.
We compensate for these limitations by providing reconciliations of these
non-GAAP
measures to the most comparable GAAP measures. We encourage investors and others to review our business, results of operations, and financial information in its entirety, not to rely on any single financial measure, and to view these
non-GAAP
measures in conjunction with the most directly comparable GAAP financial measures.
 
30

Contribution Margin
The following table provides a reconciliation of contribution margin for the three and nine months ended September 30, 2021 and 2020 (in thousands, except percentages):
 
    
Three Months Ended September 30,
 
Nine Months Ended September 30,
    
2021
 
2020
 
2021
 
2020
Loss from operations
   $ (91,941   $ (847,777   $ (352,103   $ (1,017,107
Add:
        
Research and development expenses
(1)
     59,844     57,146     180,335     156,832
General and administrative expenses
(1)
     71,145     107,130     207,006     226,455
Stock-based compensation
     184,835     846,959     611,308     1,028,914
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contribution
   $ 223,883   $ 163,458   $ 646,546   $ 395,094
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contribution margin
     57     56     58     51
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
Excludes stock-based compensation.
Gross Profit and Gross Margin, Excluding Stock-Based Compensation
The following table provides a reconciliation of gross profit and gross margin, excluding stock-based compensation for the three and nine months ended September 30, 2021 and 2020 (in thousands, except percentages):
 
   
Three Months Ended September 30,
 
Nine Months Ended September 30,
   
2021
 
2020
 
2021
 
2020
Gross profit
  $ 305,342   $   140,026   $   857,181   $      488,538
Add: stock-based compensation
    14,860     94,385     54,866     120,285
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross profit, excluding stock-based compensation
  $ 320,202   $ 234,411   $ 912,047   $ 608,823
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross margin, excluding stock-based compensation
    82     81     82     79
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted Income from Operations
The following table provides a reconciliation of adjusted income from operations, which excludes stock-based compensation, related employer payroll taxes, and
non-recurring
Direct Listing charges, for the three and nine months ended September 30, 2021 and 2020 (in thousands):
 
    
Three Months Ended September 30,
 
Nine Months Ended September 30,
    
2021
 
2020
 
2021
 
2020
Loss from operations
   $ (91,941   $ (847,777   $ (352,103   $ (1,017,107
Add: stock-based compensation
     184,835     846,959     611,308     1,028,914
Add: employer payroll taxes related to stock-based compensation
     23,215     20,172     90,214     20,172
Add:
non-recurring
Direct Listing charges
(1)
           53,737           53,737
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted income from operations
   $ 116,109   $ 73,091   $ 349,419   $ 85,716
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
Non-recurring
Direct Listing charges were primarily incurred during the quarter ended September 30, 2020 and were immaterial in other periods.
 
31

Components of Results of Operations
Revenue
We generate revenue from the sale of subscriptions to access our software in our hosted environment with O&M services (“Palantir Cloud”), software subscriptions in our customers’ environments with ongoing O&M services
(“On-Premises
Software”), and professional services.
Palantir Cloud
Our Palantir Cloud subscriptions grant customers the right to access the software functionality in a hosted environment controlled by Palantir and are sold together with stand-ready O&M services, as further described below. We promise to provide continuous access to the hosted software throughout the contract term. Revenue associated with Palantir Cloud subscriptions is generally recognized over the contract term on a ratable basis, which is consistent with the transfer of control of the Palantir services to the customer.
On-Premises
Software
Sales of our software subscriptions grant customers the right to use functional intellectual property, either on their internal hardware infrastructure or on their own cloud instance, over the contractual term and are also sold together with stand-ready O&M services. O&M services include critical updates and support and maintenance services required to operate the software and, as such, are necessary for the software to maintain its intended utility over the contractual term. Because of this requirement, we have concluded that the software subscriptions and O&M services, which together we refer to as our
On-Premises
Software, are highly interdependent and interrelated and represent a single distinct performance obligation within the context of the contract. Revenue is generally recognized over the contract term on a ratable basis.
Professional Services
Our professional services support the customers’ use of the software and include, as needed,
on-demand
user support, user-interface configuration, training, and ongoing ontology and data modeling support. Professional services contracts typically include the provision of
on-demand
professional services for the duration of the contractual term. These services are typically coterminous with a Palantir Cloud or
On-Premises
Software subscriptions. Professional services are
on-demand,
whereby we perform services throughout the contract period; therefore, the revenue is recognized over the contractual term.
Cost of Revenue
Cost of revenue primarily includes salaries, stock-based compensation expense, and benefits for personnel involved in performing O&M and professional services, as well as third-party cloud hosting services, allocated overhead, and other direct costs.
We expect that cost of revenue will increase in absolute dollars as our revenue grows and will vary from
period-to-period
as a percentage of revenue.
Sales and Marketing
Our sales and marketing efforts span all stages of our sales cycle, including personnel engaging with or executing pilots at new or existing customers. Sales and marketing costs primarily include salaries, stock-based compensation expense, and benefits for our sales force and personnel involved in executing on pilots and customer growth activities, as well as third-party cloud hosting services for our pilots, marketing and sales event-related costs, and allocated overhead. Sales and marketing costs are generally expensed as incurred.
We expect that sales and marketing expenses will increase in absolute dollars as we continue to invest in our potential and current customers, in growing our business, sales force, and enhancing our brand awareness.
Research and Development
Our research and development efforts are aimed at continuing to develop and refine our platforms, including adding new features and modules, increasing their functionality, and enhancing the usability of our platforms. Research and development costs primarily include salaries, stock-based compensation expense, and benefits for personnel involved in performing the activities to develop and refine our platforms, internal use third-party cloud hosting services and other
IT-related
costs, and allocated overhead. Research and development costs are expensed as incurred.
 
 
32

We plan to continue to invest in personnel to support our research and development efforts. As a result, we expect that research and development expenses will increase in absolute dollars for the foreseeable future as we continue to invest to support these activities.
General and Administrative
General and administrative costs include salaries, stock-based compensation expense, and benefits for personnel involved in our executive, finance, legal, human resources, and administrative functions, as well as third-party professional services and fees, and allocated overhead.
We expect that general and administrative expenses will increase in absolute dollars as we hire additional personnel and enhance our systems, processes, and controls to support the growth in our business as well as our increased compliance and reporting requirements as a public company.
Interest Income
Interest income consists primarily of interest income earned on our cash, cash equivalents, and restricted cash balances.
Interest Expense
Interest expense consists primarily of interest expense and commitment fees incurred under our credit facilities.
Other Income (Expense), Net
Other income (expense), net consists primarily of foreign currency exchange gains and losses, realized and unrealized losses from investments, and our share of income and losses from our equity method investments.
Change in Fair Value of Warrants
The change in the fair value of warrants consists of the net changes in the fair value of our liability classified warrants to purchase redeemable convertible and convertible preferred stock that were remeasured at the end of each reporting period. During September 2020, in connection with the Direct Listing, all of our outstanding preferred stock warrants were converted into common stock warrants, which resulted in the reclassification of the warrants liability to additional
paid-in
capital. As such, we do not expect additional charges related to the fair value of these warrants.
Provision (Benefit) for Income Taxes
Provision (benefit) for income taxes consists of income taxes related to foreign and state jurisdictions in which we conduct business and withholding taxes.
Segments
We have two operating segments, commercial and government, which were determined based on the manner in which the chief operating decision maker (“CODM”), who is our chief executive officer, manages our operations for purposes of allocating resources and evaluating performance. Various factors, including our organizational and management reporting structure and customer type, were considered in determining these operating segments.
Our operating segments are described below:
 
   
Commercial
: This segment primarily serves customers working in
non-government
industries.
 
   
Government
: This segment primarily serves customers that are agencies in the U.S. federal government and
non-U.S.
governments.
 
33

Segment profitability is evaluated based on contribution and contribution margin. Contribution is segment revenue less the related costs of revenue and sales and marketing expenses, excluding stock-based compensation expense. Contribution margin is contribution divided by revenue. To the extent costs of revenue or sales and marketing expenses are not directly attributable to a particular segment, they are allocated based upon headcount at each operating segment during the period. We use it, in part, to evaluate the performance of, and allocate resources to, each of our operating segments, which excludes certain operating expenses that are not allocated to operating segments because they are separately managed at the consolidated corporate level. These unallocated costs include stock-based compensation expense, research and development costs, and general and administrative costs, such as legal and accounting.
Results of Operations
The following table summarizes our condensed consolidated statements of operations data (in thousands):
 
    
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
    
2021
   
2020
   
2021
   
2020
Revenue
     $         392,146        $         289,366        $ 1,109,022        $         770,582   
Cost of revenue
(1)
     86,804        149,340        251,841        282,044   
  
 
 
   
 
 
   
 
 
   
 
 
 
Gross profit
     305,342        140,026        857,181        488,538   
Operating expenses:
        
Sales and marketing
(1)
     153,443        334,911        451,919        536,082   
Research and development
(1)
     94,316        313,915        303,311        466,530   
General and administrative
(1)
     149,524        338,977        454,054        503,033   
  
 
 
   
 
 
   
 
 
   
 
 
 
Total operating expenses
     397,283        987,803        1,209,284        1,505,645   
  
 
 
   
 
 
   
 
 
   
 
 
 
Loss from operations
     (91,941)         (847,777)         (352,103)         (1,017,107)    
Interest income
     379        494        1,127        4,312   
Interest expense
     (609)         (2,085)         (3,039)         (12,325)    
Change in fair value of warrants
     —          (9,201)         —          811   
Other income (expense), net
     (8,528)         (3,293)         (11,297)         1,218   
  
 
 
   
 
 
   
 
 
   
 
 
 
Loss before provision (benefit) for income taxes
     (100,699)         (861,862)         (365,312)         (1,023,091)    
Provision (benefit) for income taxes
     1,438        (8,543)         (1,121)         (5,043)    
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss
     $ (102,137)         $ (853,319)         $ (364,191)         $ (1,018,048)    
  
 
 
   
 
 
   
 
 
   
 
 
 
 
 
(1)
 
Includes stock-based compensation expense as follows (in thousands):
 
    
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
    
2021
   
2020
   
2021
   
2020
Cost of revenue
     $ 14,860        $ 94,385        $ 54,866        $         120,285   
Sales and marketing
     57,124        263,958        186,418        322,353   
Research and development
     34,472        256,769        122,976        309,698   
General and administrative
     78,379        231,847        247,048        276,578   
  
 
 
   
 
 
   
 
 
   
 
 
 
Total stock-based compensation expense
(i)
     $         184,835        $         846,959        $ 611,308        $ 1,028,914   
  
 
 
   
 
 
   
 
 
   
 
 
 
 
 
(i)
 
On September 30, 2020, in connection with the Direct Listing, we incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date.
 
34

The following table sets forth the components of our condensed consolidated statements of operations data as a percentage of revenue:
 
                                                                                           
    
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
    
2021
   
2020
   
2021
   
2020
Revenue
  
 
100%
 
 
 
100%
 
 
 
100%
 
 
 
100%
 
Cost of revenue
  
 
22   
 
 
 
52   
 
 
 
23   
 
 
 
37   
 
  
 
 
   
 
 
   
 
 
   
 
 
 
Gross profit
  
 
78   
 
 
 
48   
 
 
 
77   
 
 
 
63   
 
Operating expenses:
        
Sales and marketing
  
 
39   
 
 
 
116   
 
 
 
41   
 
 
 
70   
 
Research and development
  
 
24   
 
 
 
108   
 
 
 
27   
 
 
 
61   
 
General and administrative
  
 
38   
 
 
 
           117   
 
 
 
41   
 
 
 
64   
 
  
 
 
   
 
 
   
 
 
   
 
 
 
Total operating expenses
  
 
101   
 
 
 
341   
 
 
 
109   
 
 
 
           195   
 
  
 
 
   
 
 
   
 
 
   
 
 
 
Loss from operations
  
 
(23)  
 
 
 
(293)  
 
 
 
(32)  
 
 
 
(132)  
 
Interest income
  
 
—   
 
 
 
—   
 
 
 
        —   
 
 
 
1   
 
Interest expense
  
 
—   
 
 
 
(1)  
 
 
 
—   
 
 
 
(2)  
 
Change in fair value of warrants
  
 
—   
 
 
 
(3)  
 
 
 
—   
 
 
 
—   
 
Other income (expense), net
  
 
(3)  
 
 
 
(1)  
 
 
 
(1)  
 
 
 
—   
 
  
 
 
   
 
 
   
 
 
   
 
 
 
Loss before provision (benefit) for income taxes
  
 
(26)  
 
 
 
(298)
 
 
 
(33)  
 
 
 
(133)  
 
Provision (benefit) for income taxes
  
 
—   
 
 
 
(3)  
 
 
 
—   
 
 
 
(1)  
 
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss
  
 
        (26)%
 
 
 
(295)%
 
 
 
(33)%
 
 
 
(132)%
 
  
 
 
   
 
 
   
 
 
   
 
 
 
Comparison of the Three Months Ended September 30, 2021 and 2020
Revenue
 
                                                                                                                   
    
Three Months Ended September 30,
   
Change
 
    
2021
   
2020
   
Amount
   
%
Revenue:
        
Government
  
  $
            217,836  
 
  $
        162,561  
 
  $
     55,275  
 
 
          34%
 
Commercial
  
 
174,310  
 
 
126,805  
 
 
47,505  
 
 
37%
 
  
 
 
   
 
 
   
 
 
   
Total revenue
  
  $
392,146  
 
  $
289,366  
 
  $
102,780  
 
 
36%
 
  
 
 
   
 
 
   
 
 
   
Revenue increased by $102.8 million, or 36%, for the three months ended September 30, 2021 compared to the three months ended September 30, 2020. Revenue from government customers increased by $55.3 million, or 34%, for the three months ended September 30, 2021 compared to the three months ended September 30, 2020, primarily from customers in the United States. Of the increase, $53.4 million was from government customers existing as of December 31, 2020. Revenue from commercial customers increased by $47.5 million, or 37%, for the three months ended September 30, 2021 compared to the three months ended September 30, 2020. The increase is primarily due to an increase of $35.0 million from new customers that were not yet our customers as of December 31, 2020. Generally, increases in revenue from our existing customers are related to increased adoption of our products and services within their organizations.
Cost of Revenue and Gross Profit
 
                                                                                                           
    
Three Months Ended September 30,
   
Change
 
    
2021
   
2020
   
Amount
   
        %        
Cost of revenue
  
  $
86,804   
 
$
149,340   
 
  $
(62,536)  
 
 
 
(42)% 
 
Gross profit
  
 
305,342   
 
 
140,026   
 
 
    165,316   
 
 
118%  
 
Gross margin
  
 
    78%
 
 
 
48%
 
 
 
    30%
 
 
 
35

Cost of revenue for the three months ended September 30, 2021 decreased by $62.5 million, or 42%, compared to the three months ended September 30, 2020. The decrease was primarily due to decreases in personnel costs of $78.6 million, which included a decrease of $79.5 million in stock-based compensation expense primarily due to higher RSU expense in the prior period related to the recognition of cumulative stock-based compensation expense upon our Direct Listing. These decreases in personnel costs were partially offset by an increase of $13.2 million related to third-party cloud hosting services.
Our gross margin for the three months ended September 30, 2021 increased by 30% compared to the three months ended September 30, 2020. Gross margin increased primarily as a result of higher RSU expense in the prior period related to the recognition of cumulative stock-based compensation expense upon our Direct Listing and as a result of increased efficiencies in supporting revenue growth at our customer deployments, including investments in our platforms. This was partly offset by an increase in third-party cloud hosting services. For the three months ended September 30, 2021 and 2020, gross margin, excluding stock-based compensation, would have been 82% and 81%, respectively.
Operating Expenses
 
                                                                                                           
    
Three Months Ended September 30,
    
Change
 
    
2021
    
2020
    
Amount
    
        %        
Sales and marketing
  
  $
        153,443  
  
  $
334,911  
  
  $
      (181,468)  
 
  
 
(54)%  
 
Research and development
  
 
94,316  
  
 
313,915  
  
 
(219,599)  
 
  
 
(70)%  
 
General and administrative
  
 
149,524  
  
 
338,977  
  
 
(189,453)  
 
  
 
(56)%  
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Total operating expenses
  
  $
397,283  
  
  $
        987,803  
  
  $
(590,520)  
 
  
 
(60)%  
 
  
 
 
    
 
 
    
 
 
    
Sales and Marketing
Sales and marketing expenses decreased by $181.5 million, or 54%, for the three months ended September 30, 2021 compared to the three months ended September 30, 2020. The decrease was primarily driven by decreases in personnel costs of $199.2 million, which included a decrease of $206.8 million in stock-based compensation expense primarily due to higher RSU expense in the prior period related to the recognition of cumulative stock-based compensation expense upon our Direct Listing. These decreases in personnel costs were partially offset by an increase of $5.3 million in payroll costs due to an increase in headcount attributable to our sales and marketing functions, average cost per head, and commission payments. Additionally, there was an increase of $9.8 million in marketing costs.
Research and Development
Research and development expenses decreased by $219.6 million, or 70%, for the three months ended September 30, 2021 compared to the three months ended September 30, 2020. The decrease was primarily driven by decreases in personnel costs of $219.2 million, which included a decrease of $222.3 million in stock-based compensation expense primarily due to higher RSU expense in the prior period related to the recognition of cumulative stock-based compensation expense upon our Direct Listing.
General and Administrative
General and administrative expenses decreased by $189.5 million, or 56%, for the three months ended September 30, 2021 compared to the three months ended September 30, 2020. The decrease was primarily driven by decreases in personnel costs of $150.8 million, which included a decrease of $153.5 million in stock-based compensation expense primarily due to higher RSU expense in the prior period related to the recognition of cumulative stock-based compensation expense upon our Direct Listing. Additionally, there was a decrease of $44.1 million in legal and other consulting services primarily from
non-recurring
expenses related to our Direct Listing incurred in the third quarter of 2020, partially offset by an increase of $5.5 million from increased recruiting costs, cloud-based hosting costs, and allocated overhead.
Interest Income
 
                                                                          
    
Three Months Ended September 30,
    
Change
    
2021
    
2020
    
Amount
Interest income
  
  $
        379  
  
  $
        494   
  
  $
        (115)  
 
 
36

Interest income decreased by $0.1 million for the three months ended September 30, 2021 compared to the three months ended September 30, 2020 primarily due to a reduction in U.S. interest rates on interest earned from our cash, cash equivalents, and restricted cash.
Interest Expense
 
    
  Three Months Ended September 30,  
   
Change
    
2021
   
2020
   
Amount
Interest expense
     $             (609)         $       (2,085)       $             1,476   
Interest expense decreased by $1.5 million for the three months ended September 30, 2021 compared to the three months ended September 30, 2020. The decrease was primarily due to the full repayment of the outstanding debt balance during the second quarter of 2021.
Change in Fair Value of Warrants
 
    
  Three Months Ended September 30,  
   
Change
    
2021
   
2020
   
Amount
Change in fair value of warrants
     $             —          $       (9,201)         $         9,201   
During the three months ended September 30, 2020, the $9.2 million loss from the change in fair value of warrants was primarily driven by the increase in the fair value of our stock during the period. During the three months ended September 30, 2021, there were no outstanding liability classified warrants.
Other Income (Expense), Net
 
    
  Three Months Ended September 30,  
   
Change
    
      2021      
   
      2020      
   
    Amount    
Other income (expense), net
     $        (8,528)         $            (3,293)         $       (5,235)    
Other income (expense), net changed by $5.2 million for the three months ended September 30, 2021 compared to the three months ended September 30, 2020 primarily due to changes in realized and unrealized gains, net from foreign exchange transactions and unrealized losses, net from our investments in marketable securities.
Provision (Benefit) for Income Taxes
 
    
  Three Months Ended September 30,  
   
Change
    
      2021      
   
      2020      
   
    Amount    
Provision (benefit) for income taxes
     $         1,438       $            (8,543)       $             9,981  
We recorded a provision for income taxes of $1.4 million for the three months ended September 30, 2021 compared to a benefit from income taxes of $8.5 million for the three months ended September 30, 2020. The change was primarily due to the benefits from stock-based compensation windfalls and the revaluation of the UK deferred tax assets as a result of a change in the UK corporate tax rate recorded in the third quarter of 2020 but not in the current quarter.
 
37

Comparison of the Nine Months Ended September 30, 2021 and 2020
Revenue
 
   
Nine Months Ended September 30,
 
Change
   
2021
 
2020
 
Amount
 
        %        
Revenue:
       
Government
  $ 658,375   $ 420,257     $ 238,118     57%  
Commercial
    450,647     350,325     100,322     29%  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total revenue
  $ 1,109,022   $ 770,582     $ 338,440     44%  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue increased by $338.4 million, or 44%, for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020. Revenue from government customers increased by $238.1 million, or 57%, for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020, primarily from customers in the United States. Of the increase, $236.0 million was from government customers existing as of December 31, 2020. Revenue from commercial customers increased by $100.3 million, or 29%, for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020. Of such increase, $51.0 million is from customers existing as of December 31, 2020 and the remaining amount is from new customers acquired during the nine months ended September 30, 2021. Generally, increases in revenue from our existing customers are related to increased adoption of our products and services within their organizations.
Cost of Revenue and Gross Profit
 
   
Nine Months Ended September 30,
 
Change
   
2021
 
2020
 
Amount
 
       %       
Cost of revenue
  $ 251,841   $ 282,044   $ (30,203     (11 )%  
Gross profit
    857,181     488,538     368,643     75
Gross margin
    77     63     14  
Cost of revenue for the nine months ended September 30, 2021 decreased by $30.2 million, or 11%, compared to the nine months ended September 30, 2020. The decrease was primarily due to decreases in personnel costs of $63.1 million, which included a decrease of $65.4 million in stock-based compensation expense primarily due to higher RSU expense in the prior period related to the recognition of cumulative stock-based compensation expense upon our Direct Listing. These decreases in personnel costs were partially offset by increases of $27.8 million related to third-party cloud hosting services and $10.6 million related to other direct deployment costs and increased usage of field service representatives.
Our gross margin for the nine months ended September 30, 2021 increased by 14% compared to the nine months ended September 30, 2020. Gross margin increased primarily as a result of higher RSU expense in the prior period related to the recognition of cumulative stock-based compensation expense upon our Direct Listing and as a result of increased efficiencies in supporting revenue growth at our customer deployments, including investments in our platforms. This was partly offset by an increase in third-party cloud hosting services and direct deployment costs. For the nine months ended September 30, 2021 and 2020, gross margin, excluding stock-based compensation, would have been 82%.
Operating Expenses
 
   
Nine Months Ended September 30,
 
Change
   
2021
 
2020
 
Amount
 
        %        
Sales and marketing
  $ 451,919   $ 536,082   $ (84,163)       (16 )% 
Research and development
    303,311     466,530     (163,219)       (35 )% 
General and administrative
    454,054     503,033     (48,979)       (10 )% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total operating expenses
  $ 1,209,284   $ 1,505,645   $ (296,361)       (20 )% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sales and Marketing
Sales and marketing expenses decreased by $84.2 million, or 16%, for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020. The decrease was primarily driven by decreases in personnel costs of $100.8 million, which included a decrease of $135.9 million in stock-based compensation expense primarily due to higher RSU expense in the prior period related to the recognition of cumulative stock-based compensation expense upon our Direct Listing. These decreases in personnel costs were partially offset by increases of $24.8 million in employer payroll taxes primarily related to income from share-based payments and $13.1 million in payroll mainly due to an increase in headcount attributable to our sales and marketing functions, average costs per head, and commission payments. Additionally, there was an increase of $11.0 million in marketing costs.
 
38

Research and Development
Research and development expenses decreased by $163.2 million, or 35%, for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020. The decrease was primarily driven by decreases in personnel costs of $160.8 million, which included a decrease of $186.7 million in stock-based compensation expense primarily due to higher RSU expense in the prior period related to the recognition of cumulative stock-based compensation expense upon our Direct Listing. These decreases in personnel costs were partially offset by increases of $15.0 million related to payroll taxes primarily for income from share-based payments and $13.7 million in payroll related to increases in headcount attributable to our research and development functions and cost per head.
General and Administrative
General and administrative expenses decreased by $49.0 million, or 10%, for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020. The decrease was primarily driven by a decrease of $49.6 million in legal professional services primarily from
non-recurring
expenses related to our Direct Listing incurred in the third quarter of 2020, partially offset by an increase of $6.1 million from office related expenses. Additionally, there were decreases in personnel costs of $8.6 million, which included a decrease of $29.5 million in stock-based compensation expense primarily due to higher RSU expense in the prior period related to the recognition of cumulative stock-based compensation expense upon our Direct Listing. These decreases in personnel costs were partially offset by an increase of $16.8 million related to payroll taxes primarily for income from share-based payments.
Interest Income
 
    
Nine Months Ended September 30,
   
Change
    
        2021        
   
        2020        
   
    Amount    
Interest income
    $ 1,127       $ 4,312       $ (3,185)  
Interest income decreased by $3.2 million for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020 primarily due to a reduction in U.S. interest rates on interest earned from our cash, cash equivalents, and restricted cash.
Interest Expense
 
    
Nine Months Ended September 30,
   
Change
    
        2021        
   
        2020        
   
    Amount    
Interest expense
    $ (3,039)      $ (12,325)      $ 9,286   
Interest expense decreased by $9.3 million for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020. The decrease was primarily due to the full repayment of the outstanding debt balance during the second quarter of 2021.
Change in Fair Value of Warrants
 
    
Nine Months Ended September 30,
   
Change
    
        2021        
   
        2020        
   
    Amount    
Change in fair value of warrants
    $ —       $ 811       $ (811)  
During the nine months ended September 30, 2020, the $0.8 million gain from the change in fair value of warrants was primarily driven by the decrease of fair value of the underlying stock. During the nine months ended September 30, 2021, there were no outstanding liability classified warrants.
 
39

Other Income (Expense), Net
 
    
Nine Months Ended September 30,
   
Change
    
    2021    
   
    2020    
   
    Amount    
Other income (expense), net
     $             (11,297)         $                     1,218      $         (12,515)     
Other income (expense), net changed by $12.5 million for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020 primarily due to changes in realized and unrealized gains, net from foreign exchange transactions and unrealized losses, net for investments in marketable securities.
Benefit from Income Taxes
 
    
Nine Months Ended September 30,
   
Change
    
    2021    
   
    2020    
   
    Amount    
Benefit from income taxes
     $               (1,121)         $                   (5,043)        $             3,922    
We recorded a benefit from income taxes of $1.1 million for the nine months ended September 30, 2021 compared to a benefit from income taxes of $5.0 million for the nine months ended September 30, 2020. The change was primarily due to the benefits from stock-based compensation windfalls and the revaluations of the UK deferred tax assets as a result of a change in the UK corporate tax rate enacted during the third quarter of 2020 and the second quarter of 2021, which will be effective on April 1, 2023, offset by decreases in profits from our international operations.
Liquidity and Capital Resources
Historically, we primarily generated negative cash flows from operations and have financed our operations primarily through the sale of our equity securities, including proceeds from option exercises, and payments received from our customers. We believe our existing cash and cash equivalents and cash flows from operations will be sufficient to meet our working capital and capital expenditure needs for at least the next twelve months, as well as our short-term and long-term contractual obligations and commitments primarily consisting of operating lease commitments and
non-cancelable
purchase commitments related to third-party cloud hosting services.
As of September 30, 2021, our accumulated deficit balance was $5.3 billion, and our principal sources of liquidity were $2.3 billion of cash and cash equivalents, exclusive of additional restricted cash of $88.1 million. Cash and cash equivalents consist primarily of cash on deposit with banks as well as institutional money market funds. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees we are required to maintain for various purposes.
During April 2021, we repaid our outstanding term loans of $200.0 million. As of September 30, 2021, we had no outstanding balance under the 2014 Credit Facility and a $400.0 million revolving credit facility available and undrawn. For more information, see the section titled “
Management’s Discussion and Analysis of
Financial Condition and Results of Operations
Credit Facilities.
Our future capital requirements will depend on many factors, including, but not limited to the rate of our growth, our ability to attract and retain customers and their willingness and ability to pay for our products and services, and the timing and extent of spending to support our efforts to market and develop our products. Further, as of September 30, 2021, our approved investment commitments outstanding totaled $226.5 million, which are in addition to the investments we made during the period, and we may enter into future arrangements to acquire or invest in businesses, products, services, strategic partnerships, and technologies. As such, we may be required to seek additional equity or debt financing. In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all. If additional funds are not available to us on acceptable terms, or at all, our business, financial condition, and results of operations could be adversely affected.
 
40

The following table summarizes our cash flows for the periods indicated (in thousands):
 
    
Nine Months Ended September 30,
 
    
2021
   
2020
Net cash provided by (used in):
    
Operating activities
    $ 240,424      $ (278,320)  
Investing activities
     (216,039)         (9,975)  
Financing activities
     274,282        817,344 
Effect of foreign exchange on cash, cash equivalents, and restricted cash
     (3,638)         (678)  
  
 
 
   
 
 
 
Net increase in cash, cash equivalents, and restricted cash
    $ 295,029       $ 528,371 
  
 
 
   
 
 
 
Operating Activities
Net cash provided by operating activities was $240.4 million for the nine months ended September 30, 2021. The factors affecting our operating cash flows during this period were our net loss of $364.2 million, offset by
non-cash
charges of $656.1 million and changes in net operating assets and liabilities of $51.5 million. The
non-cash
charges primarily consisted of $611.3 million in stock-based compensation expense, $23.4 million in operating lease expense, $11.1 million in depreciation and amortization, $7.2 million in unrealized loss from marketable securities and $3.1 million in other operating activities. The net change in operating assets and liabilities were due to a net increase in assets of $31.4 million, primarily due to an increase of $15.4 million in accounts receivable, a net decrease of $20.0 million in deferred revenue and customer deposits due to increases in revenue recognized from amounts billed and collected in prior periods, and a net decrease of $22.8 million in operating lease liabilities due to payments on our operating leases, partially offset by an increase in accounts payable and accrued liabilities of $21.5 million due to timing of expense payments.
Net cash used in operating activities was $278.3 million for the nine months ended September 30, 2020. The factors affecting our operating cash flows during this period were our net loss of $1.0 billion, offset by
non-cash
charges of $1.1 billion and changes in net operating assets and liabilities of $331.9 million. The
non-cash
charges primarily consisted of $1.0 billion in stock-based compensation expense, $28.8 million in operating lease expense, and $10.3 million of depreciation and amortization. The net change in operating assets and liabilities were due to a net decrease of $171.1 million in deferred revenue and customer deposits due to increases in revenue recognized from amounts billed and collected in prior periods, a net increase in accounts payable and accrued liabilities of $12.8 million as a result of timing of payments to vendors accrued for in prior periods, and an increase in assets of $145.3 million primarily due to an increase in accounts receivable.
Investing Activities
Net cash used in investing activities was $216.0 million for the nine months ended September 30, 2021, which primarily consisted of purchases of marketable securities of $155.3 million, alternative investments of $50.9 million, and property and equipment of $6.8 million.
Net cash used in investing activities was $10.0 million for the nine months ended September 30, 2020, which primarily consisted of purchases of property and equipment.
Financing Activities
Net cash provided by financing activities was $274.3 million for the nine months ended September 30, 2021, which primarily consisted of $474.7 million of proceeds from the exercise of common stock options, partially offset by $200.0 million of payments on term loans.
Net cash provided by financing activities was $817.3 million for the nine months ended September 30, 2020, which primarily consisted of $942.5 million of net proceeds from the issuance of common stock, $199.4 million of net proceeds from borrowings under our credit facilities, and $79.5 million of proceeds from exercise of common stock options, partially offset by the repayments of debt of $400.0 million and $3.8 million net cash used for repurchases of common stock.
 
41

Credit Facilities
2014 Credit Facility
In October 2014, we entered into an unsecured revolving credit facility which has been subsequently amended (the “2014 Credit Facility”). The 2014 Credit Facility bears interest at the London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75% per annum, subject to certain adjustments, and incurs a commitment fee of 0.375% assessed on the daily average undrawn portion of revolving commitments. The 2014 Credit Facility is secured with substantially all of our assets.
During April 2021, we amended the credit facility to increase the total undrawn revolving credit facility to be $400.0 million and which also provides for an incremental loan facility for additional loans in an aggregate principal amount of up to $100.0 million with one or more existing or new lenders upon mutual agreement between us and such lenders. Upon amending the facility, we repaid the outstanding $200.0 million term loans. As of September 30, 2021, there were no amounts outstanding under the 2014 Credit Facility.
Contractual Obligations and Commitments
Our contractual obligations and commitments primarily consist of operating lease commitments for our facilities,
non-cancelable
purchase commitments related to third-party cloud hosting services, and commitments to invest in shares of various entities, certain of which are contingent upon certain business combinations. For additional information, refer to
Note 8. Commitments and Contingencies
and
Note 14. Subsequent Events
to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form
10-Q.
Except as already disclosed in
Note 8. Commitments and Contingencies
and
Note 14. Subsequent Events
in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form
10-Q,
there has been no other material change in our contractual obligations and commitments other than in the ordinary course of business since our fiscal year ended December 31, 2020. See our Annual Report on Form
10-K
for the year ended December 31, 2020, which was filed with the SEC on February 26, 2021, for additional information regarding our contractual obligations.
Off-Balance
Sheet Arrangements
We did not have, during the periods presented, any
off-balance
sheet financing arrangements or any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities, that were established for the purpose of facilitating
off-balance
sheet arrangements or other contractually narrow or limited purposes.
Critical Accounting Policies and Estimates
Our condensed consolidated financial statements and the accompanying notes thereto included elsewhere in this Quarterly Report on Form
10-Q
are prepared in accordance with GAAP. The preparation of condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from our estimates. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations, and cash flows will be affected.
There have been no material changes to our critical accounting policies and estimates as compared to the critical accounting policies and estimates discussed in the Annual Report on Form
10-K
for the year ended December 31, 2020, which was filed with the SEC on February 26, 2021.
Recent Accounting Pronouncements
For information on recently issued accounting pronouncements, refer to
Note
2. Significant Accounting Policies
in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form
10-Q.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to market risks in the ordinary course of our business, which primarily relate to fluctuations in the value of our investments, interest rates, foreign exchange, and inflation.
Market Risk
As of September 30, 2021, we had investments valued at $148.1 million in marketable securities. We may continue to make additional investments or sell the existing investments. These investments are often in early or growth stage companies that have minimal public trading history; as such the fair value of these investments may fluctuate depending on the financial outcome and prospects of the investees, as well as global market conditions including recent and ongoing volatility related to the impacts of
COVID-19.
We record gains or losses as the fair value of these investments changes and as we sell them. We anticipate additional volatility to our condensed consolidated statements of operations due to changes in market prices, and as such gains and losses are realized.
 
42

During the three and nine months ended September 30, 2021, net unrealized losses of $7.2 million related to marketable securities were recorded in other income (expense), net on the condensed consolidated statements of operations.
Interest Rate Risk
Our cash, cash equivalents, and restricted cash consist of cash, certificates of deposit, and money market funds. Our primary investment policy and strategies are focused on the preservation of capital and supporting our liquidity requirements. Other than the investments disclosed in
Note 4. Investments and Fair Value Measurements
and investment commitments disclosed in
Note
8. Commitments and Contingencies
and
Note
14. Subsequent Events
in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form
10-Q,
we have not entered into investments for trading or speculative purposes.
Due to the short-term nature of the financial instruments, we have not been exposed to, nor do we anticipate being exposed to, material risks due to changes in interest rates. A hypothetical 10% change in interest rates during any of the periods presented would not have had a material impact on our condensed consolidated financial statements. As of September 30, 2021, we had no debt outstanding.
Foreign Currency Exchange Risk
Our contracts with customers are primarily denominated in U.S. dollars, with a small amount denominated in foreign currencies. Our expenses are generally denominated in the currencies of the jurisdictions in which we conduct our operations, which are primarily in the United States, United Kingdom, and other European countries. Our results of current and future operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates, particularly changes in the Euro and GBP. Additionally, fluctuations in foreign currency exchange rates may cause us to recognize transaction gains and losses in our statement of operations. To date, foreign currency transaction gains and losses have not been material to our condensed consolidated financial statements, and we have not engaged in any foreign currency hedging transactions.
Inflation Risk
We do not believe that inflation has had a material effect on our business, results of operations, or financial condition.
 
43

ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our disclosure controls and procedures are designed to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Our management, with the participation and supervision of our Chief Executive Officer and our Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules
13a-15(e)
and
15d-15(e)
under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form
10-Q.
Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were, in design and operation, effective at a reasonable assurance level.
Changes in Internal Controls Over Financial Reporting
There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule
13a-15(d)
and
15d-15(d)
of the Exchange Act that occurred during the period covered by this Quarterly Report on Form
10-Q
that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on the Effectiveness of Controls
The effectiveness of any system of internal control over financial reporting, including ours, is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, in designing and evaluating the disclosure controls and procedures, management recognizes that any system of internal control over financial reporting, including ours, no matter how well designed and operated, can only provide reasonable, not absolute, assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business but cannot assure you that such improvements will be sufficient to provide us with effective internal control over financial reporting.
 
44

PART II - OTHER INFORMATION
 
ITEM 1.
LEGAL PROCEEDINGS
From time to time, we are subject to legal proceedings and claims arising in the ordinary course of business. Based on our current knowledge, we believe that the amount or range of reasonably possible losses will not, either individually or in the aggregate, have a material adverse effect on our business, results of operations, or financial condition.
The results of any litigation cannot be predicted with certainty, and an unfavorable resolution in any legal proceedings could materially affect our future business, results of operations, or financial condition. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.
For information on legal proceedings, refer to
Note 8. Commitments and Contingencies—Litigation and Legal Proceedings
in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form
10-Q.
 
ITEM 1A.
RISK FACTORS
Investing in our Class A common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information in this Quarterly Report on Form
10-Q,
including the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our condensed consolidated financial statements and accompanying notes, before making a decision to invest in our Class A common stock. Our business, financial condition, results of operations, or prospects could also be harmed by risks and uncertainties not currently known to us or that we currently do not believe are material. If any of the risks actually occur, our business, financial condition, results of operations, and prospects could be adversely affected. In that event, the trading price of our Class A common stock could decline, and you could lose part or all of your investment.
Risk Factor Summary
Our business is subject to numerous risks and uncertainties that you should consider before investing in our Class A common stock. These risks are described more fully below and include, but are not limited to, risks relating to the following:
 
 
we have incurred losses each year and we may not become profitable in the future;
 
 
we may not be able to sustain our revenue growth rate;
 
 
our sales efforts involve considerable time and expense and our sales cycle is often long and unpredictable;
 
 
a limited number of customers account for a substantial portion of our revenue;
 
 
our results of operations and our key business measures are likely to fluctuate significantly on a quarterly basis;
 
 
seasonality may cause fluctuations in our results of operations and position;
 
 
our platforms are complex and may have a lengthy implementation process;
 
 
we may not successfully develop and deploy new technologies to address the needs of our customers;
 
 
our platforms must operate with third-party products and services;
 
 
we may be unable to hire, retain, train, and motivate qualified personnel and senior management and deploy our personnel and resources to meet customer demand;
 
 
we may be unable to successfully build, expand, and deploy our marketing and sales organization;
 
 
we may not be able to maintain and enhance our brand and reputation;
 
 
unfavorable news or social media coverage may harm our reputation and business;
 
 
exclusive arrangements or unique terms with customers or partners may result in significant risks or liabilities to us;
 
45

 
we face intense competition in our markets;
 
 
we may be unable to maintain or properly manage our culture as we grow;
 
 
we may not enter into relationships with potential customers if we consider their activities to be inconsistent with our organizational mission or values;
 
 
joint ventures, channel sales relationships, platform partners, and strategic alliances may be unsuccessful;
 
 
we may not be successful in executing our strategy to increase our sales to larger customers;
 
 
breach of the systems of any third parties upon which we rely, our customers’ cloud or
on-premises
environments, or our internal systems or unauthorized access to data;
 
 
the
COVID-19
pandemic may continue to significantly affect our business and operations;
 
 
the market for our platforms and services may develop more slowly than we expect;
 
 
we have made and may continue to make strategic investments to support key business initiatives, including in privately-held and publicly-traded companies as well as alternative investments, and we may not realize a return on these investments;
 
 
issues raised by the use of artificial intelligence in our platforms may result in reputational harm or liability;
 
 
we depend on computing infrastructure of third parties and they may experience errors, disruption, performance problems, or failure;
 
 
we may fail to adequately obtain, maintain, protect, and enforce our intellectual property and other proprietary rights;
 
 
we may be subject to intellectual property rights claims;
 
 
there may be real or perceived errors, failures, defects, or bugs in our platforms;
 
 
we rely on the availability of third-party technology that may be difficult to replace or that may cause errors;
 
 
our business is subject to complex and evolving U.S. and
non-U.S.
laws and regulations regarding privacy, data protection and security, technology protection, and other matters;
 
 
our
non-U.S.
sales and operations subject us to additional risks and regulations;
 
 
we may encounter unfavorable outcomes in legal, regulatory, and administrative inquiries and proceedings;
 
 
we may fail to receive and maintain government contracts or there may be changes in the contracting or fiscal policies of the public sector;
 
 
the majority of our customer contracts may be terminated by the customer at any time for convenience and may contain other provisions permitting the customer to discontinue contract performance;
 
 
we may not realize the full value of our customer contracts;
 
 
there may be a decline in the U.S. and other government budgets, changes in spending or budgetary priorities, or delays in contract awards; and
 
 
the multi-class structure of our common stock, the Founder Voting Trust Agreement, and the Founder Voting Agreement concentrate voting power with certain stockholders, in particular, our Founders and their affiliates.
 
46

Risks Related to Our Business and Industry
We have incurred losses each year since our inception, we expect our operating expenses to increase, and we may not become profitable in the future.
We have incurred losses each year since our inception as reflected in our condensed consolidated statements of operations included elsewhere in this filing, and we may never achieve or maintain profitability. In addition, our operating expenses have increased over time. As we continue to expand our business, industry verticals, and the breadth of our operations, upgrade our infrastructure, hire additional employees, expand into new markets, invest in research and development, invest in sales and marketing, including expanding our sales organization and related sales-based payments that may come with such expansion, lease more real estate to accommodate our anticipated future growth, and incur costs associated with general administration, including expenses related to being a public company, we expect that our costs of revenue and operating expenses will continue to increase. To the extent we are successful in increasing our customer base, we may also incur increased losses because the costs associated with acquiring and growing our customers via our Acquire, Expand, and Scale business model and with research and development are generally incurred upfront, while our revenue from customer contracts is generally recognized over the contract term. Furthermore, our sales model often requires us to spend months and invest significant resources working with customers on pilot deployments at no or low cost to them, which may result in no or minimal future revenue. We may not be able to increase our revenue at a rate sufficient to offset increases in our costs of revenue and operating expenses in the near term or at all, which would prevent us from achieving or maintaining profitability in the future. Any failure by us to achieve, and then sustain or increase, profitability on a consistent basis could adversely affect our business, financial condition, and results of operations.
We may not be able to sustain our revenue growth rate in the future.
Although our revenue has increased in recent periods, there can be no assurances that revenue will continue to grow or do so at current rates, and you should not rely on the revenue of any prior quarterly or annual period as an indication of our future performance. Our revenue growth rate may decline in future periods. Many factors may contribute to declines in our revenue growth rate, including increased competition, slowing demand for our platforms from existing and new customers, a failure by us to continue capitalizing on growth opportunities, terminations of existing contracts or failure to exercise existing options by our customers, and the maturation of our business, among others. If our revenue growth rate declines, our business, financial condition, and results of operations could be adversely affected.
Our sales efforts involve considerable time and expense and our sales cycle is often long and unpredictable.
Our results of operations may fluctuate, in part, because of the intensive nature of our sales efforts and the length and unpredictability of our sales cycle. As part of our sales efforts, we invest considerable time and expense evaluating the specific organizational needs of our potential customers and educating these potential customers about the technical capabilities and value of our platforms and services. We often also provide our platforms to potential customers at no or low cost initially to them for evaluation purposes through short-term pilot deployments of our platforms in the Acquire phase of our business model, and there is no guarantee that we will be able to move customers from the Acquire phase into later phases. In addition, we currently have a growing but limited direct sales force, and our sales efforts have historically depended on the significant involvement of our senior management team. The length of our sales cycle, from initial demonstration of our platforms to sale of our platforms and services, tends to be long and varies substantially from customer to customer. Our sales cycle often lasts six to nine months but can extend to a year or more for some customers. Because decisions to purchase our platforms involve significant financial commitments, potential customers generally evaluate our platforms at multiple levels within their organization, each of which often have specific requirements, and typically involve their senior management.
Our results of operations depend on sales to enterprise customers, which make product purchasing decisions based in part or entirely on factors, or perceived factors, not directly related to the features of the platforms, including, among others, that customer’s projections of business growth, uncertainty about economic conditions (including as a result of the ongoing
COVID-19
pandemic), capital budgets, anticipated cost savings from the implementation of our platforms, potential preference for such customer’s internally-developed software solutions, perceptions about our business and platforms, more favorable terms offered by potential competitors, and previous technology investments. In addition, certain decision makers and other stakeholders within our potential customers tend to have vested interests in the continued use of internally developed or existing software, which may make it more difficult for us to sell our platforms and services. As a result of these and other factors, our sales efforts typically require an extensive effort throughout a customer’s organization, a significant investment of human resources, expense and time, including by our senior management, and there can be no assurances that we will be successful in making a sale to a potential customer. If our sales efforts to a potential customer do not result in sufficient revenue to justify our investments, our business, financial condition, and results of operations could be adversely affected.
 
47

Historically, existing customers have expanded their relationships with us, which has resulted in a limited number of customers accounting for a substantial portion of our revenue. If existing customers do not make subsequent purchases from us or renew their contracts with us, or if our relationships with our largest customers are impaired or terminated, our revenue could decline, and our results of operations would be adversely impacted.
We derive a significant portion of our revenue from existing customers that expand their relationships with us. Increasing the size and number of the deployments of our existing customers is a major part of our growth strategy. We may not be effective in executing this or any other aspect of our growth strategy.
Our top three customers together accounted for 25% and 28% of our revenue for the years ended December 31, 2020 and 2019, respectively, and 18% and 27% of our revenue for the nine months ended September 30, 2021 and 2020, respectively. Our top three customers by revenue, for the nine months ended September 30, 2021, have been with us for an average of five years as of September 30, 2021. Certain of our customers, including customers that represent a significant portion of our business, have in the past reduced their spend with us or terminated their agreements with us, which has reduced our anticipated future payments or revenue from these customers, and which has required us to refund some previously paid amounts to these customers. It is not possible for us to predict the future level of demand from our larger customers for our platforms and applications.
While we generally offer contract terms up to five years in length, our customers sometimes enter into shorter-term contracts, such as
one-year
subscriptions, which may not provide for automatic renewal and may require the customer to
opt-in
to extend the term. Our customers have no obligation to renew, upgrade, or expand their agreements with us after the terms of their existing agreements have expired. In addition, many of our customer contracts permit the customer to terminate their contracts with us with notice periods of varying lengths, generally three to six months. If one or more of our customers terminate their contracts with us, whether for convenience, for default in the event of a breach by us, or for other reasons specified in our contracts, as applicable; if our customers elect not to renew their contracts with us; if our customers renew their contractual arrangements with us for shorter contract lengths or for a reduced scope; or if our customers otherwise seek to renegotiate terms of their existing agreements on terms less favorable to us, our business and results of operations could be adversely affected. This adverse impact would be even more pronounced for customers that represent a material portion of our revenue or business operations.
Our ability to renew or expand our customer relationships may decrease or vary as a result of a number of factors, including our customers’ satisfaction or dissatisfaction with our platforms and services, the frequency and severity of software and implementation errors, our platforms’ reliability, our pricing, the effects of general economic conditions, competitive offerings or alternatives, or reductions in our customers’ spending levels. If our customers do not renew or expand their agreements with us or if they renew their contracts for shorter lengths or on other terms less favorable to us, our revenue may grow more slowly than expected or decline, and our business could suffer. Our business, financial condition, and results of operations would also be adversely affected if we face difficulty collecting our accounts receivable from our customers or if we are required to refund customer deposits.
Achieving renewal or expansion of deployments may require us to increasingly engage in sophisticated and costly sales efforts that may not result in additional sales. In addition, our customers’ decisions to expand the deployment of our platforms depends on a number of factors, including general economic conditions, the functioning of our platforms, the ability of our forward-deployed engineers to assist our customers in identifying new use cases, modernizing their data architectures, and achieving success with data-driven initiatives, and our customers’ satisfaction with our services. If our efforts to expand within our existing customer base are not successful, our business may suffer.
We may not realize the full deal value of our customer contracts, which may result in lower than expected revenue.
As of December 31, 2020, the total remaining deal value of the contracts that we had been awarded by, or entered into with, commercial and government customers, including existing contractual obligations and contractual options available to those customers, was $2.8 billion. Of our total remaining deal value, as of December 31, 2020, $1.5 billion was the remaining deal value of our contracts with commercial customers and $1.3 billion was the remaining deal value of our contracts with government customers.
The majority of these contracts are subject to termination for convenience provisions. Also, a majority of commercial contracts entered into in connection with our strategic investments are subject to termination, including for convenience in the event the proposed business combination is not completed. Additionally, the U.S. federal government is prohibited from exercising contract options more than one year in advance. As a result, there can be no guarantee that our customer contracts will not be terminated or that contract options will be exercised.
We historically have not realized all of the revenue from the full deal value of our customer contracts, and we may not do so in the future. This is because the actual timing and amount of revenue under contracts included are subject to various contingencies, including exercise of contractual options, customers not terminating their contracts, and renegotiation of contracts. In addition, delays in the completion of the U.S. government’s budgeting process, the use of continuing resolutions, and a potential lapse in appropriations, or similar events in other jurisdictions, could adversely affect our ability to timely recognize revenue under certain government contracts.
 
48

Our results of operations and our key business measures are likely to fluctuate significantly on a quarterly basis in future periods and may not fully reflect the underlying performance of our business, which makes our future results difficult to predict and could cause our results of operations to fall below expectations.
Our quarterly results of operations, including cash flows, have fluctuated significantly in the past and are likely to continue to do so in the future. Accordingly, the results of any one quarter should not be relied upon as an indication of future performance. Our quarterly results, financial position, and operations are likely to fluctuate as a result of a variety of factors, many of which are outside of our control, and as a result, may not fully reflect the underlying performance of our business. Fluctuation in quarterly results may negatively impact the value of our Class A common stock.
We typically close a large portion of our sales in the last several weeks of a quarter, which impacts our ability to plan and manage margins and cash flows. Our sales cycle is often long, and it is difficult to predict exactly when, or if, we will actually make a sale with a potential customer or when we will be able to move them to the Expand or Scale phases. As a result, large individual sales have, in some cases, occurred in quarters subsequent to those we anticipated, or have not occurred at all. The loss or delay of one or more large sales transactions in a quarter would impact our results of operations and cash flow for that quarter and any future quarters in which revenue from that transaction is lost or delayed. In addition, downturns in new sales may not be immediately reflected in our revenue because we generally recognize revenue over the term of our contracts. The timing of customer billing and payment varies from contract to contract. A delay in the timing of receipt of such collections, or a default on a large contract, may negatively impact our liquidity for the period and in the future. Because a substantial portion of our expenses are relatively fixed in the short-term and require time to adjust, our results of operations and liquidity would suffer if revenue falls below our expectations in a particular period.
Other factors that may cause fluctuations in our quarterly results of operations and financial position include, without limitation, those listed below:
 
 
The success of our sales and marketing efforts, including the success of our pilot deployments;
 
 
Our ability to increase our contribution margins and move our customers into the Expand or Scale phases;
 
 
The timing of expenses and revenue recognition;
 
 
The timing and amount of payments received from our customers;
 
 
Termination of one or more large contracts by customers, including for convenience;
 
 
The time and cost-intensive nature of our sales efforts and the length and variability of sales cycles;
 
 
The amount and timing of operating expenses related to the maintenance and expansion of our business and operations;
 
 
The timing and effectiveness of new sales and marketing initiatives;
 
 
Changes in our pricing policies or those of our competitors;
 
 
The timing and success of new products, features, and functionality introduced by us or our competitors;
 
 
Interruptions or delays in our operations and maintenance (“O&M”) services;
 
 
Cyberattacks and other actual or perceived data or security breaches;
 
 
Our ability to hire and retain employees, in particular, those responsible for operations and maintenance of and the selling or marketing of our platforms, and develop and retain talented sales personnel who are able to achieve desired productivity levels in a reasonable period of time and provide sales leadership in areas in which we are expanding our sales and marketing efforts;
 
49

 
The amount and timing of our stock-based compensation expenses;
 
 
Changes in the way we organize and compensate our sales teams;
 
 
Changes in the way we operate and maintain our platforms;
 
 
Unforeseen negative results in operations from our partnerships, including those accounted for under the equity method;
 
 
Changes in the competitive dynamics of our industry;
 
 
The cost of and potential outcomes of existing and future claims or litigation, which could have a material adverse effect on our business;
 
 
Changes in laws and regulations that impact our business, such as the Federal Acquisition Streamlining Act of 1994 (“FASA”);
 
 
Indemnification payments to our customers or other third parties;
 
 
Ability to scale our business with increasing demands;
 
 
The timing of expenses related to any future acquisitions; and
 
 
General economic, regulatory, and market conditions, including the impact of the
COVID-19
pandemic.
In addition, our contracts generally contain termination for convenience provisions, and we may be obligated to repay prepaid amounts or otherwise not realize anticipated future revenue should we fail to provide future services as anticipated. These factors make it difficult for us to accurately predict financial metrics for any particular period.
The variability and unpredictability of our quarterly results of operations, cash flows, or other operating metrics could result in our failure to meet our expectations or those of analysts that cover us or investors with respect to revenue or other key metrics for a particular period. If we fail to meet or exceed such expectations for these or any other reasons, the trading price of our Class A common stock could fall, and we could face costly lawsuits, including securities class action suits.
Seasonality may cause fluctuations in our results of operations and position.
Historically, the first quarter of our year generally has relatively lower sales, and sales generally increase in each subsequent quarter with substantial increases during our third and fourth quarters ending September 30 and December 31, respectively. We believe that this seasonality results from a number of factors, including:
 
 
The fiscal year end procurement cycle of our government customers, and in particular U.S. government customers which have a fiscal year end of September 30;
 
 
The fiscal year budgeting process for our commercial customers, many of which have a fiscal year end of December 31;
 
 
Seasonal reductions in business activity during the summer months in the United States, Europe, and certain other regions; and
 
 
Timing of projects and our customers’ evaluation of our work progress.
This seasonality has historically impacted and may in the future continue to impact the timing of collections and recognized revenue. Because a significant portion of our customer contracts are typically finalized near the end of the quarter, and we typically invoice customers shortly after entering into a contract, we may receive a portion of our customer payments near the end of the quarter and record such payment as an increase in contract liabilities, while the revenue from our customer contracts is generally recognized over the contract term. While we have historically billed and collected payments for multiple contract years from certain customers in advance, we have and may continue to shift to collecting payments on an annual or other basis.
While this has been the historical seasonal pattern of our quarterly sales, we believe that our customers’ required timing for certain new government or commercial programs requiring new software may outweigh the nature or magnitude of seasonal factors that might have influenced our business to date. As a result, we may experience future growth from additional government or commercial mandates that do not follow the seasonal purchasing and evaluation decisions by our customers that we have historically observed.
 
50

For example, increased government spending on technology aimed at national defense, financial or policy regulation, cybersecurity, or healthcare mandates may drive customer demand at different times throughout our year, the timing of which we may not be able to anticipate and may cause fluctuations in our results of operations. The timing of our fiscal quarters and the U.S. federal government’s September 30 fiscal year end also may impact sales to governmental agencies in the third quarter of our year, offsetting, at least in part, the otherwise seasonal downturn we have historically observed in later summer months.
Our rapid growth in recent years may obscure the extent to which seasonality trends have affected our business and may continue to affect our business. We expect that seasonality will continue to materially impact our business in the future and may become more pronounced over time. The seasonality of our business may cause continued or increased fluctuations in our results of operations and cash flows, which may prevent us from achieving our quarterly or annual forecasts or meeting or exceeding the expectations of research analysts or investors, which in turn may cause a decline in the trading price of our Class A common stock.
Our platforms are complex and may have a lengthy implementation process, and any failure of our platforms to satisfy our customers or perform as desired could harm our business, results of operations, and financial condition.
Our platforms and services are complex and are deployed in a wide variety of network environments. Implementing our platforms can be a complex and lengthy process since we often configure our existing platforms for a customer’s unique environment. Inability to meet the unique needs of our customers may result in customer dissatisfaction and/or damage to our reputation, which could materially harm our business. Further, the proper use of our platforms may require training of the customer and the initial or ongoing services of our technical personnel as well as O&M services over the contract term. If training and/or ongoing services require more of our expenditures than we originally estimated, our margins will be lower than projected.
In addition, if our customers do not use our platforms correctly or as intended, inadequate performance or outcomes may result. It is possible that our platforms may also be intentionally misused or abused by customers or their employees or third parties who obtain access and use of our platforms. Similarly, our platforms sometimes are used by customers with smaller or less sophisticated IT departments, potentially resulting in
sub-optimal
performance at a level lower than anticipated by the customer. Because our customers rely on our platforms and services to address important business goals and challenges, the incorrect or improper use or configuration of our platforms and O&M services, failure to properly train customers on how to efficiently and effectively use our platforms, or failure to properly provide implementation or analytical or maintenance services to our customers may result in contract terminations or
non-renewals,
reduced customer payments, negative publicity, or legal claims against us. For example, as we continue to expand our customer base, any failure by us to properly provide these services may result in lost opportunities for
follow-on
expansion sales of our platforms and services.
Furthermore, if customer personnel are not well trained in the use of our platforms, customers may defer the deployment of our platforms and services, may deploy them in a more limited manner than originally anticipated, or may not deploy them at all. If there is substantial turnover of the Company or customer personnel responsible for procurement and use of our platforms, our platforms may go unused or be adopted less broadly, and our ability to make additional sales may be substantially limited, which could negatively impact our business, results of operations, and growth prospects.
If we do not successfully develop and deploy new technologies to address the needs of our customers, our business and results of operations could suffer.
Our success has been based on our ability to design software and products that enable the integration of data into a common operating environment to facilitate advanced data analysis, knowledge management, and collaboration. We spend substantial amounts of time and money researching and developing new technologies and enhanced versions of existing features to meet our customers’ and potential customers’ rapidly evolving needs. There is no assurance that our enhancements to our platforms or our new product features, capabilities, or offerings, including new product modules, will be compelling to our customers or gain market acceptance. If our research and development investments do not accurately anticipate customer demand or if we fail to develop our platforms in a manner that satisfies customer preferences in a timely and cost-effective manner, we may fail to retain our existing customers or increase demand for our platforms.
The introduction of new products and services by competitors or the development of entirely new technologies to replace existing offerings could make our platforms obsolete or adversely affect our business, financial condition, and results of operations. We may experience difficulties with software development, design, or marketing that delay or prevent our development, introduction, or implementation of new platforms, features, or capabilities. We have in the past experienced delays in our internally planned release dates of new features and capabilities, and there can be no assurance that new platforms, features, or capabilities will be released according to schedule. Any delays could result in adverse publicity, loss of revenue or market acceptance, or claims by customers brought against us, any of which could harm our business. Moreover, the design and development of new platforms or new features and capabilities to our existing platforms may require substantial investment, and we have no assurance that such investments will be successful. If customers do not widely adopt our new platforms, experiences, features, and capabilities, we may not be able to realize a return on our investment and our business, financial condition, and results of operations may be adversely affected.
 
51

Our new and existing platforms and changes to our existing platforms could fail to attain sufficient market acceptance for many reasons, including:
 
 
Our failure to predict market demand accurately in terms of product functionality and to supply offerings that meet this demand in a timely fashion;
 
 
Product defects, errors, or failures or our inability to satisfy customer service level requirements;
 
 
Negative publicity or negative private statements about the security, performance, or effectiveness of our platforms or product enhancements;
 
 
Delays in releasing to the market our new offerings or enhancements to our existing offerings, including new product modules;
 
 
Introduction or anticipated introduction of competing platforms or functionalities by our competitors;
 
 
Inability of our platforms or product enhancements to scale and perform to meet customer demands;
 
 
Receiving qualified or adverse opinions in connection with security or penetration testing, certifications or audits, such as those related to IT controls and security standards and frameworks or compliance;
 
 
Poor business conditions for our customers, causing them to delay software purchases;
 
 
Reluctance of customers to purchase proprietary software products;
 
 
Reluctance of our customers to purchase products hosted by our vendors and/or service interruption from such providers; and
 
 
Reluctance of customers to purchase products incorporating open source software.
If we are not able to continue to identify challenges faced by our customers and develop, license, or acquire new features and capabilities to our platforms in a timely and cost-effective manner, or if such enhancements do not achieve market acceptance, our business, financial condition, results of operations, and prospects may suffer and our anticipated revenue growth may not be achieved.
Because we derive, and expect to continue to derive, substantially all of our revenue from customers purchasing our two platforms Gotham and Foundry, market acceptance of these platforms, and any enhancements or changes thereto, is critical to our success.
The competitive position of our platforms depends in part on their ability to operate with third-party products and services, and if we are not successful in maintaining and expanding the compatibility of our platforms with such third-party products and services, our business, financial condition, and results of operations could be adversely impacted.
The competitive position of our platforms depends in part on their ability to operate with products and services of third parties, software services, and infrastructure, including but not limited to, in connection with our joint ventures, channel sales relationships, platform partnerships, strategic alliances, and other similar arrangements where applicable. As such, we must continuously modify and enhance our platforms to adapt to changes in, or to be integrated or otherwise compatible with, hardware, software, networking, browser, and database technologies. In the future, one or more technology companies may choose not to support the operation of their hardware, software, or infrastructure, or our platforms may not support the capabilities needed to operate with such hardware, software, or infrastructure. In addition, to the extent that a third-party were to develop software or services that compete with ours, that provider may choose not to support one or more of our platforms. We intend to facilitate the compatibility of our platforms with various third-party hardware, software, and infrastructure by maintaining and expanding our business and technical relationships. If we are not successful in achieving this goal, our business, financial condition, and results of operations could be adversely impacted.
 
52

If we fail to manage future growth effectively, our business could be harmed.
Since our founding in 2003, we have experienced rapid growth. We operate in a growing market and have experienced, and may continue to experience, significant expansion of our operations. This growth has placed, and may continue to place, a strain on our employees, management systems, operational, financial, and other resources. As we have grown, we have increasingly managed larger and more complex deployments of our platforms and services with a broader base of government and commercial customers. As we continue to grow, we face challenges of integrating, developing, retaining, and motivating a rapidly growing employee base in various countries around the world. For example, our headcount has grown from 313 full-time employees as of December 31, 2010 to 2,733 full-time employees as of September 30, 2021, with employees located both in the United States and outside the United States. In the event of continued growth of our operations, our operational resources, including our information technology systems, our employee base, or our internal controls and procedures may not be adequate to support our operations and deployments. Managing our growth may require significant expenditures and allocation of valuable management resources, improving our operational, financial, and management processes and systems, and effectively expanding, training, and managing our employee base. If we fail to achieve the necessary level of efficiency in our organization as it grows, our business, financial condition, and results of operations would be harmed. As our organization continues to grow, we may find it increasingly difficult to maintain the benefits of our traditional company culture, including our ability to quickly respond to customers, and avoid unnecessary delays that may be associated with a formal corporate structure. This could negatively affect our business performance or ability to hire or retain personnel in the near- or long-term.
In addition, our rapid growth may make it difficult to evaluate our future prospects. Our ability to forecast our future results of operations is subject to a number of uncertainties, including our ability to effectively plan for and model future growth. We have encountered in the past, and may encounter in the future, risks and uncertainties frequently experienced by growing companies with global operations in rapidly changing industries. If we fail to achieve the necessary level of efficiency in our organization as it grows, or if we are not able to accurately forecast future growth, our business, financial condition, and results of operations would be harmed.
If we are unable to hire, retain, train, and motivate qualified personnel and senior management, including Alexander Karp, one of our founders and our Chief Executive Officer, and deploy our personnel and resources to meet customer demand around the world, our business could suffer.
Our ability to compete in the highly competitive technology industry depends upon our ability to attract, motivate, and retain qualified personnel. We are highly dependent on the continued contributions and customer relationships of our management and particularly on the services of Alexander Karp, our Chief Executive Officer. Mr. Karp was part of our founding team and has been integral to our growth since our founding. We believe that Mr. Karp’s management experience would be difficult to replace. All of our executive officers and many key personnel are
at-will
employees and may terminate their employment relationship with us at any time. The loss of the services of our key personnel and any of our other executive officers, and our inability to find suitable replacements, could result in a decline in sales, delays in product development, and harm to our business and operations.
At times, we have experienced, and we may continue to experience, difficulty in hiring and retaining personnel with appropriate qualifications, and we may not be able to fill positions in a timely manner or at all. Potential candidates may not perceive our compensation package, including our equity awards, as favorably as personnel hired prior to our listing. In addition, our recruiting personnel, methodology, and approach may need to be altered to address a changing candidate pool and profile. We may not be able to identify or implement such changes in a timely manner. In addition, we may incur significant costs to attract and recruit skilled personnel, and we may lose new personnel to our competitors or other technology companies before we realize the benefit of our investment in recruiting and training them. As we move into new geographies, we will need to attract and recruit skilled personnel in those geographic areas, but it may be challenging for us to compete with traditional local employers in these regions for talent. If we fail to attract new personnel or fail to retain and motivate our current personnel who are capable of meeting our growing technical, operational, and managerial requirements on a timely basis or at all, our business may be harmed.
In addition, certain personnel may be required to receive various security clearances and substantial training in order to work on certain customer engagements or to perform certain tasks. Necessary security clearances may be delayed or unsuccessful, which may negatively impact our ability to perform on our U.S. and
non-U.S.
government contracts in a timely manner or at all.
Our success depends on our ability to effectively source and staff people with the right mix of skills and experience to perform services for our customers, including our ability to transition personnel to new assignments on a timely basis. If we are unable to effectively utilize our personnel on a timely basis to fulfill the needs of our customers, our business could suffer. Further, if we are not able to utilize the talent we need because of increased regulation of immigration or work visas, including limitations placed on the number of visas granted, limitations on the type of work performed or location in which the work can be performed, and new or higher minimum salary requirements, it could be more difficult to staff our personnel on customer engagements and could increase our costs.
 
53

We face intense competition for qualified personnel, especially engineering personnel, in major U.S. markets, where a large portion of our personnel are based, as well as in other
non-U.S.
markets where we expect to expand our
non-U.S.
operations. We incur costs related to attracting, relocating, and retaining qualified personnel in these highly competitive markets, including leasing real estate in prime areas in these locations. Further, many of the companies with which we compete for qualified personnel have greater resources than we have. If the perceived value of our equity awards declines, or if the mix of equity and cash compensation that we offer is less attractive than that of our competitors, it may adversely affect our ability to recruit and retain highly skilled personnel. Additionally, laws and regulations, such as restrictive immigration laws, may limit our ability to recruit outside of the United States. We seek to retain and motivate existing personnel through our compensation practices, company culture, and career development opportunities. If we fail to attract new personnel or to retain our current personnel, our business and operations could be harmed.
Volatility or lack of appreciation in the trading price of our Class A common stock may also affect our ability to attract and retain qualified personnel. Many of our senior and other key personnel hold equity awards that have vested in part or are exercisable, which could adversely affect our ability to retain these personnel. Personnel may be more likely to leave us if the shares they own or the shares underlying their vested options or RSUs have significantly appreciated in value. In addition, many of our personnel may be able to receive significant proceeds from sales of our equity in the public markets, which may reduce their motivation to continue to work for us. Any of these factors could harm our business, financial condition, and results of operations.
If we are unable to successfully build, expand, and deploy our marketing and sales organization in a timely manner, or at all, or to successfully hire, retain, train, and motivate our sales personnel, our growth and long-term success could be adversely impacted.
We have a growing but limited direct sales force and our sales efforts have historically depended on the significant direct involvement of our senior management team, including Mr. Karp. The successful execution of our strategy to increase our sales to existing customers, identify and engage new customers, and enter new U.S. and
non-U.S.
markets will depend, among other things, on our ability to successfully build and expand our sales organization and operations. Identifying, recruiting, training, and managing sales personnel requires significant time, expense, and attention, including from our senior management and other key personnel, which could adversely impact our business, financial condition, and results of operations in the short and long term.
In order to successfully scale our unique sales model, we must, and we intend to continue to, increase the size of our direct sales force, both in the United States and outside of the United States, to generate additional revenue from new and existing customers while preserving the cultural and mission-oriented elements of our company. If we do not hire a sufficient number of qualified sales personnel, our future revenue growth and business could be adversely impacted. It may take a significant period of time before our sales personnel are fully trained and productive, particularly in light of our unique sales model, and there is no guarantee we will be successful in adequately training and effectively deploying our sales personnel. In addition, we have invested, and may need to continue investing, significant resources in our sales operations to enable our sales organization to run effectively and efficiently, including supporting sales strategy planning, sales process optimization, data analytics and reporting, and administering incentive compensation arrangements. Furthermore, hiring personnel in new countries requires additional setup and upfront costs that we may not recover if those personnel fail to achieve full productivity in a timely manner. Our business would be adversely affected if our efforts to build, expand, train, and manage our sales organization are not successful. We periodically change and make adjustments to our sales organization in response to market opportunities, competitive threats, management changes, product introductions or enhancements, acquisitions, sales performance, increases in sales headcount, cost levels, and other internal and external considerations. Any future sales organization changes may result in a temporary reduction of productivity, which could negatively affect our rate of growth. In addition, any significant change to the way we structure and implement the compensation of our sales organization may be disruptive or may not be effective and may affect our revenue growth. If we are unable to attract, hire, develop, retain, and motivate qualified sales personnel, if our new sales personnel are unable to achieve sufficient sales productivity levels in a reasonable period of time or at all, if our marketing programs are not effective or if we are unable to effectively build, expand, and manage our sales organization and operations, our sales and revenue may grow more slowly than expected or materially decline, and our business may be significantly harmed.
Our ability to sell our platforms and satisfy our customers is dependent on the quality of our services, and our failure to offer high quality services could have a material adverse effect on our sales and results of operations.
 
54

Once our platforms are deployed and integrated with our customers’ existing information technology investments and data, our customers depend on our O&M services to resolve any issues relating to our platforms. Increasingly, our platforms have been deployed in large-scale, complex technology environments, and we believe our future success will depend on our ability to increase sales of our platforms for use in such deployments. Further, our ability to provide effective ongoing services, or to provide such services in a timely, efficient, or scalable manner, may depend in part on our customers’ environments and their upgrading to the latest versions of our platforms and participating in our centralized platform management and services.
In addition, our ability to provide effective services is largely dependent on our ability to attract, train, and retain qualified personnel with experience in supporting customers on platforms such as ours. The number of our customers has grown significantly, and that growth has and may continue to put additional pressure on our services teams. We may be unable to respond quickly enough to accommodate short-term increases in customer demand for our O&M services. We also may be unable to modify the future scope and delivery of our O&M services to compete with changes in the services provided by our competitors. Increased customer demand for support, without corresponding revenue, could increase costs and negatively affect our business and results of operations. In addition, as we continue to grow our operations and expand outside of the United States, we need to be able to provide efficient services that meet our customers’ needs globally at scale, and our services teams may face additional challenges, including those associated with operating the platforms and delivering support, training, and documentation in languages other than English and providing services across expanded time-zones. If we are unable to provide efficient O&M services globally at scale, our ability to grow our operations may be harmed, and we may need to hire additional services personnel, which could negatively impact our business, financial condition, and results of operations.
Our customers typically need training in the proper use of and the variety of benefits that can be derived from our platforms to maximize the potential of our platforms. If we do not effectively deploy, update, or upgrade our platforms, succeed in helping our customers quickly resolve post-deployment issues, and provide effective ongoing services, our ability to sell additional products and services to existing customers could be adversely affected, we may face negative publicity, and our reputation with potential customers could be damaged. Many enterprise and government customers require higher levels of services than smaller customers. If we fail to meet the requirements of the larger customers, it may be more difficult to execute on our strategy to increase our penetration with larger customers. As a result, our failure to maintain high quality services may have a material adverse effect on our business, financial condition, results of operations, and growth prospects.
If we are not able to maintain and enhance our brand and reputation, our relationships with our customers, partners, and employees may be harmed, and our business and results of operations may be adversely affected.
We believe that maintaining and enhancing our brand identity and reputation is important to our relationships with, and to our ability to attract and retain customers, partners, investors, and employees. The successful promotion of our brand depends upon our ability to continue to offer high-quality software, maintain strong relationships with our customers, the community, and others, while successfully differentiating our platforms from those of our competitors. Unfavorable media coverage may adversely affect our brand and reputation. We anticipate that as our market becomes increasingly competitive, maintaining and enhancing our brand may become increasingly difficult and expensive. If we do not successfully maintain and enhance our brand identity and reputation, we may fail to attract and retain employees, customers, investors, or partners, grow our business, or sustain pricing power, all of which could adversely impact our business, financial condition, results of operations, and growth prospects. Additionally, despite our internal safeguards and efforts to the contrary, we cannot guarantee that our customers will not ultimately use our platforms for purposes inconsistent with our company values, and such uses may harm our brand and reputation.
Our reputation and business may be harmed by news or social media coverage of Palantir, including but not limited to coverage that presents, or relies on, inaccurate, misleading, incomplete, or otherwise damaging information.
Publicly available information regarding Palantir has historically been limited, in part due to the sensitivity of our work with customers or contractual requirements limiting or preventing public disclosure of certain aspects of our work or relationships with certain customers. As our business has grown and as interest in Palantir and the technology industry overall has increased and we have engaged more actively with media and marketing efforts, we have attracted, and may continue to attract, significant attention from news and social media outlets, including unfavorable coverage and coverage that is not directly attributable to statements authorized by our leadership, that incorrectly reports on statements made by our leadership or employees and the nature of our work, perpetuates unfounded speculation about company involvements, or that is otherwise misleading. If such news or social media coverage presents, or relies on, inaccurate, misleading, incomplete, or otherwise damaging information regarding Palantir, such coverage could damage our reputation in the industry and with current and potential customers, employees, and investors, and our business, financial condition, results of operations, and growth prospects could be adversely affected. Due to the sensitive nature of our work and our confidentiality obligations and despite our ongoing efforts to provide increased transparency into our business, operations, and product capabilities, we may be unable to or limited in our ability to respond to such harmful coverage, which could have a negative impact on our business.
 
55

Our relationships with government customers and customers that are engaged in certain sensitive industries, including organizations whose products or activities are or are perceived to be harmful, has resulted in public criticism, including from political and social activists, and unfavorable coverage in the media. Activists have also engaged in public protests at our properties. Activist criticism of our relationships with customers could potentially engender dissatisfaction among potential and existing customers, investors, and employees with how we address political and social concerns in our business activities. Conversely, being perceived as yielding to activism targeted at certain customers could damage our relationships with certain customers, including governments and government agencies with which we do business, whose views may or may not be aligned with those of political and social activists. Actions we take in response to the activities of our customers, up to and including terminating our contracts or refusing a particular product use case could harm our brand and reputation. In either case, the resulting harm to our reputation could:
 
 
cause certain customers to cease doing business with us;
 
 
impair our ability to attract new customers, or to expand our relationships with existing customers;
 
 
diminish our ability to recruit, hire, or retain employees;
 
 
undermine our standing in professional communities to which we contribute and from which we receive expert knowledge; or
 
 
prompt us to cease doing business with certain customers.
Any of these factors could adversely impact our business, financial condition, and results of operations.
Because we recognize a substantial portion of our revenue from our platforms and O&M services over the contractual term, downturns or upturns in new sales and renewals may not be immediately reflected in our results of operations.
We generally recognize revenue from our platforms and O&M services over the contractual term. As a result, a portion of the revenue we recognize in each quarter is derived from customer contracts generally entered into during previous periods. Consequently, a decline in new or renewed contracts in any single quarter may have an immaterial impact on the revenue that we recognize for that quarter. However, such a decline would negatively affect our revenue in future quarters. Accordingly, the effect of significant downturns in sales or renewals, significant customer terminations, and potential changes in our contracting terms and pricing policies would not be fully reflected in our results of operations until future periods. The timing of our revenue recognition model also makes it difficult for us to rapidly increase our revenue through additional sales in any given period, as revenue is generally recognized over the applicable contractual term.
Our pricing structures for our platforms and services may change from time to time, which could adversely impact our business, financial condition, and results of operations.
We expect that we may change our pricing model from time to time, including as a result of competition, global economic conditions, general reductions in our customers’ spending levels, pricing studies, or changes in how our platforms are broadly consumed. Similarly, as we introduce new products and services, or as a result of the evolution of our existing platforms and services, we may have difficulty determining the appropriate price structure for our products and services. In addition, as new and existing competitors introduce new products or services that compete with ours, or revise their pricing structures, we may be unable to attract new customers at the same price or based on the same pricing model as we have used historically. Moreover, as we continue to target selling our platforms and services to larger organizations, these larger organizations may demand substantial price concessions. In addition, we may need to change pricing policies to accommodate government pricing guidelines for our contracts with federal, state, local, and foreign governments and government agencies. If we are unable to modify or develop pricing models and strategies that are attractive to existing and prospective customers, while enabling us to significantly grow our sales and revenue relative to our associated costs and expenses in a reasonable period of time, our business, financial condition, and results of operations may be adversely impacted.
If our customers are not able or willing to accept our product-based business model, instead of a labor-based business model, our business and results of operations could be negatively impacted.
Our platforms are generally offered on a productized basis to minimize our customers’ overall cost of acquisition, maintenance, and deployment time of our platforms. Many of our customers and potential customers are instead generally familiar with the practice of purchasing or licensing software through labor contracts, where custom software is written for specific applications, the intellectual property in such software is often owned by the customer, and the software typically requires additional labor contracts for modifications, updates, and services during the life of that specific software. Customers may be unable or unwilling to accept our model of commercial software procurement. Should our customers be unable or unwilling to accept this model of commercial software procurement, our growth could be materially diminished, which could adversely impact our business, financial condition, results of operations, and growth prospects.
 
56

We have entered into, and expect in the future to enter into, agreements with our customers that include exclusivity arrangements or unique contractual or pricing terms, which may result in significant risks or liabilities to us.
Our contracts with our customers are typically
non-exclusive,
but we have historically entered into arrangements with our customers and our partners that include exclusivity provisions, and we expect to continue to do so in the future. These exclusivity provisions limit our ability to license our platforms and provide services to specific customers, or to compete in certain geographic markets and industries, which may limit our growth and negatively impact our results. In addition, we have entered into joint ventures and strategic alliances with our customers, as described below, which also limit our ability to compete in certain geographic markets or industry verticals.
Historically, we have in limited circumstances entered into unique contractual and pricing arrangements with our customers, including some that may be outside of our typical scope of business, including arrangements relating to
non-cash
items.
We face intense competition in our markets, and we may lack sufficient financial or other resources to maintain or improve our competitive position.
The markets for our platforms are very competitive, and we expect such competition to continue or increase in the future. A significant number of companies are developing products that currently, or in the future may, compete with some or all aspects of our proprietary platforms. We may not be successful in convincing the management teams of our potential customers to deploy our platforms in lieu of existing software solutions or
in-house
software development projects often favored by internal IT departments or other competitive products and services. In addition, our competitors include large enterprise software companies, government contractors, and system integrators, and we may face competition from emerging companies as well as established companies who have not previously entered this market. Additionally, we may be required to make substantial additional investments in our research, development, services, marketing, and sales functions in order to respond to competition, and there can be no assurance that we will be able to compete successfully in the future.
Many of our existing competitors have, and some of our potential competitors could have, substantial competitive advantages such as:
 
 
Greater name recognition, longer operating histories, and larger customer bases;
 
 
Larger sales and marketing budgets and resources and the capacity to leverage their sales efforts and marketing expenditures across a broader portfolio of products;
 
 
Broader, deeper, or otherwise more established relationships with technology, channel and distribution partners, and customers;
 
 
Wider geographic presence or greater access to larger potential customer bases;
 
 
Greater focus in specific geographies;
 
 
Lower labor and research and development costs;
 
 
Larger and more mature intellectual property portfolios; and
 
 
Substantially greater financial, technical, and other resources to provide services, to make acquisitions, and to develop and introduce new products and capabilities.
In addition, some of our larger competitors have substantially broader and more diverse product and service offerings and may be able to leverage their relationships with distribution partners and customers based on other products or incorporate functionality into existing products to gain business in a manner that discourages customers from purchasing our platforms, including by selling at zero or negative margins, product bundling, or offering closed technology platforms. Potential customers may also prefer to purchase from their existing provider rather than a new provider regardless of platform performance or features. As a result, even if the features of our platforms offer advantages that others do not, customers may not purchase our platforms. These larger competitors often have broader product lines and market focus or greater resources and may therefore not be as susceptible to economic downturns or other significant reductions in capital spending by customers. If we are unable to sufficiently differentiate our platforms from the integrated or bundled products of our competitors, such as by offering enhanced functionality, performance, or value, we may see a decrease in demand for those platforms, which could adversely affect our business, financial condition, and results of operations.
 
57

In addition, new, innovative
start-up
companies and larger companies that are making significant investments in research and development may introduce products that have greater performance or functionality, are easier to implement or use, incorporate technological advances that we have not yet developed, or implemented or may invent similar or superior platforms and technologies that compete with our platforms. Our current and potential competitors may also establish cooperative relationships among themselves or with third parties that may further enhance their resources.
Some of our competitors have made or could make acquisitions of businesses that allow them to offer more competitive and comprehensive solutions. As a result of such acquisitions, our current or potential competitors may be able to accelerate the adoption of new technologies that better address customer needs, devote greater resources to bring these products and services to market, initiate or withstand substantial price competition, or develop and expand their product and service offerings more quickly than we do. These competitive pressures in our market, or our failure to compete effectively, may result in fewer orders, reduced revenue and margins, and loss of market share. In addition, it is possible that industry consolidation may impact customers’ perceptions of the viability of smaller or even
mid-size
software firms and consequently customers’ willingness to purchase from such firms.
We may not compete successfully against our current or potential competitors. If we are unable to compete successfully, or if competing successfully requires us to take costly actions in response to the actions of our competitors, our business, financial condition and results of operations could be adversely affected. In addition, companies competing with us may have an entirely different pricing or distribution model. Increased competition could result in fewer customer orders, price reductions, reduced margins, and loss of market share, any of which could harm our business and results of operations.
Our culture emphasizes rapid innovation and advancement of successful hires who may in some cases have limited prior industry expertise and prioritizes customer outcomes over short-term financial results, and if we cannot maintain or properly manage our culture as we grow, our business may be harmed.
We have a culture that encourages employees to quickly develop and launch key technologies and platforms intended to solve our customers’ most important problems and prioritizes the advancement of employees to positions of significant responsibility based on merit despite, in some cases, limited prior work or industry experience. Much of our hiring into technical roles comes through our internship program or from candidates joining us directly from undergraduate or graduate engineering programs rather than industry hires. Successful entry-level hires are often quickly advanced and rewarded with significant responsibilities, including in important customer-facing roles as project managers, development leads, and product managers. Larger competitors, such as defense contractors, system integrators, and large software and service companies that traditionally target large enterprises typically have more sizeable direct sales forces staffed by individuals with significantly more industry experience than our customer-facing personnel, which may negatively impact our ability to compete with these larger competitors. We have historically operated with a relatively flat reporting and organization structure and have few formal promotions. As our business grows and becomes more complex, the staffing of customer-facing personnel, some of whom may have limited industry experience, may result in unintended outcomes or in decisions that are poorly received by customers or other stakeholders. For example, in many cases we launch, at our expense, pilot deployments with customers without a long-term contract in place, and some of those deployments have not resulted in the customer’s adoption or expansion of its use of our platforms and services, or the generation of significant, or any, revenue or payments. In addition, as we continue to grow, including geographically, we may find it difficult to maintain our culture.
Our culture also prioritizes customer outcomes over short-term financial results, and we frequently make service and product decisions that may reduce our short-term revenue or cash flow if we believe that the decisions are consistent with our mission and responsive to our customers’ goals and thereby have the potential to improve our financial performance over the long term. These decisions may not produce the long-term benefits and results that we expect or may be poorly received in the short term by the public markets, in which case our customer growth and our business, financial condition, and results of operations may be harmed.
 
58

We may not enter into relationships with potential customers if we consider their activities to be inconsistent with our organizational mission or values.
We generally do not enter into business with customers or governments whose positions or actions we consider inconsistent with our mission to support Western liberal democracy and its strategic allies. Our decisions to not enter into these relationships may not produce the long-term financial benefits and results that we expect, in which case our growth prospects, business, and results of operations could be harmed. Although we endeavor to do business with customers and governments that are aligned with our mission and values, we cannot predict how the activities and values of our government and private sector customers will evolve over time, and they may evolve in a manner inconsistent with our mission.
We do not work with the Chinese communist party and have chosen not to host our platforms in China, which may limit our growth prospects.
Our leadership believes that working with the Chinese communist party is inconsistent with our culture and mission. We do not consider any sales opportunities with the Chinese communist party, do not host our platforms in China, and impose limitations on access to our platforms in China in order to protect our intellectual property, to promote respect for and defend privacy and civil liberties protections, and to promote data security. Our decision to avoid this large potential market may limit our growth prospects and could adversely impact our business, results of operations, and financial condition, and we may not compete successfully against our current or potential competitors who choose to work in China.
Joint ventures, channel sales relationships, platform partnerships, and strategic alliances may have a material adverse effect on our business, results of operations and prospects.
We expect to continue to enter into joint ventures, channel sales relationships (including original equipment manufacturer (“OEM”) and reseller relationships), platform partnerships, and strategic alliances as part of our long-term business strategy. Joint ventures, channel sales relationships, platform partnerships, strategic alliances, and other similar arrangements involve significant investments of both time and resources, and there can be no assurances that they will be successful. They may present significant challenges and risks, including that they may not advance our business strategy, we may get an unsatisfactory return on our investment or lose some or all of our investment, they may distract management and divert resources from our core business, including our business development and product development efforts, they may expose us to unexpected liabilities, they may conflict with our increased sales hiring and direct sales strategy, or we may choose a partner that does not cooperate as we expect them to and that fails to meet its obligations or that has economic, business, or legal interests or goals that are inconsistent with ours. For example, in January 2021, we entered into a channel sales relationship with International Business Machines Corporation (“IBM”), pursuant to which IBM is supplying a new product leveraging certain components of Foundry integrated with IBM’s Cloud Pak for Data. In addition, in November 2019, we created a jointly controlled entity in Japan with SOMPO. We believe this arrangement offers our business strategic operational advantages within the Japanese market, but it also limits our ability to independently sell our platforms, provide certain services, engage certain customers, or compete in Japanese markets or industry verticals, which limits our opportunities for growth in Japan and, depending on the success of the entity, may negatively impact our results. Additionally, in 2016, we entered into a partnership with Airbus S.A.S. (“Airbus”) that, over time, developed into the Skywise platform partnership, which provides our business strategic advantages but also limits our ability to independently provide our platforms to certain airlines and companies that compete with Airbus.
Entry into certain joint ventures, channel sales relationships, platform partnerships, or strategic alliances now or in the future may be subject to government regulation, including review by U.S. or foreign government entities related to foreign direct investment. If a joint venture or similar arrangement were subject to regulatory review, such regulatory review might limit our ability to enter into the desired strategic alliance and thus our ability to carry out our long-term business strategy.
As our joint ventures, channel sales relationships, platform partnerships, and strategic alliances come to an end or terminate, we may be unable to renew or replace them on comparable terms, or at all. When we enter into joint ventures, channel sales relationships, platform partnerships, and strategic alliances, our partners may be required to undertake some portion of sales, marketing, implementation services, engineering services, or software configuration that we would otherwise provide. In such cases, our partner may be less successful than we would have otherwise been absent the arrangement and our ability to influence, or have visibility into, the sales, marketing, and related efforts of our partners may be limited. In the event we enter into an arrangement with a particular partner, we may be less likely (or unable) to work with one or more direct competitors of our partner with which we would have worked absent the arrangement. We may have interests that are different from our joint venture partners and/or which may affect our ability to successfully collaborate with a given partner. Similarly, one or more of our partners in a joint venture, channel sales relationship, platform partnership, or strategic alliance may independently suffer a bankruptcy or other economic hardship that negatively affects its ability to continue as a going concern or successfully perform on its obligation under the arrangement. In addition, customer satisfaction with our products provided in connection with these arrangements may be less favorable than anticipated, negatively impacting anticipated revenue growth and results of operations of arrangements in question. Further, some of our strategic partners offer competing products and services or work with our competitors. As a result of these and other factors, many of the companies with which we have or are seeking joint ventures, channel sales relationships, platform partnerships, or strategic alliances may choose to pursue alternative technologies and develop alternative products and services in addition to or in lieu of our platforms, either on their own or in collaboration with others, including our competitors. If we are unsuccessful in establishing or maintaining our relationships with these partners, our ability to compete in a given marketplace or to grow our revenue would be impaired, and our results of operations may suffer. Even if we are successful in establishing and maintaining these relationships with our partners, we cannot assure you that these relationships will result in increased customer usage of our platforms or increased revenue. Additionally, if our partners’ brand, reputation, or products are negatively impacted in any way, that could impact our expected outcomes in those markets.
 
59

Further, winding down joint ventures, channel sales relationships, platform partnerships, or other strategic alliances can result in additional costs, litigation, and negative publicity. Any of these events could adversely affect our business, financial condition, results of operations, and growth prospects.
If we are not successful in executing our strategy to increase our sales to larger customers, our results of operations may suffer.
An important part of our growth strategy is to increase sales of our platforms to large enterprises and government entities. Sales to large enterprises and government entities involve risks that may not be present (or that are present to a lesser extent) with sales to
small-to-mid-sized
entities. These risks include:
 
 
Increased leverage held by large customers in negotiating contractual arrangements with us;
 
 
Changes in key decision makers within these organizations that may negatively impact our ability to negotiate in the future;
 
 
Customer IT departments may perceive that our platforms and services pose a threat to their internal control and advocate for legacy or internally developed solutions over our platforms;
 
 
Resources may be spent on a potential customer that ultimately elects not to purchase our platforms and services;
 
 
More stringent requirements in our service contracts, including stricter service response times, and increased penalties for any failure to meet service requirements;
 
 
Increased competition from larger competitors, such as defense contractors, system integrators, or large software and service companies that traditionally target large enterprises and government entities and that may already have purchase commitments from those customers; and
 
 
Less predictability in completing some of our sales than we do with smaller customers.
Large enterprises and government entities often undertake a significant evaluation process that results in a lengthy sales cycle, in some cases over twelve months, requiring approvals of multiple management personnel and more technical personnel than would be typical of a smaller organization. Due to the length, size, scope, and stringent requirements of these evaluations, we typically provide short-term pilot deployments of our platforms at no or low cost in the Acquire phase. We sometimes spend substantial time, effort, and money in our sales efforts without producing any sales. The success of the investments that we make in the Acquire phase depends on factors such as our ability to identify potential customers for which our platforms have an opportunity to add significant value to the customer’s organization, our ability to identify and agree with the potential customer on an appropriate pilot deployment to demonstrate the value of our platforms, and whether we successfully execute on such pilot deployment. Even if the pilot deployment is successful, we or the customer could choose not to enter into a larger contract for a variety of reasons. For example, product purchases by large enterprises and government entities are frequently subject to budget constraints, leadership changes, multiple approvals, and unplanned administrative, processing, and other delays, any of which could significantly delay or entirely prevent our realization of sales. Finally, large enterprises and government entities typically (i) have longer implementation cycles, (ii) require greater product functionality and scalability and a broader range of services, including design services, (iii) demand that vendors take on a larger share of risks, (iv) sometimes require acceptance provisions that can lead to a delay in revenue recognition, (v) typically have more complex IT and data environments, and (vi) expect greater payment flexibility from vendors. Customers, and sometimes we, may also engage third parties to be the users of our platforms, which may result in contractual complexities and risks, require additional investment of time and human resources to train the third parties and allow third parties (who may be building competitive projects or engaging in other competitive activities) to influence our customers’ perception of our platforms. All these factors can add further risk to business conducted with these customers. If sales expected from a large customer for a particular quarter are not realized in that quarter or at all, our business, financial condition, results of operations, and growth prospects could be materially and adversely affected.
 
60

The ongoing global
COVID-19
pandemic has significantly affected our business and operations.
In light of the uncertain and rapidly evolving situation relating to the spread of
COVID-19,
we took precautionary measures intended to minimize the risk of the virus to our employees, our customers, and the communities in which we operate, including temporarily closing our offices worldwide and virtualizing, postponing, or canceling customer, employee, or industry events, which may negatively impact our business. We have, however, begun to reopen our offices on a limited basis and will continue to monitor the
COVID-19
pandemic to determine if additional actions are required. While the
COVID-19
pandemic has provided certain new opportunities for our business to expand, it has also created many negative headwinds that present risks to our business and results of operations. For example, the
COVID-19
pandemic has generally disrupted the operations of our customers and prospective customers, and may continue to disrupt their operations, including as a result of travel restrictions and/or business shutdowns, uncertainty in the financial markets or other harm to their business and financial results, which could result in a reduction to information technology budgets, delayed purchasing decisions, longer sales cycles, extended payment terms, the timing of payments, and postponed or canceled projects, all of which would negatively impact our business and operating results, including sales and cash flows. We do not yet know the net impact of the
COVID-19
pandemic on our business and cannot guarantee that it will not be materially negative. Although we continue to monitor the situation and may adjust our current policies as more information and public health guidance become available, the ongoing effects of the
COVID-19
pandemic and/or the precautionary measures that we have adopted may create operational and other challenges, any of which could harm our business and results of operations.
Historically, a significant portion of our field sales, operations and maintenance, and professional services have been conducted in person. Currently, as a result of certain work and travel restrictions related to the
COVID-19
pandemic, and the precautionary measures that we have adopted, many of our field sales and professional services activities are still being conducted remotely, which has resulted in a decrease in our travel and office expenditures. However, we expect our travel expenditures to increase in the future as we resume such travel, which could negatively impact our financial condition and results of operations. As of the date of this Quarterly Report on Form
10-Q,
we do not yet know the extent of the negative impact of such restrictions and precautionary measures on our ability to attract new customers or retain and expand our relationships with existing customers.
In addition,
COVID-19
may disrupt the operations of our customers and partners for an indefinite period of time, including as a result of travel restrictions and/or business shutdowns, all of which could negatively impact our business, financial condition, and results of operations. Moreover, the potential impact on our workforce and business of implementing government orders or rules requiring COVID-19 vaccinations, including but not limited to the U.S. executive order requiring COVID-19 vaccination for federal contractor employees, is currently unknown.
Furthermore, as a result of the
COVID-19
pandemic, we are not requiring employees who are able to work remotely to come into the office through at least January 2022 but have opened our offices on a limited basis for those employees who wish to return early. It is possible that widespread remote work arrangements may have a negative impact on our operations; the execution of our business plans; our ability to recruit, train, manage, and retain employees; the productivity and availability of key personnel and other employees necessary to conduct our business; and on third-party service providers who perform critical services for us, or otherwise cause operational failures due to changes in our normal business practices necessitated by the pandemic and related governmental actions. If a natural disaster, power outage, connectivity issue, or other event occurred that impacted our employees’ ability to work remotely, it may be difficult or, in certain cases, impossible, for us to continue our business for a substantial period of time. The increase in remote working may also result in increased consumer privacy, data security, and fraud risks, and our understanding of applicable legal and regulatory requirements, as well as the latest guidance from regulatory authorities in connection with the
COVID-19
pandemic, may be subject to legal or regulatory challenge, particularly as regulatory guidance evolves in response to future developments.
More generally, the
COVID-19
pandemic has and is expected to continue to adversely affect economies and financial markets globally, leading to a continued economic downturn, which may decrease technology spending generally and could adversely affect demand for our platforms and services. It is not possible at this time to estimate the full impact that
COVID-19
will have on our business, as the impact will depend on future developments, which are highly uncertain and cannot be predicted.
Moreover, to the extent the
COVID-19
pandemic adversely affects our business, financial condition, and results of operations, it may also have the effect of heightening many of the other risks described in this “Risk Factors” section, including but not limited to, those related to our ability to increase sales to existing and new customers, continue to perform on existing contracts, develop and deploy new technologies, expand our marketing capabilities and sales organization, generate sufficient cash flow to service our indebtedness, and comply with the covenants in the agreements that govern our indebtedness.
 
61

If the market for our platforms and services develops more slowly than we expect, our growth may slow or stall, and our business, financial condition, and results of operations could be harmed.
The market for our platforms is rapidly evolving. Our future success will depend in large part on the growth and expansion of this market, which is difficult to predict and relies on a number of factors, including customer adoption, customer demand, changing customer needs, the entry of competitive products, the success of existing competitive products, potential customers’ willingness to adopt an alternative approach to data collection, storage, and processing and their willingness to invest in new software after significant prior investments in legacy data collection, storage, and processing software. The estimates and assumptions that are used to calculate our market opportunity are subject to change over time, and there is no guarantee that any particular number or percentage of the organizations covered by our market opportunity estimates will pay for our platforms and services at all or generate any particular level of revenue for us. Even if the market in which we compete meets the size estimates and growth forecasts, our business could fail to grow at the levels we expect or at all for a variety of reasons outside our control, including competition in our industry. Further, if we or other data management and analytics providers experience security breaches or incidents; loss, corruption, or unavailability of or unauthorized access to customer data; disruptions in delivery; or other problems, this market as a whole, including our platforms, may be negatively affected. If software for the challenges that we address does not achieve widespread adoption, or there is a reduction in demand caused by a lack of customer acceptance, technological challenges, weakening economic conditions (including due to the
COVID-19
pandemic), security or privacy concerns, competing technologies and products, decreases in corporate spending, or otherwise, or, alternatively, if the market develops but we are unable to continue to penetrate it due to the cost, performance, and perceived value associated with our platforms, or other factors, it could result in decreased revenue and our business, financial condition, and results of operations could be adversely affected.
We will face risks associated with the growth of our business in new commercial markets and with new customer verticals, and we may neither be able to continue our organic growth nor have the necessary resources to dedicate to the overall growth of our business.
We plan to expand our operations in new commercial markets, including those where we may have limited operating experience, and may be subject to increased business, technology and economic risks that could affect our financial results. In recent periods, we have increased our focus on commercial customers. In the future, we may increasingly focus on such customers, including in the banking, financial services, healthcare, pharmaceutical, manufacturing, telecommunication, automotive, airlines and aerospace, consumer packaged goods, insurance, retail, transportation, shipping and logistics, energy, and other emerging industries. Entering new verticals and expanding in the verticals in which we are already operating will continue to require significant resources and there is no guarantee that such efforts will be successful or beneficial to us. Historically, sales to new customers have often led to additional sales to the same customers or similarly situated customers. As we expand into and within new and emerging markets and heavily regulated industry verticals, we will likely face additional regulatory scrutiny, risks, and burdens from the governments and agencies which regulate those markets and industries. While this approach to expansion within new commercial markets and verticals has proven successful in the past, it is uncertain we will achieve the same penetration and organic growth in the future and our reputation, business, financial condition, and results of operations could be negatively impacted.
In the future, we may not be able to secure the financing necessary to operate and grow our business as planned, or to make acquisitions.
In the future, we may seek to raise or borrow additional funds to expand our product or business development efforts, make acquisitions or otherwise fund or grow our business and operations. During April 2021, we fully repaid our outstanding term loans in an aggregate principal amount of $200.0 million and mutually agreed with the lenders and other applicable parties under our secured credit facility to amend our credit facility to, among other things, increase the revolving commitments under the credit facility by $200.0 million, for total undrawn revolving commitments of $400.0 million. Any principal amounts outstanding under our secured credit facility will be due and payable in June 2023, and any interest or facility payments are due and payable quarterly or more or less frequently in certain circumstances. Additional equity or debt financing may not be available on favorable terms, or at all.
Historically, we have funded our operations and capital expenditures primarily through equity issuances, proceeds from option exercises, debt, and cash received from our customers. Although we currently anticipate that our existing cash and cash equivalents will be sufficient to meet our cash needs for at least the next twelve months, we may require additional financing, and we may not be able to obtain debt or equity financing on favorable terms, if at all. If we raise equity financing to fund operations or on an opportunistic basis, our stockholders may experience significant dilution of their ownership interests. If adequate funds are not available on acceptable terms, or at all, we may be unable to, among other things:
 
 
Develop new products, features, capabilities, and enhancements;
 
 
Continue to expand our product development, sales, and marketing organizations;
 
 
Recruit, hire, train, and retain employees;
 
62

 
Respond to competitive pressures or unanticipated working capital requirements; or
 
 
Pursue acquisition or other growth or investment opportunities.
Our inability to take any of these actions because adequate funds are not available on acceptable terms could have an adverse impact on our business, financial condition, results of operations, and growth prospects.
Our debt agreements contain restrictions that may limit our flexibility in operating our business.
Our credit agreement and related documents, including our pledge and security agreements, contain, and instruments governing any future indebtedness of ours would likely contain, a number of covenants that will impose significant operating and financial restrictions on us, including restrictions on our ability to, among other things:
 
 
Create liens on certain assets;
 
 
Incur additional debt;
 
 
Consolidate, merge, sell or otherwise dispose of all or substantially all of our assets;
 
 
Sell certain assets;
 
 
Pay dividends on or make distributions in respect of our capital stock;
 
 
Place restrictions on certain activities of subsidiaries;
 
 
Transact with our affiliates; and
 
 
Use a portion of our cash resources.
Any of these restrictions could limit our ability to plan for or react to market conditions and could otherwise restrict corporate activities. Any failure to comply with these covenants could result in a default under our secured credit facility or instruments governing any future indebtedness of ours. Additionally, our credit facility is secured by substantially all of our assets. Upon a default, unless waived, the lenders under our secured credit facility could elect to terminate their commitments and cease making further loans, and, when amounts are outstanding, foreclose on our assets pledged to such lenders to secure our obligations under our credit agreement and force us into bankruptcy or liquidation. In addition, a default under our secured credit facility could trigger a cross default under agreements governing any future indebtedness. If we experience a default under our secured credit facility or instruments governing our future indebtedness, our business, financial condition, and results of operations may be adversely impacted.
In addition, a portion of our cash is pledged as cash collateral for letters of credit and bank guarantees which support certain of our real estate leases, customer contracts, and other guarantees and financing obligations. While these obligations remain outstanding and are cash collateralized, we do not have access to and cannot use the pledged cash for our operations or to repay our other indebtedness. As of September 30, 2021, we were in compliance with all covenants and restrictions associated with our secured credit facility.
Variable rate indebtedness that we may incur under our secured credit facility will subject us to interest rate risk, which could cause our debt service obligations to increase significantly.
As of September 30, 2021, no borrowings were outstanding under our secured credit facility. Any borrowings under the secured credit facility bear interest at variable rates, which exposes us to interest rate risk. Our loans under our secured credit facility would incur interest at LIBOR (or any successor rate) plus 2.75% or a base rate plus 1.75% and are payable quarterly or more or less frequently in certain circumstances.
 
63

We may acquire or invest in companies and technologies, which may divert our management’s attention, and result in additional dilution to our stockholders. We may be unable to integrate acquired businesses and technologies successfully or achieve the expected benefits of such acquisitions or investments. In particular, we are subject to risks associated with our investments, including a partial or complete loss of invested capital.
As part of our business strategy, we have engaged in strategic transactions and alternative investments in the past and expect to evaluate and consider potential strategic transactions, including acquisitions of, or investments in, businesses, technologies, services, products and other assets in the future. We also may enter into relationships with other businesses to expand our products or our ability to provide services. An acquisition, investment or business relationship may result in unforeseen risks, operating difficulties and expenditures, including the following:
 
 
Any such transactions may negatively affect our financial results because it may require us to incur charges or assume substantial debt or other liabilities, may cause adverse tax consequences or unfavorable accounting treatment, may expose us to claims and disputes by third parties, including intellectual property claims and disputes, or may not generate sufficient financial return to offset additional costs and expenses related to the acquisition;
 
 
Costs and potential difficulties associated with the requirement to test and assimilate the internal control processes of the acquired business;
 
 
We may encounter difficulties or unforeseen expenditures assimilating or integrating the businesses, technologies, infrastructure, products, personnel, or operations of the acquired companies, particularly if the key personnel of the acquired company choose not to work for us or if we are unable to retain key personnel, if their technology is not easily adapted to work with ours, or if we have difficulty retaining the customers of any acquired business due to changes in ownership, management, or otherwise;
 
 
We may not realize the expected benefits of the transactions;
 
 
The transaction may disrupt our ongoing business, divert resources, increase our expenses, result in unfavorable public perception, and distract our management;
 
 
An acquisition may result in a delay or reduction of customer purchases for both us and the company acquired due to customer uncertainty about continuity and effectiveness of service from either company;
 
 
The potential impact on relationships with existing customers, vendors, and distributors as business partners;
 
 
The potential that our due diligence of the applicable company or business does not identify significant problems or liabilities, or that we underestimate the costs and effects of identified liabilities;
 
 
Exposure to litigation or other claims in connection with, or inheritance of claims or litigation risk as a result of, the transaction, including but not limited to claims from former employees, customers, or other third parties, which may differ from or be more significant than the risks our business faces;
 
 
Potential goodwill impairment charges related to acquisitions;
 
 
We may encounter difficulties in, or may be unable to, successfully sell any acquired products;
 
 
The transaction may involve the entry into geographic or business markets in which we have little or no prior experience or where competitors have stronger market positions;
 
 
An acquisition may require us to comply with additional laws and regulations, or to engage in substantial remediation efforts to cause the acquired company to comply with applicable laws or regulations, or result in liabilities resulting from the acquired company’s failure to comply with applicable laws or regulations;
 
 
Our use of cash to pay for the transaction would limit other potential uses for our cash;
 
 
If we incur debt to fund such a transaction, such debt may subject us to material restrictions on our ability to conduct our business as well as financial maintenance covenants; and
 
 
To the extent that we issue a significant amount of equity securities in connection with such transactions, existing stockholders may be diluted and earnings per share may decrease.
 
64

We have made and may continue to make strategic investments pursuant to certain approved agreements (“Investment Agreements”) to purchase, or commit to purchase, securities of various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities (each, an “Investee”).
As of September 30, 2021, we had outstanding approved investment commitments, subject to the applicable terms and conditions, to purchase a total of 22.7 million shares for an aggregate purchase price of $226.5 million. The closings of certain of such investments are contingent upon the completion of a proposed business combination between the applicable Investee and other applicable parties, and are subject to numerous terms and conditions, including approvals of the stockholders of applicable parties and regulatory review, which are inherently uncertain.
Additionally, in connection with approving and signing the Investment Agreements, we and each Investee or an associated entity entered into a commercial contract for access to our products and services. The maximum potential revenue from these commercial contracts, including investments that have already closed, is $640.2 million, which is inclusive of $82.9 million of contractual options. The terms of such contracts, including these contractual options, range from three to ten years. The majority of these commercial contracts are subject to various termination provisions, including, as applicable, for convenience in the event a proposed business combination or our proposed investment is not completed. Parties to certain of these and other commercial contracts entered into in connection with our investments may elect to exercise termination rights, including, to the extent applicable, in the event a proposed business combination is not completed, which would negatively impact our expected revenue and collections. The total revenue recognized by us from the commercial contracts during the three and nine months ended September 30, 2021 was $19.0 million and $22.0 million, respectively. In addition to the above, as of September 30, 2021, we have entered into certain commercial contracts that, if corresponding contemplated investment agreements are negotiated, approved, and executed, could result in additional maximum potential revenue of $218 million.
If the companies that we enter into commercial contracts with, including, as applicable, companies that complete their proposed business combinations as contemplated, are unable to generate sufficient revenues or profitability or to access any necessary financing or funding in a timely manner or on favorable terms to them, our commercial contracts and expected revenue and collections would be negatively impacted. These companies may be engaged in businesses that involve novel and unproven technologies, products, and services and such companies may be unable to perform their obligations under any commercial contracts that we enter into with them, in a timely manner or at all.
We entered into additional Investment Agreements from October 1, 2021 through the date of this filing. In connection with signing certain of these Investment Agreements, we and each Investee or an associated entity entered into a commercial contract to access our products and services. For additional information on these agreements and other investments, refer to
Note 14. Subsequent Events
to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form
10-Q.
Our ability to sell or transfer, or realize value from our investments may be limited by applicable securities laws and regulations, including the requirement that offers or sales of securities must be registered with the Securities and Exchange Commission (“SEC”) pursuant to applicable laws or qualify for an exemption from such registration, and our ability to liquidate and realize value from our investments may be negatively and materially impacted by any delays or limitations on our ability to offer, sell, or transfer our investments. In addition, our investments are speculative in nature and may be volatile or decline in value or be entirely lost.
The occurrence of any of these risks could have a material adverse effect on our business, results of operations, and financial condition. Moreover, we cannot assure you that we would not be exposed to unknown liabilities.
Risks Related to Intellectual Property, Information Technology, Data Privacy, and Security
If any of the systems of any third parties upon which we rely, our customers’ cloud or
on-premises
environments, or our internal systems, are breached or if unauthorized access to customer or third-party data is otherwise obtained, public perception of our platforms and O&M services may be harmed, and we may lose business and incur losses or liabilities.
Our success depends in part on our ability to provide effective data security protection in connection with our technology platforms and services, and we rely on information technology networks and systems to securely store, transmit, index, and otherwise process electronic information. Because our platforms and services are used by our customers to store, transmit, index, or otherwise process and analyze large data sets that often contain proprietary, confidential, and/or sensitive information (including in some instances personal or identifying information and personal health information), our software is perceived as an attractive target for attacks by computer hackers or others seeking unauthorized access, and our software faces threats of unintended exposure, exfiltration, alteration, deletion, or loss or unavailability of data. Additionally, because many of our customers use our platforms to store, transmit, and otherwise process proprietary, confidential, or sensitive information, and complete mission critical tasks, they have a lower risk tolerance for security vulnerabilities in our platforms and services than for vulnerabilities in other, less critical, software products and services.
 
65

Our platforms and services operate in conjunction with, and we are dependent upon, third-party products and components across a broad ecosystem. There have been and may continue to be significant attacks on certain third-party providers, and we cannot guarantee that our or our third-party providers’ systems and networks have not been breached or that they do not contain exploitable defects or bugs that could result in a breach of or disruption to our systems and networks or the systems and networks of third parties that support us and our platforms and services. If there is a security vulnerability, error, or other bug in one of these third-party products or components and if there is a security exploit targeting them, we could face increased costs, claims, liability, reduced revenue, and harm to our reputation or competitive position. The natural sunsetting of third-party products and operating systems that we use requires that our infrastructure teams reallocate time and attention to migration and updates, during which period potential security vulnerabilities could be exploited.
We, and the third-party vendors upon which we rely, have experienced, and may in the future experience, cybersecurity attacks and threats, including threats or attempts to disrupt our information technology infrastructure and unauthorized attempts to gain access to sensitive or confidential information. Our and our third-party vendors’ technology systems may be damaged, disrupted, or compromised by malicious events, such as cyberattacks (including computer viruses, ransomware and other malicious and destructive code, phishing attacks, and denial of service attacks), physical or electronic security breaches, natural disasters, fire, power loss, telecommunications failures, personnel misconduct, and human error. Such attacks or security breaches may be perpetrated by internal bad actors, such as employees or contractors, or by third parties (including traditional computer hackers, persons involved with organized crime, or foreign state or foreign state-supported actors). Cybersecurity threats can employ a wide variety of methods and techniques, which may include the use of social engineering techniques or supply-chain attacks, are constantly evolving, and have become increasingly complex and sophisticated; all of which increase the difficulty of detecting and successfully defending against them. Furthermore, because the techniques used to obtain unauthorized access or sabotage systems change frequently and generally are not identified until after they are launched against a target, we and our third-party vendors may be unable to anticipate these techniques or implement adequate preventative measures. Although prior known cyberattacks directed at us have not had a material impact on our financial results, and we are continuing to bolster our threat detection and mitigation processes and procedures, we cannot guarantee that past, future, or ongoing cyberattacks against us or a third party, if successful or other security breaches or incidents, will not have a material impact on our business or financial results, whether directly or indirectly. While we have security measures in place to protect our information and our customers’ information and to prevent data loss and other security breaches and incidents, we have not always been able to do so and there can be no assurance that in the future we will be able to anticipate or prevent security breaches or incidents, or unauthorized access of our information technology systems or the information technology systems of the third-party vendors upon which we rely. Despite our implementation of network security measures and internal information security policies, data stored on personnel computer systems is also vulnerable to similar security breaches and incidents, unauthorized tampering or human error.
Many governments have enacted laws requiring companies to provide notice of security breaches or incidents involving certain types of data, including personal data. In addition, most of our customers, including U.S. government customers, contractually require us to notify them of certain data security breaches and incidents. If an actual or perceived breach of security measures, unauthorized access to our system or the systems of the third-party vendors that we rely upon, or any other cybersecurity attack, threat, or incident occurs, we may face direct or indirect liability, costs, or damages, contract termination, our reputation in the industry and with current and potential customers may be compromised, our ability to attract new customers could be negatively affected, and our business, financial condition, and results of operations could be materially and adversely affected.
Further, unauthorized access to our or our third-party vendors’ information technology systems or data or other security breaches or incidents could result in the loss, corruption, or unavailability of information; significant remediation costs; litigation, disputes, regulatory action, or investigations that could result in damages, material fines, and penalties; indemnity obligations; interruptions in the operation of our business, including our ability to provide new product features, new platforms, or services to our customers; damage to our operation technology networks and information technology systems; and other liabilities. Moreover, our remediation efforts may not be successful. Any or all of these issues, or the perception that any of them have occurred, could negatively affect our ability to attract new customers, cause existing customers to terminate or not renew their agreements, hinder our ability to obtain and maintain required or desirable cybersecurity certifications, and result in reputational damage, any of which could materially adversely affect our results of operations, financial condition, and future prospects. There can be no assurance that any limitations of liability provisions in our license arrangements with customers or in our agreements with vendors, partners, or others would be enforceable, applicable, or adequate or would otherwise protect us from any such liabilities or damages with respect to any particular claim.
We maintain cybersecurity insurance and other types of insurance, subject to applicable deductibles and policy limits, but our insurance may not be sufficient to cover all costs associated with a potential data security incident. We also cannot be sure that our existing general liability insurance coverage and coverage for cyber liability or errors or omissions will continue to be available on acceptable terms or will be available in sufficient amounts to cover one or more large claims or that the insurer will not deny coverage as to any future claim. The successful assertion of one or more large claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or
co-insurance
requirements, could harm our financial condition.
 
66

Issues raised by the use of artificial intelligence (“AI”) (including machine learning) in our platforms may result in reputational harm or liability.
AI is enabled by or integrated into some of our technology platforms and is a significant and potentially growing element of our business. As with many developing technologies, AI presents risks and challenges that could affect its further development, adoption, and use, and therefore our business. AI algorithms may be flawed. Datasets may be insufficient, of poor quality, or contain biased information. Inappropriate or controversial data practices by, or practices reflecting inherent biases of, data scientists, engineers, and
end-users
of our systems could impair the acceptance of AI solutions. If the recommendations, forecasts, or analyses that AI applications assist in producing are deficient or inaccurate, we could be subjected to competitive harm, potential legal liability, and brand or reputational harm. Some AI scenarios present ethical issues. Though our technologies and business practices are designed to mitigate many of these risks, if we enable or offer AI solutions that are controversial because of their purported or real impact on human rights, privacy, employment, or other social issues, we may experience brand or reputational harm.
We depend on computing infrastructure operated by Amazon Web Services (“AWS”), Microsoft, and other third parties to support some of our customers and any errors, disruption, performance problems, or failure in their or our operational infrastructure could adversely affect our business, financial condition, and results of operations.
We rely on the technology, infrastructure, and software applications, including
software-as-a-service
offerings, of certain third parties, such as AWS and Microsoft Azure, in order to host or operate some or all of certain key technology platform features or functions of our business, including our cloud-based services (including Palantir Cloud), customer relationship management activities, billing and order management, and financial accounting services. Additionally, we rely on computer hardware purchased in order to deliver our platforms and services. We do not have control over the operations of the facilities of the third parties that we use. If any of these third-party services experience errors, disruptions, security issues, or other performance deficiencies, if they are updated such that our platforms become incompatible, if these services, software, or hardware fail or become unavailable due to extended outages, interruptions, defects, or otherwise, or if they are no longer available on commercially reasonable terms or prices (or at all), these issues could result in errors or defects in our platforms, cause our platforms to fail, our revenue and margins could decline, or our reputation and brand to be damaged, we could be exposed to legal or contractual liability, our expenses could increase, our ability to manage our operations could be interrupted, and our processes for managing our sales and servicing our customers could be impaired until equivalent services or technology, if available, are identified, procured, and implemented, all of which may take significant time and resources, increase our costs, and could adversely affect our business. Many of these third-party providers attempt to impose limitations on their liability for such errors, disruptions, defects, performance deficiencies, or failures, and if enforceable, we may have additional liability to our customers which may not be compensated by our third-party providers which are responsible for the liability.
We have experienced, and may in the future experience, disruptions, failures, data loss, corruption, unavailability, outages, and other performance problems with our infrastructure and cloud-based offerings due to a variety of factors, including infrastructure changes, introductions of new functionality, human or software errors, employee misconduct, capacity constraints, denial of service attacks, phishing attacks, computer viruses, ransomware, and other malicious or destructive code, or other security-related incidents, and our disaster recovery planning may not be sufficient for all situations. If we experience disruptions, failures, data loss, outages, or other performance problems, our business, financial condition, and results of operations could be adversely affected.
Our systems and the third-party systems upon which we and our customers rely are also vulnerable to damage or interruption from catastrophic occurrences such as earthquakes, floods, fires, power loss, telecommunication failures, cybersecurity threats, terrorist attacks, natural disasters, public health crises such as the
COVID-19
pandemic, geopolitical and similar events, or acts of misconduct. Moreover, we have business operations in the San Francisco Bay Area, which is a seismically active region. Despite any precautions we may take, the occurrence of a catastrophic disaster or other unanticipated problems at our or our third-party vendors’ hosting facilities, or within our systems or the systems of third parties upon which we rely, could result in interruptions, performance problems, or failure of our infrastructure, technology, or platforms, which may adversely impact our business. In addition, our ability to conduct normal business operations could be severely affected. In the event of significant physical damage to one of these facilities, it may take a significant period of time to achieve full resumption of our services, and our disaster recovery planning may not account for all eventualities. In addition, any negative publicity arising from these disruptions could harm our reputation and brand and adversely affect our business.
Furthermore, our platforms are in many cases important or essential to our customers’ operations, including in some cases, their cybersecurity or oversight and compliance programs, and subject to service level agreements (“SLAs”). Any interruption in our service, whether as a result of an internal or third-party issue, could damage our brand and reputation, cause our customers to terminate or not renew their contracts with us or decrease use of our platforms and services, require us to indemnify our customers against certain losses, result in our issuing credit or paying penalties or fines, subject us to other losses or liabilities, cause our platforms to be perceived as unreliable or unsecure, and prevent us from gaining new or additional business from current or future customers, any of which could harm our business, financial condition, and results of operations.
 
67

Moreover, to the extent that we do not effectively address capacity constraints, upgrade our systems as needed, and continually develop our technology and network architecture to accommodate actual and anticipated changes in technology, our business, financial condition, and results of operations could be adversely affected. The provisioning of additional cloud hosting capacity requires lead time. AWS, Microsoft Azure, and other third parties have no obligation to renew their agreements with us on commercially reasonable terms, or at all. If AWS, Microsoft Azure, or other third parties increase pricing terms, terminate or seek to terminate our contractual relationship, establish more favorable relationships with our competitors, or change or interpret their terms of service or policies in a manner that is unfavorable with respect to us, we may be required to transfer to other cloud providers or invest in a private cloud. If we are required to transfer to other cloud providers or invest in a private cloud, we could incur significant costs and experience possible service interruption in connection with doing so, or risk loss of customer contracts if they are unwilling to accept such a change.
A failure to maintain our relationships with our third-party providers (or obtain adequate replacements), and to receive services from such providers that do not contain any material errors or defects, could adversely affect our ability to deliver effective products and solutions to our customers and adversely affect our business and results of operations.
Our policies regarding customer confidential information and support for individual privacy and civil liberties could cause us to experience adverse business and reputational consequences.
We strive to protect our customers’ confidential information and individuals’ privacy interests consistent with applicable laws, directives, and regulations. Consequently, we do not provide information about our customers to third parties without legal process. From time to time, government entities may seek our assistance with obtaining information about our customers or could request that we modify our technology platforms in a manner to permit access or monitoring. In light of our confidentiality and privacy commitments, we may legally challenge law enforcement or other government requests to provide information, to obtain encryption keys, or to modify or weaken encryption. To the extent that we do not provide assistance to or comply with requests from government entities, or if we challenge those requests publicly or in court, we may experience adverse political, business, and reputational consequences among certain customers or portions of the public. Conversely, to the extent that we do provide such assistance, or do not challenge those requests publicly in court, we may experience adverse political, business, and reputational consequences from other customers or portions of the public arising from concerns over privacy or the government’s activities.
Failure to adequately obtain, maintain, protect and enforce our intellectual property and other proprietary rights could adversely affect our business.
Our success and ability to compete depends in part on our ability to protect proprietary methods and technologies that we develop under a combination of patent and other intellectual property and proprietary rights in the United States and other jurisdictions outside the United States so that we can prevent others from using our inventions and proprietary information and technology. Despite our efforts, third parties may attempt to disclose, obtain, copy, or use our intellectual property or other proprietary information or technology without our authorization, and our efforts to protect our intellectual property and other proprietary rights may not prevent such unauthorized disclosure or use, misappropriation, infringement, reverse engineering or other violation of our intellectual property or other proprietary rights. Effective protection of our rights may not be available to us in every country in which our technology platforms or services are available. The laws of some countries may not be as protective of intellectual property and other proprietary rights as those in the United States, and mechanisms for enforcement of intellectual property and other proprietary rights may be inadequate. Also, our involvement in standard setting activity or the need to obtain licenses from others may require us to license our intellectual property. Accordingly, despite our efforts, we may be unable to prevent third parties from using our intellectual property or other proprietary information or technology.
In addition, we may be the subject of intellectual property infringement or misappropriation claims, which could be very time-consuming and expensive to settle or litigate and could divert our management’s attention and other resources. These claims could also subject us to significant liability for damages if we are found to have infringed patents, copyrights, trademarks, or other intellectual property rights, or breached trademark
co-existence
agreements or other intellectual property licenses and could require us to cease using or to rebrand all or portions of our platforms. Any of our patents, copyrights, trademarks, or other intellectual property rights may be challenged by others or invalidated through administrative process or litigation.
While we have issued patents and patent applications pending, we may be unable to obtain patent protection for the technology covered in our patent applications or such patent protection may not be obtained quickly enough to meet our business needs. Furthermore, the patent prosecution process is expensive, time-consuming, and complex, and we may not be able to prepare, file, prosecute, maintain, and enforce all necessary or desirable patent applications at a reasonable cost or in a timely manner. The scope of patent protection also can be reinterpreted after issuance and issued patents may be invalidated. Even if our patent applications do issue as patents, they may not issue in a form that is sufficiently broad to protect our technology, prevent competitors or other third parties form competing with us or otherwise provide us with any competitive advantage. Even if our patents issue in a form that covers our technology, enforcing patents against suspected infringers is time consuming, expensive and involves risks associated with litigation, including the risk the suspected infringers file counterclaims against us.
 
68

In addition, any of our patents, copyrights, trademarks, or other intellectual property or proprietary rights may be challenged, narrowed, invalidated, held unenforceable, or circumvented in litigation or other proceedings, including, where applicable, opposition,
re-examination,
inter partes review, post-grant review, interference, nullification and derivation proceedings, and equivalent proceedings in foreign jurisdictions, and such intellectual property or other proprietary rights may be lost or no longer provide us meaningful competitive advantages. Such proceedings may result in substantial cost and require significant time from our management, even if the eventual outcome is favorable to us. Third parties also may legitimately and independently develop products, services, and technology similar to or duplicative of our platforms. In addition to protection under intellectual property laws, we rely on confidentiality or license agreements that we generally enter into with our corporate partners, employees, consultants, advisors, vendors, and customers, and generally limit access to and distribution of our proprietary information. However, we cannot be certain that we have entered into such agreements with all parties who may have or have had access to our confidential information or that the agreements we have entered into will not be breached or challenged, or that such breaches will be detected. Furthermore,
non-disclosure
provisions can be difficult to enforce, and even if successfully enforced, may not be entirely effective. We cannot guarantee that any of the measures we have taken will prevent infringement, misappropriation, or other violation of our technology or other intellectual property or proprietary rights. Because we may be an attractive target for cyberattacks, we also may have a heightened risk of unauthorized access to, and misappropriation of, our proprietary and competitively sensitive information. We may be required to spend significant resources to monitor and protect our intellectual property and other proprietary rights, and we may conclude that in at least some instances the benefits of protecting our intellectual property or other proprietary rights may be outweighed by the expense or distraction to our management. We may initiate claims or litigation against third parties for infringement, misappropriation, or other violation of our intellectual property or other proprietary rights or to establish the validity of our intellectual property or other proprietary rights. Any such litigation, whether or not it is resolved in our favor, could be time-consuming, result in significant expense to us and divert the efforts of our technical and management personnel. Furthermore, attempts to enforce our intellectual property rights against third parties could also provoke these third parties to assert their own intellectual property or other rights against us, or result in a holding that invalidates or narrows the scope of our rights, in whole or in part.
We have been, and may in the future be, subject to intellectual property rights claims, which are extremely costly to defend, could require us to pay significant damages and could limit our ability to use certain technologies.
Our success and ability to compete also depends in part on our ability to operate without infringing, misappropriating or otherwise violating the intellectual property or other proprietary rights of third parties. Companies in the software and technology industries, including some of our current and potential competitors, own large numbers of patents, copyrights, trademarks and trade secrets and frequently pursue litigation based on allegations of infringement, misappropriation or other violations of intellectual property rights. In addition, many of these companies have the capability to dedicate substantial resources to enforce their intellectual property rights and to defend claims that may be brought against them. Such litigation also may involve
non-practicing
patent assertion entities or companies who use their patents as a means to extract license fees by threatening costly litigation or that have minimal operations or relevant product revenue and against whom our patents may provide little or no deterrence or protection. We have received notices, and may continue to receive notices in the future, that claim we have infringed, misappropriated, misused or otherwise violated other parties’ intellectual property rights, and, to the extent we become exposed to greater visibility, we face a higher risk of being the subject of intellectual property infringement, misappropriation or other violation claims, which is not uncommon with respect to software technologies in particular. There may be third-party intellectual property rights, including issued patents or pending patent applications, that cover significant aspects of our technologies, or business methods. There may also be third-party intellectual property rights, including trademark registrations and pending applications, that cover the goods and services that we offer in certain regions. We may also be exposed to increased risk of being the subject of intellectual property infringement, misappropriation, or other violation claims as a result of acquisitions and our incorporation of open source and other third-party software into, or new branding for, our technology platforms, as, among other things, we have a lower level of visibility into the development process with respect to such technology or the care taken to safeguard against infringement, misappropriation, or other violation risks. In addition, former employers of our current, former, or future employees may assert claims that such employees have improperly disclosed to us confidential or proprietary information of these former employers. Any intellectual property claims, with or without merit, are difficult to predict, could be very time-consuming and expensive to settle or litigate, could divert our management’s attention and other resources, and may not be covered by the insurance that we carry. These claims could subject us to significant liability for damages, potentially including treble damages if we are found to have willfully infringed a third party’s intellectual property rights. These claims could also result in our having to stop using technology, branding or marks found to be in violation of a third party’s rights and any necessary rebranding could result in the loss of goodwill. We could be required to seek a license for the intellectual property, which may not be available on commercially reasonable terms or at all. Even if a license were available, we could be required to pay significant royalties, which would increase our expenses. As a result, we could be required to develop alternative
non-infringing
technology, branding or marks, which could require significant effort and expense. If we cannot license rights or develop technology for any infringing aspect of our business, we would be forced to limit or stop sales of one or more of our platforms or features, we could lose existing customers, and we may be unable to compete effectively. Any of these results would harm our business, financial condition, and results of operations.
 
69

Further, our agreements with customers and other third parties may include indemnification provisions under which we agree to indemnify them for losses suffered or incurred as a result of third-party claims of intellectual property infringement, misappropriation, or other violations of intellectual property rights, damages caused by us to property or persons, or other liabilities relating to or arising from our platforms, services, or other contractual obligations. Large indemnity payments could harm our business, financial condition, and results of operations. Any dispute with a customer with respect to such obligations could have adverse effects on our relationship with that customer and other existing customers and new customers and harm our business and results of operations.
Real or perceived errors, failures, defects, or bugs in our platforms could adversely affect our results of operations and growth prospects.
Because we offer very complex technology platforms, undetected errors, defects, failures, or bugs may occur, especially when platforms or capabilities are first introduced or when new versions or other product or infrastructure updates are released. Our platforms are often installed and used in large-scale computing environments with different operating systems, software products and equipment, and data source and network configurations, which may cause errors or failures in our platforms or may expose undetected errors, failures, or bugs in our platforms. Despite testing by us, errors, failures, or bugs may not be found in new software or releases until after commencement of commercial shipments. In the past, errors have affected the performance of our platforms and can also delay the development or release of new platforms or capabilities or new versions of platforms, adversely affect our reputation and our customers’ willingness to buy platforms from us, and adversely affect market acceptance or perception of our platforms. Many of our customers use our platforms in applications that are critical to their businesses or missions and may have a lower risk tolerance to defects in our platforms than to defects in other, less critical, software products. Any errors or delays in releasing new software or new versions of platforms or allegations of unsatisfactory performance, errors, defects, or failures in released software could cause us to lose revenue or market share, increase our service costs, cause us to incur substantial costs in redesigning the software, cause us to lose significant customers, subject us to liability for damages and divert our resources from other tasks, any one of which could materially and adversely affect our business, results of operations and financial condition. In addition, our platforms could be perceived to be ineffective for a variety of reasons outside of our control. Hackers or other malicious parties could circumvent our or our customers’ security measures, and customers may misuse our platforms resulting in a security breach or perceived product failure.
Real or perceived errors, failures, or bugs in our platforms and services, or dissatisfaction with our services and outcomes, could result in customer terminations and/or claims by customers for losses sustained by them. In such an event, we may be required, or we may choose, for customer relations or other reasons, to expend additional resources in order to help correct any such errors, failures, or bugs. Although we have limitation of liability provisions in our standard software licensing and service agreement terms and conditions, these provisions may not be enforceable in some circumstances, may vary in levels of protection across our agreements, or may not fully or effectively protect us from such claims and related liabilities and costs. We generally provide a warranty for our software products and services and an SLA for our performance of software operations via our O&M services to customers. In the event that there is a failure of warranties in such agreements, we are generally obligated to correct the product or service to conform to the warranty provision as set forth in the applicable SLA, or, if we are unable to do so, the customer is entitled to seek a refund of the purchase price of the product and service (generally prorated over the contract term). The sale and support of our products also entail the risk of product liability claims. We maintain insurance to protect against certain claims associated with the use of our products, but our insurance coverage may not adequately cover any claim asserted against us. In addition, even claims that ultimately are unsuccessful could result in our expenditure of funds in litigation and divert management’s time and other resources.
In addition, our platforms integrate a wide variety of other elements, and our platforms must successfully interoperate with products from other vendors and our customers’ internally developed software. As a result, when problems occur for a customer using our platforms, it may be difficult to identify the sources of these problems, and we may receive blame for a security, access control, or other compliance breach that was the result of the failure of one of other elements in a customer’s or another vendor’s IT, security, or compliance infrastructure. The occurrence of software or errors in data, whether or not caused by our platforms, could delay or reduce market acceptance of our platforms and have an adverse effect on our business and financial performance, and any necessary revisions may cause us to incur significant expenses. The occurrence of any such problems could harm our business, financial condition, and results of operations. If an actual or perceived breach of information correctness, auditability, integrity, or availability occurs in one of our customers’ systems, regardless of whether the breach is attributable to our platforms, the market perception of the effectiveness of our platforms could be harmed. Alleviating any of these problems could require additional significant expenditures of our capital and other resources and could cause interruptions, delays, or cessation of our product licensing, which could cause us to lose existing or potential customers and could adversely affect our business, financial condition, results of operations, and growth prospects.
 
70

We rely on the availability of licenses to third-party technology that may be difficult to replace or that may cause errors or delay implementation of our platforms and services should we not be able to continue or obtain a commercially reasonable license to such technology.
Our technology platforms include software or other intellectual property licensed from third parties. It may be necessary in the future to renew licenses relating to various aspects of these platforms or to seek new licenses for existing or new platforms or other products. There can be no assurance that the necessary licenses would be available on commercially acceptable terms, if at all. Third parties may terminate their licenses with us for a variety of reasons, including actual or perceived failures or breaches of security or privacy, or reputational concerns, or they may choose not to renew their licenses with us. In addition, we may be subject to liability if third-party software that we license is found to infringe, misappropriate, or otherwise violate intellectual property or privacy rights of others. The loss of, or inability to obtain, certain third-party licenses or other rights or to obtain such licenses or rights on favorable terms, or the need to engage in litigation regarding these matters, could result in product roll-backs, delays in product releases until equivalent technology can be identified, licensed or developed, if at all, and integrated into our platforms, and may have a material adverse effect on our business, financial condition, and results of operations. Moreover, the inclusion in our platforms of software or other intellectual property licensed from third parties on a nonexclusive basis could limit our ability to differentiate our platforms from products of our competitors and could inhibit our ability to provide the current level of service to existing customers.
In addition, any data that we license from third parties for potential use in our platforms may contain errors or defects, which could negatively impact the analytics that our customers perform on or with such data. This may have a negative impact on how our platforms are perceived by our current and potential customers and could materially damage our reputation and brand.
Changes in or the loss of third-party licenses could lead to our platforms becoming inoperable or the performance of our platforms being materially reduced resulting in our potentially needing to incur additional research and development costs to ensure continued performance of our platforms or a material increase in the costs of licensing, and we may experience decreased demand for our platforms.
Our platforms contain “open source” software, and any failure to comply with the terms of one or more of these open source licenses could negatively affect our business.
Our technology platforms are distributed with software licensed by its authors or other third parties under “open source” licenses. Some of these licenses contain requirements that we make available source code for modifications or derivative works we create based upon the open source software, and that we license these modifications or derivative works under the terms of a particular open source license or other license granting third-parties certain rights of further use. If we combine our proprietary software with open source software in a certain manner, we could, under certain provisions of the open source licenses, be required to release the source code of our proprietary software. In addition to risks related to license requirements, usage of open source software can lead to greater risks than use of third-party commercial software, as open source licensors generally do not provide updates, warranties, support, indemnities, assurances of title, or controls on origin of the software, and are provided on an
“as-is”
basis. Likewise, some open source projects have known security and other vulnerabilities and architectural instabilities, or are otherwise subject to security attacks due to their wide availability, and are provided on an
“as-is”
basis. We have established processes to help alleviate these risks, including a review process for screening requests from our development organization for the use of open source software, and the use of software tools to review our source code for open source software, but we cannot be sure that all open source software is submitted for approval prior to use in our platforms or that such software tools will be effective. In addition, open source license terms may be ambiguous and many of the risks associated with usage of open source software cannot be eliminated, and could, if not properly addressed, negatively affect our business. If we were found to have inappropriately used open source software, we may be required to
re-engineer
our platforms, to release proprietary source code, to discontinue the sale of our platforms in the event
re-engineering
could not be accomplished on a timely basis, or to take other remedial action that may divert resources away from our development efforts, any of which could adversely affect our business, results of operations, financial condition, and growth prospects. In addition, if the open source software we use is no longer maintained by the relevant open source community, then it may be more difficult to make the necessary revisions to our software, including modifications to address security vulnerabilities, which could impact our ability to mitigate cybersecurity risks or fulfill our contractual obligations to our customers. We may also face claims from copyright owners seeking to enforce the terms of an open source license governing the software, including by demanding release of the open source software, derivative works or our proprietary source code that was developed using such software. Such claims, with or without merit, could result in litigation, could be time-consuming and expensive to settle or litigation, including copyright infringement claims, could divert our management’s attention and other resources, could require us to lease some of our proprietary code, or could require us to devote additional research and development resources to change our software, any of which could adversely affect our business.
 
71

Additionally, we have intentionally made certain proprietary software available on an open source basis, both by contributing modifications back to existing open source projects, and by making certain internally developed tools available pursuant to open source licenses, and we plan to continue to do so in the future. While we have established procedures, including a review process for any such contributions, which is designed to protect any code that may be competitively sensitive, we cannot guarantee that this process has always been applied consistently. Even when applied, because any software source code we contribute to open source projects is publicly available, our ability to protect our intellectual property rights with respect to such software source code may be limited or lost entirely, and we may be unable to prevent our competitors or others from using such contributed software source code for competitive purposes, or for commercial or other purposes beyond what we intended.
Many of these risks associated with usage of open source software could be difficult to eliminate or manage, and could, if not properly addressed, negatively affect the performance of our offerings and our business.
Risks Related to Legal, Regulatory, and Accounting
Our business is subject to complex and evolving U.S. and
non-U.S.
laws and regulations regarding privacy, data protection and security, technology protection, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or otherwise harm our business.
We are subject to a variety of local, state, national, and international laws, directives, and regulations in the United States and abroad that involve matters central to our business, including privacy and data protection, data security, data storage, retention, transfer and deletion, technology protection, and personal information. Foreign data protection, data security, privacy, and other laws and regulations can impose different obligations or be more restrictive than those in the United States. These U.S. federal and state and foreign laws and regulations, which, depending on the regime, may be enforced by private parties or government entities, are constantly evolving and can be subject to significant change, and they are likely to remain uncertain for the foreseeable future. In addition, the application, interpretation, and enforcement of these laws and regulations are often uncertain, particularly in the new and rapidly evolving software and technology industry in which we operate, and may be interpreted and applied inconsistently from country to country and inconsistently with our current policies and practices. A number of proposals are pending before U.S. federal, state, and foreign legislative and regulatory bodies that could significantly affect our business. For example, legal challenges in Europe to the mechanisms allowing companies to transfer personal data from the European Economic Area to certain other jurisdictions, including the United States, could result in further limitations on the ability to transfer data across borders, particularly if governments are unable or unwilling to reach new or maintain existing agreements that permit cross-border data transfers. The California state legislature passed the California Consumer Privacy Act (“CCPA”) in 2018 and California voters approved a ballot measure subsequently establishing the California Privacy Rights Act (“CPRA”) in 2020, which will jointly regulate the processing of personal information of California residents and increase the privacy and security obligations of entities handling certain personal information of California residents, including requiring covered companies to provide new disclosures to California consumers, and affords such consumers new abilities to
opt-out
of certain sales of personal information. The CCPA came into effect on January 1, 2020, and the California Attorney General may bring enforcement actions, with penalties for violations of the CCPA. The CPRA will go into effect on January 1, 2023 instilling enforcement authority in a new dedicated regulatory body, the California Privacy Protection Agency, which will begin carrying out enforcement actions as soon as six months after the enactment date. While aspects of both the CCPA and CPRA and their interpretations remain to be determined in practice, we are committed to complying with their applicable obligations. More generally, some observers have noted the CCPA could mark the beginning of a trend toward more stringent privacy legislation in the United States, as observed with the subsequent Virginia Consumer Data Protection Act (“CDPA”), enacted in March 2021 and scheduled to become effective on January 1, 2023, and the more recent Colorado Privacy Act (“CPA”), which was enacted in June 2021, will become effective on July 1, 2023. The CDPA and CPA are comprehensive privacy laws that share similarities with the CCPA, the CPRA, and legislation proposed in other states. We cannot yet fully predict the impact of the CCPA, CPRA, CDPA, CPA, and other new laws or regulations on our business or operations, but developments regarding these and all privacy and data protection laws and regulations around the world may require us to modify our data processing practices and policies and to incur substantial costs and expenses in an effort to maintain compliance on an ongoing basis. Outside of the United States, virtually every jurisdiction in which we operate has established its own legal framework relating to privacy, data protection, and information security matters with which we and/or our customers must comply. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage, retention, disclosure, security, transfer, and other processing of data that identifies or may be used to identify or locate an individual. Some countries and regions, including the European Union, are considering or have passed legislation that imposes significant obligations in connection with privacy, data protection, and information security that could increase the cost and complexity of delivering our platforms and services, including the European General Data Protection Regulation (“GDPR”) which took effect in May 2018. Complying with the GDPR or other data protection laws and regulations as they emerge may cause us to incur substantial operational costs or require us to modify our data handling practices on an ongoing basis.
Non-compliance
with the GDPR specifically may result in administrative fines or monetary penalties of up to 4% of worldwide annual revenue in the preceding financial year or €20 million (whichever is higher) for the most serious infringements, and could result in proceedings against us by governmental entities or other related parties and may otherwise adversely impact our business, financial condition, and results of operations.
 
72

The overarching complexity of laws and regulations relating to privacy, data protection, and information security around the world pose a compliance challenge that could manifest in costs, damages, or liability in other forms as a result of failure to implement proper programmatic controls, failure to adhere to those controls, or the malicious or inadvertent breach of applicable privacy and data protection requirements by us, our employees, our business partners, or our customers.
In addition to government regulation, self-regulatory standards and other industry standards may legally or contractually apply to us, be argued to apply to us, or we may elect to comply with such standards or to facilitate our customers’ compliance with such standards. Because privacy, data protection, and information security are critical competitive factors in our industry, we may make statements on our website, in marketing materials, or in other settings about our data security measures and our compliance with, or our ability to facilitate our customers’ compliance with, these standards. We also expect that there will continue to be new proposed laws and regulations concerning privacy, data protection, and information security, and we cannot yet determine the impact such future laws, regulations and standards, or amendments to or
re-interpretations
of existing laws and regulations, industry standards, or other obligations may have on our business. New laws, amendments to or
re-interpretations
of existing laws and regulations, industry standards, and contractual and other obligations may require us to incur additional costs and restrict our business operations. As these legal regimes relating to privacy, data protection, and information security continue to evolve, they may result in ever-increasing public scrutiny and escalating levels of enforcement and sanctions. Furthermore, because the interpretation and application of laws, standards, contractual obligations and other obligations relating to privacy, data protection, and information security are uncertain, these laws, standards, and contractual and other obligations may be interpreted and applied in a manner that is, or is alleged to be, inconsistent with our data management practices, our policies or procedures, or the features of our platforms, or we may simply fail to properly develop or implement our practices, policies, procedures, or features in compliance with such obligations. If so, in addition to the possibility of fines, lawsuits, and other claims, we could be required to fundamentally change our business activities and practices or modify our platforms, which could have an adverse effect on our business. We may be unable to make such changes and modifications in a commercially reasonable manner or at all, and our ability to fulfill existing obligations, make enhancements, or develop new platforms and features could be limited. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations, and policies that are applicable to the businesses of our customers may limit the use and adoption of, and reduce the overall demand for, our platforms.
These existing and proposed laws and regulations can be costly to comply with and can make our platforms and services less effective or valuable, delay or impede the development of new products, result in negative publicity, increase our operating costs, require us to modify our data handling practices, limit our operations, impose substantial fines and penalties, require significant management time and attention, or put our data or technology at risk. Any failure or perceived failure by us or our platforms to comply with the laws, regulations, directives, policies, industry standards, or legal obligations of the U.S., European Union, or other governmental or
non-governmental
bodies at the regional, national, or supra-national level relating to privacy, data protection, or information security, or any security incident that results in actual or suspected loss of or the unauthorized access to, or acquisition, use, release, or transfer of, personal information, personal data, or other customer or sensitive data or information may result in governmental investigations, inquiries, enforcement actions and prosecutions, private claims and litigation, indemnification or other contractual obligations, other remedies, including fines or demands that we modify or cease existing business practices, or adverse publicity, and related costs and liabilities, which could significantly and adversely affect our business and results of operations.
Our
non-U.S.
sales and operations subject us to additional risks and regulations that can adversely affect our results of operations.
Our successes to date have primarily come from customers in relatively stable and developed countries, but we are in the process of entering new and emerging markets in
non-U.S.
countries, including with
COVID-19
response efforts and defense, law enforcement, national security, and other government agencies, as part of our growth strategy. These new and emerging markets may involve uncertain business, technology, and economic risks and may be difficult or impossible for us to penetrate, even if we were to commit significant resources to do so.
We currently have sales personnel and sales and services operations in the United States and certain countries around the world. To the extent that we experience difficulties in recruiting, training, managing, or retaining
non-U.S.
staff, and specifically sales management and sales personnel staff, we may experience difficulties in sales productivity in, or market penetration of,
non-U.S.
markets. Our ability to convince customers to expand their use of our platforms or renew their subscription, license, or maintenance and service agreements with us is correlated to, among other things, our direct engagement with the customer. To the extent we are restricted or unable to engage with
non-U.S.
customers effectively with our limited sales force and services capacity, we may be unable to grow sales to existing customers to the same degree we have experienced in the United States.
 
73

Our
non-U.S.
operations subject us to a variety of risks and challenges, including:
 
 
Increased management, travel, infrastructure, and legal and financial compliance costs and time associated with having multiple
non-U.S.
operations, including but not limited to compliance with local employment laws and other applicable laws and regulations;
 
 
Longer payment cycles, greater difficulty in enforcing contracts, difficulties in collecting accounts receivable, especially in emerging markets, and the likelihood that revenue from
non-U.S.
system integrators, government contractors, and customers may need to be recognized when cash is received, at least until satisfactory payment history has been established, or upon confirmation of certain acceptance criteria or milestones;
 
 
The need to adapt our platforms for
non-U.S.
customers whether to accommodate customer preferences or local law;
 
 
Differing regulatory and legal requirements and possible enactment of additional regulations or restrictions on the use, import, or
re-export
of our platforms or the provision of services, which could delay, restrict, or prevent the sale or use of our platforms and services in some jurisdictions;
 
 
Compliance with multiple and changing foreign laws and regulations, including those governing employment, privacy, data protection, information security, data transfer, and the risks and costs of
non-compliance
with such laws and regulations;
 
 
New and different sources of competition not present in the United States;
 
 
Heightened risks of unfair or corrupt business practices in certain geographies and of improper or fraudulent sales arrangements that may cause us to withdraw from particular markets, or impact financial results and result in restatements of financial statements and irregularities in financial statements;
 
 
Volatility in
non-U.S.
political and economic environments, including by way of examples, the potential effects of
COVID-19
and the United Kingdom’s departure from the European Union;
 
 
Weaker protection of intellectual property rights in some countries and the risk of potential theft, copying, or other compromises of our technology, data, or intellectual property in connection with our
non-U.S.
operations, whether by state-sponsored malfeasance or other foreign entities or individuals;
 
 
Volatility and fluctuations in currency exchange rates, including that, because many of our
non-U.S.
contracts are denominated in U.S. dollars, an increase in the strength of the U.S. dollar may make doing business with us less appealing to a
non-U.S.
dollar denominated customer;
 
 
Management and employee communication and integration problems resulting from language differences, cultural differences, and geographic dispersion;
 
 
Difficulties in repatriating or transferring funds from, or converting currencies in, certain countries;
 
 
Potentially adverse tax consequences, including multiple and possibly overlapping tax regimes, the complexities of foreign value-added tax systems, and changes in tax laws;
 
 
Lack of familiarity with local laws, customs, and practices, and laws and business practices favoring local competitors or partners; and
 
 
Interruptions to our business operations and our customers’ business operations subject to events such as war, incidents of terrorism, natural disasters, public health concerns or epidemics (such as the
COVID-19
pandemic), shortages or failures of power, internet, telecommunications, or hosting service providers, cyberattacks or malicious acts, or responses to these events.
In addition to the factors above, foreign governments may take administrative, legislative, or regulatory action that could materially interfere with our ability to sell our platforms in certain countries. For example, foreign governments may require a percentage of prime contracts be fulfilled by local contractors or provide special incentives to government-backed local customers to buy from local competitors, even if their products are inferior to ours. Moreover, both the U.S. government and foreign governments may regulate the acquisition of or import of our technologies or our entry into certain foreign markets or partnership with foreign third parties through investment screening or other regulations. Such regulations may apply to certain
non-U.S.
joint ventures, platform partnerships and strategic alliances that may be integral to our long-term business strategy.
 
74

Compliance with laws and regulations applicable to our
non-U.S.
operations increases our cost of doing business in foreign jurisdictions. We may be unable to keep current with changes in foreign government requirements and laws as they change from time to time. Failure to comply with these regulations could subject us to investigations, sanctions, enforcement actions, disgorgement of profits, fines, damages, civil and criminal penalties, injunctions, or other collateral consequences. In many foreign countries, it is common for others to engage in business practices that are prohibited by our internal policies and procedures or U.S. regulations applicable to us. In addition, although we have implemented policies and procedures designed to ensure compliance with these laws and policies, there can be no assurance that all of our employees, contractors, partners, and agents will comply with these laws and policies. Violations of laws or key control policies by our employees, contractors, partners, or agents could result in delays in revenue recognition, financial reporting misstatements, governmental sanctions, fines, penalties, or the prohibition of the importation or exportation of our platforms. In addition, responding to any action may result in a significant diversion of management’s attention and resources and an increase in professional fees. Enforcement actions and sanctions or failure to prevail in any possible civil or criminal litigation could harm our business, reputation, financial condition, and results of operations.
Also, we are expanding operations, including our work with existing commercial customers, into countries in Asia, Europe, the Middle East, and elsewhere, which may place restrictions on the transfer of data and potentially the import and use of foreign encryption technology. Any of these risks could harm our
non-U.S.
operations and reduce our
non-U.S.
sales, adversely affecting our business, results of operations, financial condition, and growth prospects.
Some of our business partners also have
non-U.S.
operations and are subject to the risks described above. Even if we are able to successfully manage the risks of our own
non-U.S.
operations, our business may be adversely affected if our business partners are not able to successfully manage these risks.
Failure to comply with governmental laws and regulations could harm our business, and we have been, and expect to be, the subject of legal and regulatory inquiries, which may result in monetary payments or may otherwise negatively impact our reputation, business, and results of operations.
Our business is subject to regulation by various federal, state, local, and foreign governments in which we operate. In certain jurisdictions, the regulatory requirements imposed by foreign governments may be more stringent than those in the United States. Noncompliance with applicable regulations or requirements could subject us to investigations, administrative proceedings, sanctions, enforcement actions, disgorgement of profits, fines, damages, litigation, civil and criminal penalties, termination of contracts, exclusion from sales channels or sales opportunities, injunctions, or other consequences. Such matters may include, but are not limited to, claims, disputes, allegations, or investigations related to alleged violations of laws or regulations relating to anti-corruption requirements, lobbying or
conflict-of-interest
requirements, export or other trade controls, data privacy or data protection requirements, or laws or regulations relating to employment, procurement, cybersecurity, securities, or antitrust/competition requirements. The effects of recently imposed and proposed actions are uncertain because of the dynamic nature of governmental action and responses. We may be subject to government inquiries that drain our time and resources, tarnish our brand among customers and potential customers, prevent us from doing business with certain customers or markets, including government customers, affect our ability to hire, attract and maintain qualified employees, or require us to take remedial action or pay penalties. From time to time, we receive formal and informal inquiries from governmental agencies and regulators regarding our compliance with laws and regulations or otherwise relating to our business or transactions. Any negative outcome from such inquiries or investigations or failure to prevail in any possible civil or criminal litigation could adversely affect our business, reputation, financial condition, results of operations, and growth prospects.
We have previously been, and may currently or in the future become, involved in a number of legal, regulatory, and administrative inquiries and proceedings, and unfavorable outcomes in litigation or other of these matters could negatively impact our business, financial conditions, and results of operations.
We have previously been, may currently be, and from time to time going forward may become involved in and subject to regulatory or other governmental inquiries or investigations, or governmental or private-party litigation or proceedings for a variety of claims or disputes. These claims, lawsuits, and proceedings could involve labor and employment, discrimination and harassment, commercial disputes, intellectual property rights (including patent, trademark, copyright, trade secret, and other proprietary rights), class actions, general contract, tort, defamation, data privacy rights, antitrust, common law fraud, government regulation, or compliance, alleged federal and state securities and “blue sky” law violations or other investor claims, and other matters. Derivative claims, lawsuits, and proceedings, which may, from time to time, be asserted against our directors by our stockholders, could involve breach of fiduciary duty, failure of oversight, corporate waste claims, and other matters. One of our stockholders with respect to whom we are currently engaged in litigation as described in the notes to our condensed consolidated financial statements has threatened to bring various of these claims. In addition, our business and results may be adversely affected by the outcome of any currently pending or any future legal, regulatory, and/or administrative claims or proceedings, including through monetary damages or injunctive relief.
 
75

The number and significance of our legal disputes and inquiries may increase as we continue to grow larger, as our business expands in employee headcount, scope, and geographic reach, and as our platforms and services become more complex. Additionally, if customers fail to pay us under the terms of our agreements, we may be adversely affected due to the cost of enforcing the terms of our contracts through litigation. Litigation or other proceedings can be expensive and time consuming and can divert our resources and leadership’s attention from our primary business operations. The results of our litigation also cannot be predicted with certainty. If we are unable to prevail in litigation, we could incur payments of substantial monetary damages or fines, or undesirable changes to our platforms or business practices, and accordingly, our business, financial condition, or results of operations could be materially and adversely affected. Furthermore, if we accrue a loss contingency for pending litigation and determine that it is probable, any disclosures, estimates, and reserves we reflect in our financial statements with regard to these matters may not reflect the ultimate disposition or financial impact of litigation or other such matters. These proceedings could also result in negative publicity, which could harm customer and public perception of our business, regardless of whether the allegations are valid or whether we are ultimately found liable. Additional information regarding certain of the lawsuits we are involved in is described further in
Note 8. Commitments and Contingencies
in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form
10-Q.
Failure to comply with anti-bribery and anti-corruption laws could subject us to penalties and other adverse consequences.
As we operate and sell our platforms and services around the world, we are subject to the United States Foreign Corrupt Practices Act (“FCPA”), the UK Bribery Act, the U.S. domestic bribery statute contained in 18 U.S.C. § 201, the United States Travel Act, and other anti-corruption and anti-bribery laws and regulations in the jurisdictions in which we do business, both domestic and abroad. These laws and regulations generally prohibit improper payments or offers of improper payments to government officials, political parties, or commercial partners for the purpose of obtaining or retaining business or securing an improper business advantage.
We have operations, deal with and make sales to governmental or quasi-governmental entities in the United States and in
non-U.S.
countries, including those known to experience corruption, particularly certain emerging countries in East Asia, Eastern Europe, Africa, South America, and the Middle East, and further expansion of our
non-U.S.
sales efforts may involve additional regions.
Corruption issues pose a risk in every country and jurisdiction, but in many countries, particularly in countries with developing economies, it may be more common for businesses to engage in practices that are prohibited by the FCPA or other applicable laws and regulations, and our activities in these countries pose a heightened risk of unauthorized payments or offers of payments by one of our employees or third-party business partners, representatives, and agents that could be in violation of various laws including the FCPA. The FCPA, U.K. Bribery Act and other applicable anti-bribery and anti-corruption laws also may hold us liable for acts of corruption and bribery committed by our third-party business partners, representatives, and agents. We and our third-party business partners, representatives, and agents may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities and we may be held liable for the corrupt or other illegal activities of our employees or such third parties even if we do not explicitly authorize such activities. The FCPA or other applicable laws and regulations laws also require that we keep accurate books and records and maintain internal controls and compliance procedures designed to prevent any such actions. While we have implemented policies and procedures to address compliance with such laws, we cannot assure you that our employees or other third parties working on our behalf will not engage in conduct in violation of our policies or applicable law for which we might ultimately be held responsible. Violations of the FCPA, the UK Bribery Act, and other laws may result in whistleblower complaints, adverse media coverage, investigations, imposition of significant legal fees, loss of export privileges, as well as severe criminal or civil sanctions, including suspension or debarment from U.S. government contracting, and we may be subject to other liabilities and adverse effects on our reputation, which could negatively affect our business, results of operations, financial condition, and growth prospects. In addition, responding to any enforcement action may result in a significant diversion of management’s attention and resources and significant defense costs and other professional fees. Our exposure for violating these laws increases as our
non-U.S.
presence expands and as we increase sales and operations in foreign jurisdictions.
Governmental trade controls, including export and import controls, sanctions, customs requirements, and related regimes, could subject us to liability or loss of contracting privileges or limit our ability to compete in certain markets.
Our offerings are subject to U.S. export controls, and we incorporate encryption technology into certain of our offerings. Our controlled software offerings and the underlying technology may be exported outside of the United States only with the required export authorizations, which may include license requirements in some circumstances. Additionally, our current or future products may be classified under the Commerce Department Export Administration Regulations (“EAR”) or as defense articles subject to the United States International Traffic in Arms Regulations (“ITAR”). Most of our products, including our core software platforms, have been classified under the EAR and are generally exportable without needing a specific license, under an EAR exception for encrypted software. If a product, or component of a product, is classified under the ITAR, or is ineligible for the EAR encryption exception, then those products could be exported outside the United States only if we obtain the applicable export license or qualify for a different license exception. In certain contexts, the services we provide might be classified as defense services subject to the ITAR separately from the products we provide. Compliance with the EAR, ITAR, and other applicable regulatory requirements regarding the export of our products, including new releases of our products and/or the performance of services, may create delays in the introduction of our products in
non-U.S.
markets, prevent our customers with
non-U.S.
operations from deploying our products throughout their global systems or, in some cases, prevent the export of our products to some countries altogether.
 
76

Furthermore, our activities are subject to the economic sanctions, laws and regulations of the United States and other jurisdictions. Such controls prohibit the shipment or transfer of certain products and services without the required export authorizations or export to countries, governments, and persons targeted by applicable sanctions. We take precautions to prevent our offerings from being exported in violation of these laws, including: (i) seeking to proactively classify our platforms and obtain authorizations for the export and/or import of our platforms where appropriate, (ii) implementing certain technical controls and screening practices to reduce the risk of violations, and (iii) requiring compliance with U.S. export control and sanctions obligations in customer and vendor contracts. However, we cannot guarantee the precautions we take will prevent violations of export control and sanctions laws.
As discussed above, if we misclassify a product or service, export or provide access to a product or service in violation of applicable restrictions, or otherwise fail to comply with export regulations, we may be denied export privileges or subjected to significant per violation fines or other penalties, and our platforms may be denied entry into other countries. Any decreased use of our platforms or limitation on our ability to export or sell our platforms would likely adversely affect our business, results of operations and financial condition. Violations of U.S. sanctions or export control laws can result in fines or penalties, including civil penalties of over $300,000 or twice the value of the transaction, whichever is greater, per EAR violation and a civil penalty of over $1,000,000 for ITAR violations. In the event of criminal knowing and willful violations of these laws, fines of up to $1,000,000 per violation and possible incarceration for responsible employees and managers could be imposed.
We also note that if we or our business partners or counterparties, including licensors and licensees, prime contractors, subcontractors, sublicensors, vendors, customers, shipping partners, or contractors, fail to obtain appropriate import, export, or
re-export
licenses or permits, notwithstanding regulatory requirements or contractual commitments to do so, or if we fail to secure such contractual commitments where necessary, we may also be adversely affected, through reputational harm as well as other negative consequences, including government investigations and penalties. For instance, violations of U.S. sanctions or export control laws can result in fines or penalties, including significant civil and criminal penalties per violation, depending on the circumstances of the violation or violations.
Negative consequences for violations or apparent violations of trade control requirements may include the absolute loss of the right to sell our platforms or services to the government of the United States, or to other public bodies, or a reduction in our ability to compete for such sales opportunities. Further, complying with export control and sanctions regulations for a particular sale may be time-consuming and may result in the delay or loss of sales opportunities.
Also, various countries, in addition to the United States, regulate the import and export of certain encryption and other technology, including import and export permitting and licensing requirements, and have enacted laws that could limit our ability to distribute our platforms or could limit our customers’ abilities to implement our platforms in those countries. Any new export restrictions, new legislation, changes in economic sanctions, or shifting approaches in the enforcement or scope of existing regulations, or in the countries, persons, or technologies targeted by such regulations, could result in decreased use of our platforms by existing customers with
non-U.S.
operations, declining adoption of our platforms by new customers with
non-U.S.
operations, limitation of our expansion into new markets, and decreased revenue.
Changes in accounting principles or their application to us could result in unfavorable accounting charges or effects, which could adversely affect our results of operations and growth prospects.
We prepare our condensed consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”). In particular, we make certain estimates and assumptions related to the adoption and interpretation of these principles including the recognition of our revenue, the accounting for our provision for income taxes, and stock-based compensation expense with respect to our financial statements. If these assumptions turn out to be incorrect, our financial results and position could materially differ from our expectations and could be materially adversely affected. A change in any of these principles or guidance, or in their interpretations or application to us, may have a significant effect on our reported results, as well as our processes and related controls, and may retroactively affect previously reported results or our forecasts, which may negatively impact our financial statements.
 
77

If our judgments or estimates relating to our critical accounting policies are based on assumptions that change or prove to be incorrect, our results of operations could fall below expectations of securities analysts and investors, resulting in a decline in our stock price.
The preparation of our financial statements in conformity with GAAP requires management to make judgments, estimates, and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, as provided in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” the results of which form the basis for making judgments about the carrying values of assets, liabilities, and equity, and the amount of revenue and expenses that are not readily apparent from other sources. Our results of operations may be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could cause our results of operations to fall below the expectations of securities analysts and investors, resulting in a decline in the trading price of our Class A common stock. Significant judgments, estimates, and assumptions used in preparing our condensed consolidated financial statements include, or may in the future include, those related to revenue recognition, income taxes, and stock-based compensation.
We could be subject to additional tax liabilities.
We are subject to federal, state, and local income taxes in the U.S. and numerous foreign jurisdictions. Determining our provision for income taxes requires significant management judgment, and the ultimate tax outcome may be uncertain. In addition, our provision for income taxes is subject to volatility and could be adversely affected by many factors, including, among other things, changes to our operating or holding structure, changes in the amounts of earnings in jurisdictions with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, and changes in U.S. and foreign tax laws. Tax authorities in the United States and various foreign jurisdictions may disagree with our calculation of research and development tax credits, cross-jurisdictional transfer pricing, or other matters and assess additional taxes, interest or penalties. While we regularly assess the likely outcomes of these examinations to determine the adequacy of our provision for income taxes and we believe that our financial statements reflect adequate reserves to cover any such contingencies, there can be no assurance that the outcomes of such examinations will not have a material impact on our results of operations and cash flows. If U.S. or other foreign tax authorities change applicable tax laws, our overall taxes could increase, and our financial condition or results of operations may be adversely impacted.
We may not be able to utilize a significant portion of our net operating loss carry-forwards and tax credits, which could adversely affect our results of operations.
We record an asset for the future tax benefits from unused U.S. federal, state, and
non-U.S.
net operating losses (“NOLs”) and tax credits subject to a full valuation allowance. Federal, state, and
non-U.S.
taxing bodies often place limitations on NOLs and tax credit carryforward benefits. As a result, we may not be able to utilize the net operating and tax credit assets reflected on our balance sheet. In general, under Section 382 of the United States Internal Revenue Code of 1986 (the “Code”), a corporation that undergoes an ownership change is subject to limitations on its ability to utilize its
pre-change
NOLs to offset future taxable income. Future changes in our stock ownership, some of which are outside of our control, could result in an ownership change under Section 382 of the Code. If our existing NOLs are subject to limitations arising from an ownership change, our ability to utilize NOLs could be limited by Section 382 of the Code, and a certain amount of our prior year NOLs could expire without benefit. Changes in the law may also impact our ability to use our NOLs and tax credit carryforwards.
There is also a risk that the expiration of our existing NOLs or tax credits or a limitation on their use to offset future income tax liabilities could result from statutory or regulatory changes, especially in reaction to the
COVID-19
pandemic.
Our results of operations may be harmed if we are required to collect sales or other related taxes for our license arrangements in jurisdictions where we have not historically done so.
States and some local taxing jurisdictions have differing rules and regulations governing sales and use taxes, and these rules and regulations are subject to varying interpretations that may change over time. We collect and remit U.S. sales and use tax, value-added tax (“VAT”), and goods and services tax (“GST”) in a number of jurisdictions. It is possible, however, that we could face sales tax, VAT, or GST audits and that our liability for these taxes could exceed our estimates as state and
non-U.S.
tax authorities could still assert that we are obligated to collect additional tax amounts from our customers and remit those taxes to those authorities. We could also be subject to audits in states and
non-U.S.
jurisdictions for which we have not accrued tax liabilities. One or more states or countries may seek to impose incremental or new sales, use, or other tax collection obligations on us or may determine that such taxes should have, but have not been, paid by us.
 
78

Risks Related to Relationships and Business with the Public Sector
A significant portion of our business depends on sales to the public sector, and our failure to receive and maintain government contracts or changes in the contracting or fiscal policies of the public sector could have a material adverse effect on our business.
We derive a significant portion of our revenue from contracts with federal, state, local, and foreign governments and government agencies, and we believe that the success and growth of our business will continue to depend on our successful procurement of government contracts. For example, we have historically derived, and expect to continue to derive, a significant portion of our revenue from sales to agencies of the U.S. federal government, either directly by us or through other government contractors. Our perceived relationship with the U.S. government could adversely affect our business prospects in certain
non-U.S.
geographies or with certain
non-U.S.
governments.
Sales to such government agencies are subject to a number of challenges and risks. Selling to government agencies can be highly competitive, expensive, and time-consuming, often requiring significant upfront time and expense without any assurance that these efforts will generate a sale. We also must comply with laws and regulations relating to the formation, administration, and performance of contracts, which provide public sector customers rights, many of which are not typically found in commercial contracts.
Accordingly, our business, financial condition, results of operations, and growth prospects may be adversely affected by certain events or activities, including, but not limited to:
 
 
Changes in fiscal or contracting policies or decreases in available government funding;
 
 
Changes in government programs or applicable requirements;
 
 
Restrictions in the grant of personnel security clearances to our employees;
 
 
Ability to maintain facility clearances required to perform on classified contracts for U.S. federal government and foreign government agencies;
 
 
Changes in the political environment, including before or after a change to the leadership within the government administration, and any resulting uncertainty or changes in policy or priorities and resultant funding;
 
 
Changes in the government’s attitude towards the capabilities that we offer, especially in the areas of national defense, cybersecurity, and critical infrastructure, including the financial, energy, telecommunications, and healthcare sectors;
 
 
Changes in the government’s attitude towards us as a company or our platforms as viable or acceptable software solutions;
 
 
Appeals, disputes, or litigation relating to government procurement, including but not limited to bid protests by unsuccessful bidders on potential or actual awards of contracts to us or our partners by the government;
 
 
The adoption of new laws or regulations or changes to existing laws or regulations;
 
 
Budgetary constraints, including automatic reductions as a result of “sequestration” or similar measures and constraints imposed by any lapses in appropriations for the federal government or certain of its departments and agencies;
 
 
Influence by, or competition from, third parties with respect to pending, new, or existing contracts with government customers;
 
 
Changes in political or social attitudes with respect to security or data privacy issues;
 
 
Potential delays or changes in the government appropriations or procurement processes, including as a result of events such as war, incidents of terrorism, natural disasters, and public health concerns or epidemics, such as the coronavirus pandemic; and
 
 
Increased or unexpected costs or unanticipated delays caused by other factors outside of our control, such as performance failures of our subcontractors.
 
79

Any such event or activity, among others, could cause governments and governmental agencies to delay or refrain from purchasing our platforms and services in the future, reduce the size or payment amounts of purchases from existing or new government customers, or otherwise have an adverse effect on our business, results of operations, financial condition, and growth prospects.
We have contracts with governments that involve classified programs, which may limit investor insight into portions of our business.
We derive a portion of our revenue from programs with governments and government agencies that are subject to security restrictions (e.g., contracts involving classified information, classified contracts, and classified programs), which preclude the dissemination of information and technology that is classified for national security purposes under applicable law and regulation. In general, access to classified information, technology, facilities, or programs requires appropriate personnel security clearances, is subject to additional contract oversight and potential liability, and may also require appropriate facility clearances and other specialized infrastructure. In the event of a security incident involving classified information, technology, facilities, or programs or personnel holding clearances, we may be subject to legal, financial, operational, and reputational harm. We are limited in our ability to provide specific information about these classified programs, their risks, or any disputes or claims relating to such programs. As a result, investors have less insight into our classified programs than our other businesses and therefore less ability to fully evaluate the risks related to our classified business or our business overall. However, historically the business risks associated with our work on classified programs have not differed materially from those of our other government contracts.
Our business could be adversely affected if our employees cannot obtain and maintain required personnel security clearances or we cannot establish and maintain a required facility security clearance.
Certain government contracts may require our employees to maintain various levels of security clearances and may require us to maintain a facility security clearance to comply with U.S. and international government agency requirements. Many governments have strict security clearance requirements for personnel who perform work in support of classified programs. Obtaining and maintaining security clearances for employees typically involves a lengthy process, and it can be difficult to identify, recruit, and retain employees who already hold security clearances. If our employees are unable to obtain security clearances in a timely manner, or at all, or if our employees who hold security clearances are unable to maintain their clearances or terminate employment with us, then we may be unable to comply with relevant U.S. and international government agency requirements, or our customers requiring classified work could choose to terminate or decide not to renew one or more contracts requiring employees to obtain or maintain security clearances upon expiration. To the extent we are not able to obtain or maintain a facility security clearance, we may not be able to bid on or win new classified contracts, and existing contracts requiring a facility security clearance could be terminated, either of which would have an adverse impact on our business, financial condition, and results of operations.
The majority of our customer contracts may be terminated by the customer at any time for convenience and may contain other provisions permitting the customer to discontinue contract performance, and if terminated contracts are not replaced, our results of operations may differ materially and adversely from those anticipated. In addition, our contracts with government customers often contain provisions with additional rights and remedies favorable to such customers that are not typically found in commercial contracts.
The majority of our contracts, including our government contracts, contain termination for convenience provisions. Customers that terminate such contracts may also be entitled to a pro rata refund of the amount of the customer deposit for the period of time remaining in the contract term after the applicable termination notice period expires. Government contracts often contain provisions and are subject to laws and regulations that provide government customers with additional rights and remedies not typically found in commercial contracts. These rights and remedies allow government customers, among other things, to:
 
 
Terminate existing contracts for convenience with short notice;
 
 
Reduce orders under or otherwise modify contracts;
 
 
For contracts subject to the Truth in Negotiations Act, reduce the contract price or cost where it was increased because a contractor or subcontractor furnished cost or pricing data during negotiations that was not complete, accurate, and current;
 
 
For some contracts, (i) demand a refund, make a forward price adjustment, or terminate a contract for default if a contractor provided inaccurate or incomplete data during the contract negotiation process and (ii) reduce the contract price under triggering circumstances, including the revision of price lists or other documents upon which the contract award was predicated;
 
80

 
Cancel multi-year contracts and related orders if funds for contract performance for any subsequent year become unavailable;
 
 
Decline to exercise an option to renew a multi-year contract or issue task orders in connection with indefinite delivery/indefinite quantity (“IDIQ”) contracts;
 
 
Claim rights in solutions, systems, or technology produced by us, appropriate such work-product for their continued use without continuing to contract for our services, and disclose such work-product to third parties, including other government agencies and our competitors, which could harm our competitive position;
 
 
Prohibit future procurement awards with a particular agency due to a finding of organizational conflicts of interest based upon prior related work performed for the agency that would give a contractor an unfair advantage over competing contractors, or the existence of conflicting roles that might bias a contractor’s judgment;
 
 
Subject the award of contracts to protest by competitors, which may require the contracting federal agency or department to suspend our performance pending the outcome of the protest and may also result in a requirement to resubmit offers for the contract or in the termination, reduction, or modification of the awarded contract;
 
 
Suspend or debar us from doing business with the applicable government; and
 
 
Control or prohibit the export of our services.
If a customer were to unexpectedly terminate, cancel, or decline to exercise an option to renew with respect to one or more of our significant contracts, or if a government were to suspend or debar us from doing business with such government, our business, financial condition, and results of operations would be materially harmed.
Failure to comply with laws, regulations, or contractual provisions applicable to our business could cause us to lose government customers or our ability to contract with the U.S. and other governments.
As a government contractor, we must comply with laws, regulations, and contractual provisions relating to the formation, administration, and performance of government contracts and inclusion on government contract vehicles, which affect how we and our partners do business with government agencies. As a result of actual or perceived noncompliance with government contracting laws, regulations, or contractual provisions, we may be subject to audits and internal investigations which may prove costly to our business financially, divert management time, or limit our ability to continue selling our platforms and services to our government customers. These laws and regulations may impose other added costs on our business, and failure to comply with these or other applicable regulations and requirements, including
non-compliance
in the past, could lead to claims for damages from our channel partners, penalties, and termination of contracts and suspension or debarment from government contracting for a period of time with government agencies. Any such damages, penalties, disruption, or limitation in our ability to do business with a government could adversely impact, and could have a material adverse effect on, our business, results of operations, financial condition, public perception, and growth prospects.
Evolving government procurement policies and increased emphasis on cost over performance could adversely affect our business.
Federal, state, local, and foreign governments and government agencies could implement procurement policies that negatively impact our profitability. Changes in procurement policy favoring more
non-commercial
purchases, different pricing, or evaluation criteria or government contract negotiation offers based upon the customer’s view of what our pricing should be may affect the predictability of our margins on such contracts or make it more difficult to compete on certain types of programs.
Governments and government agencies are continually evaluating their contract pricing and financing practices, and we have no assurance regarding the full scope and recurrence of any study and what changes will be proposed, if any, and their impact on our financial position, cash flows, or results of operations.
Increased competition and bid protests in a budget-constrained environment may make it more difficult to maintain our financial performance and customer relationships.
A substantial portion of our business is awarded through competitive bidding. Even if we are successful in obtaining an award, we may encounter bid protests from unsuccessful bidders on any specific award. Bid protests could result, among other things, in significant expenses to us, contract modifications, or even loss of the contract award. Even where a bid protest does not result in the loss of a contract award, the resolution can extend the time until contract activity can begin and, as a result, delay the recognition of revenue. We also may not be successful in our efforts to protest or challenge any bids for contracts that were not awarded to us, and we would be required to incur significant time and expense in such efforts.
 
81

In addition, governments and agencies increasingly have relied on competitive contract award types, including IDIQ and other multi-award contracts, which have the potential to create pricing pressure and to increase our costs by requiring us to submit multiple bids and proposals. Multi-award contracts require us to make sustained efforts to obtain orders under the contract. The competitive bidding process entails substantial costs and managerial time to prepare bids and proposals for contracts that may not be awarded to us or may be split among competitors.
We are experiencing increased competition while, at the same time, many of our customers are facing budget pressures, cutting costs, identifying more affordable solutions, performing certain work internally rather than hiring contractors, and reducing product development cycles. To remain competitive, we must maintain consistently strong customer relationships, seek to understand customer priorities, and provide superior performance, advanced technology solutions, and service at an affordable cost with the agility that our customers require to satisfy their objectives in an increasingly price competitive environment. Failure to do so could have an adverse impact on our business, financial condition, and results of operations.
The U.S. government may procure
non-commercial
developmental services rather than commercial products, which could materially impact our future U.S. government business and revenue.
U.S. government agencies, including our customers, often award large developmental item and service contracts to build custom software rather than firm fixed-price contracts for commercial products. We sell commercial items and services and do not contract for
non-commercial
developmental services. The U.S. government is required to procure commercial items and services to the maximum extent practicable in accordance with FASA, 10 U.S.C. § 2377; 41 U.S.C. § 3307, and the U.S. government may instead decide to procure
non-commercial
developmental items and services if commercial items and services are not practicable. In order to challenge a government decision to procure developmental items and services instead of commercial items and services, we would be required to file a bid protest at the agency level and/or with the Government Accountability Office. This can result in contentious communications with government agency legal and contracting offices, and may escalate to litigation in federal court. The results of any future challenges or potential litigation cannot be predicted with certainty, however, and any dispute or litigation with the U.S. government may not be resolved in our favor; moreover, whether or not it is resolved in our favor, such disputes or litigation could result in significant expense and divert the efforts of our technical and management personnel. These proceedings could adversely affect our reputation and relationship with government customers and could also result in negative publicity, which could harm customer and public perception of our business. The enforcement of FASA has resulted in a significant increase in our business with the U.S. federal government. Any change in or repeal of FASA, or a contrary interpretation of FASA by a court of competent jurisdiction, would adversely affect our competitive position for U.S. federal government contracts.
A decline in the U.S. and other government budgets, changes in spending or budgetary priorities, or delays in contract awards may significantly and adversely affect our future revenue and limit our growth prospects.
Because we generate a substantial portion of our revenue from contracts with governments and government agencies, and in particular from contracts with the U.S. government and government agencies, our results of operations could be adversely affected by government spending caps or changes in government budgetary priorities, as well as by delays in the government budget process, program starts, or the award of contracts or orders under existing contract vehicles, including as a result of a new U.S. administration. Current U.S. government spending levels for defense-related and other programs may not be sustained beyond government fiscal year 2021. Future spending and program authorizations may not increase or may decrease or shift to programs in areas in which we do not provide services or are less likely to be awarded contracts. Such changes in spending authorizations and budgetary priorities may occur as a result of shifts in spending priorities from defense-related and other programs as a result of competing demands for federal funds and the number and intensity of military conflicts or other factors.
The U.S. government also conducts periodic reviews of U.S. defense strategies and priorities which may shift Department of Defense budgetary priorities, reduce overall spending, or delay contract or task order awards for defense-related programs from which we would otherwise expect to derive a significant portion of our future revenue. A significant decline in overall U.S. government spending, a significant shift in spending priorities, the substantial reduction or elimination of particular defense-related programs, or significant budget-related delays in contract or task order awards for large programs could adversely affect our future revenue and limit our growth prospects.
 
82

Risks Related to Ownership of Our Class A Common Stock
The public trading price of our Class A common stock may be volatile and may decline regardless of our operating performance.
Prior to the listing of our Class A common stock, there was no public market for shares of our Class A common stock. The market prices of the securities of other newly public companies have historically been highly volatile. The public trading price of our Class A common stock could be subject to fluctuations in response to various factors, including those listed in this Quarterly Report on Form
10-Q,
some of which are beyond our control. These fluctuations could cause you to lose all or part of your investment in our Class A common stock since you might be unable to sell your shares at or above the price you paid. Factors that could cause fluctuations in the public trading price of our Class A common stock include the following:
 
 
The number of shares of our Class A common stock publicly owned and available for trading;
 
 
Price and volume fluctuations in the overall stock market from time to time;
 
 
Volatility in the trading prices and trading volumes of technology stocks;
 
 
Changes in operating performance and stock market valuations of other technology companies generally, or those in our industry in particular;
 
 
Sales or expected sales of shares of our Class A common stock by us or our stockholders;
 
 
Short-selling of our Class A common stock or related derivative securities;
 
 
Failure of securities analysts to maintain coverage of us, changes in financial estimates by securities analysts who follow our company or our failure to meet these estimates or the expectations of investors;
 
 
Any financial projections we may provide to the public, any changes in those projections or our failure to meet those projections;
 
 
Announcements by us or our competitors of new services or platform features;
 
 
The public’s reaction to our press releases, other public announcements, and filings with the SEC;
 
 
Rumors and market speculation involving us or other companies in our industry;
 
 
Actual or anticipated changes in our results of operations or fluctuations in our results of operations;
 
 
Actual or anticipated developments in our business, our competitors’ businesses, or the competitive landscape generally;
 
 
Litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors;
 
 
Actual or perceived privacy or security breaches or other incidents;
 
 
Developments or disputes concerning our intellectual property or other proprietary rights;
 
 
Announced or completed acquisitions of businesses, services or technologies by us or our competitors;
 
 
Changes in our management, including any departures of one of our Founders;
 
 
New laws or regulations, public expectations regarding new laws or regulations or new interpretations of existing laws or regulations applicable to our business;
 
 
Changes in accounting standards, policies, guidelines, interpretations, or principles;
 
 
Any significant change in our management;
 
 
Other events or factors, including those resulting from war, incidents of terrorism, pandemics, including the
COVID-19
pandemic, or responses to these events; and
 
 
General economic conditions and slow or negative growth of our markets.
 
83

In addition, stock markets, and the market for technology companies in particular, have experienced price and volume fluctuations that have affected and continue to affect the trading prices of equity securities of many companies. Stock prices of many companies, including technology companies, have fluctuated in a manner often unrelated to the operating performance of those companies. In the past, following periods of volatility in the overall market and the trading price of a particular company’s securities, securities class action litigation has often been instituted against these companies. Such litigation, if instituted against us, could result in substantial costs and a diversion of our management’s attention and resources and harm our business, financial condition, and results of operations.
Our amended and restated bylaws designate a state or federal court located within the State of Delaware as the exclusive forum for substantially all disputes between us and our stockholders, and also provide that the federal district courts will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, each of which could limit our stockholders’ ability to choose the judicial forum for disputes with us or our directors, officers, stockholders, or employees.
Our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (a) any derivative action or proceeding brought on our behalf, (b) any action asserting a claim of breach of a fiduciary duty owed by any of our current or former directors, stockholders, officers, or other employees to us or our stockholders, (c) any action or proceeding asserting a claim arising pursuant to, or seeking to enforce any right, obligation or remedy under, any provision of the Delaware General Corporation Law, our amended and restated certificate of incorporation, or our amended and restated bylaws, (d) any action or proceeding as to which the Delaware General Corporation Law confers jurisdiction on the Court of Chancery of the State of Delaware, or (e) any action or proceeding asserting a claim that is governed by the internal affairs doctrine shall be the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another state court in Delaware or, if no state court in Delaware has jurisdiction, the federal district court for the District of Delaware) and any appellate court therefrom, in all cases subject to the court having jurisdiction over the claims at issue and the indispensable parties; provided that the exclusive forum provision will not apply to suits brought to enforce any liability or duty created by the Exchange Act.
Section 22 of the Securities Act of 1933, as amended (the “Securities Act”), creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated bylaws also provide that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act.
Any person or entity purchasing or otherwise acquiring or holding or owning (or continuing to hold or own) any interest in any of our securities shall be deemed to have notice of and consented to the foregoing bylaw provisions. Although we believe these exclusive forum provisions benefit us by providing increased consistency in the application of Delaware law and federal securities laws in the types of lawsuits to which each applies, the exclusive forum provisions may limit a stockholder’s ability to bring a claim in a judicial forum of its choosing for disputes with us or any of our directors, officers, stockholders, or other employees, which may discourage lawsuits with respect to such claims against us and our current and former directors, officers, stockholders, or other employees. Our stockholders will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder as a result of our exclusive forum provisions. Further, in the event a court finds either exclusive forum provision contained in our amended and restated bylaws to be unenforceable or inapplicable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our results of operations.
Sales of substantial amounts of our Class A common stock in the public markets or the perception that sales might occur, including sales by our Founders and their affiliates, could cause the trading price of our Class A common stock to decline.
Sales of substantial amounts of our Class A common stock in the public markets or the perception that sales might occur, could cause the trading price of our Class A common stock to decline.
In addition to the supply and demand and volatility risk factors discussed above, sales of a substantial number of shares of our Class A common stock into the public market, particularly sales by our directors, executive officers, and principal stockholders, or the perception that these sales might occur in large quantities, could cause the trading price of our Class A common stock to decline. As of September 30, 2021, approximately 30.6 million options will expire through December 2022 (including approximately 17.2 million options held by Mr. Karp which will expire in December 2021) if not exercised prior to their respective expiration dates, and we expect many holders will elect to exercise such options prior to expiration. Upon exercise, the holders will receive shares of our Class A or Class B common stock, which may subsequently be sold.
 
84

As of September 30, 2021, there were 1,900,440,709 shares of our Class A common stock outstanding, 89,672,006 shares of our Class B common stock outstanding and 1,005,000 shares of our Class F common stock outstanding. Substantially all of these shares may be immediately sold, although sales by our affiliates remain subject to compliance with the limitations of Rule 144.
Further, as of September 30, 2021, there were outstanding options to purchase an aggregate of 163,164,831 shares of our Class A common stock and 211,364,014 shares of our Class B common stock, and 108,058,307 shares of our Class A common stock and 57,975,000 shares of Class B common stock subject to RSUs. All shares of our common stock reserved for future issuance under our equity compensation plans have been registered for sale under the Securities Act. Subject to compliance with Rule 144 or the availability of an alternative exemption, the shares issued upon exercise of stock options or upon settlement of RSUs will be available for immediate resale in the United States in the open market.
While the registration rights of our
non-affiliates
pursuant to our Amended and Restated Investors’ Rights Agreement dated August 24, 2020 requiring us to register shares owned by them for public sale in the United States have expired under the terms of that agreement, our affiliates who are party to the Amended and Restated Investors’ Rights Agreement, including our Founders and certain of the entities affiliated with Peter Thiel, will retain the right to cause us to register shares held by them for resale until such rights terminate in accordance with our Amended and Restated Investors’ Rights Agreement. Any registration statement we file to register additional shares, whether as a result of registration rights or otherwise and whether in connection with the exercise of stock options, the settlement of RSUs, or the exercise or settlement of other awards or otherwise, could cause the trading price of our Class A common stock to decline or be volatile.
We also may issue our capital stock or securities convertible into our capital stock from time to time in connection with a financing, acquisition, investments or otherwise. Any such issuance could result in substantial dilution to our existing stockholders and cause the trading price of our Class A common stock to decline.
Provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage certain types of transactions that may involve an actual or threatened acquisition of the Company, which will likely depress the trading price of our Class A common stock.
Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that may make the acquisition of our company more difficult, including the following:
 
 
Our multi-class common stock structure, which provides our Founders and their affiliates with the ability to effectively control the outcome of matters requiring stockholder approval, even if they own significantly less than a majority of the shares of our outstanding common stock;
 
 
Prior to the Final Class F Conversion Date (as defined in our amended and restated certificate of incorporation), the holders of our common stock will only be able to take action by written consent if the action also receives the affirmative consent of a majority of the outstanding shares of our Class F common stock, and after such point the holders of our common stock will only be able to take action at a meeting of the stockholders and will not be able to take action by written consent for any matter;
 
 
From and after the Final Class F Conversion Date, our Board of Directors will be classified into three classes of directors with staggered three-year terms;
 
 
Our amended and restated certificate of incorporation does not provide for cumulative voting;
 
 
Vacancies on our Board of Directors will be able to be filled only by our Board of Directors and not by stockholders;
 
 
Our directors may only be removed as provided in the Delaware General Corporation Law;
 
 
A special meeting of our stockholders may only be called by the chairperson of our Board of Directors, our Chief Executive Officer, our President, or our Board of Directors pursuant to a resolution adopted by a majority of the total number of authorized directorships, whether or not there exist any vacancies or other unfilled seats in previously authorized directorships;
 
 
Our amended and restated certificate of incorporation authorizes undesignated preferred stock, the terms of which may be established and shares of which may be issued without further action by our stockholders, except that any designation and issuance of preferred stock must receive the affirmative vote of a majority of the outstanding shares of our Class F common stock; and
 
85

 
Advance notice procedures apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders.
These provisions, alone or together, could discourage, delay or prevent a transaction involving a change in control of our company. These provisions could also discourage proxy contests and make it more difficult for stockholders to elect directors of their choosing and to cause us to take other corporate actions they desire, any of which, under certain circumstances, could limit the opportunity for our stockholders to receive a premium for their shares of our Class A common stock, and could also affect the price that some investors are willing to pay for our Class A common stock.
If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about us, our business or our market, or if they change their recommendation regarding our Class A common stock adversely, the trading price and trading volume of our Class A common stock could decline.
The trading market for our Class A common stock will depend in part on the research and reports that securities or industry analysts publish about us, our business, our market or our competitors. If one or more of the analysts who cover us downgrade our ordinary shares or publish inaccurate or unfavorable research about us, the trading price of our Class A common stock would likely decline. If these analysts publish target prices for our Class A common stock that are below the then-current public price of our Class A common stock, it could cause the trading price of our Class A common stock to decline significantly. Further, if one or more of these analysts cease coverage of Palantir or fail to publish reports on us regularly, demand for our Class A common stock could decrease, which might cause our Class A common stock trading price and trading volume to decline.
Although we currently are not considered to be a “controlled company” under the NYSE corporate governance rules, we may in the future become a controlled company due to the concentration of voting power among our Founders and their affiliates.
Although we currently are not considered to be a “controlled company” under the NYSE corporate governance rules, we may in the future become a controlled company due to the concentration of voting power among our Founders and their affiliates resulting from the issuance of our Class F common stock. See “Risks Related to the Multiple Class Structure of our Common Stock, the Founder Voting Trust Agreement, and the Founder Voting Agreement” below. A “controlled company” pursuant to the NYSE corporate governance rules is a company of which more than 50% of the voting power is held by an individual, group, or another company. In the event that our Founders and their affiliates or other stockholders acquire more than 50% of the voting power of the Company, we may in the future be able to rely on the “controlled company” exemptions under the NYSE corporate governance rules due to this concentration of voting power and the ability of our Founders and their affiliates to act as a group. If we were a controlled company, we would be eligible, and could elect, not to comply with certain of the NYSE corporate governance standards. Such standards include the requirement that a majority of directors on our board of directors are independent directors, subject to certain
phase-in
periods, and the requirement that our compensation, nominating and governance committee consist entirely of independent directors. In such a case, if the interests of our stockholders differ from the group of stockholders holding a majority of the voting power, our stockholders would not have the same protection afforded to stockholders of companies that are subject to all of the NYSE corporate governance standards, and the ability of our independent directors to influence our business policies and corporate matters may be reduced.
We do not expect to pay dividends in the foreseeable future.
We have never declared nor paid cash dividends on our capital stock. We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not anticipate declaring or paying any dividends to holders of our capital stock in the foreseeable future. In addition, our credit facility contains restrictions on our ability to pay dividends. Any determination to pay dividends in the future will be at the discretion of our Board of Directors. Consequently, stockholders must rely on sales of their Class A common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investment.
Risks Related to the Multiple Class Structure of our Common Stock, the Founder Voting Trust Agreement, and the Founder Voting Agreement
The multiple class structure of our common stock has the effect of concentrating voting power with certain stockholders, in particular, our Founders and their affiliates, which will effectively eliminate your ability to influence the outcome of important transactions, including a change in control.
 
86

Our Class A common stock has one (1) vote per share, and our Class B common stock has ten (10) votes per share with respect to each matter submitted to our stockholders. Assuming that the Founders and certain of their affiliates collectively meet the Ownership Threshold (as defined below) on the applicable record date for a vote of the stockholders (except as provided in our amended and restated certificate of incorporation), shares of Class F common stock will generally have a number of votes per share in respect of a matter submitted to our stockholders that would cause the total votes of all shares of Class F common stock, together with the votes attributable to shares of Class A common stock and Class B common stock held by our Founders and their affiliates that are subject to the voting agreement among our Founders and Wilmington Trust, National Association (the “Founder Voting Agreement”) and the votes attributable to shares of Class A common stock and Class B common stock held by our Founders and their affiliates that are designated as Designated Founders’ Excluded Shares (as defined in our amended and restated certificate of incorporation), in each case entitled to vote on such matter, to equal, with respect to such matter, 49.999999% of the voting power of (i) all of the outstanding shares of capital stock of the Company entitled to vote on such matter (including in the case of the election of directors); or (ii) the shares present in person or represented by proxy and entitled to vote on such matter only if a majority of the shares present in person or represented by proxy and entitled to vote on such matter is the applicable voting standard (as applicable, “49.999999% of the Voting Power”). Accordingly, such Founders will effectively control all matters submitted to the stockholders for the foreseeable future, including the election of directors, amendments of our organizational documents, compensation matters, and any merger, consolidation, sale of all or substantially all of our assets, or other major corporate transaction requiring stockholder approval. Our Founders and their affiliates also hold the substantial majority of our outstanding Class B common stock. Because of the
ten-to-one
voting ratio between our Class B and Class A common stock, even without regard to the voting power of the Class F common stock, our Founders and their affiliates collectively control a significant portion of the voting power of our capital stock based on their current ownership and may significantly increase their ownership of Class B common stock in the future due to the exercise of currently outstanding warrants and stock options or the settlement of RSUs.
The Founders may have interests that differ from yours and may vote in a way with which you disagree, and which may be adverse to your interests. This concentration of voting power is likely to have the effect of limiting the likelihood of an unsolicited merger proposal, unsolicited tender offer, or proxy contest for the removal of directors. As a result, our governance structure, including the provisions of our amended and restated certificate of incorporation, may have the effect of depriving our stockholders of an opportunity to sell their shares at a premium over prevailing market prices and make it more difficult to replace our directors and management.
The Founder Voting Trust Agreement and the Founder Voting Agreement also have the effect of concentrating voting power with our Founders and their affiliates, which will effectively eliminate your ability to influence the outcome of important transactions, including a change in control.
All shares of our Class F common stock are held in a voting trust (the “Founder Voting Trust”), established by our Founders pursuant to a voting trust agreement (the “Founder Voting Trust Agreement”) with Wilmington Trust, National Association as trustee (the “Trustee”). Our Founders are also currently party to the Founder Voting Agreement. Our Founders have agreed through the Founder Voting Trust Agreement and Founder Voting Agreement that all of the shares of Class F common stock and all of the shares of our capital stock over which they and their affiliates have granted a proxy under the Founder Voting Agreement will be voted in the manner instructed by a majority of our Founders who are then party to the Founder Voting Agreement. Accordingly, together with the multiple class structure of our common stock, such Founders will effectively control all matters submitted to the stockholders for the foreseeable future, including the election of directors, amendments of our organizational documents, compensation matters, and any merger, consolidation, sale of all or substantially all of our assets, or other major corporate transaction requiring stockholder approval.
Upon the withdrawal or removal of any of our Founders from the Founder Voting Agreement, including upon their death or disability, the remaining Founders or Founder, as the case may be, will determine the manner in which the shares of our Class F common stock as well as the shares subject to the Founder Voting Agreement are voted. In such cases, the voting power of our outstanding capital stock will be further concentrated among the remaining Founders, which may be as few as one. Further, if there are only two Founders who are party to the Founder Voting Agreement, one Founder will be able to effectively defeat any stockholder action, except for the election of directors or other matters that are decided by a plurality of votes, if his instruction to vote the shares of Class F common stock differs from the other Founder. The Founders who are then party to the Founder Voting Agreement will retain the right to direct the voting of the Class F common stock without regard to their employment status with us.
All shares of our Class F common stock are held in the Founder Voting Trust and voted pursuant to the Founder Voting Trust Agreement. Accordingly, our Founders who are then party to the Founder Voting Agreement will control any vote that requires the affirmative vote of the holders of a majority of our Class F common stock, including action of our stockholders by written consent, the designation or issuance by us of shares of preferred stock, and certain amendments to our amended and restated certificate of incorporation relating to our preferred stock.
 
87

Although we are a third-party beneficiary of the Founder Voting Agreement and the Founder Voting Trust Agreement, we do not have a general consent right with respect to amendments thereto, and either agreement may be amended or modified in the future in a manner that is adverse to our stockholders, which may include increasing the ability of one or more of our Founders to exercise control over matters submitted to a vote of our stockholders.
In certain circumstances in the future, the Founders and their affiliates could have voting power that exceeds 49.999999% of the Voting Power.
If the voting power of shares of Class A common stock and Class B common stock held by the Founders or their affiliates that are subject to the Founder Voting Agreement or are Designated Founders’ Excluded Shares collectively equals greater than 49.999999% of the Voting Power with respect to a matter submitted to our stockholders, then the Class F common stock will have zero votes with respect to such matter. In this case, although the shares of our Class F common stock would generally be entitled to zero votes per share on that matter, all of the shares that are then subject to the Founder Voting Agreement would continue to be voted in accordance with the decision of a majority in number of the Founders who are then party to the Founder Voting Agreement.
For example, if the Founders and their affiliates hold shares other than the Class F common stock, such as Class B common stock, that, in the aggregate, have voting power that exceeds 49.999999% of the Voting Power with respect to a matter submitted to our stockholders, then the total voting power of the Founders and their affiliates would exceed 49.999999% of the Voting Power with respect to such matter. Our Founders and their affiliates may acquire additional shares of our Class A common stock or Class B common stock. Shares of our Class B common stock may be transferred (without converting into shares of Class A common stock) to, among others, our Founders or their affiliates, and such transfers to our Founders or their affiliates could increase the total voting power of the Founders and their affiliates above 49.999999% of the Voting Power with respect to such matter. Excluding the voting power of the Class F common stock, our Founders and their affiliates owned shares entitled to approximately 26.8% of the voting power of our outstanding capital stock in the aggregate as of November 4, 2021.
In addition, if one or two Founders withdraw from the Founder Voting Agreement, the total voting power of the Founders and their affiliates in the aggregate could exceed 49.999999% of the Voting Power. For instance, if one Founder has withdrawn from the Founder Voting Agreement and such withdrawing Founder votes his shares in the same manner as the shares of Class F common stock are voted pursuant to the Founder Voting Trust Agreement, then our Founders and their affiliates, in the aggregate, could exercise 49.999999% of the Voting Power of our capital stock plus the voting power of shares held by the withdrawing Founder (which would no longer represent a subset of the 49.999999% of the Voting Power of our capital stock voted by those Founders that remain party to the Founder Voting Agreement).
As a result of future issuances of our common stock or the disposal of shares of our common stock by our Founders and their affiliates, our Founders and their affiliates could have voting power that is substantially greater than, and outsized in comparison to, their economic interests and the percentage of our common stock that they hold.
In certain circumstances, our Founders and their affiliates could have voting power that is substantially greater than, and outsized in comparison to, their economic interests and the percentage of our common stock that they hold. This separation between voting power and economic interests could cause conflicts of interest between our Founders and our other stockholders, which may result in our Founders undertaking, or causing us to undertake, actions that would be desirable for the Founders or their affiliates but would not be desirable for our other stockholders.
In the event that our Founders and their affiliates have less than 49.999999% of the Voting Power prior to giving effect to the voting power of the Class F common stock, the issuance of additional shares by us in the future to stockholders other than our Founders who are then party to the Founder Voting Agreement or their affiliates will dilute the economic interests of our Founders but will generally not result in further dilution of the voting power of such Founders and their affiliates. Because of the voting rights of the Class F common stock, such issuances will instead correspondingly increase the voting power of the Class F common stock. Any future issuances of additional shares of Class A common stock and Class B common stock will not be subject to approval by our stockholders except as required by the listing standards of the NYSE.
In addition, our Founders and their affiliates are free to transfer or otherwise dispose of their shares of Class A common stock and Class B common stock without diminishing their voting power so long as our Founders and certain of their affiliates continue to collectively hold 100,000,000 Corporation Equity Securities (as defined in our amended and restated certificate of incorporation) on the applicable record date (subject to equitable adjustments as provided in our amended and restated certificate of incorporation) (the “Ownership Threshold”). Shares of our Class F common stock will not convert into shares of our Class B common stock, and our multi-class structure will not terminate, solely because our Founders and certain of their affiliates do not satisfy this Ownership Threshold on the applicable record date. Upon the withdrawal, or removal, of one or more of our Founders from the Founder Voting Agreement (including as a result of death or disability), the Ownership Threshold that must be met on the applicable record date will be reduced on a pro rata basis based on the ownership of Corporation Equity Securities (which excludes Designated Founders’ Excluded Shares) of the Founders and certain of their affiliates as of August 10, 2020, which could substantially decrease the Ownership Threshold without reducing the effective voting power of the Class F common stock. Accordingly, our Founders who are then party to the Founder Voting Agreement will be able to achieve substantial liquidity in their holdings, and substantially diminish their economic interest in us, without diminishing their voting power.
 
88

Furthermore, meeting the Ownership Threshold on the applicable record date will not ensure that the Founders and their affiliates do not or will not have differing economic interests from the interests of holders of the Class A common stock. For example, the Founder Voting Agreement does not prohibit a Founder from hedging his economic exposure to our common stock; however, we have implemented a policy that will prohibit hedging by our directors, officers and employees, which currently includes the Founders. In addition, the trustee will vote shares of Class F common stock in accordance with the decision of a majority in number of the Founders who are then party to the Founder Voting Agreement, regardless of such Founders’ relative ownership of any class of our common stock.
In August 2020, we granted two of our Founders, Mr. Karp, our Chief Executive Officer and a member of our Board of Directors, and Mr. Cohen, our President and a member of our Board of Directors, options and RSUs for an aggregate of 207.0 million shares of our Class B common stock (collectively, the “Founder Grants”), which will become vested, exercisable and/or settle upon the future satisfaction of service conditions and certain other conditions. These awards are expected to contribute to the Founders’ ability to meet the Ownership Threshold on the applicable record date at least until the sale of such shares by Mr. Karp and Mr. Cohen.
Shares of our common stock designated by one or more of our Founders pursuant to our amended and restated certificate of incorporation may be voted or not voted by such Founders or their affiliates in their discretion and will reduce the voting power exercised in accordance with the decision of a majority in number of the Founders who are then party to the Founder Voting Agreement.
Mr. Thiel has identified a portion of the shares of Class B common stock and Class A common stock beneficially owned by him and his affiliates as Designated Founders’ Excluded Shares, which will not be subject to the Founder Voting Agreement. Such Designated Founders’ Excluded Shares would reduce the total voting power that will be exercised in accordance with the decision of a majority in number of the Founders who are then party to the Founder Voting Agreement. Mr. Thiel or his affiliates would vote or not vote such Designated Founders’ Excluded Shares in their discretion, which may include in a manner different than the voting power exercised in accordance with the decision of a majority in number of the Founders who are then party to the Founder Voting Agreement. Depending on certain circumstances, including the extent to which other holders of Class B common stock convert or sell such shares of Class B common stock, such Designated Founders’ Excluded Shares may have significant voting power and increase Mr. Thiel or his affiliates’ relative voting power compared to the other Founders. The shares identified by Mr. Thiel as Designated Founders’ Excluded Shares represented less than 5% of the voting power of our outstanding capital stock as of November 4, 2021. In the future, Mr. Thiel or our other Founders could designate additional shares as Designated Founders’ Excluded Shares.
The Ownership Threshold that must be met on any applicable record date is a small minority of our outstanding Corporation Equity Securities, and future issuances of Corporation Equity Securities may decrease this percentage.
The Ownership Threshold that must be met on any applicable record date is currently 100,000,000 Corporation Equity Securities, which is a small minority of our outstanding Corporation Equity Securities. While the number of outstanding Corporation Equity Securities may exceed the number of shares of our outstanding capital stock, as a comparison, there were 1,991,117,715 shares of our common stock outstanding as of September 30, 2021. Except for certain equitable adjustments as provided in our amended and restated certificate of incorporation, future issuances of Corporation Equity Securities by us will not increase the Ownership Threshold that must be met on any applicable record date and, accordingly, will decrease the percentage of outstanding Corporation Equity Securities represented by the Ownership Threshold.
Upon the withdrawal, or removal, of one or more of our Founders from the Founder Voting Agreement (including as a result of death or disability), the Ownership Threshold that must be met on the applicable record date will be reduced on a pro rata basis based on the ownership of Corporation Equity Securities of the Founders and certain of their affiliates as of August 10, 2020. We expect that the Ownership Threshold will be reduced by approximately 57 million Corporation Equity Securities upon the withdrawal or removal from the Founder Voting Agreement of Alexander Karp, approximately 12 million Corporation Equity Securities upon the withdrawal or removal of Stephen Cohen, and approximately 31 million Corporation Equity Securities upon the withdrawal or removal of Peter Thiel if such withdrawals or removals were to happen.
In addition, in the future we could create a new class of equity securities with different economic or voting rights than existing classes. If we were to create a new class of equity security, because of the broad definition of “Corporation Equity Securities,” such security could qualify as Corporation Equity Securities and therefore count towards the Ownership Threshold if held by our Founders who are then party to the Founder Voting Agreement or certain of their affiliates. If such security has lesser or no economic rights, it could have the effect of further increasing the divergence between the economic interests of our Founders who are then party to the Founder Voting Agreement and their affiliates, on the one hand, and the voting power of such Founders and their affiliates, on the other. Further, Corporation Equity Securities includes, among other things, any warrants, calls, options or other right, whether vested or unvested, to acquire from the Company certain voting or equity securities from the Company. Accordingly, the Board of Directors could issue additional equity securities, or additional options, RSUs, warrants or other rights to acquire equity securities (whether vested or unvested), to our Founders or certain of their affiliates, which would increase the number of Corporation Equity Securities they hold and enable them to meet the Ownership Threshold notwithstanding sales of Corporation Equity Securities that they currently hold. As a result, any Founders who are then party to the Founder Voting Agreement or certain of their affiliates could hold a nominal equity interest with little to no voting rights but meet the Ownership Threshold and therefore have voting power that provides effective control of our company.
 
89

The multiple class structure of our common stock features certain provisions that are novel or otherwise not common among other corporations with multiple class structures.
A number of provisions relating to the multiple class structure of our common stock are novel or otherwise not common among other corporations with multiple class structures. For instance, our Founders who are then party to the Founder Voting Agreement are free to transfer or otherwise dispose of their shares of Class A common stock and Class B common stock without diminishing their voting control so long as our Founders who are then party to the Founder Voting Agreement and certain of their affiliates meet the Ownership Threshold on the applicable record date. Shares of our Class B common stock, which have ten (10) votes per share, may remain outstanding in perpetuity. Additionally, shares of our Class B common stock may be transferred (without converting into shares of Class A common stock) to, among others, our Founders or their affiliates, which could result in our Founders and their affiliates or other stockholders obtaining additional voting control.
Additionally, certain provisions of our amended and restated certificate of incorporation related to the calculation of the voting power of the Class F common stock may have an adverse effect on our stockholders other than our Founders. Under our amended and restated certificate of incorporation, our Founders have the right to challenge our calculation of the voting power of the Class F common stock. Such a challenge may cause delays in the certification of any vote of our stockholders or in the effectiveness of any action of our stockholders.
The multi-class structure of our common stock, the Founder Voting Trust Agreement and the Founder Voting Agreement by which our Founders exercise effective control over all matters submitted to a vote of our stockholders will exist for the foreseeable future.
Shares of our Class F common stock will convert automatically into shares of our Class B common stock only if the Founder Voting Trust Agreement or the Founder Voting Agreement is terminated. Each of these agreements could remain in place until the death of our last living Founder. As of September 30, 2021, our Founders were 53, 53, and 39 years old. Further, upon a discretionary or compulsory withdrawal of a Founder as a beneficiary of the Founder Voting Trust Agreement, the Trustee will instruct our transfer agent and us to convert the withdrawing Founder’s pro rata portion of the shares of Class F common stock held in the Founder Voting Trust at the time of the withdrawal into shares of Class B common stock in accordance with our amended and restated certificate of incorporation.
Because of the
ten-to-one
voting ratio between our Class B and Class A common stock, even if the Class F common stock converts to Class B common stock, our Founders will collectively control a significant portion of the voting power of our capital stock based on their current ownership. Future transfers by holders of shares of Class B common stock will generally result in those shares converting to Class A common stock, subject to limited exceptions, such as certain transfers effected for estate planning purposes and transfers between related entities. The conversion of Class B common stock to Class A common stock will have the effect, over time, of increasing the relative voting power of those individual holders of Class B common stock who retain their shares in the long term. If our Founders and their affiliates, individually or collectively, retain a significant portion of their holdings of Class B common stock for an extended period of time, they could, in the future, individually or collectively, continue to control a significant portion of the combined voting power of our Class A common stock and Class B common stock, even without the use of the Class F common stock, and such voting power could enable holders of Class B common stock to effectively control all matters subject to the stockholder approval. Shares of our Class B common stock may remain outstanding in perpetuity.
Further, if all, or a large portion, of the Founder Grants should be exercised or vest and settle, our Founders will increase their voting power of our Class B common stock. Although the terms of our amended and restated certificate of incorporation only provide for a separate vote of the holders of our Class B common stock on limited matters, under Delaware law, certain actions may require the approval of the holders of the Class B common stock voting as a separate class. For example, if we amend our amended and restated certificate of incorporation to adversely affect the special rights, powers, or preferences of our Class B common stock in a manner that does not so affect the Class A common stock or Class F common stock, Delaware law could require approval of the holders of our Class B common stock voting separately as single class. For any vote of the Class B common stock voting as a separate class, our Founders will significantly influence such vote if all, or a large portion, of the Founder Grants should vest and settle and the Founders retain such shares.
 
90

Our governance structure may negatively affect the decision by certain institutional investors to purchase or hold shares of our Class A common stock.
The holding of
low-voting
stock, such as our Class A common stock, may not be permitted by the investment policies of certain institutional investors or may be less attractive to the portfolio managers of certain institutional investors. In addition, in July 2017, FTSE Russell and Standard & Poor’s announced that they would cease to allow most newly public companies utilizing dual- or multi-class capital structures to be included in their indices. Affected indices include the Russell 2000 and the S&P 500, S&P MidCap 400, and S&P SmallCap 600, which together make up the S&P Composite 1500. Our multi-class capital structure may make us ineligible for inclusion in any of these and certain other indices, and as a result, mutual funds, exchange-traded funds, and other investment vehicles that attempt to passively track these indices would not invest in our stock. These policies may depress our valuation compared to those of other similar companies that are included.
Future issuances of our Class A common stock will dilute the voting power of our Class A common stockholders but may not result in further dilution of the voting power of our Founders who are then party to the Founder Voting Agreement.
Future issuances of our Class A common stock will dilute the voting power of our Class A common stockholders, and future issuances to stockholders other than our Founders who are then party to the Founder Voting Agreement will dilute the economic interests of our Founders and their affiliates. However, because of the voting rights of the shares of Class F common stock, in the event that our Founders and their affiliates have less than 49.999999% of the Voting Power prior to giving effect to the voting power of the Class F common stock, future issuances of Class A common stock to stockholders other than our Founders and their affiliates will generally not result in dilution of the voting power of our Founders who are then party to the Founder Voting Agreement or their affiliates, but rather, will correspondingly increase the voting power of the Class F common stock. Any future issuances of additional shares of Class A common stock will not be subject to approval by our stockholders except as required by the listing standards of the NYSE.
General Risk Factors
Adverse economic conditions or reduced technology spending may adversely impact our business.
Our business depends on the economic health of our current and prospective customers and overall demand for technology. In addition, the purchase of our platforms and services is often discretionary and typically involves a significant commitment of capital and other resources. A further downturn in economic conditions, global political and economic uncertainty, a lack of availability of credit, a reduction in business confidence and activity, the curtailment of government or corporate spending, public health concerns or emergencies, financial market volatility, and other factors have in the past and may in the future affect the industries to which we sell our platforms and services. Our customers may suffer from reduced operating budgets, which could cause them to defer or forego purchases of our platforms or services. Moreover, competitors may respond to market conditions by lowering prices and attempting to lure away our customers, and the increased pace of consolidation in certain industries may result in reduced overall spending on our offerings. Uncertainty about global and regional economic conditions, a downturn in the technology sector or any sectors in which our customers operate, or a reduction in information technology spending even if economic conditions are stable, could adversely impact our business, financial condition, and results of operations in a number of ways, including longer sales cycles, lower prices for our platforms and services, material default rates among our customers, reduced sales of our platforms or services, and lower or no growth.
We cannot predict the timing, strength, or duration of any crises, economic slowdown or any subsequent recovery generally, or for any industry in particular. Although certain aspects of the effects of a crisis or an economic slowdown may provide potential new opportunities for our business, we cannot guarantee that the net impact of any such events will not be materially negative. Accordingly, if the conditions in the general economy and the markets in which we operate worsen from present levels, our business, financial condition, and results of operations could be adversely affected.
If we fail to maintain an effective system of internal controls, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired.
We are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, and the rules and regulations of the listing standards of the NYSE. We expect that the requirements of these rules and regulations will continue to increase our legal, accounting, and financial compliance costs, make some activities more difficult, time-consuming, and costly, and place significant strain on our personnel, systems, and resources.
 
91

The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We have developed and refined our financial reporting and other disclosure controls and procedures, and we will continue to do so. For example, we recently reimplemented our enterprise resource planning (“ERP”) system. This may be disruptive to our business if the ERP system does not work as planned or if we experience issues relating to the reimplementation, in which case we may be unable to timely or accurately prepare financial reports, make payments to our suppliers and employees, or invoice and collect from our customers. Our controls are designed to ensure that information required to be disclosed by us in the reports that we will file with the SEC is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms and that information required to be disclosed in reports under the Exchange Act is accumulated and communicated to our principal executive and financial officers. We are also continuing to improve our internal control over financial reporting. Some members of our management team have limited or no experience managing a publicly traded company, interacting with public company investors, and complying with the increasingly complex laws pertaining to public companies, and we have limited accounting and financial reporting personnel and other resources with which to address our internal controls and related procedures, including complying with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act that we will be required to include in our annual reports filed with the SEC starting with our Annual Report on Form
10-K
for year ending December 31, 2021. We will need to hire and successfully integrate additional accounting and financial staff with appropriate company experience and technical accounting knowledge, as well as implement and integrate new technological systems. In order to maintain and improve the effectiveness of our financial statement and disclosure controls and procedures and internal control over financial reporting, we have expended, and anticipate that we will continue to expend, significant resources, including accounting-related costs and significant management oversight.
Our current controls and any new controls that we develop may become inadequate because of changes in conditions in our business. Further, we have identified in the past, and may identify in the future, deficiencies in our controls. Any failure to develop or maintain effective controls or any difficulties encountered in their implementation or improvement could harm our results of operations or cause us to fail to meet our reporting obligations and may result in a restatement of our financial statements for prior periods. Any failure to implement and maintain effective internal control over financial reporting also could adversely affect the results of periodic management evaluations and annual independent registered public accounting firm attestation reports. Ineffective disclosure controls and procedures and internal control over financial reporting could also cause investors to lose confidence in our reported financial and other information, which could have a negative effect on the trading price of our Class A common stock. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on the NYSE. As of December 31, 2020 we were not required to comply with the SEC rules that implement Section 404 of the Sarbanes-Oxley Act and are therefore not required to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. We will be required to provide an annual management report on the effectiveness of our internal control over financial reporting as of December 31, 2021, with our second Annual Report on Form
10-K.
We expect our independent registered public accounting firm will be required to formally attest to the effectiveness of our internal control over financial reporting commencing with our Annual Report on Form
10-K
for the year ending December 31, 2021. At such time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our internal control over financial reporting is documented, designed or operating. Any failure to maintain effective disclosure controls and internal control over financial reporting could have an adverse effect on our business, financial condition and results of operations and could cause a decline in the market price of our Class A common stock.
We will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies which could adversely affect our business, financial condition, and results of operations.
As a public company, we have incurred and will continue to incur greater legal, accounting, finance, and other expenses than we incurred as a private company. We are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) and the rules and regulations of the NYSE. These requirements have increased and will continue to increase our legal, accounting, and financial compliance costs and have made, and will continue to make, some activities more time-consuming and costly. For example, the Exchange Act requires, among other things, that we file annual, quarterly, and current reports with respect to our business and results of operations. As a result of the complexity involved in complying with the rules and regulations applicable to public companies, our management’s attention may be diverted from the
day-to-day
management of our business, which could harm our business, financial condition, and results of operations. Although we have already hired additional employees to assist us in complying with these requirements, we may need to hire more employees in the future or engage outside consultants, which will increase our operating expenses. Additionally, as a public company subject to additional rules and regulations and oversight, we may not have the same flexibility we had as a private company.
In addition, changing laws, regulations, and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance costs, and making some activities more time-consuming. These laws, regulations, and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to invest substantial resources to comply with evolving laws, regulations, and standards, and this investment may result in increased general and administrative expenses and a diversion of management’s time and attention from business operations to compliance activities. If our efforts to comply with new laws, regulations, and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be harmed.
 
92

We also expect these rules and regulations to make it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to maintain the same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified individuals to serve on our Board of Directors or as our executive officers.
We ceased to be an “emerging growth company” as defined in the Jumpstart our Business Startups Act of 2012 as of December 31, 2020. As a result, we have experienced, and expect to continue to experience, additional costs associated with being a public company, including costs associated with compliance with the auditor attestation requirement of Section 404 of the Sarbanes-Oxley Act, the adoption of certain ASUs upon losing such status, and additional disclosure requirements.
As a result of disclosure of information in this Quarterly Report on Form
10-Q
and other filings required of a public company, our business and financial condition will become more visible, which may result in an increased risk of threatened or actual litigation, including by competitors and other third parties. If such claims are successful, our business, financial condition, and results of operations could be harmed, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and harm our business, financial condition, and results of operations.
Natural disasters and other events beyond our control could harm our business.
Natural disasters or other catastrophic events may cause damage or disruption to our operations,
non-U.S.
commerce and the global economy, and thus could have a negative effect on us. Our business operations are subject to interruption by natural disasters, earthquakes, flooding, fire, power shortages, pandemics such as the recent spread of
COVID-19,
terrorism, political unrest, telecommunications failure, vandalism, cyberattacks, geopolitical instability, war, the effects of climate change (such as drought, wildfires, increased storm severity, and sea level rise), and other events beyond our control. Although we maintain crisis management and disaster response plans, such events could make it difficult or impossible for us to deliver our services to our customers, could decrease demand for our services, could make existing customers unable or unwilling to fulfill their contractual requirements to us, including their payment obligations, and could cause us to incur substantial expense, including expenses or liabilities arising from potential litigation. Our insurance may not be sufficient to cover losses or additional expense that we may sustain. Customer data could be lost, significant recovery time could be required to resume operations and our financial condition and results of operations could be adversely affected in the event of a major natural disaster or catastrophic event.
We may face exposure to foreign currency exchange rate fluctuations.
Our results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates, particularly changes in the Euro and GBP. We expect our
non-U.S.
operations to continue to grow in the near term and we are continually monitoring our foreign currency exposure to determine if we should consider a hedging program. Today, our
non-U.S.
contracts are denominated in either U.S. dollars or local currency, while our
non-U.S.
operating expenses are often denominated in local currencies. Additionally, as we expand our
non-U.S.
operations, a larger portion of our operating expenses may be denominated in local currencies. Therefore, increases in the value of the U.S. dollar and decreases in the value of foreign currencies could result in the dollar equivalent of our revenues being lower.
 
ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES
Not applicable.
 
ITEM 3.
DEFAULTS UPON SENIOR SECURITIES
Not applicable.
 
ITEM 4.
MINE SAFETY DISCLOSURES
Not applicable.
 
ITEM 5.
OTHER INFORMATION
Not applicable.
 
93

ITEM 6.
EXHIBITS
 
         
Incorporated by Reference
 
Exhibit
Number
  
Description
  
Form
    
File
No.
    
Exhibit
    
Filing
Date
 
  31.1*               
  31.2*               
  32.1†               
101.INS*   
XBRL Instance Document.
           
101.SCH*   
XBRL Taxonomy Extension Schema Document.
           
101.CAL*   
XBRL Taxonomy Extension Calculation Linkbase Document.
           
101.DEF*   
XBRL Taxonomy Extension Definition Linkbase Document.
           
101.LAB*   
XBRL Taxonomy Extension Label Linkbase Document.
           
101.PRE*   
XBRL Taxonomy Extension Presentation Linkbase Document.
           
 
*
Filed Herewith
The certifications attached as Exhibit 32.1 that accompany this Quarterly Report on Form
10-Q
are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form
10-Q,
irrespective of any general incorporation language contained in such filing.
 
94

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
   
PALANTIR TECHNOLOGIES INC.
Date: November 9, 2021
   
By:
 
/s/ Alexander C. Karp
     
Alexander C. Karp
     
Chief Executive Officer
     
(
Principal Executive Officer
)
Date: November 9, 2021
   
By:
 
/s/ David Glazer
     
David Glazer
     
Chief Financial Officer
     
(
Principal Financial Officer
)
Date: November 9, 2021
   
By:
 
/s/ Jeffrey Buckley
     
Jeffrey Buckley
     
Chief Accounting Officer
     
(
Principal Accounting Officer
)
 
95
EX-31.1 2 d178745dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14a OF

THE SECURITIES EXCHANGE ACT OF 1934

AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES OXLEY ACT OF 2002

I, Alexander C. Karp, certify that:

1.    I have reviewed this Quarterly Report on Form 10-Q of Palantir Technologies Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a.    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c.    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  

PALANTIR TECHNOLOGIES INC.

Date: November 9, 2021

  

By:                                         

  

 /s/ Alexander C. Karp                        

     

 Alexander C. Karp

     

 Chief Executive Officer

     

 (Principal Executive Officer)

EX-31.2 3 d178745dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14a OF

THE SECURITIES EXCHANGE ACT OF 1934

AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES OXLEY ACT OF 2002

I, David Glazer, certify that:

1.    I have reviewed this Quarterly Report on Form 10-Q of Palantir Technologies Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a.    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c.    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  

PALANTIR TECHNOLOGIES INC.

Date: November 9, 2021

  

By:                                         

  

 /s/ David Glazer                        

     

 David Glazer

     

 Chief Financial Officer

     

 (Principal Financial Officer)

 

EX-32.1 4 d178745dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Alexander C. Karp, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Palantir Technologies Inc. for the fiscal quarter ended September 30, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Palantir Technologies Inc.

 

  

PALANTIR TECHNOLOGIES INC.

Date: November 9, 2021

  

By:                                             

  

 /s/ Alexander C. Karp                    

     

 Alexander C. Karp

     

 Chief Executive Officer

     

(Principal Executive Officer)

I, David Glazer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Palantir Technologies Inc. for the fiscal quarter ended September 30, 2021 fully complies with the requirements of Section 13 (a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Palantir Technologies Inc.

 

  

PALANTIR TECHNOLOGIES INC.

Date: November 9, 2021

  

By:                                             

  

 /s/ David Glazer                    

     

 David Glazer

     

 Chief Financial Officer

     

 (Principal Financial Officer)

EX-101.SCH 5 pltr-20210930.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Consolidated Statements of Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Contract Liabilities and Remaining Performance Obligations link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Investments and Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Balance Sheet Components link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Equity Method Investments link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Net Loss Per Share Attributable to Common Stockholders link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Segment and Geographic Information link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Investments and Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Balance Sheet Components (Tables) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Segment and Geographic Information (Tables) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Subsequent Events (Tables) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Contract Liabilities and Remaining Performance Obligations - Additional information (Detail) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Investments and Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Investments and Fair Value Measurements - Summary Of The Investments Purchased Under Such Investment Agreements (Detail) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Investments and Fair Value Measurements - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Balance Sheet Components - Additional information (Detail) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Equity Method Investments - Additional information (Detail) link:presentationLink link:definitionLink link:calculationLink 1042 - Disclosure - Debt - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1043 - Disclosure - Commitments and Contingencies - Summary of Investment commitments (Detail) link:presentationLink link:definitionLink link:calculationLink 1044 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1045 - Disclosure - Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail) link:presentationLink link:definitionLink link:calculationLink 1046 - Disclosure - Stockholders' Equity - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1047 - Disclosure - Stock-Based Compensation - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1048 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) link:presentationLink link:definitionLink link:calculationLink 1049 - Disclosure - Stock-Based Compensation - Summary of RSU Activity (Detail) link:presentationLink link:definitionLink link:calculationLink 1050 - Disclosure - Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) link:presentationLink link:definitionLink link:calculationLink 1051 - Disclosure - Stock-Based Compensation - Summary of Stock Based Compensation Expense (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1052 - Disclosure - Income Taxes - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1053 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1054 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail) link:presentationLink link:definitionLink link:calculationLink 1055 - Disclosure - Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail) link:presentationLink link:definitionLink link:calculationLink 1056 - Disclosure - Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail) link:presentationLink link:definitionLink link:calculationLink 1057 - Disclosure - Segment and Geographic Information - Summary of Revenue by Geography (Detail) link:presentationLink link:definitionLink link:calculationLink 1058 - Disclosure - Segment and Geographic Information - Summary of Revenue by Geography (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1059 - Disclosure - Subsequent Events - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1060 - Disclosure - Subsequent Events - Summary of Additional Investment Commitments (Detail) link:presentationLink link:definitionLink link:calculationLink 1061 - Disclosure - Subsequent Event - Summary of Investment Commitments (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 pltr-20210930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 pltr-20210930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 pltr-20210930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 9 pltr-20210930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 d178745d10q_htm.xml IDEA: XBRL DOCUMENT 0001321655 2020-12-31 0001321655 2021-09-30 0001321655 2020-01-01 2020-09-30 0001321655 2021-01-01 2021-09-30 0001321655 2020-07-01 2020-09-30 0001321655 2021-07-01 2021-09-30 0001321655 2020-09-30 0001321655 2021-01-01 2021-03-31 0001321655 2020-01-01 2020-12-31 0001321655 2019-12-31 0001321655 2021-06-30 0001321655 2020-06-30 0001321655 us-gaap:CommonClassAMember 2020-12-31 0001321655 us-gaap:CommonClassBMember 2020-12-31 0001321655 pltr:CommonClassFMember 2020-12-31 0001321655 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001321655 us-gaap:FairValueInputsLevel2Member 2020-12-31 0001321655 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001321655 us-gaap:ComputerEquipmentMember 2020-12-31 0001321655 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001321655 us-gaap:ConstructionInProgressMember 2020-12-31 0001321655 pltr:PalantirTechnologiesJapanKKMember 2020-12-31 0001321655 us-gaap:CommonClassAMember 2021-09-30 0001321655 us-gaap:CommonClassBMember 2021-09-30 0001321655 pltr:CommonClassFMember 2021-09-30 0001321655 srt:MinimumMember 2021-09-30 0001321655 us-gaap:FairValueInputsLevel1Member 2021-09-30 0001321655 us-gaap:FairValueInputsLevel2Member 2021-09-30 0001321655 us-gaap:LeaseholdImprovementsMember 2021-09-30 0001321655 us-gaap:ComputerEquipmentMember 2021-09-30 0001321655 us-gaap:FurnitureAndFixturesMember 2021-09-30 0001321655 us-gaap:ConstructionInProgressMember 2021-09-30 0001321655 pltr:PalantirTechnologiesJapanKKMember 2021-09-30 0001321655 us-gaap:RestrictedStockUnitsRSUMember 2021-09-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2021-09-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember pltr:IncrementalCreditFacilityMember 2021-09-30 0001321655 pltr:TelecommunicationsCompanyMember 2021-09-30 0001321655 pltr:RigettiCoInc.Member 2021-09-30 0001321655 pltr:AlternativeInvestmentMember 2021-09-30 0001321655 srt:MaximumMember pltr:InvestmentAgreementMember pltr:CommercialContractMember 2021-09-30 0001321655 pltr:CelularityMember 2021-09-30 0001321655 pltr:FaradayFutureMember 2021-09-30 0001321655 pltr:AstrocastMember 2021-09-30 0001321655 pltr:BlackSkyMember 2021-09-30 0001321655 pltr:LiliumMember 2021-09-30 0001321655 pltr:RoivantSciencesMember 2021-09-30 0001321655 pltr:SarcosRoboticsMember 2021-09-30 0001321655 pltr:AutonomousAerialVehicleCompanyMember 2021-09-30 0001321655 pltr:ConversionOfConvertiblePreferredStockWarrantsIntoCommonStockWarrantsMember 2020-01-01 2020-09-30 0001321655 pltr:ConversionOfRedeemableConvertiblePreferredStockToCommonStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember pltr:SeriesHOneConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:CommonStockMember pltr:SeriesHOneConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember pltr:SeriesHOneConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 pltr:SeriesHOneConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember pltr:SeriesKConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember pltr:SeriesDConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:TreasuryStockMember 2020-01-01 2020-09-30 0001321655 us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 pltr:CustomerFMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-09-30 0001321655 srt:MaximumMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-09-30 0001321655 pltr:WarrantsToPurchaseRedeemableConvertibleAndConvertiblePreferredStockMember 2020-01-01 2020-09-30 0001321655 pltr:OptionsAndSarsIssuedAndOutstandingMember 2020-01-01 2020-09-30 0001321655 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0001321655 pltr:GrowthUnitsOutstandingMember 2020-01-01 2020-09-30 0001321655 us-gaap:OperatingSegmentsMember us-gaap:GovernmentMember 2020-01-01 2020-09-30 0001321655 us-gaap:OperatingSegmentsMember pltr:CommercialMember 2020-01-01 2020-09-30 0001321655 us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0001321655 us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-09-30 0001321655 country:US us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-09-30 0001321655 country:GB us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-09-30 0001321655 country:FR us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-09-30 0001321655 pltr:RestOfWorldMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-09-30 0001321655 srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001321655 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001321655 us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001321655 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-09-30 0001321655 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001321655 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001321655 pltr:AlternativeInvestmentMember 2020-01-01 2020-09-30 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember 2020-07-01 2020-09-30 0001321655 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember pltr:SeriesDConvertiblePreferredStockMember 2020-07-01 2020-09-30 0001321655 us-gaap:RedeemableConvertiblePreferredStockMember 2020-07-01 2020-09-30 0001321655 srt:MaximumMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0001321655 pltr:CustomerAMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0001321655 us-gaap:OperatingSegmentsMember us-gaap:GovernmentMember 2020-07-01 2020-09-30 0001321655 us-gaap:OperatingSegmentsMember pltr:CommercialMember 2020-07-01 2020-09-30 0001321655 us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0001321655 us-gaap:MaterialReconcilingItemsMember 2020-07-01 2020-09-30 0001321655 country:US us-gaap:GeographicConcentrationRiskMember 2020-07-01 2020-09-30 0001321655 country:GB us-gaap:GeographicConcentrationRiskMember 2020-07-01 2020-09-30 0001321655 pltr:RestOfWorldMember us-gaap:GeographicConcentrationRiskMember 2020-07-01 2020-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember 2020-07-01 2020-09-30 0001321655 srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001321655 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001321655 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001321655 us-gaap:SellingAndMarketingExpenseMember 2020-07-01 2020-09-30 0001321655 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2020-09-30 0001321655 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2020-09-30 0001321655 pltr:ConversionOfConvertiblePreferredStockWarrantsIntoCommonStockWarrantsMember 2021-01-01 2021-09-30 0001321655 pltr:ConversionOfRedeemableConvertiblePreferredStockToCommonStockMember 2021-01-01 2021-09-30 0001321655 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001321655 pltr:CustomerHMember us-gaap:AccountsReceivableMember 2021-01-01 2021-09-30 0001321655 srt:MaximumMember us-gaap:AccountsReceivableMember 2021-01-01 2021-09-30 0001321655 srt:MaximumMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-09-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-09-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2021-01-01 2021-09-30 0001321655 srt:MinimumMember pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2021-01-01 2021-09-30 0001321655 pltr:PurchaseCommitmentTwoMember 2021-01-01 2021-09-30 0001321655 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001321655 pltr:OptionsAndSarsIssuedAndOutstandingMember 2021-01-01 2021-09-30 0001321655 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001321655 us-gaap:OperatingSegmentsMember us-gaap:GovernmentMember 2021-01-01 2021-09-30 0001321655 us-gaap:OperatingSegmentsMember pltr:CommercialMember 2021-01-01 2021-09-30 0001321655 us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0001321655 us-gaap:MaterialReconcilingItemsMember 2021-01-01 2021-09-30 0001321655 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001321655 country:US us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001321655 country:GB us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001321655 country:FR us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001321655 pltr:RestOfWorldMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001321655 srt:MinimumMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001321655 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001321655 us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0001321655 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-09-30 0001321655 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-09-30 0001321655 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001321655 pltr:PurchaseCommitmentOneMember 2021-01-01 2021-09-30 0001321655 pltr:InvestmentCommitmentsMember pltr:InvestmentAgreementMember 2021-01-01 2021-09-30 0001321655 pltr:MobilityCompanyMember 2021-01-01 2021-09-30 0001321655 pltr:WejoMember 2021-01-01 2021-09-30 0001321655 pltr:BabylonHealthMember 2021-01-01 2021-09-30 0001321655 pltr:BoxedMember 2021-01-01 2021-09-30 0001321655 pltr:PearTherapeuticsMember 2021-01-01 2021-09-30 0001321655 pltr:AutonomousVehicleCompanyMember 2021-01-01 2021-09-30 0001321655 pltr:FastRadiusMember 2021-01-01 2021-09-30 0001321655 pltr:TritiumMember 2021-01-01 2021-09-30 0001321655 pltr:AdtheorentMember 2021-01-01 2021-09-30 0001321655 pltr:FinaccelMember 2021-01-01 2021-09-30 0001321655 pltr:ElectricvehiclechargingcompanyMember 2021-01-01 2021-09-30 0001321655 pltr:EnergyVaultMember 2021-01-01 2021-09-30 0001321655 pltr:TelecommunicationsCompanyMember 2021-01-01 2021-09-30 0001321655 pltr:RigettiCoInc.Member 2021-01-01 2021-09-30 0001321655 srt:MaximumMember pltr:InvestmentAgreementMember pltr:CommercialContractMember 2021-01-01 2021-09-30 0001321655 srt:MinimumMember pltr:InvestmentAgreementMember pltr:CommercialContractMember 2021-01-01 2021-09-30 0001321655 pltr:CommercialContractMember 2021-01-01 2021-09-30 0001321655 pltr:GrowthUnitsMember 2021-01-01 2021-09-30 0001321655 srt:MaximumMember us-gaap:SalesRevenueNetMember 2021-07-01 2021-09-30 0001321655 us-gaap:OperatingSegmentsMember us-gaap:GovernmentMember 2021-07-01 2021-09-30 0001321655 us-gaap:OperatingSegmentsMember pltr:CommercialMember 2021-07-01 2021-09-30 0001321655 us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0001321655 us-gaap:MaterialReconcilingItemsMember 2021-07-01 2021-09-30 0001321655 country:US us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0001321655 country:GB us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0001321655 pltr:RestOfWorldMember us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0001321655 us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0001321655 srt:MinimumMember us-gaap:SalesRevenueNetMember 2021-07-01 2021-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001321655 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001321655 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001321655 us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0001321655 us-gaap:SellingAndMarketingExpenseMember 2021-07-01 2021-09-30 0001321655 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2021-09-30 0001321655 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001321655 srt:MinimumMember 2021-07-01 2021-09-30 0001321655 srt:MaximumMember 2021-07-01 2021-09-30 0001321655 pltr:CommercialContractMember 2021-07-01 2021-09-30 0001321655 us-gaap:CommonClassBMember 2020-09-30 0001321655 pltr:CustomerGMember us-gaap:AccountsReceivableMember 2020-01-01 2020-12-31 0001321655 srt:MaximumMember us-gaap:AccountsReceivableMember 2020-01-01 2020-12-31 0001321655 pltr:PalantirTechnologiesJapanKKMember 2019-11-01 2019-11-30 0001321655 pltr:PalantirTechnologiesJapanKKMember 2019-11-30 0001321655 pltr:SompoHoldingsIncMember 2019-11-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2014-10-30 2014-10-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2014-10-30 2014-10-30 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember 2021-04-01 2021-04-01 0001321655 pltr:TwoThousandAndFourteenRevolvingCreditFacilityMember pltr:IncrementalCreditFacilityMember 2021-04-01 2021-04-01 0001321655 pltr:AmendedTwoThousandAndFourteenRevolvingCreditFacilityMember 2021-04-01 0001321655 pltr:AmendedTwoThousandAndFourteenRevolvingCreditFacilityMember pltr:TermLoanMember pltr:IncrementalCreditFacilityMember 2021-04-01 0001321655 pltr:PurchaseCommitmentOneMember 2019-12-01 2019-12-31 0001321655 pltr:PurchaseCommitmentTwoMember 2020-06-01 2020-06-30 0001321655 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:CommonClassBMember 2020-09-30 2020-09-30 0001321655 us-gaap:ConvertiblePreferredStockMember us-gaap:CommonClassBMember 2020-09-30 2020-09-30 0001321655 pltr:GrowthUnitsMember 2021-01-01 2021-03-31 0001321655 pltr:GrowthUnitsMember 2021-03-31 0001321655 pltr:EquityInvestmentMember us-gaap:SubsequentEventMember 2021-10-01 2021-10-01 0001321655 srt:MaximumMember us-gaap:SubsequentEventMember pltr:AdditionalInvestmentAgreementMember 2021-10-01 2021-10-01 0001321655 srt:MinimumMember us-gaap:SubsequentEventMember pltr:AdditionalInvestmentAgreementMember 2021-10-01 2021-10-01 0001321655 srt:MaximumMember us-gaap:SubsequentEventMember pltr:InvestmentAgreementMember pltr:CommercialContractMember 2021-10-01 0001321655 pltr:CommonClassFMember 2021-11-04 0001321655 us-gaap:CommonClassAMember 2021-11-04 0001321655 us-gaap:CommonClassBMember 2021-11-04 0001321655 srt:ScenarioForecastMember pltr:InvestmentAgreementMember 2021-12-31 0001321655 srt:ScenarioForecastMember pltr:BabylonHealthMember 2021-12-31 0001321655 srt:ScenarioForecastMember pltr:MobilityCompanyMember 2021-12-31 0001321655 us-gaap:RedeemableConvertiblePreferredStockMember 2019-12-31 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember 2019-12-31 0001321655 us-gaap:CommonStockMember 2019-12-31 0001321655 us-gaap:TreasuryStockMember 2019-12-31 0001321655 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001321655 us-gaap:RetainedEarningsMember 2019-12-31 0001321655 us-gaap:CommonStockMember 2020-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001321655 us-gaap:RetainedEarningsMember 2020-09-30 0001321655 us-gaap:RedeemableConvertiblePreferredStockMember 2020-06-30 0001321655 us-gaap:NonredeemableConvertiblePreferredStockMember 2020-06-30 0001321655 us-gaap:CommonStockMember 2020-06-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001321655 us-gaap:RetainedEarningsMember 2020-06-30 0001321655 us-gaap:CommonStockMember 2020-12-31 0001321655 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001321655 us-gaap:RetainedEarningsMember 2020-12-31 0001321655 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001321655 us-gaap:CommonStockMember 2021-09-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001321655 us-gaap:RetainedEarningsMember 2021-09-30 0001321655 us-gaap:CommonStockMember 2021-06-30 0001321655 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001321655 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001321655 us-gaap:RetainedEarningsMember 2021-06-30 iso4217:USD shares pure utr:Year iso4217:USD shares utr:oz false Q3 0001321655 --12-31 P3Y P3Y 10-Q true 2021-09-30 2021 false 001-39540 Palantir Technologies Inc. DE 68-0551851 1555 Blake Street, Suite 250 Denver CO 80202 720 358-3679 Class A Common Stock, par value $0.001 per share PLTR NYSE Yes Yes Non-accelerated Filer false false false 1906589959 97225971 1005000 2335068000 2011323000 41316000 37285000 174405000 156932000 148077000 112624000 51889000 2811490000 2257429000 28778000 29541000 46791000 79538000 220846000 217075000 116422000 106921000 3224327000 2690504000 17654000 16358000 179467000 158546000 208100000 189520000 232707000 210320000 43581000 29079000 681509000 603823000 26723000 50525000 42734000 81513000 197977000 219646000 229800000 5659000 4316000 976271000 1167954000 0.001 0.001 2000000000 2000000000 0 0 0 0 0 0 0.001 0.001 0.001 0.001 0.001 0.001 20000000000 20000000000 1900441000 1900441000 1542058000 1542058000 2700000000 2700000000 89672000 89672000 249077000 249077000 1005000 1005000 1005000 1005000 1005000 1005000 1991000 1792000 7577305000 6488857000 -1695000 -2745000 -5329545000 -4965354000 2248056000 1522550000 3224327000 2690504000 38600000 68200000 392146000 289366000 1109022000 770582000 86804000 149340000 251841000 282044000 305342000 140026000 857181000 488538000 153443000 334911000 451919000 536082000 94316000 313915000 303311000 466530000 149524000 338977000 454054000 503033000 397283000 987803000 1209284000 1505645000 -91941000 -847777000 -352103000 -1017107000 379000 494000 1127000 4312000 609000 2085000 3039000 12325000 9201000 -811000 -8528000 -3293000 -11297000 1218000 -100699000 -861862000 -365312000 -1023091000 1438000 -8543000 -1121000 -5043000 -102137000 -853319000 -364191000 -1018048000 -0.05 -0.94 -0.19 -1.43 -0.05 -0.94 -0.19 -1.43 1964395000 905462000 1893911000 713879000 1964395000 905462000 1893911000 716027000 -102137000 -853319000 -364191000 -1018048000 -1760000 268000 1050000 1871000 -103897000 -853051000 -363141000 -1016177000 1936578000 1937000 7294369000 65000 -5227408000 2068963000 41249000 41000 97954000 97995000 13291000 13000 -13000 184995000 184995000 -1760000 -1760000 -102137000 -102137000 1991118000 1991000 7577305000 -1695000 -5329545000 2248056000 1792140000 1792000 6488857000 -2745000 -4965354000 1522550000 155720000 155000 474528000 474683000 37123000 37000 -37000 1471000 1000 -1000 4664000 6000 1706000 1712000 612252000 612252000 1050000 1050000 -364191000 -364191000 1991118000 1991000 7577305000 -1695000 -5329545000 2248056000 4017000 33569000 742933000 2094509000 736635000 737000 2563354000 900000 -3963692000 -1398701000 2380000 10810000 7631000 8000 -8000 88280000 88000 404591000 404679000 -4017000 -33569000 4017000 4000 33565000 33569000 -745313000 -2105319000 793726000 794000 2104525000 2105319000 31007000 31007000 31748000 32000 87175000 87207000 68149000 68000 -68000 841929000 841929000 -3500000 -4000 -201000 -205000 268000 268000 -853319000 -853319000 1726686000 1727000 6065869000 1168000 -4817011000 1251753000 4017000 33569000 742840000 2093662000 581497000 588000 1857331000 6393000 -38895000 -703000 -3798963000 -1980642000 -28000 -100000 28000 100000 100000 121000 947000 2380000 10810000 -808000 808000 3777000 3777000 7000 42665000 7201000 -42672000 7631000 8000 -8000 206501000 207000 942322000 942529000 -4017000 -33569000 4017000 4000 33565000 33569000 -745313000 -2105319000 793726000 794000 2104525000 2105319000 31007000 31007000 69444000 69000 115961000 116030000 68150000 68000 -68000 1024000000 1024000000 -3500000 -4000 -201000 -205000 1871000 1871000 -1018048000 -1018048000 1726686000 1727000 6065869000 1168000 -4817011000 1251753000 -364191000 -1018048000 11057000 10308000 611308000 1028914000 23417000 28815000 -7238000 0 3076000 3621000 15412000 112723000 7872000 11598000 8155000 20944000 1158000 -29372000 20360000 42138000 -3781000 -30937000 -16227000 -140162000 -22786000 -34725000 1234000 6393000 240424000 -278320000 6783000 7475000 155315000 0 50941000 0 3000000 2500000 -216039000 -9975000 0 942529000 0 199369000 200000000 400000000 474683000 79473000 0 3777000 -401000 -250000 274282000 817344000 -3638000 -678000 295029000 528371000 2128146000 1401962000 2423175000 1930333000 3588000 9143000 2774000 9737000 0 2138988000 396000 36557000 0 31007000 0 10810000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1. Organization </div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Palantir Technologies Inc. (including its subsidiaries, “Palantir,” or “the Company”) was incorporated in Delaware on May 6, 2003. The Company builds and deploys software platforms, Palantir Gotham and Palantir Foundry, that serve as the central operating systems for its customers. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2. Significant Accounting Policies </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation and Consolidation </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over the investee, but does not control, are accounted for using the equity method of accounting. The Company’s fiscal year ends on December 31. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The unaudited condensed consolidated balance sheet as of December 31, 2020, included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity (deficit), and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company ceased to be an emerging growth company as of December 31, 2020, which accelerated its adoption of Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leases (Topic 842)</div></div>. As a result, certain components of cash flows used in operating activities within the Company’s condensed consolidated statements of cash flows for the nine months ended September 30, 2020, have been presented to conform to the new standard. The impact to the presentation of the other statements was not material. </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the year ended December 31, 2020, which was filed with the SEC on February 26, 2021. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts<div style="display:inline;">;</div> the valuation of deferred tax assets and uncertain tax positions<div style="display:inline;">;</div> collectability of contract consideration, including accounts receivable<div style="display:inline;">;</div> useful lives of tangible assets<div style="display:inline;">;</div> and the incremental borrowing rate for operating leases. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Summary of Significant Accounting Policies </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company’s significant accounting policies are discussed in <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Note 2. Significant Accounting Policies</div></div> in the notes to consolidated financial statements in its Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the year ended December 31, 2020, which was filed with the SEC on February 26, 2021. There have been no significant changes to these policies during the nine months ended September 30, 2021. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash, Cash Equivalents, and Restricted Cash </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30,</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,335,068  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,800,190  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">41,316  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,800  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash, noncurrent</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46,791  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86,343  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total cash, cash equivalents, and restricted cash</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">            2,423,175  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">            1,930,333  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> </div> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounts Receivable and Allowance for Credit Losses </div></div></div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;">Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses, if any. The Company generally grants <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-collateralized</div> credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, including the ongoing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">written-off</div> and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the assessment as of September 30, 2021, the Company recorded an immaterial allowance for credit losses. As of December 31, 2020, the Company did not record an allowance for credit losses. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentrations of Credit Risk and Other Concentrations </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents primarily consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of September 30, 2021 and December 31, 2020 were $174.4 million and $156.9 million, respectively. Customer H represented 11% of total accounts receivable as of September 30, 2021. Customer G represented 13% of total accounts receivable as of December 31, 2020. No other customer represented more than 10% of total accounts receivable as of September 30, 2021 and December 31, 2020. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of September 30, 2021 and December 31, 2020, the Company had not experienced any significant losses on its accounts receivable. </div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three and nine months ended September 30, 2021, no customer represented more than 10% of total revenue. For the three months ended September 30, 2020, no customer represented more than 10% of total revenue. For the nine months ended September 30, 2020, Customer F, which is in the government operating segment, represented 11% of total revenue. No other customer represented more than 10% of total revenue for the three and nine months ended September 30, 2020. </div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The Company relies on the technology, infrastructure, and software applications, including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">software-as-a-service</div></div></div> offerings, of third parties in order to host or operate certain key products and functions of its business. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Adopted Accounting Pronouncements </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Simplifying the Accounting for Income Taxes (Topic 740), </div></div>as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> also amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> as of January 1, 2021 using transition methods allowed under each aspect of the guidance. The adoption of the standard did not have a material impact on the Company’s condensed consolidated financial statements. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation and Consolidation </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over the investee, but does not control, are accounted for using the equity method of accounting. The Company’s fiscal year ends on December 31. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The unaudited condensed consolidated balance sheet as of December 31, 2020, included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity (deficit), and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company ceased to be an emerging growth company as of December 31, 2020, which accelerated its adoption of Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leases (Topic 842)</div></div>. As a result, certain components of cash flows used in operating activities within the Company’s condensed consolidated statements of cash flows for the nine months ended September 30, 2020, have been presented to conform to the new standard. The impact to the presentation of the other statements was not material. </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the year ended December 31, 2020, which was filed with the SEC on February 26, 2021. </div> 0.20 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts<div style="display:inline;">;</div> the valuation of deferred tax assets and uncertain tax positions<div style="display:inline;">;</div> collectability of contract consideration, including accounts receivable<div style="display:inline;">;</div> useful lives of tangible assets<div style="display:inline;">;</div> and the incremental borrowing rate for operating leases. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash, Cash Equivalents, and Restricted Cash </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30,</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,335,068  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,800,190  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">41,316  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,800  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash, noncurrent</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46,791  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86,343  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total cash, cash equivalents, and restricted cash</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">            2,423,175  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">            1,930,333  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> </div> </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30,</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,335,068  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,800,190  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">41,316  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,800  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash, noncurrent</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46,791  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86,343  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total cash, cash equivalents, and restricted cash</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">            2,423,175  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">            1,930,333  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> </div> </div> 2335068000 1800190000 41316000 43800000 46791000 86343000 2423175000 1930333000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounts Receivable and Allowance for Credit Losses </div></div></div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;">Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses, if any. The Company generally grants <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-collateralized</div> credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, including the ongoing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">written-off</div> and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the assessment as of September 30, 2021, the Company recorded an immaterial allowance for credit losses. As of December 31, 2020, the Company did not record an allowance for credit losses. </div> 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentrations of Credit Risk and Other Concentrations </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents primarily consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of September 30, 2021 and December 31, 2020 were $174.4 million and $156.9 million, respectively. Customer H represented 11% of total accounts receivable as of September 30, 2021. Customer G represented 13% of total accounts receivable as of December 31, 2020. No other customer represented more than 10% of total accounts receivable as of September 30, 2021 and December 31, 2020. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of September 30, 2021 and December 31, 2020, the Company had not experienced any significant losses on its accounts receivable. </div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three and nine months ended September 30, 2021, no customer represented more than 10% of total revenue. For the three months ended September 30, 2020, no customer represented more than 10% of total revenue. For the nine months ended September 30, 2020, Customer F, which is in the government operating segment, represented 11% of total revenue. No other customer represented more than 10% of total revenue for the three and nine months ended September 30, 2020. </div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The Company relies on the technology, infrastructure, and software applications, including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">software-as-a-service</div></div></div> offerings, of third parties in order to host or operate certain key products and functions of its business. </div> 174400000 156900000 0.11 0.13 0.10 0.10 0.10 0.10 0.10 0.11 0.10 0.10 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Adopted Accounting Pronouncements </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Simplifying the Accounting for Income Taxes (Topic 740), </div></div>as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> also amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> as of January 1, 2021 using transition methods allowed under each aspect of the guidance. The adoption of the standard did not have a material impact on the Company’s condensed consolidated financial statements. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3. Contract Liabilities and Remaining Performance Obligations </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Contract Liabilities </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s contract liabilities consist of deferred revenue and customer deposits. As of September 30, 2021 and December 31, 2020, the Company’s contract liability balances were $510.3 million and $531.9 million, respectively. Revenue of $347.7 million and $406.4 million was recognized during the nine months ended September 30, 2021 and 2020, respectively, that was included in the contract liability balances as of December 31, 2020 and 2019, respectively. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Remaining Performance Obligations </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s arrangements with its customers often have terms that span over multiple years. However, the Company generally allows its customers to terminate contracts for convenience prior to the end of the stated term with less than twelve months’ notice. Revenue allocated to remaining performance obligations represents noncancelable contracted revenue that has not yet been recognized, which includes deferred revenue and, in certain instances, amounts that will be invoiced. The Company has elected the practical expedient allowing the Company to not disclose remaining performance obligations for contracts with original terms of twelve months or less. Cancelable contracted revenue, which includes customer deposits, is not considered a remaining performance obligation. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s remaining performance obligations were $873.9 million as of September 30, 2021, of which the Company expects to recognize approximately 45% as revenue over the next twelve months. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Disaggregation of Revenue </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">See <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Note 13. Segment and Geographic Information</div></div> for disaggregated revenue by customer segment and geographic region. </div> 510300000 531900000 347700000 406400000 873900000 0.45 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4. Investments and Fair Value Measurements </div></div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments consist of money market funds and certificates of deposit included in cash equivalents and restricted cash, accounts receivable, equity securities, other assets accounted for at fair value, accounts payable, and accrued liabilities. Money market funds, certificates of deposit, and marketable securities are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 1pt;"> <td colspan="17"/> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">767,372</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">767,372</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certificates of deposit</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">60,061</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">60,061</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable securities</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">148,077</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">148,077</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">975,510</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">915,449</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">60,061</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">                —</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 12pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="16" style="height: 12pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,075,783</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,075,783</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certificates of deposit</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,097</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,097</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">    1,149,880</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,075,783</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">    74,097</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">                —</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Certificates of Deposit </div></div></div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s Level 2 instruments consist of cash equivalents and restricted cash invested in certificates of deposit. The fair value of such instruments is estimated based on valuations obtained from third-party pricing services that utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable either directly or indirectly. These inputs include interest rate curves, foreign exchange rates, and credit ratings. Gross unrealized gains or losses on certificate of deposits as of September 30, 2021 and December 31, 2020 were not material. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Marketable Securities </div></div></div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Marketable securities consist of equity securities in publicly-traded companies and are recorded at fair market value each reporting period. Realized and unrealized gains and losses are recorded in other income (expense), net on the condensed consolidated statements of operations. During the three and nine months ended September 30, 2021, the Company recorded net unrealized losses of </div>$7.2 million within other income (expense), net on the condensed consolidated statements of operations. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments </div></div></div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;">The Company approved and entered into certain agreements (“Investment Agreements”) to purchase, or commit to purchase, as further discussed in <div style="font-style: normal; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Note 8. Commitments and Contingencies—Investment Commitments, </div></div>shares of various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities (each, an “Investee,” and such purchases, and commitments to purchase, the “Investments”). In connection with signing the Investment Agreements, each Investee or an associated entity and the Company entered into a commercial contract for access to the Company’s products and services. The maximum potential revenue from all of these commercial contracts is $640.2 million, which is inclusive of $82.9 <div style="letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">million of contractual options. The terms of <div style="letter-spacing: 0px; top: 0px;;display:inline;">such contracts, including such contractual options, range</div> </div>from <span style="-sec-ix-hidden:hidden29210159">three</span> to ten years. The majority of these commercial contracts are subject to various termination provisions, including for convenience in the event a proposed business combination is not completed. </div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;">During 2021, the Company assessed the concurrent agreements under the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-monetary</div> guidance within Accounting Standards Codification (“ASC”) 606 - <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revenue from Contracts with Customers</div></div> and the total revenue recognized from the commercial contracts during the three and nine months ended September 30, 2021 was $19.0 million and $22.0 million, respectively. </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the details of the investments purchased under such Investment Agreements during the nine months ended September 30, 2021 (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 68%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 3%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Entity <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Investment Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Celularity</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 3%;;text-align:right;">    </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">                    2,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Faraday Future</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">2,500</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Astrocast</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">1,520</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BlackSky</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">800</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lilium</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">4,100</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">41,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Roivant Sciences</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">3,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sarcos Robotics</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">2,100</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Autonomous aerial vehicle company<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px"> (2)</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">3,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 68%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">19,020</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">153,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 68%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="width: 9%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; margin-left: 8%; border-bottom: 1px solid rgb(0, 0, 0); text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 8%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1)</div> </div></td> <td style="vertical-align: top; font-size: 9pt;;text-align:left;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments are in publicly-traded marketable securities, unless otherwise noted. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 8%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(2)</div> </div></td> <td style="vertical-align: top; font-size: 9pt;;text-align:left;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment in privately-held company. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Privately-Held Securities </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equity investments in private-held companies without readily determinable fair values are recorded using the measurement alternative of cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. As of September 30, 2021, the carrying value of investments without readily determinable fair values were recorded in other assets in the Company’s condensed consolidated balance sheets and were not material. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Alternative Investments </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company purchased $50.9 million in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">100-ounce</div> gold bars, which are included within prepaid expenses and other current assets on the condensed consolidated balance sheet. The investment is initially recorded as cost and is subsequently remeasured at lower of cost or market each reporting period. The gold bars will initially be kept in a secure third-party facility located in the northeastern United States. The Company is able to take physical possession of the gold bars stored at the facility at any time with reasonable notice. </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 1pt;"> <td colspan="17"/> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">767,372</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">767,372</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certificates of deposit</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">60,061</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">60,061</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable securities</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">148,077</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">148,077</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">975,510</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">915,449</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">60,061</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">                —</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 12pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="16" style="height: 12pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market funds</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,075,783</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,075,783</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certificates of deposit</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,097</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,097</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">    1,149,880</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,075,783</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">    74,097</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">                —</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 767372000 767372000 60061000 60061000 148077000 148077000 975510000 915449000 60061000 1075783000 1075783000 74097000 74097000 1149880000 1075783000 74097000 -7200000 -7200000 640200000 82900000 P10Y 19000000.0 22000000.0 <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the details of the investments purchased under such Investment Agreements during the nine months ended September 30, 2021 (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 68%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 3%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Entity <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Investment Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Celularity</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 3%;;text-align:right;">    </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">                    2,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Faraday Future</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">2,500</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Astrocast</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">1,520</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BlackSky</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">800</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lilium</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">4,100</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">41,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Roivant Sciences</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">3,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sarcos Robotics</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">2,100</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Autonomous aerial vehicle company<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px"> (2)</div></div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">3,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 68%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 68%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">19,020</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">153,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 68%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 3%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="width: 9%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; margin-left: 8%; border-bottom: 1px solid rgb(0, 0, 0); text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 8%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1)</div> </div></td> <td style="vertical-align: top; font-size: 9pt;;text-align:left;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments are in publicly-traded marketable securities, unless otherwise noted. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 8%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(2)</div> </div></td> <td style="vertical-align: top; font-size: 9pt;;text-align:left;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment in privately-held company. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 2000 20000000 2500 25000000 1520 5000000 800 8000000 4100 41000000 3000 30000000 2100 21000000 3000 3000000 19020 153000000 50900000 100 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5. Balance Sheet Components </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Property and Equipment, Net </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 93%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.75pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> <br/>  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,<br/> 2020</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">    $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80,215   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">85,196   </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment, software, and other</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,451   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,275   </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,021   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,976   </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Construction in progress</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,305   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">493   </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total property and equipment, gross</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">            120,992   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">        117,940   </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: accumulated depreciation and amortization</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(92,214)  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(88,399)  </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total property and equipment, net</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,778   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,541   </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation and amortization expense related to property and equipment, net was $3.1 million and $2.5 million for the three months ended September 30, 2021 and 2020, respectively, and $9.3 million and $9.3 million for the nine months ended September 30, 2021 and 2020, <div style="letter-spacing: 0px; top: 0px;;display:inline;">respectively.</div> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accrued Liabilities </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued liabilities consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 94%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,<br/> 2020</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued payroll and related expenses</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,157</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">85,466</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued other liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">79,310</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">73,080</td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total accrued liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">            179,467</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">        158,546</td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 93%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.75pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> <br/>  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,<br/> 2020</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">    $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80,215   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">85,196   </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment, software, and other</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,451   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,275   </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,021   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,976   </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Construction in progress</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,305   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">493   </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total property and equipment, gross</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">            120,992   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">        117,940   </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: accumulated depreciation and amortization</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(92,214)  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(88,399)  </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total property and equipment, net</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,778   </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,541   </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> 80215000 85196000 25451000 22275000 10021000 9976000 5305000 493000 120992000 117940000 92214000 88399000 28778000 29541000 3100000 2500000 9300000 9300000 <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued liabilities consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 94%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,<br/> 2020</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued payroll and related expenses</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,157</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">85,466</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued other liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">79,310</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">73,080</td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total accrued liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">            179,467</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">        158,546</td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> 100157000 85466000 79310000 73080000 179467000 158546000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6. Equity Method Investments </div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Palantir Technologies Japan, K.K. </div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During November 2019, the Company and SOMPO Holdings, Inc. (“SOMPO”) created a Japanese Kabushiki Kaisha (“K.K.”), Palantir Technologies Japan, K.K. (“Palantir Japan”), to distribute Palantir platforms to the Japanese market. Upon closing of the transaction with SOMPO, the Company purchased a total of 100,000 shares of Palantir Japan common stock for $25.0 million. The shares the Company received in exchange represent a 50% voting interest in Palantir Japan. The remaining 50% of the voting interest is held by SOMPO. The Company’s investment in Palantir Japan is accounted for as an equity method investment as the Company is able to exercise significant influence over, but does not control, the investee. </div></div> 100000 25000000.0 0.50 0.50 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7. Debt </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2014 Credit Facility </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In October 2014, the Company entered into an unsecured revolving credit facility which has been subsequently amended (the “2014 Credit Facility”). The 2014 Credit Facility incurred interest at the London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75% per annum, subject to certain adjustments, and incurs a commitment fee of 0.375% assessed on the daily average undrawn portion of revolving commitments. Interest and commitment fees are payable at the end of an interest period or at each three-month interval if the interest period is longer than three months. The 2014 Credit Facility, as amended, matures on June 4, 2023. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During April 2021, the Company entered into an amendment to the 2014 Credit Facility, which provided for an increase of $200.0 million to the revolving commitments of the existing lenders under the 2014 Credit Facility, for total revolving commitments of $400.0 million, and which also provided for an incremental loan facility for additional loans in an aggregate principal amount of up to $100.0 million with one or more existing or new lenders upon mutual agreement between the Company and such lenders. Upon entering into the amendment, the Company repaid its outstanding term loans of $200.0 million. As of September 30, 2021, the Company had no amounts outstanding under the 2014 Credit Facility and a $400.0 million undrawn revolving credit facility. </div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The 2014 Credit Facility contains customary r<div style="letter-spacing: 0px; top: 0px;;display:inline;">epresentat</div>ions and warranties, and certain financial and nonfinancial covenants, including but not limited to maintaining minimum liquidity of $50.0 million, and certain limitations on liens and indebtedness. The Company was in compliance with all covenants associated with the 2014 Credit Facility as of September 30, 2021. </div> London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75% London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75% 0.0275 0.00375 2023-06-04 200000000.0 400000000.0 100000000.0 200000000.0 0 400000000.0 50000000.0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">8. Commitments and Contingencies </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Purchase Commitments </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">In December 2019, the Company entered into, and subsequently amended during December 2020, a minimum annual commitment to purchase cloud hosting services of at least $1.49 billion over six contract years, with an optional carryover period through June 30, 2029, in exchange for various discounts on such services. I<div style="letter-spacing: 0px; top: 0px;;display:inline;">f the spend does not meet the minimum annual commitment each year or at the end of the term, the Company is obligated to make a return payment. If the difference is greater than $30.0 million for each of the first three contract years or $50.0 million for each of the contract years thereafter (“relief amounts”), the Company has the option to pay the respective relief amount for that year for services to be utilized in the future and the excess amount of the difference above the relief amount would be added to the minimum annual commitment of the following year through the end of the contract.</div> As of September 30, 2021, the Company had satisfied $34.0 million of its $167.0 million <div style="letter-spacing: 0px; top: 0px;;display:inline;">commitment for the contract year ending June 30, 2022. </div> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In June 2020, the Company entered into an additional commitment to purchase at least $45.0 million of cloud hosting services over a period of five years commencing on June 1, 2020 and ending on May 31, 2025. If the spend commitment is not met at the end of the term, the Company is obligated to pay the full amount of the outstanding balance (“shortfall payment”). The shortfall payment may be applied as a prepayment against consumption during an additional twelve-month coverage period expiring on May 31, 2026, at which time any unused amount would be forfeited. As of September 30, 2021, the Company had satisfied $8.0 million of its commitment. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investment Commitments </div></div></div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;">The Company approved and entered into certain Investment Agreements with Investees, as further discussed in <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Note 4. Investments and Fair Value Measurements - Investments</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">.</div></div></div></div> As of September 30, 2021, the Company had outstanding investment commitments, subject to the applicable terms and conditions, to purchase a total of 22.7 million shares for an aggregate purchase price of $226.5 million. The closings of certain of such Investments are contingent upon the completion of a proposed business combination between the applicable Investee and other applicable parties. </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents details related to the Company’s investment commitments outstanding as of September 30, 2021 (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 93%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Entity</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Investment<br/> Agreement Date</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Committed<br/> Share Amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Committed<br/> Investment Amount</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Mobility company <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">May 11, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Wejo</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">May 28, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,500</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;">Babylon Health <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1) (2)</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">June 3, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,500</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Boxed <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">June 13, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pear Therapeutics</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">June 21, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Autonomous vehicle company <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">June 22, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,800</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fast Radius <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">July 18, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tritium <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">July 27, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,500</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">AdTheorent <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">July 27, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,500</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FinAccel</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">August 2, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Energy Vault <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">September 8, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">850</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,500</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Electric vehicle charging company <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">September 10, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 93%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,650</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">226,500</td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 93%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> </div> </div> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"/> </div> </div> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom: 1px solid rgb(0, 0, 0); text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1)</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company’s investment closed after September 30, 2021. See further discussion in <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Note 14. Subsequent Events</div></div>. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(2)</div> </div></td> <td style="vertical-align: top; font-size: 9pt;;text-align:left;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> </div> </div> </div> </div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> </div> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Litigation and Legal Proceedings </div></div></div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">From time to time, third parties may assert patent infringement claims against the Company. In addition, from time to time, the Company may be subject to other legal proceedings and claims in the ordinary course of business, including claims of alleged infringement of trademarks, copyrights, and other intellectual property rights; employment claims; securities claims; investor claims; corporate claims; class action claims; and general contract, tort, or other claims. The Company may from time to time also be subject to various legal or government claims, disputes, or investigations. Such matters may include, but not be limited to, claims, disputes, allegations, or investigations related to warranty; refund; breach of contract; breach, leak, or misuse of personal data or confidential information; employment; government procurement; intellectual property; government regulation or compliance (including but not limited to anti-corruption requirements, export or other trade controls, data privacy or data protection, cybersecurity requirements, or antitrust/competition law requirements); securities; investor; corporate; or other matters. The Company is unable to predict whether or when any such matters may arise, the outcome of these matters, or the ultimate legal and financial liability, and cannot reasonably estimate the possible loss or range of loss at this time and accordingly has not accrued a related liability. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 14, 2017, members of KT4 Partners LLC (Managing Member Marc Abramowitz) and Sandra Martin Clark, as trustee for the Marc Abramowitz Irrevocable Trust Number 7 (together, “KT4 Plaintiffs”), filed an action in the Delaware Superior Court against the Company and Disruptive Technology Advisers LLC. The complaint alleges tortious interference with prospective economic advantage and civil conspiracy in connection with a potential sale of stock by the KT4 Plaintiffs to a third party. The KT4 Plaintiffs seek compensatory and punitive damages, interest, fees, and costs. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company believes this lawsuit is without merit and is vigorously defending itself against it. Given the uncertainty of litigation, it may be reasonably possible that the Company will incur a loss with regards to the matter; however, it cannot currently estimate a range of possible losses. Accordingly, the Company is unable, at this time, to estimate the overall effects that may result from the lawsuit on its financial condition, results of operations, or cash flows. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2021, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that were expected to have a material adverse impact on its condensed consolidated financial statements.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Letters of Credit and Guarantees </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company had irrevocable standby letters of credit and guarantees, including bank guarantees, outstanding in the amounts of $88.1 million and $116.8 million as of September 30, 2021 and December 31, 2020, respectively, all of which were fully collateralized. The Company is required to maintain these letters of credit and guarantees primarily for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. As of September 30, 2021, these letters of credit and guarantees had expiration dates through August 2028. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warranties and Indemnification </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company generally provides a warranty for its software products and services and a service level agreement (“SLA”) for the Company’s performance of software operations via its operations and maintenance (“O&amp;M”) services to its customers. The Company’s products are generally warranted to perform substantially as described in the associated product documentation during the subscription term or for a period of up to 90 days where the software is hosted by the customer; and the Company includes O&amp;M services as part of its subscription and license agreements to support this warranty and maintain the operability of the software. The Company’s services are generally warranted to be performed in a professional manner and by an adequate staff with knowledge about the products. In the event there is a failure of such warranties, the Company generally is obligated to correct the product or service to conform to the warranty provision, as set forth in the applicable SLA, or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product and service (generally prorated over the contract term). Due to the absence of historical warranty claims, the Company’s expectations of future claims related to products under warranty continue to be insignificant. The Company has not recorded warranty expense or related accruals as of September 30, 2021 and December 31, 2020. </div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company generally agrees to indemnify its customers against legal claims that the Company’s software products infringe certain third-party intellectual property rights and accounts for its indemnification obligations. In the event of such a claim, the Company is generally obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of an infringement, the Company generally agrees to secure the right for the customer to continue using the infringing product; to modify or replace the infringing product; or, if those options are not commercially practicable, to refund the cost of the software, as prorated over the period. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers and does not believe that the Company will be liable for such claims in the foreseeable future. As such, the Company has not recorded a liability for infringement costs as of September 30, 2021 and December 31, 2020. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has obligations under certain circumstances to indemnify each of the defendant directors and certain officers against judgments, fines, settlements, and expenses related to claims against such directors and certain officers and otherwise to the fullest extent permitted under the law and the Company’s bylaws and Amended and Restated Certificate of Incorporation. </div></div> 1490000000 If the spend does not meet the minimum annual commitment each year or at the end of the term, the Company is obligated to make a return payment. If the difference is greater than $30.0 million for each of the first three contract years or $50.0 million for each of the contract years thereafter (“relief amounts”), the Company has the option to pay the respective relief amount for that year for services to be utilized in the future and the excess amount of the difference above the relief amount would be added to the minimum annual commitment of the following year through the end of the contract. 34000000.0 167000000.0 45000000.0 8000000.0 22700000 226500000 <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents details related to the Company’s investment commitments outstanding as of September 30, 2021 (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 93%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Entity</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Investment<br/> Agreement Date</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Committed<br/> Share Amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Committed<br/> Investment Amount</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Mobility company <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">May 11, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Wejo</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">May 28, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,500</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;">Babylon Health <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1) (2)</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">June 3, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,500</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Boxed <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">June 13, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pear Therapeutics</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">June 21, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Autonomous vehicle company <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">June 22, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,800</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fast Radius <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">July 18, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tritium <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">July 27, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,500</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">AdTheorent <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">July 27, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,500</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FinAccel</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">August 2, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,000</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Energy Vault <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">September 8, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">850</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,500</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="3" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Electric vehicle charging company <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>)</div></div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">September 10, 2021</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 93%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,650</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; width: 1%;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">226,500</td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 93%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="line-height: normal;"> </div> </td> <td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> </div> </div> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"/> </div> </div> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom: 1px solid rgb(0, 0, 0); text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1)</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company’s investment closed after September 30, 2021. See further discussion in <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Note 14. Subsequent Events</div></div>. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(2)</div> </div></td> <td style="vertical-align: top; font-size: 9pt;;text-align:left;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> </div> </div> </div> </div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> </div> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> 2021-05-11 2000000 20000000 2021-05-28 3500000 35000000 2021-06-03 3500000 35000000 2021-06-13 2000000 20000000 2021-06-21 1000000 10000000 2021-06-22 1800000 18000000 2021-07-18 2000000 20000000 2021-07-27 1500000 15000000 2021-07-27 1500000 15000000 2021-08-02 1000000 10000000 2021-09-08 850 8500000 2021-09-10 2000000 20000000 22650000 226500000 88100000 116800000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">9. Stockholders’ Equity </div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s Class A, Class B, and Class F common stock (collectively, the “common stock”) all have the same rights, except with respect to voting and conversion rights. Class A and Class B common stock have voting rights of 1 and 10 votes per share, respectively. The Class F common stock has the voting rights generally described below and each share of Class F common stock is convertible at any time, at the option of the holder thereof, into one share of Class B common stock. All shares of Class F common stock are held in a voting trust established by Stephen Cohen, Alexander Karp, and Peter Thiel (the “Founders”). The Class F common stock generally gives the Founders the ability to control up to 49.999999% of the total voting power of the Company’s capital stock, so long as the Founders and certain of their affiliates collectively meet a minimum ownership threshold, which was 100 million of the Company’s equity securities as of September 30, 2021. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Holders of common stock are entitled to dividends when, as and if declared by the Company’s Board of Directors, subject to the rights of the holders of all classes of stock outstanding having priority rights to dividends. No dividends have been declared as of September 30, 2021. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with the Company’s direct listing of its Class A common stock on the New York Stock Exchange (“Direct Listing”) in September 2020, all outstanding shares of redeemable convertible preferred stock and convertible preferred stock were converted into 4,017,378 and 793,725,807 shares of Class B common stock, respectively, and 1,005,000 shares of Class B common stock held by the Founders were exchanged for an equal number of shares of Class F common stock. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Authorized</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Issued and<br/> Outstanding</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Authorized</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Issued and<br/> Outstanding</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock:</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="5" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,900,441</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,542,058</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class B</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,700,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">89,672</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,700,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">249,077</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class F</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,701,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,991,118</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,701,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,792,140</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> </div> </div> 0.49999999 100000000 0 4017378 793725807 1005000 <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Authorized</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Issued and<br/> Outstanding</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Authorized</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Issued and<br/> Outstanding</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock:</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="5" style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,900,441</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,542,058</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class B</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,700,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">89,672</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,700,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">249,077</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class F</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 62%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,701,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,991,118</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,701,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,792,140</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 62%;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> </div> </div> 20000000000 1900441000 1900441000 20000000000 1542058000 1542058000 2700000000 89672000 89672000 2700000000 249077000 249077000 1005000 1005000 1005000 1005000 1005000 1005000 22701005000 1991118000 1991118000 22701005000 1792140000 1792140000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">10. Stock-Based Compensation </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Stock Options </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes stock option activity for the nine months ended September 30, 2021 (in thousands, except per share amounts): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="vertical-align: bottom;"/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Options</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted-</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercise Price</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Share</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted-</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Remaining</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Contractual</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life (years)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Intrinsic Value</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance as of December 31, 2020</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">535,767</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.12</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.99</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,340,245  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options exercised</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(155,720</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.05</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options canceled and forfeited</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,518</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.26</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance as of September 30, 2021</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">              374,529</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.40</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8.82</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,230,308  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options vested and exercisable as of September 30, 2021</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">182,617</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.48</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.08</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,571,719  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> </table> </div> </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2021, the unrecognized expense related to options outstanding was $940.0 million, which is expected to be recognized over a weighted-average service period of eight years. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">RSUs </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the RSU activity for the nine months ended September 30, 2021 (in thousands, except per share amounts): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 95%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RSUs<br/> Outstanding</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted Average<br/> Grant Date Fair<br/> Value per Share</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested and outstanding as of December 31, 2020</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">184,870</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.97</td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSUs granted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,093</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24.01</td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSUs vested</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(37,123</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8.17</td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSUs canceled</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,807</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8.18</td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested and outstanding as of September 30, 2021</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">166,033</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.22</td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> </table> </div> </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2021, the total unrecognized stock-based compensation expense related to the RSUs outstanding was $985.1 million, which <div style="letter-spacing: 0px; top: 0px;;display:inline;">the</div> Company expects to recognize over three years. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Growth Units </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In May 2019, the Company granted growth units which vest upon the satisfaction of both a performance-based vesting condition, which was satisfied upon the Company’s Direct Listing, and a service-based vesting condition, which was satisfied in March 2021. In March 2021, the 3.6 million outstanding growth units vested and, per the formula applicable to the awards, converted into 1.5 million shares of common stock. During the three months ended March 31, 2021, the Company recognized the remaining stock-based compensation expense related to the growth units of $1.2 million. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Stock-based Compensation Expense </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total stock-based compensation expense was as follows (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 66%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended September 30,</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost of revenue</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,860</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">94,385</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,866</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">120,285</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales and marketing</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">57,124</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">263,958</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">186,418</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">322,353</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,472</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">256,769</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">122,976</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">309,698</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">78,379</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">231,847</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">247,048</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">276,578</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total stock-based compensation expense <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">184,835</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">846,959</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">611,308</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,028,914</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> </div> </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1)</div> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date. </div></div> </td> </tr> </table> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes stock option activity for the nine months ended September 30, 2021 (in thousands, except per share amounts): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="vertical-align: bottom;"/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Options</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted-</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercise Price</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Share</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted-</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Remaining</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Contractual</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life (years)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Intrinsic Value</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance as of December 31, 2020</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">535,767</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.12</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.99</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,340,245  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options exercised</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(155,720</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.05</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options canceled and forfeited</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,518</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.26</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance as of September 30, 2021</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">              374,529</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.40</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8.82</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,230,308  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options vested and exercisable as of September 30, 2021</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">182,617</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.48</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7.08</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,571,719  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> </table> </div> </div> 535767000 6.12 P7Y11M26D 9340245000 155720000 3.05 5518000 5.26 374529000 7.40 P8Y9M25D 6230308000 182617000 4.48 P7Y29D 3571719000 940000000000.0 P8Y <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the RSU activity for the nine months ended September 30, 2021 (in thousands, except per share amounts): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 95%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RSUs<br/> Outstanding</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted Average<br/> Grant Date Fair<br/> Value per Share</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested and outstanding as of December 31, 2020</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">184,870</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.97</td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSUs granted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,093</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24.01</td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSUs vested</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(37,123</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8.17</td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSUs canceled</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,807</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8.18</td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested and outstanding as of September 30, 2021</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">166,033</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">  $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.22</td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> </table> </div> </div> 184870000 6.97 25093000 24.01 37123000 8.17 6807000 8.18 166033000 9.22 985100000 P3Y 3600000 1500000 1200000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Stock-based Compensation Expense </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total stock-based compensation expense was as follows (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 66%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended September 30,</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost of revenue</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,860</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">94,385</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,866</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> $</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">120,285</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales and marketing</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">57,124</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">263,958</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">186,418</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">322,353</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,472</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">256,769</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">122,976</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">309,698</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">78,379</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">231,847</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">247,048</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">276,578</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total stock-based compensation expense <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">184,835</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">846,959</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">611,308</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,028,914</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> </div> </div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1)</div> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date. </div></div> </td> </tr> </table> 14860000 94385000 54866000 120285000 57124000 263958000 186418000 322353000 34472000 256769000 122976000 309698000 78379000 231847000 247048000 276578000 184835000 846959000 611308000 1028914000 769500000 8400000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">11. Income Taxes </div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company recorded a provision for income taxes of $1.4 million and a benefit <div style="letter-spacing: 0px; top: 0px;;display:inline;">from</div> income taxes of $8.5 million for the three months ended September 30, 2021 and 2020, respectively, and <div style="letter-spacing: 0px; top: 0px;;display:inline;">a </div>benefit <div style="letter-spacing: 0px; top: 0px;;display:inline;">from</div> income taxes of $1.1 million and $5.0 million for the nine months ended September 30, 2021 and 2020, respectively. The Company is subject to income tax in the U.S. as well as other tax jurisdictions in which it conducts business. The Company’s effective rate differs from the U.S. statutory rate primarily due to the valuation allowance recorded on its losses from the U.S. and other jurisdictions, foreign income taxed at different rates, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-deductible</div> stock-based compensation and the revaluation of its United Kingdom (“UK”) deferred tax assets as a result of a change in the UK corporate tax rate enacted during the second quarter of 2021, which increased the rate from 19% to 25% effective April 1, 2023. </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. The Company assesses its ability to realize the deferred tax assets on a quarterly basis, and it establishes a valuation allowance if it is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> that some portion of the deferred tax assets will not be realized. The Company weighs all available positive and negative evidence, including its earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies. For example, due to the weight of objectively verifiable negative evidence, including its history of losses in certain jurisdictions, the Company believes that it is more likely than not that its U.S. federal and state deferred tax assets will not be fully realized. Accordingly, the Company has maintained a valuation allowance on its U.S. federal and state deferred tax assets. </div> 1400000 -8500000 -1100000 -5000000.0 0.19 0.25 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">12. Net Loss Per Share Attributable to Common Stockholders </div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 67%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss attributable to common stockholders</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(102,137</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(853,319</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(364,191</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,018,048</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Change in fair value attributable to participating securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,483</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss attributable to common stockholders, for diluted net loss per share</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(102,137</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(853,319</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(364,191</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,023,531</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average shares used in computing net loss per share, basic</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,964,395</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">905,462</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,893,911</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">713,879</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average shares used in computing net loss per share, diluted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,964,395</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">905,462</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,893,911</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">716,027</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share attributable to common stockholders, basic</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.05</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.94</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.19</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.43</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share attributable to common stockholders, diluted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.05</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.94</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.19</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.43</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> </div> </div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30,</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2021        </div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2020        </div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants to purchase common stock</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,042</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,068</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options and Stock Appreciation Rights issued and outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">374,555</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">587,977</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSUs outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">166,033</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">199,655</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Growth units outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,583</td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">553,630</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">810,283</td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> </div> </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 67%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss attributable to common stockholders</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(102,137</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(853,319</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(364,191</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,018,048</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Change in fair value attributable to participating securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,483</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss attributable to common stockholders, for diluted net loss per share</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(102,137</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(853,319</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(364,191</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,023,531</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average shares used in computing net loss per share, basic</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,964,395</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">905,462</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,893,911</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">713,879</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average shares used in computing net loss per share, diluted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,964,395</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">905,462</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,893,911</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">716,027</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share attributable to common stockholders, basic</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.05</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.94</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.19</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.43</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> <td colspan="4" style="height: 1.5pt; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss per share attributable to common stockholders, diluted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.05</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.94</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.19</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.43</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> </div> </div> -102137000 -853319000 -364191000 -1018048000 0 0 0 -5483000 -102137000 -853319000 -364191000 -1023531000 1964395000 905462000 1893911000 713879000 1964395000 905462000 1893911000 716027000 -0.05 -0.94 -0.19 -1.43 -0.05 -0.94 -0.19 -1.43 <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September 30,</div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2021        </div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2020        </div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants to purchase common stock</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,042</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,068</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Options and Stock Appreciation Rights issued and outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">374,555</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">587,977</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RSUs outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">166,033</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">199,655</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Growth units outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,583</td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">553,630</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">810,283</td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> </div> </div> 13042000 19068000 374555000 587977000 166033000 199655000 3583000 553630000 810283000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">13. Segment and Geographic Information </div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables reflect the results of the Company’s reportable operating segments consistent with the manner in which the chief operating decision maker (“CODM”) evaluates the performance of each segment and allocates the Company’s resources. The CODM does not evaluate the performance of the Company’s assets on a segment basis for internal management reporting and, therefore, such information is not presented. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contribution is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. A segment’s contribution is calculated as segment revenue less the related costs of revenue and sales and marketing expenses. It excludes certain operating expenses that are not allocated to segments because they are separately managed at the consolidated corporate level. These unallocated costs include stock-based compensation expense, research and development expenses, and general and administrative expenses. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial information for each reportable segment was <div style="letter-spacing: 0px; top: 0px;;display:inline;">as</div> follows (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 60%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended September 30,</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended September 30,</div></div></div></div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Government</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">217,836</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">162,561</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">658,375</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">420,257</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Commercial</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">174,310</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">126,805</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">450,647</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">350,325</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">392,146</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">289,366</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,109,022</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">  770,582</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 60%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended September 30,</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended September 30,</div></div></div></div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contribution:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Government</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,706</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">93,962</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400,705</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">226,186</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Commercial</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">98,177</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">69,496</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">245,841</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">168,908</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total contribution</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">223,883</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">163,458</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">   646,546</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">  395,094</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> </div> </div> </div> </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The reconciliation of contribution to loss from operations is as follows (in thousands): </div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 64%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended September 30,</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended September 30,</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Loss from operations</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">(91,941)</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">(847,777)</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">(352,103)</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">(1,017,107)</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">59,844 </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">57,146</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">180,335</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">156,832</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">71,145 </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">107,130</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">207,006</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">226,455</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation expense</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">184,835 </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">846,959</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">611,308</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">1,028,914</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total contribution</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">223,883 </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">163,458</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">646,546</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">395,094</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0pt; text-indent: 0px;"/></div></div> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1) </div>Excludes stock-based compensation expense. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Geographic Information </div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): </div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 64%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">                           </div></td> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">                           </div></td> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">                           </div></td> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">                           </div></td> <td/></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="15" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended September 30,</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">227,285</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">58</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">156,336</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">54</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United Kingdom</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">47,914</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">12</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">35,432</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">12</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rest of world<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">116,947</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">30</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">97,598</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">34</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">            392,146</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">                100</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">          289,366</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">                    100</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0pt; text-indent: 0px;"/></div></div> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1) </div>No other country represents 10% or more of total revenue for the three months ended September 30, 2021 or 2020. </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1) </div>No other country represents 10% or more of total revenue for the nine months ended September 30, 2021 or 2020. </div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial information for each reportable segment was <div style="letter-spacing: 0px; top: 0px;;display:inline;">as</div> follows (in thousands): </div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 60%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended September 30,</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended September 30,</div></div></div></div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Government</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">217,836</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">162,561</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">658,375</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">420,257</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Commercial</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">174,310</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">126,805</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">450,647</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">350,325</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">392,146</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">289,366</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,109,022</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">  770,582</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 60%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended September 30,</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended September 30,</div></div></div></div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contribution:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Government</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,706</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">93,962</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400,705</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">226,186</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Commercial</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">98,177</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">69,496</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">245,841</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">168,908</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total contribution</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">223,883</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">163,458</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">   646,546</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">  395,094</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> </table> </div> </div> </div> </div> 217836000 162561000 658375000 420257000 174310000 126805000 450647000 350325000 392146000 289366000 1109022000 770582000 125706000 93962000 400705000 226186000 98177000 69496000 245841000 168908000 223883000 163458000 646546000 395094000 <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The reconciliation of contribution to loss from operations is as follows (in thousands): </div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 64%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended September 30,</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended September 30,</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Loss from operations</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">(91,941)</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">(847,777)</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">(352,103)</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">(1,017,107)</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">59,844 </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">57,146</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">180,335</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">156,832</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">71,145 </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">107,130</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">207,006</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">226,455</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation expense</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">184,835 </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">846,959</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">611,308</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">1,028,914</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px; background-color: rgb(229, 229, 229);"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total contribution</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">223,883 </div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">163,458</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">646,546</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">395,094</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0pt; text-indent: 0px;"/></div></div> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1) </div>Excludes stock-based compensation expense. </div></div> -91941000 -847777000 -352103000 -1017107000 59844000 57146000 180335000 156832000 71145000 107130000 207006000 226455000 184835000 846959000 611308000 1028914000 223883000 163458000 646546000 395094000 <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): </div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 64%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">                           </div></td> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">                           </div></td> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">                           </div></td> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">                           </div></td> <td/></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="15" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended September 30,</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">227,285</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">58</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">156,336</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">54</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United Kingdom</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">47,914</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">12</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">35,432</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">12</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rest of world<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">116,947</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">30</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">97,598</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">34</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">            392,146</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">                100</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">          289,366</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">                    100</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0pt; text-indent: 0px;"/></div></div> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1) </div>No other country represents 10% or more of total revenue for the three months ended September 30, 2021 or 2020. </div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 67%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">                         </div></div></div></td> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">                         </div></div></div></td> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">                         </div></div></div></td> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">                         </div></div></div></td> <td/></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="15" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended September 30,</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="7" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 67%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue:</div></div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 67%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">625,662</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">56</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">391,106</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">51</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 67%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United Kingdom</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">122,234</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">11</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">94,440</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">12</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 67%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">France</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">61,558</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">6</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">78,572</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">10</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; width: 67%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rest of world<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">299,568</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">27</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">206,464</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">27</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 67%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 67%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">            1,109,022</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">                  100</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">            770,582</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">                    100</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 67%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; width: 2%;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0pt; text-indent: 0px;"/></div></div><div style="clear: both; max-height: 0pt; text-indent: 0px;"/></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1) </div>No other country represents 10% or more of total revenue for the nine months ended September 30, 2021 or 2020. </div></div> 227285000 0.58 156336000 0.54 47914000 0.12 35432000 0.12 116947000 0.30 97598000 0.34 392146000 1 289366000 1 0.10 0.10 625662000 0.56 391106000 0.51 122234000 0.11 94440000 0.12 61558000 0.06 78572000 0.10 299568000 0.27 206464000 0.27 1109022000 1 770582000 1 0.10 0.10 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">14. Subsequent Events </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investment Commitments and Investments </div></div></div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company approved and entered into additional Investment Agreements from October 1, 2021 through the date of this filing. As of the date of this filing, the Company had additional outstanding investment commitments, subject to applicable terms and conditions, to purchase a total of 2.6 million shares for an aggregate purchase price of $26.0 million.</div></div> <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents details regarding the Company’s additional investment commitments outstanding as of the date of this filing (in thousands): </div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 47%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td style="width: 21%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Entity</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment Agreement<br/> Date</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Committed<br/> Share Amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Committed<br/> Investment Amount</div></div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Telecommunications company (1)</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">October 6, 2021</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,600</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,000</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rigetti &amp; Co, Inc. <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">October 6, 2021</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,000</td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><div style="margin-left: 0.26in; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Tota<div style="letter-spacing: 0px; top: 0px;;display:inline;">l</div></div></div></td> <td style="vertical-align: bottom; text-indent: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> </td> <td style="vertical-align: bottom; text-indent: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;;text-align:right;">2,600</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> </td> <td style="vertical-align: bottom; text-indent: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;">$</td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;;text-align:right;">26,000</td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0pt; text-indent: 0px;"/></div></div> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="width: 9%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; margin-left: 8%; border-bottom: 1px solid rgb(0, 0, 0); text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="margin: 0pt 10% 0pt 8%; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1)</div> Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed. </div></div></div></div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-right: 11%; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with signing each of the Investment Agreements entered into between October 1, 2021 and the date of this filing, each Investee or an associated entity and the Company entered into a commercial contract for the Company’s products and services. The maximum potential revenue from these commercial contracts, including option years, is $26.0 million, and the terms of such agreements range from <span style="-sec-ix-hidden:hidden29280598">three</span> to four years. </div></div></div></div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additionally, from October 1 to the date of this filing, the Company purchased 5.5 million shares for an aggregate purchase price of $55.0 million, as set forth in the following table (in thousands): </div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 16%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 16%; vertical-align: bottom;"/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Entity</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share Amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Investment Amount</div></div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Babylon Health <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;;text-align:right;">3,500</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom;;text-align:right;">35,000</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;">Mobility company <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;">Total</div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5,500</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">55,000</td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0pt; text-indent: 0px;"/><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="width: 9%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; margin-left: 8%; border-bottom: 1px solid rgb(0, 0, 0); text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 8%; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1)</div> Reflected as commitments in <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Note 8. Commitments and Contingencies</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> - Investment Commitments</div></div> as of September 30, 2021. </div></div></div></div></div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 8%; text-indent: 0px;"/></div></div> 2600000 26000000.0 <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents details regarding the Company’s additional investment commitments outstanding as of the date of this filing (in thousands): </div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 47%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td style="width: 21%;"/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Entity</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment Agreement<br/> Date</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Committed<br/> Share Amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Committed<br/> Investment Amount</div></div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Telecommunications company (1)</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">October 6, 2021</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,600</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,000</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rigetti &amp; Co, Inc. <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">October 6, 2021</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,000</td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><div style="margin-left: 0.26in; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Tota<div style="letter-spacing: 0px; top: 0px;;display:inline;">l</div></div></div></td> <td style="vertical-align: bottom; text-indent: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> </td> <td style="vertical-align: bottom; text-indent: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;;text-align:right;">2,600</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> </td> <td style="vertical-align: bottom; text-indent: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;">$</td> <td style="vertical-align: bottom; white-space: nowrap; text-indent: 0px;;text-align:right;">26,000</td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0pt; text-indent: 0px;"/></div></div> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="width: 9%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; margin-left: 8%; border-bottom: 1px solid rgb(0, 0, 0); text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="margin: 0pt 10% 0pt 8%; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1)</div> Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed. </div></div></div></div></div> 2021-10-06 1600 16000000 2021-10-06 1000 10000000 2600000 26000000 <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-right: 11%; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with signing each of the Investment Agreements entered into between October 1, 2021 and the date of this filing, each Investee or an associated entity and the Company entered into a commercial contract for the Company’s products and services. The maximum potential revenue from these commercial contracts, including option years, is $26.0 million, and the terms of such agreements range from <span style="-sec-ix-hidden:hidden29280598">three</span> to four years. </div></div></div></div></div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additionally, from October 1 to the date of this filing, the Company purchased 5.5 million shares for an aggregate purchase price of $55.0 million, as set forth in the following table (in thousands): </div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 16%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 16%; vertical-align: bottom;"/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Entity</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share Amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Investment Amount</div></div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Babylon Health <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;;text-align:right;">3,500</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom;;text-align:right;">35,000</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4em; line-height: normal;">Mobility company <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0px;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,000</td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(229, 229, 229);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.4em; line-height: normal;">Total</div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5,500</div></td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">55,000</td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0pt; text-indent: 0px;"/><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="width: 9%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; margin-left: 8%; border-bottom: 1px solid rgb(0, 0, 0); text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 8%; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:8.5px">(1)</div> Reflected as commitments in <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Note 8. Commitments and Contingencies</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> - Investment Commitments</div></div> as of September 30, 2021. </div></div></div></div></div></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 8%; text-indent: 0px;"/></div></div> 26000000.0 P4Y 5500000 55000000.0 3500000 35000000 2000000 20000000 5500000 55000000 Deferred revenue as of September 30, 2021 and December 31, 2020 includes $38.6 million and $68.2 million, respectively, from Palantir Technologies Japan, K.K. See Note 6. Equity Method Investments for more information. No other country represents 10% or more of total revenue for the three months ended September 30, 2021 or 2020. No other country represents 10% or more of total revenue for the nine months ended September 30, 2021 or 2020. On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date. The Company’s investment closed after September 30, 2021. See further discussion in Note 14. Subsequent Events. Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed. Investments are in publicly-traded marketable securities, unless otherwise noted. Investment in privately-held company. Reflected as commitments in Note 8. Commitments and Contingencies - Investment Commitments as of September 30, 2021. XML 11 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover Page - shares
9 Months Ended
Sep. 30, 2021
Nov. 04, 2021
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q3  
Document Quarterly Report true  
Document Transition Report false  
Entity Registrant Name Palantir Technologies Inc.  
Entity Central Index Key 0001321655  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Incorporation, State or Country Code DE  
Entity Address, City or Town Denver  
Entity Address, State or Province CO  
Title of 12(b) Security Class A Common Stock, par value $0.001 per share  
Trading Symbol PLTR  
Security Exchange Name NYSE  
Entity File Number 001-39540  
Entity Address, Address Line One 1555 Blake Street, Suite 250  
Entity Address, Postal Zip Code 80202  
Entity Tax Identification Number 68-0551851  
City Area Code 720  
Local Phone Number 358-3679  
Common Class A [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   1,906,589,959
Common Class B [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   97,225,971
Common Class F [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   1,005,000
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 2,335,068 $ 2,011,323
Restricted cash 41,316 37,285
Accounts receivable 174,405 156,932
Marketable securities 148,077  
Prepaid expenses and other current assets 112,624 51,889
Total current assets 2,811,490 2,257,429
Property and equipment, net 28,778 29,541
Restricted cash, noncurrent 46,791 79,538
Operating lease right-of-use assets 220,846 217,075
Other assets 116,422 106,921
Total assets 3,224,327 2,690,504
Current liabilities:    
Accounts payable 17,654 16,358
Accrued liabilities 179,467 158,546
Deferred revenue [1] 208,100 189,520
Customer deposits 232,707 210,320
Operating lease liabilities 43,581 29,079
Total current liabilities 681,509 603,823
Deferred revenue, noncurrent [1] 26,723 50,525
Customer deposits, noncurrent 42,734 81,513
Debt, noncurrent, net   197,977
Operating lease liabilities, noncurrent 219,646 229,800
Other noncurrent liabilities 5,659 4,316
Total liabilities 976,271 1,167,954
Commitments and Contingencies (Note 8)
Stockholders' equity (deficit):    
Preferred stock, par value $0.001: 2,000,000 shares authorized and 0 issued and outstanding as of September 30, 2021 and December 31, 2020 0 0
Common stock 1,991 1,792
Additional paid-in capital 7,577,305 6,488,857
Accumulated other comprehensive loss (1,695) (2,745)
Accumulated deficit (5,329,545) (4,965,354)
Total stockholders' equity 2,248,056 1,522,550
Total liabilities and stockholders' equity $ 3,224,327 $ 2,690,504
[1] Deferred revenue as of September 30, 2021 and December 31, 2020 includes $38.6 million and $68.2 million, respectively, from Palantir Technologies Japan, K.K. See Note 6. Equity Method Investments for more information.
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2021
Dec. 31, 2020
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 2,000,000,000 2,000,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, shares authorized 22,701,005,000 22,701,005,000
Common stock, shares issued 1,991,118,000 1,792,140,000
Common stock, shares outstanding 1,991,118,000 1,792,140,000
Palantir Technologies Japan, K.K. [Member]    
Deferred revenue $ 38.6 $ 68.2
Class A Common Stock [Member]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 20,000,000,000 20,000,000,000
Common stock, shares issued 1,900,441,000 1,542,058,000
Common stock, shares outstanding 1,900,441,000 1,542,058,000
Class B Common Stock [Member]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 2,700,000,000 2,700,000,000
Common stock, shares issued 89,672,000 249,077,000
Common stock, shares outstanding 89,672,000 249,077,000
Class F Common Stock [Member]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 1,005,000 1,005,000
Common stock, shares issued 1,005,000 1,005,000
Common stock, shares outstanding 1,005,000 1,005,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenue $ 392,146 $ 289,366 $ 1,109,022 $ 770,582
Cost of revenue 86,804 149,340 251,841 282,044
Gross profit 305,342 140,026 857,181 488,538
Operating expenses:        
Sales and marketing 153,443 334,911 451,919 536,082
Research and development 94,316 313,915 303,311 466,530
General and administrative 149,524 338,977 454,054 503,033
Total operating expenses 397,283 987,803 1,209,284 1,505,645
Loss from operations (91,941) (847,777) (352,103) (1,017,107)
Interest income 379 494 1,127 4,312
Interest expense (609) (2,085) (3,039) (12,325)
Change in fair value of warrants   (9,201)   811
Other income (expense), net (8,528) (3,293) (11,297) 1,218
Loss before provision (benefit) for income taxes (100,699) (861,862) (365,312) (1,023,091)
Provision (benefit) for income taxes 1,438 (8,543) (1,121) (5,043)
Net loss $ (102,137) $ (853,319) $ (364,191) $ (1,018,048)
Net loss per share attributable to common stockholders, basic $ (0.05) $ (0.94) $ (0.19) $ (1.43)
Net loss per share attributable to common stockholders, diluted $ (0.05) $ (0.94) $ (0.19) $ (1.43)
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, basic 1,964,395 905,462 1,893,911 713,879
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, diluted 1,964,395 905,462 1,893,911 716,027
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Statement of Comprehensive Income [Abstract]        
Net loss $ (102,137) $ (853,319) $ (364,191) $ (1,018,048)
Other comprehensive income (loss):        
Foreign currency translation adjustments (1,760) 268 1,050 1,871
Comprehensive loss $ (103,897) $ (853,051) $ (363,141) $ (1,016,177)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Series H-1 Convertible Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Series H-1 Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Series H-1 Convertible Preferred Stock [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit
Redeemable Convertible Preferred Stock [Member]
Nonredeemable Convertible Preferred Stock [Member]
Nonredeemable Convertible Preferred Stock [Member]
Series H-1 Convertible Preferred Stock [Member]
Nonredeemable Convertible Preferred Stock [Member]
Series K Convertible Preferred Stock [Member]
Nonredeemable Convertible Preferred Stock [Member]
Series D Convertible Preferred Stock [Member]
Temporary equity, beginning period, Shares at Dec. 31, 2019                   4,017,000 742,840,000      
Temporary equity, beginning period at Dec. 31, 2019                   $ 33,569 $ 2,093,662      
Balance at beginning period, Shares at Dec. 31, 2019     581,497,000       6,393,000              
Balance at beginning period at Dec. 31, 2019 $ (1,980,642)   $ 588   $ 1,857,331   $ (38,895) $ (703) $ (3,798,963)          
Conversion of convertible preferred stock to common stock, Shares     793,726,000 28,000             (745,313,000) (28,000)    
Conversion of convertible preferred stock to common stock 2,105,319 $ 100 $ 794   2,104,525 $ 100         $ (2,105,319) $ (100)    
Issuance of preferred stock upon net exercise of preferred stock warrants, Shares                         121,000 2,380,000
Issuance of preferred stock upon net exercise of preferred stock warrants                         $ 947 $ 10,810
Repurchase of common stock, held in treasury, Shares     (808,000)       808,000              
Repurchase of common stock, held in treasury (3,777)           $ (3,777)              
Retirement of treasury stock, Shares             (7,201,000)              
Retirement of treasury stock     $ (7)   (42,665)   $ 42,672              
Issuance of common stock upon net exercise of common stock warrants and other, Shares     7,631,000                      
Issuance of common stock upon net exercise of common stock warrants and other     $ 8   (8)                  
Issuance of common stock upon net exercise of common stock warrants, Shares     206,501,000                      
Issuance of common stock upon net exercise of common stock warrants $ 942,529   $ 207   942,322                  
Conversion of redeemable convertible preferred stock to common stock, Shares (4,017,000)   4,017,000                      
Conversion of redeemable convertible preferred stock to common stock $ 33,569   $ 4   33,565         $ (33,569)        
Conversion of preferred stock warrants to common stock warrants 31,007       31,007                  
Issuance of common stock from the exercise of stock options 116,030   $ 69   115,961                  
Issuance of common stock from the exercise of stock options, Shares     69,444,000                      
Issuance of common stock upon vesting of RSUs, Shares     68,150,000                      
Issuance of common stock upon vesting of RSUs     $ 68   (68)                  
Stock-based compensation 1,024,000       1,024,000                  
Settlement of employee loan accounted for as a modification to stock option (Shares)     (3,500,000)                      
Settlement of employee loan accounted for as a modification to stock option (Value) (205)   $ (4)   (201)                  
Other comprehensive income (loss) 1,871             1,871            
Net loss (1,018,048)               (1,018,048)          
Balance at end of period, Shares at Sep. 30, 2020     1,726,686,000                      
Balance at end of period at Sep. 30, 2020 1,251,753   $ 1,727   6,065,869     1,168 (4,817,011)          
Temporary equity, beginning period, Shares at Jun. 30, 2020                   4,017,000 742,933,000      
Temporary equity, beginning period at Jun. 30, 2020                   $ 33,569 $ 2,094,509      
Balance at beginning period, Shares at Jun. 30, 2020     736,635,000                      
Balance at beginning period at Jun. 30, 2020 (1,398,701)   $ 737   2,563,354     900 (3,963,692)          
Conversion of convertible preferred stock to common stock, Shares     793,726,000               (745,313,000)      
Conversion of convertible preferred stock to common stock 2,105,319   $ 794   2,104,525           $ (2,105,319)      
Issuance of preferred stock upon net exercise of preferred stock warrants, Shares                           2,380,000
Issuance of preferred stock upon net exercise of preferred stock warrants                           $ 10,810
Issuance of common stock upon net exercise of common stock warrants and other, Shares     7,631,000                      
Issuance of common stock upon net exercise of common stock warrants and other     $ 8   (8)                  
Issuance of common stock upon net exercise of common stock warrants, Shares     88,280,000                      
Issuance of common stock upon net exercise of common stock warrants 404,679   $ 88   404,591                  
Conversion of redeemable convertible preferred stock to common stock, Shares     4,017,000             (4,017,000)        
Conversion of redeemable convertible preferred stock to common stock 33,569   $ 4   33,565         $ (33,569)        
Conversion of preferred stock warrants to common stock warrants 31,007       31,007                  
Issuance of common stock from the exercise of stock options 87,207   $ 32   87,175                  
Issuance of common stock from the exercise of stock options, Shares     31,748,000                      
Issuance of common stock upon vesting of RSUs, Shares     68,149,000                      
Issuance of common stock upon vesting of RSUs     $ 68   (68)                  
Stock-based compensation 841,929       841,929                  
Settlement of employee loan accounted for as a modification to stock option (Shares)     (3,500,000)                      
Settlement of employee loan accounted for as a modification to stock option (Value) (205)   $ (4)   (201)                  
Other comprehensive income (loss) 268             268            
Net loss (853,319)               (853,319)          
Balance at end of period, Shares at Sep. 30, 2020     1,726,686,000                      
Balance at end of period at Sep. 30, 2020 1,251,753   $ 1,727   6,065,869     1,168 (4,817,011)          
Balance at beginning period, Shares at Dec. 31, 2020     1,792,140,000                      
Balance at beginning period at Dec. 31, 2020 1,522,550   $ 1,792   6,488,857     (2,745) (4,965,354)          
Issuance of common stock upon net exercise of common stock warrants and other, Shares     4,664,000                      
Issuance of common stock upon net exercise of common stock warrants and other 1,712   $ 6   1,706                  
Issuance of common stock from the exercise of stock options $ 474,683   $ 155   474,528                  
Issuance of common stock from the exercise of stock options, Shares 155,720,000   155,720,000                      
Issuance of common stock upon vesting of RSUs, Shares     37,123,000                      
Issuance of common stock upon vesting of RSUs     $ 37   (37)                  
Issuance of common stock upon vesting of growth units, Shares     1,471,000                      
Issuance of common stock upon vesting of growth units     $ 1   (1)                  
Stock-based compensation $ 612,252       612,252                  
Other comprehensive income (loss) 1,050             1,050            
Net loss (364,191)               (364,191)          
Balance at end of period, Shares at Sep. 30, 2021     1,991,118,000                      
Balance at end of period at Sep. 30, 2021 2,248,056   $ 1,991   7,577,305     (1,695) (5,329,545)          
Balance at beginning period, Shares at Jun. 30, 2021     1,936,578,000                      
Balance at beginning period at Jun. 30, 2021 2,068,963   $ 1,937   7,294,369     65 (5,227,408)          
Issuance of common stock from the exercise of stock options 97,995   $ 41   97,954                  
Issuance of common stock from the exercise of stock options, Shares     41,249,000                      
Issuance of common stock upon vesting of RSUs, Shares     13,291,000                      
Issuance of common stock upon vesting of RSUs     $ 13   (13)                  
Stock-based compensation 184,995       184,995                  
Other comprehensive income (loss) (1,760)             (1,760)            
Net loss (102,137)               (102,137)          
Balance at end of period, Shares at Sep. 30, 2021     1,991,118,000                      
Balance at end of period at Sep. 30, 2021 $ 2,248,056   $ 1,991   $ 7,577,305     $ (1,695) $ (5,329,545)          
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating activities    
Net loss $ (364,191) $ (1,018,048)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 11,057 10,308
Stock-based compensation 611,308 1,028,914
Non-cash operating lease expense 23,417 28,815
Unrealized loss from marketable securities 7,238 0
Other operating activities 3,076 3,621
Changes in operating assets and liabilities:    
Accounts receivable (15,412) (112,723)
Prepaid expenses and other current assets (7,872) (11,598)
Other assets (8,155) (20,944)
Accounts payable 1,158 (29,372)
Accrued liabilities 20,360 42,138
Deferred revenue, current and noncurrent (3,781) (30,937)
Customer deposits, current and noncurrent (16,227) (140,162)
Operating lease liabilities, current and noncurrent (22,786) (34,725)
Other noncurrent liabilities 1,234 6,393
Net cash used in operating activities 240,424 (278,320)
Investing activities    
Purchases of property and equipment (6,783) (7,475)
Purchases of marketable securities (155,315) 0
Purchases of alternative investments (50,941) 0
Other investing activities (3,000) (2,500)
Net cash used in investing activities (216,039) (9,975)
Financing activities    
Proceeds from the issuance of common stock, net of issuance costs 0 942,529
Proceeds from issuance of debt, net of issuance costs 0 199,369
Principal payments on borrowings (200,000) (400,000)
Proceeds from the exercise of common stock options 474,683 79,473
Repurchase of common stock 0 (3,777)
Other financing activities (401) (250)
Net cash provided by (used in) financing activities 274,282 817,344
Effect of foreign exchange on cash, cash equivalents, and restricted cash (3,638) (678)
Net increase in cash, cash equivalents, and restricted cash 295,029 528,371
Cash, cash equivalents, and restricted cash - beginning of period 2,128,146 1,401,962
Cash, cash equivalents, and restricted cash - end of period 2,423,175 1,930,333
Supplemental disclosures of cash flow information:    
Cash paid for income taxes 3,588 9,143
Cash paid for interest 2,774 9,737
Supplemental disclosures of non-cash investing and financing information:    
Receivable from the exercise of common stock options included in prepaid expenses and other current assets 396 36,557
Cashless net exercise of warrants for convertible preferred stock 0 10,810
Conversion of Redeemable Convertible Preferred Stock to Common Stock [Member]    
Supplemental disclosures of non-cash investing and financing information:    
Conversion of stock 0 2,138,988
Conversion Of Convertible Preferred Stock Warrants Into Common Stock Warrants [Member]    
Supplemental disclosures of non-cash investing and financing information:    
Conversion of stock $ 0 $ 31,007
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Organization
9 Months Ended
Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization
1. Organization
Palantir Technologies Inc. (including its subsidiaries, “Palantir,” or “the Company”) was incorporated in Delaware on May 6, 2003. The Company builds and deploys software platforms, Palantir Gotham and Palantir Foundry, that serve as the central operating systems for its customers.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Significant Accounting Policies
2. Significant Accounting Policies
Basis of Presentation and Consolidation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over the investee, but does not control, are accounted for using the equity method of accounting. The Company’s fiscal year ends on December 31.
The unaudited condensed consolidated balance sheet as of December 31, 2020, included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity (deficit), and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period.
The Company ceased to be an emerging growth company as of December 31, 2020, which accelerated its adoption of Accounting Standards Update (“ASU”)
2016-02,
Leases (Topic 842)
. As a result, certain components of cash flows used in operating activities within the Company’s condensed consolidated statements of cash flows for the nine months ended September 30, 2020, have been presented to conform to the new standard. The impact to the presentation of the other statements was not material.
These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form
10-K
for the year ended December 31, 2020, which was filed with the SEC on February 26, 2021.
Use of Estimates
The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods.
Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts
;
the valuation of deferred tax assets and uncertain tax positions
;
collectability of contract consideration, including accounts receivable
;
useful lives of tangible assets
;
and the incremental borrowing rate for operating leases. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations.
Summary of Significant Accounting Policies
The Company’s significant accounting policies are discussed in
Note 2. Significant Accounting Policies
in the notes to consolidated financial statements in its Annual Report on Form
10-K
for the year ended December 31, 2020, which was filed with the SEC on February 26, 2021. There have been no significant changes to these policies during the nine months ended September 30, 2021.
Cash, Cash Equivalents, and Restricted Cash
The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds.
Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands):
 
 
  
As of September 30,
 
  
2021
  
2020
Cash and cash equivalents
   $ 2,335,068        $ 1,800,190    
Restricted cash
     41,316          43,800    
Restricted cash, noncurrent
     46,791          86,343    
    
 
 
 
  
 
 
 
Total cash, cash equivalents, and restricted cash
   $             2,423,175        $             1,930,333    
    
 
 
 
  
 
 
 
Accounts Receivable and Allowance for Credit Losses
Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses, if any. The Company generally grants
non-collateralized
credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, including the ongoing
COVID-19
pandemic, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are
written-off
and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the assessment as of September 30, 2021, the Company recorded an immaterial allowance for credit losses. As of December 31, 2020, the Company did not record an allowance for credit losses.
Concentrations of Credit Risk and Other Concentrations
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents primarily consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.
The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of September 30, 2021 and December 31, 2020 were $174.4 million and $156.9 million, respectively. Customer H represented 11% of total accounts receivable as of September 30, 2021. Customer G represented 13% of total accounts receivable as of December 31, 2020. No other customer represented more than 10% of total accounts receivable as of September 30, 2021 and December 31, 2020. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of September 30, 2021 and December 31, 2020, the Company had not experienced any significant losses on its accounts receivable.
For the three and nine months ended September 30, 2021, no customer represented more than 10% of total revenue. For the three months ended September 30, 2020, no customer represented more than 10% of total revenue. For the nine months ended September 30, 2020, Customer F, which is in the government operating segment, represented 11% of total revenue. No other customer represented more than 10% of total revenue for the three and nine months ended September 30, 2020.
The Company relies on the technology, infrastructure, and software applications, including
software-as-a-service
offerings, of third parties in order to host or operate certain key products and functions of its business.
Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued ASU
2019-12,
Simplifying the Accounting for Income Taxes (Topic 740),
as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU
2019-12
removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU
2019-12
also amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The Company adopted ASU
2019-12
as of January 1, 2021 using transition methods allowed under each aspect of the guidance. The adoption of the standard did not have a material impact on the Company’s condensed consolidated financial statements.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Contract Liabilities and Remaining Performance Obligations
9 Months Ended
Sep. 30, 2021
Revenue from Contract with Customer [Abstract]  
Contract Liabilities and Remaining Performance Obligations
3. Contract Liabilities and Remaining Performance Obligations
Contract Liabilities
The Company’s contract liabilities consist of deferred revenue and customer deposits. As of September 30, 2021 and December 31, 2020, the Company’s contract liability balances were $510.3 million and $531.9 million, respectively. Revenue of $347.7 million and $406.4 million was recognized during the nine months ended September 30, 2021 and 2020, respectively, that was included in the contract liability balances as of December 31, 2020 and 2019, respectively.
Remaining Performance Obligations
The Company’s arrangements with its customers often have terms that span over multiple years. However, the Company generally allows its customers to terminate contracts for convenience prior to the end of the stated term with less than twelve months’ notice. Revenue allocated to remaining performance obligations represents noncancelable contracted revenue that has not yet been recognized, which includes deferred revenue and, in certain instances, amounts that will be invoiced. The Company has elected the practical expedient allowing the Company to not disclose remaining performance obligations for contracts with original terms of twelve months or less. Cancelable contracted revenue, which includes customer deposits, is not considered a remaining performance obligation.
The Company’s remaining performance obligations were $873.9 million as of September 30, 2021, of which the Company expects to recognize approximately 45% as revenue over the next twelve months.
Disaggregation of Revenue
See
Note 13. Segment and Geographic Information
for disaggregated revenue by customer segment and geographic region.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Investments and Fair Value Measurements
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Investments and Fair Value Measurements
4. Investments and Fair Value Measurements
Financial instruments consist of money market funds and certificates of deposit included in cash equivalents and restricted cash, accounts receivable, equity securities, other assets accounted for at fair value, accounts payable, and accrued liabilities. Money market funds, certificates of deposit, and marketable securities are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date.
The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation (in thousands):
 
    
As of September 30, 2021
 
    
Total
   
Level 1
   
Level 2
   
Level 3
 
Assets:
                                
Money market funds
   $ 767,372     $ 767,372     $     $  
Certificates of deposit
     60,061             60,061        
Marketable securities
     148,077       148,077              
    
 
 
   
 
 
   
 
 
   
 
 
 
         
Total
   $ 975,510     $ 915,449     $ 60,061     $                 —  
    
 
 
   
 
 
   
 
 
   
 
 
 
   
    
As of December 31, 2020
 
    
Total
   
Level 1
   
Level 2
   
Level 3
 
Assets:
                              
Money market funds
   $ 1,075,783     $ 1,075,783     $     $  
Certificates of deposit
     74,097             74,097        
    
 
 
   
 
 
   
 
 
   
 
 
 
         
Total
   $     1,149,880     $ 1,075,783     $     74,097     $                 —  
    
 
 
   
 
 
   
 
 
   
 
 
 
Certificates of Deposit
The Company’s Level 2 instruments consist of cash equivalents and restricted cash invested in certificates of deposit. The fair value of such instruments is estimated based on valuations obtained from third-party pricing services that utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable either directly or indirectly. These inputs include interest rate curves, foreign exchange rates, and credit ratings. Gross unrealized gains or losses on certificate of deposits as of September 30, 2021 and December 31, 2020 were not material.
Marketable Securities
Marketable securities consist of equity securities in publicly-traded companies and are recorded at fair market value each reporting period. Realized and unrealized gains and losses are recorded in other income (expense), net on the condensed consolidated statements of operations. During the three and nine months ended September 30, 2021, the Company recorded net unrealized losses of 
$7.2 million within other income (expense), net on the condensed consolidated statements of operations.
Investments
The Company approved and entered into certain agreements (“Investment Agreements”) to purchase, or commit to purchase, as further discussed in
Note 8. Commitments and Contingencies—Investment Commitments,
shares of various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities (each, an “Investee,” and such purchases, and commitments to purchase, the “Investments”). In connection with signing the Investment Agreements, each Investee or an associated entity and the Company entered into a commercial contract for access to the Company’s products and services. The maximum potential revenue from all of these commercial contracts is $640.2 million, which is inclusive of $82.9 
million of contractual options. The terms of
such contracts, including such contractual options, range
 
from three to ten years. The majority of these commercial contracts are subject to various termination provisions, including for convenience in the event a proposed business combination is not completed.
During 2021, the Company assessed the concurrent agreements under the
non-monetary
guidance within Accounting Standards Codification (“ASC”) 606 -
Revenue from Contracts with Customers
and the total revenue recognized from the commercial contracts during the three and nine months ended September 30, 2021 was $19.0 million and $22.0 million, respectively.
The following table presents the details of the investments purchased under such Investment Agreements during the nine months ended September 30, 2021 (in thousands):
 
Entity
(1)
     
Share Amount
   
Investment Amount
 
Celularity
                               2,000     $ 20,000  
Faraday Future
        2,500       25,000  
Astrocast
        1,520       5,000  
BlackSky
        800       8,000  
Lilium
        4,100       41,000  
Roivant Sciences
        3,000       30,000  
Sarcos Robotics
        2,100       21,000  
Autonomous aerial vehicle company
(2)
        3,000       3,000  
       
 
 
   
 
 
 
Total
        19,020     $ 153,000  
       
 
 
   
 
 
 
 
 
 
(1)
 
Investments are in publicly-traded marketable securities, unless otherwise noted.
 
(2)
 
Investment in privately-held company.
Privately-Held Securities
Equity investments in private-held companies without readily determinable fair values are recorded using the measurement alternative of cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. As of September 30, 2021, the carrying value of investments without readily determinable fair values were recorded in other assets in the Company’s condensed consolidated balance sheets and were not material.
Alternative Investments
The Company purchased $50.9 million in
100-ounce
gold bars, which are included within prepaid expenses and other current assets on the condensed consolidated balance sheet. The investment is initially recorded as cost and is subsequently remeasured at lower of cost or market each reporting period. The gold bars will initially be kept in a secure third-party facility located in the northeastern United States. The Company is able to take physical possession of the gold bars stored at the facility at any time with reasonable notice.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Balance Sheet Components
9 Months Ended
Sep. 30, 2021
Balance Sheet Related Disclosures [Abstract]  
 Balance Sheet Components
5. Balance Sheet Components
Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
 
    
 
As of September 30,
2021
 
 
  
 
As of December 31,
2020
Leasehold improvements
       $ 80,215           $ 85,196   
Computer equipment, software, and other
     25,451           22,275   
Furniture and fixtures
     10,021           9,976   
Construction in progress
     5,305           493   
    
 
 
    
 
 
Total property and equipment, gross
                 120,992                   117,940   
Less: accumulated depreciation and amortization
     (92,214)          (88,399)  
    
 
 
    
 
 
Total property and equipment, net
     $ 28,778           $ 29,541   
    
 
 
    
 
 
Depreciation and amortization expense related to property and equipment, net was $3.1 million and $2.5 million for the three months ended September 30, 2021 and 2020, respectively, and $9.3 million and $9.3 million for the nine months ended September 30, 2021 and 2020,
respectively.
 
 
Accrued Liabilities
Accrued liabilities consisted of the following (in thousands):
 
    
As of September 30,
2021
    
As of December 31,
2020
Accrued payroll and related expenses
     $ 100,157        $ 85,466
Accrued other liabilities
     79,310        73,080
    
 
 
    
 
 
Total accrued liabilities
     $             179,467        $         158,546
    
 
 
    
 
 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Method Investments
9 Months Ended
Sep. 30, 2021
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments
6. Equity Method Investments
Palantir Technologies Japan, K.K.
During November 2019, the Company and SOMPO Holdings, Inc. (“SOMPO”) created a Japanese Kabushiki Kaisha (“K.K.”), Palantir Technologies Japan, K.K. (“Palantir Japan”), to distribute Palantir platforms to the Japanese market. Upon closing of the transaction with SOMPO, the Company purchased a total of 100,000 shares of Palantir Japan common stock for $25.0 million. The shares the Company received in exchange represent a 50% voting interest in Palantir Japan. The remaining 50% of the voting interest is held by SOMPO. The Company’s investment in Palantir Japan is accounted for as an equity method investment as the Company is able to exercise significant influence over, but does not control, the investee.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Debt
9 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
Debt
7. Debt
2014 Credit Facility
In October 2014, the Company entered into an unsecured revolving credit facility which has been subsequently amended (the “2014 Credit Facility”). The 2014 Credit Facility incurred interest at the London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75% per annum, subject to certain adjustments, and incurs a commitment fee of 0.375% assessed on the daily average undrawn portion of revolving commitments. Interest and commitment fees are payable at the end of an interest period or at each three-month interval if the interest period is longer than three months. The 2014 Credit Facility, as amended, matures on June 4, 2023.
During April 2021, the Company entered into an amendment to the 2014 Credit Facility, which provided for an increase of $200.0 million to the revolving commitments of the existing lenders under the 2014 Credit Facility, for total revolving commitments of $400.0 million, and which also provided for an incremental loan facility for additional loans in an aggregate principal amount of up to $100.0 million with one or more existing or new lenders upon mutual agreement between the Company and such lenders. Upon entering into the amendment, the Company repaid its outstanding term loans of $200.0 million. As of September 30, 2021, the Company had no amounts outstanding under the 2014 Credit Facility and a $400.0 million undrawn revolving credit facility.
The 2014 Credit Facility contains customary r
epresentat
ions and warranties, and certain financial and nonfinancial covenants, including but not limited to maintaining minimum liquidity of $50.0 million, and certain limitations on liens and indebtedness. The Company was in compliance with all covenants associated with the 2014 Credit Facility as of September 30, 2021.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
8. Commitments and Contingencies
Purchase Commitments
In December 2019, the Company entered into, and subsequently amended during December 2020, a minimum annual commitment to purchase cloud hosting services of at least $1.49 billion over six contract years, with an optional carryover period through June 30, 2029, in exchange for various discounts on such services. I
f the spend does not meet the minimum annual commitment each year or at the end of the term, the Company is obligated to make a return payment. If the difference is greater than $30.0 million for each of the first three contract years or $50.0 million for each of the contract years thereafter (“relief amounts”), the Company has the option to pay the respective relief amount for that year for services to be utilized in the future and the excess amount of the difference above the relief amount would be added to the minimum annual commitment of the following year through the end of the contract.
As of September 30, 2021, the Company had satisfied $34.0 million of its $167.0 million
commitment for the contract year ending June 30, 2022. 
 
 
In June 2020, the Company entered into an additional commitment to purchase at least $45.0 million of cloud hosting services over a period of five years commencing on June 1, 2020 and ending on May 31, 2025. If the spend commitment is not met at the end of the term, the Company is obligated to pay the full amount of the outstanding balance (“shortfall payment”). The shortfall payment may be applied as a prepayment against consumption during an additional twelve-month coverage period expiring on May 31, 2026, at which time any unused amount would be forfeited. As of September 30, 2021, the Company had satisfied $8.0 million of its commitment.
Investment Commitments
The Company approved and entered into certain Investment Agreements with Investees, as further discussed in
Note 4. Investments and Fair Value Measurements - Investments
.
As of September 30, 2021, the Company had outstanding investment commitments, subject to the applicable terms and conditions, to purchase a total of 22.7 million shares for an aggregate purchase price of $226.5 million. The closings of certain of such Investments are contingent upon the completion of a proposed business combination between the applicable Investee and other applicable parties.
The following table presents details related to the Company’s investment commitments outstanding as of September 30, 2021 (in thousands):
 
Entity
  
Investment
Agreement Date
 
 
Committed
Share Amount
 
 
Committed
Investment Amount
Mobility company
(1)
     May 11, 2021        2,000   
 
$ 20,000
       
Wejo
     May 28, 2021        3,500   
 
  35,000
       
Babylon Health
(1) (2)
     June 3, 2021        3,500   
 
  35,000
       
Boxed
(
2
)
     June 13, 2021        2,000   
 
  20,000
       
Pear Therapeutics
     June 21, 2021        1,000   
 
  10,000
       
Autonomous vehicle company
(
2
)
     June 22, 2021        1,800   
 
  18,000
       
Fast Radius
(
2
)
     July 18, 2021        2,000   
 
  20,000
       
Tritium
(
2
)
     July 27, 2021        1,500   
 
  15,000
       
AdTheorent
(
2
)
     July 27, 2021        1,500   
 
  15,000
       
FinAccel
     August 2, 2021        1,000   
 
  10,000
       
Energy Vault
(
2
)
     September 8, 2021       
850
  
 
  8,500
       
Electric vehicle charging company
(
2
)
     September 10, 2021        2,000   
 
  20,000
             
 
 
  
 
 
 
Total
              22,650   
 
$ 226,500
             
 
 
  
 
 
 
 
 
(1)
The Company’s investment closed after September 30, 2021. See further discussion in
Note 14. Subsequent Events
.
(2)
 
Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.
Litigation and Legal Proceedings
From time to time, third parties may assert patent infringement claims against the Company. In addition, from time to time, the Company may be subject to other legal proceedings and claims in the ordinary course of business, including claims of alleged infringement of trademarks, copyrights, and other intellectual property rights; employment claims; securities claims; investor claims; corporate claims; class action claims; and general contract, tort, or other claims. The Company may from time to time also be subject to various legal or government claims, disputes, or investigations. Such matters may include, but not be limited to, claims, disputes, allegations, or investigations related to warranty; refund; breach of contract; breach, leak, or misuse of personal data or confidential information; employment; government procurement; intellectual property; government regulation or compliance (including but not limited to anti-corruption requirements, export or other trade controls, data privacy or data protection, cybersecurity requirements, or antitrust/competition law requirements); securities; investor; corporate; or other matters. The Company is unable to predict whether or when any such matters may arise, the outcome of these matters, or the ultimate legal and financial liability, and cannot reasonably estimate the possible loss or range of loss at this time and accordingly has not accrued a related liability.
 
 
On December 14, 2017, members of KT4 Partners LLC (Managing Member Marc Abramowitz) and Sandra Martin Clark, as trustee for the Marc Abramowitz Irrevocable Trust Number 7 (together, “KT4 Plaintiffs”), filed an action in the Delaware Superior Court against the Company and Disruptive Technology Advisers LLC. The complaint alleges tortious interference with prospective economic advantage and civil conspiracy in connection with a potential sale of stock by the KT4 Plaintiffs to a third party. The KT4 Plaintiffs seek compensatory and punitive damages, interest, fees, and costs.
The Company believes this lawsuit is without merit and is vigorously defending itself against it. Given the uncertainty of litigation, it may be reasonably possible that the Company will incur a loss with regards to the matter; however, it cannot currently estimate a range of possible losses. Accordingly, the Company is unable, at this time, to estimate the overall effects that may result from the lawsuit on its financial condition, results of operations, or cash flows.
As of September 30, 2021, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that were expected to have a material adverse impact on its condensed consolidated financial statements.
Letters of Credit and Guarantees
The Company had irrevocable standby letters of credit and guarantees, including bank guarantees, outstanding in the amounts of $88.1 million and $116.8 million as of September 30, 2021 and December 31, 2020, respectively, all of which were fully collateralized. The Company is required to maintain these letters of credit and guarantees primarily for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. As of September 30, 2021, these letters of credit and guarantees had expiration dates through August 2028.
Warranties and Indemnification
The Company generally provides a warranty for its software products and services and a service level agreement (“SLA”) for the Company’s performance of software operations via its operations and maintenance (“O&M”) services to its customers. The Company’s products are generally warranted to perform substantially as described in the associated product documentation during the subscription term or for a period of up to 90 days where the software is hosted by the customer; and the Company includes O&M services as part of its subscription and license agreements to support this warranty and maintain the operability of the software. The Company’s services are generally warranted to be performed in a professional manner and by an adequate staff with knowledge about the products. In the event there is a failure of such warranties, the Company generally is obligated to correct the product or service to conform to the warranty provision, as set forth in the applicable SLA, or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product and service (generally prorated over the contract term). Due to the absence of historical warranty claims, the Company’s expectations of future claims related to products under warranty continue to be insignificant. The Company has not recorded warranty expense or related accruals as of September 30, 2021 and December 31, 2020.
The Company generally agrees to indemnify its customers against legal claims that the Company’s software products infringe certain third-party intellectual property rights and accounts for its indemnification obligations. In the event of such a claim, the Company is generally obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of an infringement, the Company generally agrees to secure the right for the customer to continue using the infringing product; to modify or replace the infringing product; or, if those options are not commercially practicable, to refund the cost of the software, as prorated over the period. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers and does not believe that the Company will be liable for such claims in the foreseeable future. As such, the Company has not recorded a liability for infringement costs as of September 30, 2021 and December 31, 2020.
The Company has obligations under certain circumstances to indemnify each of the defendant directors and certain officers against judgments, fines, settlements, and expenses related to claims against such directors and certain officers and otherwise to the fullest extent permitted under the law and the Company’s bylaws and Amended and Restated Certificate of Incorporation.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity
9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure
9. Stockholders’ Equity
The Company’s Class A, Class B, and Class F common stock (collectively, the “common stock”) all have the same rights, except with respect to voting and conversion rights. Class A and Class B common stock have voting rights of 1 and 10 votes per share, respectively. The Class F common stock has the voting rights generally described below and each share of Class F common stock is convertible at any time, at the option of the holder thereof, into one share of Class B common stock. All shares of Class F common stock are held in a voting trust established by Stephen Cohen, Alexander Karp, and Peter Thiel (the “Founders”). The Class F common stock generally gives the Founders the ability to control up to 49.999999% of the total voting power of the Company’s capital stock, so long as the Founders and certain of their affiliates collectively meet a minimum ownership threshold, which was 100 million of the Company’s equity securities as of September 30, 2021.
 
 
Holders of common stock are entitled to dividends when, as and if declared by the Company’s Board of Directors, subject to the rights of the holders of all classes of stock outstanding having priority rights to dividends. No dividends have been declared as of September 30, 2021.
In connection with the Company’s direct listing of its Class A common stock on the New York Stock Exchange (“Direct Listing”) in September 2020, all outstanding shares of redeemable convertible preferred stock and convertible preferred stock were converted into 4,017,378 and 793,725,807 shares of Class B common stock, respectively, and 1,005,000 shares of Class B common stock held by the Founders were exchanged for an equal number of shares of Class F common stock.
The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands):
 
 
 
As of September 30, 2021
 
 
As of December 31, 2020
 
 
 
Authorized
 
 
Issued and
Outstanding
 
 
Authorized
 
 
Issued and
Outstanding
 
Common stock:
                       
         
Class A
    20,000,000       1,900,441       20,000,000       1,542,058  
         
Class B
    2,700,000       89,672       2,700,000       249,077  
         
Class F
    1,005       1,005       1,005       1,005  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
    22,701,005       1,991,118       22,701,005       1,792,140  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation
10. Stock-Based Compensation
Stock Options
The following table summarizes stock option activity for the nine months ended September 30, 2021 (in thousands, except per share amounts):
 
 
 
Options

Outstanding
 
Weighted-

Average

Exercise Price

Per Share
 
 
Weighted-

Average

Remaining

Contractual

Life (years)
 
 
Aggregate

Intrinsic Value
 
Balance as of December 31, 2020
    535,767     $ 6.12       7.99     $ 9,340,245    
         
Options exercised
    (155,720     3.05                  
         
Options canceled and forfeited
    (5,518     5.26                  
   
 
 
 
                       
         
Balance as of September 30, 2021
                  374,529     $ 7.40       8.82     $ 6,230,308    
   
 
 
 
                       
Options vested and exercisable as of September 30, 2021
    182,617     $ 4.48       7.08     $ 3,571,719    
   
 
 
 
                       
As of September 30, 2021, the unrecognized expense related to options outstanding was $940.0 million, which is expected to be recognized over a weighted-average service period of eight years.
 
 
RSUs
The following table summarizes the RSU activity for the nine months ended September 30, 2021 (in thousands, except per share amounts):
 
 
  
RSUs
Outstanding
 
 
Weighted Average
Grant Date Fair
Value per Share
Unvested and outstanding as of December 31, 2020
     184,870        $ 6.97   
     
RSUs granted
     25,093        24.01   
     
RSUs vested
     (37,123      8.17   
     
RSUs canceled
     (6,807      8.18   
    
 
 
 
        
Unvested and outstanding as of September 30, 2021
     166,033        $ 9.22   
    
 
 
 
        
As of September 30, 2021, the total unrecognized stock-based compensation expense related to the RSUs outstanding was $985.1 million, which
the
Company expects to recognize over three years.
Growth Units
In May 2019, the Company granted growth units which vest upon the satisfaction of both a performance-based vesting condition, which was satisfied upon the Company’s Direct Listing, and a service-based vesting condition, which was satisfied in March 2021. In March 2021, the 3.6 million outstanding growth units vested and, per the formula applicable to the awards, converted into 1.5 million shares of common stock. During the three months ended March 31, 2021, the Company recognized the remaining stock-based compensation expense related to the growth units of $1.2 million.
Stock-based Compensation Expense
Total stock-based compensation expense was as follows (in thousands):
 
  
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
  
2021
 
2020
 
2021
 
2020
Cost of revenue
    $ 14,860      $ 94,385      $ 54,866      $ 120,285  
         
Sales and marketing
     57,124       263,958       186,418       322,353  
         
Research and development
     34,472       256,769       122,976       309,698  
         
General and administrative
     78,379       231,847       247,048       276,578  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total stock-based compensation expense
(1)
   $ 184,835     $ 846,959     $ 611,308     $ 1,028,914  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
 
On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes
9 Months Ended
Sep. 30, 2021
Income Tax Disclosure [Abstract]  
Income Taxes
11. Income Taxes
The Company recorded a provision for income taxes of $1.4 million and a benefit
from
income taxes of $8.5 million for the three months ended September 30, 2021 and 2020, respectively, and
a
benefit 
from
income taxes of $1.1 million and $5.0 million for the nine months ended September 30, 2021 and 2020, respectively. The Company is subject to income tax in the U.S. as well as other tax jurisdictions in which it conducts business. The Company’s effective rate differs from the U.S. statutory rate primarily due to the valuation allowance recorded on its losses from the U.S. and other jurisdictions, foreign income taxed at different rates,
non-deductible
stock-based compensation and the revaluation of its United Kingdom (“UK”) deferred tax assets as a result of a change in the UK corporate tax rate enacted during the second quarter of 2021, which increased the rate from 19% to 25% effective April 1, 2023.
The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. The Company assesses its ability to realize the deferred tax assets on a quarterly basis, and it establishes a valuation allowance if it is
more-likely-than-not
that some portion of the deferred tax assets will not be realized. The Company weighs all available positive and negative evidence, including its earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies. For example, due to the weight of objectively verifiable negative evidence, including its history of losses in certain jurisdictions, the Company believes that it is more likely than not that its U.S. federal and state deferred tax assets will not be fully realized. Accordingly, the Company has maintained a valuation allowance on its U.S. federal and state deferred tax assets.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Net Loss Per Share Attributable to Common Stockholders
9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
 Net Loss Per Share Attributable to Common Stockholders
12. Net Loss Per Share Attributable to Common Stockholders
The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):
 
 
  
Three Months Ended

September 30,
 
Nine Months Ended

September 30,
 
  
2021
 
2020
 
2021
 
2020
Numerator
                                
         
Net loss attributable to common stockholders
   $ (102,137   $ (853,319   $ (364,191   $ (1,018,048
         
Less: Change in fair value attributable to participating securities
                       (5,483
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
Net loss attributable to common stockholders, for diluted net loss per share
   $ (102,137   $ (853,319   $ (364,191   $ (1,023,531
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator
                                
         
Weighted-average shares used in computing net loss per share, basic
     1,964,395       905,462       1,893,911       713,879  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average shares used in computing net loss per share, diluted
     1,964,395       905,462       1,893,911       716,027  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
Net loss per share
                                
         
Net loss per share attributable to common stockholders, basic
   $ (0.05   $ (0.94   $ (0.19   $ (1.43
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
Net loss per share attributable to common stockholders, diluted
   $ (0.05   $ (0.94   $ (0.19   $ (1.43
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands):
 
 
 
As of September 30,
 
 
        2021        
 
        2020        
Warrants to purchase common stock
     13,042        19,068
Options and Stock Appreciation Rights issued and outstanding
     374,555        587,977
RSUs outstanding
     166,033        199,655
Growth units outstanding
            3,583
    
 
 
 
  
 
 
Total
     553,630        810,283
    
 
 
 
  
 
 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Segment and Geographic Information
9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
Segment and Geographic Information
13. Segment and Geographic Information
The following tables reflect the results of the Company’s reportable operating segments consistent with the manner in which the chief operating decision maker (“CODM”) evaluates the performance of each segment and allocates the Company’s resources. The CODM does not evaluate the performance of the Company’s assets on a segment basis for internal management reporting and, therefore, such information is not presented.
Contribution is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. A segment’s contribution is calculated as segment revenue less the related costs of revenue and sales and marketing expenses. It excludes certain operating expenses that are not allocated to segments because they are separately managed at the consolidated corporate level. These unallocated costs include stock-based compensation expense, research and development expenses, and general and administrative expenses.
 
 
Financial information for each reportable segment was
as
follows (in thousands):
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2021
 
2020
 
2021
 
2020
Revenue:
                                   
Government
   $ 217,836      $ 162,561      $ 658,375      $ 420,257  
Commercial
     174,310        126,805        450,647        350,325  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Total revenue
   $ 392,146      $ 289,366      $ 1,109,022      $   770,582  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2021
 
2020
 
2021
 
2020
Contribution:
                                   
Government
   $ 125,706      $ 93,962      $ 400,705      $ 226,186  
Commercial
     98,177        69,496        245,841        168,908  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Total contribution
   $ 223,883      $ 163,458      $    646,546      $   395,094  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
The reconciliation of contribution to loss from operations is as follows (in thousands):
 
 
  
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
  
2021
 
2020
 
2021
 
2020
Loss from operations
  
$
(91,941)
 
 
$
(847,777)
 
 
$
(352,103)
 
 
$
(1,017,107)
 
Research and development expenses
(1)
  
 
59,844 
   
 
57,146
   
 
180,335
   
 
156,832
 
General and administrative expenses
(1)
  
 
71,145 
   
 
107,130
   
 
207,006
   
 
226,455
 
Stock-based compensation expense
  
 
184,835 
   
 
846,959
   
 
611,308
   
 
1,028,914
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total contribution
  
$
223,883 
   
$
163,458
   
$
646,546
   
$
395,094
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
Excludes stock-based compensation expense.
Geographic Information
Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages):
 
                           
                           
                           
                           
 
  
Three Months Ended September 30,
 
  
2021
 
2020
 
  
Amount
 
%
 
Amount
 
%
Revenue:
                                  
United States
  
 $
227,285
    
 
58
 
 $
156,336
    
 
54
United Kingdom
  
 
47,914
    
 
12
 
 
35,432
    
 
12
Rest of world
(1)
  
 
116,947
    
 
30
 
 
97,598
    
 
34
    
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
Total revenue
  
 $
            392,146
    
 
                100
 
 $
          289,366
    
 
                    100
    
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
(1)
No other country represents 10% or more of total revenue for the three months ended September 30, 2021 or 2020.
 
 
(1)
No other country represents 10% or more of total revenue for the nine months ended September 30, 2021 or 2020.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events
9 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]  
Subsequent Events
14. Subsequent Events
Investment Commitments and Investments
The Company approved and entered into additional Investment Agreements from October 1, 2021 through the date of this filing. As of the date of this filing, the Company had additional outstanding investment commitments, subject to applicable terms and conditions, to purchase a total of 2.6 million shares for an aggregate purchase price of $26.0 million.
The following table presents details regarding the Company’s additional investment commitments outstanding as of the date of this filing (in thousands):
 
Entity
 
Investment Agreement
Date
 
Committed
Share Amount
 
 
Committed
Investment Amount
Telecommunications company (1)
  October 6, 2021     1,600     $ 16,000
Rigetti & Co, Inc.
(1)
  October 6, 2021     1,000       10,000
       
 
 
   
 
 
Tota
l
        2,600     $ 26,000
       
 
 
   
 
 
 
 
(1)
Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.
In connection with signing each of the Investment Agreements entered into between October 1, 2021 and the date of this filing, each Investee or an associated entity and the Company entered into a commercial contract for the Company’s products and services. The maximum potential revenue from these commercial contracts, including option years, is $26.0 million, and the terms of such agreements range from three to four years.
Additionally, from October 1 to the date of this filing, the Company purchased 5.5 million shares for an aggregate purchase price of $55.0 million, as set forth in the following table (in thousands):
 
Entity
  
Share Amount
 
  
Investment Amount
Babylon Health
(1)
    3,500     $ 35,000
Mobility company
(1)
    2,000       20,000
   
 
 
   
 
 
Total
 
 
5,500
    $ 55,000
   
 
 
   
 
 
 
 
(1)
Reflected as commitments in
Note 8. Commitments and Contingencies
- Investment Commitments
as of September 30, 2021.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Basis of Presentation and Consolidation
Basis of Presentation and Consolidation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over the investee, but does not control, are accounted for using the equity method of accounting. The Company’s fiscal year ends on December 31.
The unaudited condensed consolidated balance sheet as of December 31, 2020, included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity (deficit), and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period.
The Company ceased to be an emerging growth company as of December 31, 2020, which accelerated its adoption of Accounting Standards Update (“ASU”)
2016-02,
Leases (Topic 842)
. As a result, certain components of cash flows used in operating activities within the Company’s condensed consolidated statements of cash flows for the nine months ended September 30, 2020, have been presented to conform to the new standard. The impact to the presentation of the other statements was not material.
These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form
10-K
for the year ended December 31, 2020, which was filed with the SEC on February 26, 2021.
Use of Estimates
Use of Estimates
The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods.
Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts
;
the valuation of deferred tax assets and uncertain tax positions
;
collectability of contract consideration, including accounts receivable
;
useful lives of tangible assets
;
and the incremental borrowing rate for operating leases. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations.
Cash, Cash Equivalents, and Restricted Cash
Cash, Cash Equivalents, and Restricted Cash
The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds.
Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands):
 
 
  
As of September 30,
 
  
2021
  
2020
Cash and cash equivalents
   $ 2,335,068        $ 1,800,190    
Restricted cash
     41,316          43,800    
Restricted cash, noncurrent
     46,791          86,343    
    
 
 
 
  
 
 
 
Total cash, cash equivalents, and restricted cash
   $             2,423,175        $             1,930,333    
    
 
 
 
  
 
 
 
Accounts Receivable and Allowance for Credit Losses
Accounts Receivable and Allowance for Credit Losses
Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses, if any. The Company generally grants
non-collateralized
credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, including the ongoing
COVID-19
pandemic, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are
written-off
and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the assessment as of September 30, 2021, the Company recorded an immaterial allowance for credit losses. As of December 31, 2020, the Company did not record an allowance for credit losses.
Concentrations of Credit Risk and Other Concentrations
Concentrations of Credit Risk and Other Concentrations
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents primarily consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.
The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of September 30, 2021 and December 31, 2020 were $174.4 million and $156.9 million, respectively. Customer H represented 11% of total accounts receivable as of September 30, 2021. Customer G represented 13% of total accounts receivable as of December 31, 2020. No other customer represented more than 10% of total accounts receivable as of September 30, 2021 and December 31, 2020. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of September 30, 2021 and December 31, 2020, the Company had not experienced any significant losses on its accounts receivable.
For the three and nine months ended September 30, 2021, no customer represented more than 10% of total revenue. For the three months ended September 30, 2020, no customer represented more than 10% of total revenue. For the nine months ended September 30, 2020, Customer F, which is in the government operating segment, represented 11% of total revenue. No other customer represented more than 10% of total revenue for the three and nine months ended September 30, 2020.
The Company relies on the technology, infrastructure, and software applications, including
software-as-a-service
offerings, of third parties in order to host or operate certain key products and functions of its business.
Recently Adopted Accounting Pronouncements
Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued ASU
2019-12,
Simplifying the Accounting for Income Taxes (Topic 740),
as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU
2019-12
removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU
2019-12
also amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The Company adopted ASU
2019-12
as of January 1, 2021 using transition methods allowed under each aspect of the guidance. The adoption of the standard did not have a material impact on the Company’s condensed consolidated financial statements.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands):
 
 
  
As of September 30,
 
  
2021
  
2020
Cash and cash equivalents
   $ 2,335,068        $ 1,800,190    
Restricted cash
     41,316          43,800    
Restricted cash, noncurrent
     46,791          86,343    
    
 
 
 
  
 
 
 
Total cash, cash equivalents, and restricted cash
   $             2,423,175        $             1,930,333    
    
 
 
 
  
 
 
 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Investments and Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis
The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation (in thousands):
 
    
As of September 30, 2021
 
    
Total
   
Level 1
   
Level 2
   
Level 3
 
Assets:
                                
Money market funds
   $ 767,372     $ 767,372     $     $  
Certificates of deposit
     60,061             60,061        
Marketable securities
     148,077       148,077              
    
 
 
   
 
 
   
 
 
   
 
 
 
         
Total
   $ 975,510     $ 915,449     $ 60,061     $                 —  
    
 
 
   
 
 
   
 
 
   
 
 
 
   
    
As of December 31, 2020
 
    
Total
   
Level 1
   
Level 2
   
Level 3
 
Assets:
                              
Money market funds
   $ 1,075,783     $ 1,075,783     $     $  
Certificates of deposit
     74,097             74,097        
    
 
 
   
 
 
   
 
 
   
 
 
 
         
Total
   $     1,149,880     $ 1,075,783     $     74,097     $                 —  
    
 
 
   
 
 
   
 
 
   
 
 
 
Summary of Investments Under Investment Agreements
The following table presents the details of the investments purchased under such Investment Agreements during the nine months ended September 30, 2021 (in thousands):
 
Entity
(1)
     
Share Amount
   
Investment Amount
 
Celularity
                               2,000     $ 20,000  
Faraday Future
        2,500       25,000  
Astrocast
        1,520       5,000  
BlackSky
        800       8,000  
Lilium
        4,100       41,000  
Roivant Sciences
        3,000       30,000  
Sarcos Robotics
        2,100       21,000  
Autonomous aerial vehicle company
(2)
        3,000       3,000  
       
 
 
   
 
 
 
Total
        19,020     $ 153,000  
       
 
 
   
 
 
 
 
 
 
(1)
 
Investments are in publicly-traded marketable securities, unless otherwise noted.
 
(2)
 
Investment in privately-held company.
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Balance Sheet Components (Tables)
9 Months Ended
Sep. 30, 2021
Balance Sheet Related Disclosures [Abstract]  
Schedule of Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
 
    
 
As of September 30,
2021
 
 
  
 
As of December 31,
2020
Leasehold improvements
       $ 80,215           $ 85,196   
Computer equipment, software, and other
     25,451           22,275   
Furniture and fixtures
     10,021           9,976   
Construction in progress
     5,305           493   
    
 
 
    
 
 
Total property and equipment, gross
                 120,992                   117,940   
Less: accumulated depreciation and amortization
     (92,214)          (88,399)  
    
 
 
    
 
 
Total property and equipment, net
     $ 28,778           $ 29,541   
    
 
 
    
 
 
Schedule of Accrued Liabilities
Accrued liabilities consisted of the following (in thousands):
 
    
As of September 30,
2021
    
As of December 31,
2020
Accrued payroll and related expenses
     $ 100,157        $ 85,466
Accrued other liabilities
     79,310        73,080
    
 
 
    
 
 
Total accrued liabilities
     $             179,467        $         158,546
    
 
 
    
 
 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2021
Investment Commitments [Abstract]  
Summary of Investment commitments
The following table presents details related to the Company’s investment commitments outstanding as of September 30, 2021 (in thousands):
 
Entity
  
Investment
Agreement Date
 
 
Committed
Share Amount
 
 
Committed
Investment Amount
Mobility company
(1)
     May 11, 2021        2,000   
 
$ 20,000
       
Wejo
     May 28, 2021        3,500   
 
  35,000
       
Babylon Health
(1) (2)
     June 3, 2021        3,500   
 
  35,000
       
Boxed
(
2
)
     June 13, 2021        2,000   
 
  20,000
       
Pear Therapeutics
     June 21, 2021        1,000   
 
  10,000
       
Autonomous vehicle company
(
2
)
     June 22, 2021        1,800   
 
  18,000
       
Fast Radius
(
2
)
     July 18, 2021        2,000   
 
  20,000
       
Tritium
(
2
)
     July 27, 2021        1,500   
 
  15,000
       
AdTheorent
(
2
)
     July 27, 2021        1,500   
 
  15,000
       
FinAccel
     August 2, 2021        1,000   
 
  10,000
       
Energy Vault
(
2
)
     September 8, 2021       
850
  
 
  8,500
       
Electric vehicle charging company
(
2
)
     September 10, 2021        2,000   
 
  20,000
             
 
 
  
 
 
 
Total
              22,650   
 
$ 226,500
             
 
 
  
 
 
 
 
 
(1)
The Company’s investment closed after September 30, 2021. See further discussion in
Note 14. Subsequent Events
.
(2)
 
Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
Summary of Total Authorized, Issued, And Outstanding Shares
The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands):
 
 
 
As of September 30, 2021
 
 
As of December 31, 2020
 
 
 
Authorized
 
 
Issued and
Outstanding
 
 
Authorized
 
 
Issued and
Outstanding
 
Common stock:
                       
         
Class A
    20,000,000       1,900,441       20,000,000       1,542,058  
         
Class B
    2,700,000       89,672       2,700,000       249,077  
         
Class F
    1,005       1,005       1,005       1,005  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
    22,701,005       1,991,118       22,701,005       1,792,140  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Activity
The following table summarizes stock option activity for the nine months ended September 30, 2021 (in thousands, except per share amounts):
 
 
 
Options

Outstanding
 
Weighted-

Average

Exercise Price

Per Share
 
 
Weighted-

Average

Remaining

Contractual

Life (years)
 
 
Aggregate

Intrinsic Value
 
Balance as of December 31, 2020
    535,767     $ 6.12       7.99     $ 9,340,245    
         
Options exercised
    (155,720     3.05                  
         
Options canceled and forfeited
    (5,518     5.26                  
   
 
 
 
                       
         
Balance as of September 30, 2021
                  374,529     $ 7.40       8.82     $ 6,230,308    
   
 
 
 
                       
Options vested and exercisable as of September 30, 2021
    182,617     $ 4.48       7.08     $ 3,571,719    
   
 
 
 
                       
Summary of RSU Activity
The following table summarizes the RSU activity for the nine months ended September 30, 2021 (in thousands, except per share amounts):
 
 
  
RSUs
Outstanding
 
 
Weighted Average
Grant Date Fair
Value per Share
Unvested and outstanding as of December 31, 2020
     184,870        $ 6.97   
     
RSUs granted
     25,093        24.01   
     
RSUs vested
     (37,123      8.17   
     
RSUs canceled
     (6,807      8.18   
    
 
 
 
        
Unvested and outstanding as of September 30, 2021
     166,033        $ 9.22   
    
 
 
 
        
Summary of Stock-Based Compensation Expense
Stock-based Compensation Expense
Total stock-based compensation expense was as follows (in thousands):
 
  
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
  
2021
 
2020
 
2021
 
2020
Cost of revenue
    $ 14,860      $ 94,385      $ 54,866      $ 120,285  
         
Sales and marketing
     57,124       263,958       186,418       322,353  
         
Research and development
     34,472       256,769       122,976       309,698  
         
General and administrative
     78,379       231,847       247,048       276,578  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total stock-based compensation expense
(1)
   $ 184,835     $ 846,959     $ 611,308     $ 1,028,914  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
 
On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date.
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Net Loss Per Share Attributable to Common Stockholders (Tables)
9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Summary of Calculation of Basic and Diluted Net Loss Per Share
The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):
 
 
  
Three Months Ended

September 30,
 
Nine Months Ended

September 30,
 
  
2021
 
2020
 
2021
 
2020
Numerator
                                
         
Net loss attributable to common stockholders
   $ (102,137   $ (853,319   $ (364,191   $ (1,018,048
         
Less: Change in fair value attributable to participating securities
                       (5,483
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
Net loss attributable to common stockholders, for diluted net loss per share
   $ (102,137   $ (853,319   $ (364,191   $ (1,023,531
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator
                                
         
Weighted-average shares used in computing net loss per share, basic
     1,964,395       905,462       1,893,911       713,879  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average shares used in computing net loss per share, diluted
     1,964,395       905,462       1,893,911       716,027  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
Net loss per share
                                
         
Net loss per share attributable to common stockholders, basic
   $ (0.05   $ (0.94   $ (0.19   $ (1.43
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
Net loss per share attributable to common stockholders, diluted
   $ (0.05   $ (0.94   $ (0.19   $ (1.43
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary of Antidilutive Securities
The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands):
 
 
 
As of September 30,
 
 
        2021        
 
        2020        
Warrants to purchase common stock
     13,042        19,068
Options and Stock Appreciation Rights issued and outstanding
     374,555        587,977
RSUs outstanding
     166,033        199,655
Growth units outstanding
            3,583
    
 
 
 
  
 
 
Total
     553,630        810,283
    
 
 
 
  
 
 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Segment and Geographic Information (Tables)
9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
Summary of Financial Information for Each Reportable Segment
Financial information for each reportable segment was
as
follows (in thousands):
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2021
 
2020
 
2021
 
2020
Revenue:
                                   
Government
   $ 217,836      $ 162,561      $ 658,375      $ 420,257  
Commercial
     174,310        126,805        450,647        350,325  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Total revenue
   $ 392,146      $ 289,366      $ 1,109,022      $   770,582  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2021
 
2020
 
2021
 
2020
Contribution:
                                   
Government
   $ 125,706      $ 93,962      $ 400,705      $ 226,186  
Commercial
     98,177        69,496        245,841        168,908  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Total contribution
   $ 223,883      $ 163,458      $    646,546      $   395,094  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Summary of Reconciliation of Segment Financial Information to Loss from Operations
The reconciliation of contribution to loss from operations is as follows (in thousands):
 
 
  
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
  
2021
 
2020
 
2021
 
2020
Loss from operations
  
$
(91,941)
 
 
$
(847,777)
 
 
$
(352,103)
 
 
$
(1,017,107)
 
Research and development expenses
(1)
  
 
59,844 
   
 
57,146
   
 
180,335
   
 
156,832
 
General and administrative expenses
(1)
  
 
71,145 
   
 
107,130
   
 
207,006
   
 
226,455
 
Stock-based compensation expense
  
 
184,835 
   
 
846,959
   
 
611,308
   
 
1,028,914
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total contribution
  
$
223,883 
   
$
163,458
   
$
646,546
   
$
395,094
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
Excludes stock-based compensation expense.
Summary of Revenue by Geography
Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages):
 
                           
                           
                           
                           
 
  
Three Months Ended September 30,
 
  
2021
 
2020
 
  
Amount
 
%
 
Amount
 
%
Revenue:
                                  
United States
  
 $
227,285
    
 
58
 
 $
156,336
    
 
54
United Kingdom
  
 
47,914
    
 
12
 
 
35,432
    
 
12
Rest of world
(1)
  
 
116,947
    
 
30
 
 
97,598
    
 
34
    
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
Total revenue
  
 $
            392,146
    
 
                100
 
 $
          289,366
    
 
                    100
    
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
(1)
No other country represents 10% or more of total revenue for the three months ended September 30, 2021 or 2020.
 
                         
                         
                         
                         
 
  
Nine Months Ended September 30,
 
  
2021
 
2020
 
  
Amount
 
%
 
Amount
 
%
Revenue:
                                  
United States
  
 $
625,662
    
 
56
 
 $
391,106
    
 
51
United Kingdom
  
 
122,234
    
 
11
 
 
94,440
    
 
12
France
  
 
61,558
    
 
6
 
 
78,572
    
 
10
Rest of world
(1)
  
 
299,568
    
 
27
 
 
206,464
    
 
27
    
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
Total revenue
  
 $
            1,109,022
    
 
                  100
 
 $
            770,582
    
 
                    100
    
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
(1)
No other country represents 10% or more of total revenue for the nine months ended September 30, 2021 or 2020.
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events (Tables)
9 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]  
Summary of Additional Investment Commitments
The following table presents details regarding the Company’s additional investment commitments outstanding as of the date of this filing (in thousands):
 
Entity
 
Investment Agreement
Date
 
Committed
Share Amount
 
 
Committed
Investment Amount
Telecommunications company (1)
  October 6, 2021     1,600     $ 16,000
Rigetti & Co, Inc.
(1)
  October 6, 2021     1,000       10,000
       
 
 
   
 
 
Tota
l
        2,600     $ 26,000
       
 
 
   
 
 
 
 
(1)
Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.
Summary of Investment Commitments
In connection with signing each of the Investment Agreements entered into between October 1, 2021 and the date of this filing, each Investee or an associated entity and the Company entered into a commercial contract for the Company’s products and services. The maximum potential revenue from these commercial contracts, including option years, is $26.0 million, and the terms of such agreements range from three to four years.
Additionally, from October 1 to the date of this filing, the Company purchased 5.5 million shares for an aggregate purchase price of $55.0 million, as set forth in the following table (in thousands):
 
Entity
  
Share Amount
 
  
Investment Amount
Babylon Health
(1)
    3,500     $ 35,000
Mobility company
(1)
    2,000       20,000
   
 
 
   
 
 
Total
 
 
5,500
    $ 55,000
   
 
 
   
 
 
 
 
(1)
Reflected as commitments in
Note 8. Commitments and Contingencies
- Investment Commitments
as of September 30, 2021.
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2019
Accounting Policies [Abstract]        
Cash and cash equivalents $ 2,335,068 $ 2,011,323 $ 1,800,190  
Restricted cash 41,316 37,285 43,800  
Restricted cash, noncurrent 46,791 79,538 86,343  
Total cash, cash equivalents, and restricted cash $ 2,423,175 $ 2,128,146 $ 1,930,333 $ 1,401,962
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies - Additional Information (Detail) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Accounts receivable $ 174,405,000   $ 174,405,000   $ 156,932,000
Allowance for doubtful accounts on trade receivables $ 0   $ 0   $ 0
Accounts Receivable [Member] | Customer H [Member]          
Percentage Concentration     11.00%    
Accounts Receivable [Member] | Customer G [Member]          
Percentage Concentration         13.00%
Revenue Benchmark [Member] | Customer A [Member]          
Percentage Concentration   10.00%      
Revenue Benchmark [Member] | Customer F [Member]          
Percentage Concentration       11.00%  
Minimum [Member]          
Equity method investment ownership percentage 20.00%   20.00%    
Minimum [Member] | Revenue Benchmark [Member]          
Percentage Concentration 10.00% 10.00% 10.00% 10.00%  
Maximum [Member] | Accounts Receivable [Member]          
Percentage Concentration     10.00%   10.00%
Maximum [Member] | Revenue Benchmark [Member]          
Percentage Concentration 10.00% 10.00% 10.00% 10.00%  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Contract Liabilities and Remaining Performance Obligations - Additional information (Detail) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Revenue from Contract with Customer [Abstract]      
Performance obligation $ 873.9    
Performance obligation percentage to be recognised as revenue in the next twelve months 45.00%    
Contract with customer, liability $ 510.3   $ 531.9
Revenue recognized from contract liability balances $ 347.7 $ 406.4  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Investments and Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds $ 767,372 $ 1,075,783
Certificates of deposit 60,061 74,097
Marketable Securities 148,077  
Total 975,510 1,149,880
Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds 767,372 1,075,783
Marketable Securities 148,077  
Total 915,449 1,075,783
Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Certificates of deposit 60,061 74,097
Total $ 60,061 $ 74,097
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Investments and Fair Value Measurements - Summary Of The Investments Purchased Under Such Investment Agreements (Detail)
$ in Thousands
Sep. 30, 2021
USD ($)
shares
[1]
Investment Amount | $ $ 153,000
Investment Owned, Balance, Shares | shares 19,020
Celularity [Member]  
Investment Amount | $ $ 20,000
Investment Owned, Balance, Shares | shares 2,000
Faraday Future [Member]  
Investment Amount | $ $ 25,000
Investment Owned, Balance, Shares | shares 2,500
Astrocast [Member]  
Investment Amount | $ $ 5,000
Investment Owned, Balance, Shares | shares 1,520
BlackSky [Member]  
Investment Amount | $ $ 8,000
Investment Owned, Balance, Shares | shares 800
Lilium [Member]  
Investment Amount | $ $ 41,000
Investment Owned, Balance, Shares | shares 4,100
Roivant Sciences [Member]  
Investment Amount | $ $ 30,000
Investment Owned, Balance, Shares | shares 3,000
Sarcos Robotics [Member]  
Investment Amount | $ $ 21,000
Investment Owned, Balance, Shares | shares 2,100
Autonomous aerial vehicle company [Member]  
Investment Amount | $ $ 3,000 [2]
Investment Owned, Balance, Shares | shares 3,000 [2]
[1] Investments are in publicly-traded marketable securities, unless otherwise noted.
[2] Investment in privately-held company.
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Investments and Fair Value Measurements - Additional Information (Detail)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
oz
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Revenues $ 392,146 $ 289,366 $ 1,109,022 $ 770,582
Unrealized loss from marketable securities 7,200   7,238 $ 0
Alternative Investment [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Weight of commodities purchased | oz       100
Investment in Physical Commodities 50,900   50,900  
Commercial Contract [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Revenues 19,000   $ 22,000  
Maximum [Member] | Investment Agreement [Member] | Commercial Contract [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Subscription contract term     10 years  
Maximum contract value 640,200   $ 640,200  
Contractual option amounts $ 82,900   $ 82,900  
Minimum [Member] | Investment Agreement [Member] | Commercial Contract [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Subscription contract term     3 years  
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Total property and equipment, gross $ 120,992 $ 117,940
Less: accumulated depreciation and amortization (92,214) (88,399)
Total property and equipment, net 28,778 29,541
Leasehold improvements [Member]    
Total property and equipment, gross 80,215 85,196
Computer equipment, software, and other [Member]    
Total property and equipment, gross 25,451 22,275
Furniture and fixtures [Member]    
Total property and equipment, gross 10,021 9,976
Construction in progress [Member]    
Total property and equipment, gross $ 5,305 $ 493
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Balance Sheet Components - Schedule of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Balance Sheet Related Disclosures [Abstract]    
Accrued payroll and related expenses $ 100,157 $ 85,466
Accrued other liabilities 79,310 73,080
Total accrued liabilities $ 179,467 $ 158,546
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Balance Sheet Components - Additional information (Detail) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Balance Sheet Related Disclosures [Abstract]        
Depreciation and amortisation expense excluding the impact of foreign exchange fluctuations $ 3.1 $ 2.5 $ 9.3 $ 9.3
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Method Investments - Additional information (Detail) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended
Nov. 30, 2019
Sep. 30, 2021
Sep. 30, 2020
Schedule of Equity Method Investments [Line Items]      
Payments made to acquire equity method investments   $ 3,000 $ 2,500
Palantir Technologies Japan, K.K. [Member]      
Schedule of Equity Method Investments [Line Items]      
Number of shares purchased 100,000    
Payments made to acquire equity method investments $ 25,000    
Equity method investment ownership percentage 50.00%    
SOMPO [Member]      
Schedule of Equity Method Investments [Line Items]      
Equity method investment ownership percentage 50.00%    
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Additional Information (Detail) - USD ($)
$ in Millions
9 Months Ended
Apr. 01, 2021
Oct. 30, 2014
Sep. 30, 2021
2014 Revolving Credit Facility [Member]      
Long-term Debt [Line Items]      
Line of credit facility variable interest rate description     London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75%
Line of credit facility commitment fee percentage   0.375%  
Line of credit maturity date     Jun. 04, 2023
Debt instrument carrying amount     $ 0.0
Debt Instrument, periodic payment, principal $ 200.0    
2014 Revolving Credit Facility [Member] | Incremental Credit Facility [Member]      
Long-term Debt [Line Items]      
Undrawn revolving credit facility amount     400.0
Increase in borrowing capacity 200.0    
2014 Revolving Credit Facility [Member] | Minimum [Member]      
Long-term Debt [Line Items]      
Line of credit minimum liquidity to be maintained     $ 50.0
2014 Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]      
Long-term Debt [Line Items]      
Line of credit facility variable interest rate spread     2.75%
Line of credit facility variable interest rate description   London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75%  
Amended 2014 Revolving Credit Facility [Member]      
Long-term Debt [Line Items]      
Debt instrument maximum borrowing capacity 400.0    
Amended 2014 Revolving Credit Facility [Member] | Term Loan [Member] | Incremental Credit Facility [Member]      
Long-term Debt [Line Items]      
Undrawn revolving credit facility amount $ 100.0    
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Summary of Investment commitments (Detail)
$ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
shares
Commitments and Contingencies [Line Items]  
Number of shares committed to purchase | shares 22,650,000
Purchase Price Commitment | $ $ 226,500
Mobility Company [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date May 11, 2021 [1]
Number of shares committed to purchase | shares 2,000,000 [1]
Purchase Price Commitment | $ $ 20,000 [1]
Wejo [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date May 28, 2021
Number of shares committed to purchase | shares 3,500,000
Purchase Price Commitment | $ $ 35,000
Babylon Health [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date Jun. 03, 2021 [1],[2]
Number of shares committed to purchase | shares 3,500,000 [1],[2]
Purchase Price Commitment | $ $ 35,000 [1],[2]
Boxed [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date Jun. 13, 2021 [2]
Number of shares committed to purchase | shares 2,000,000 [2]
Purchase Price Commitment | $ $ 20,000 [2]
Pear Therapeutics [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date Jun. 21, 2021
Number of shares committed to purchase | shares 1,000,000
Purchase Price Commitment | $ $ 10,000
Autonomous Vehicle Company [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date Jun. 22, 2021 [2]
Number of shares committed to purchase | shares 1,800,000 [2]
Purchase Price Commitment | $ $ 18,000 [2]
Fast Radius [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date Jul. 18, 2021 [2]
Number of shares committed to purchase | shares 2,000,000 [2]
Purchase Price Commitment | $ $ 20,000 [2]
Tritium [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date Jul. 27, 2021 [2]
Number of shares committed to purchase | shares 1,500,000 [2]
Purchase Price Commitment | $ $ 15,000 [2]
AdTheorent [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date Jul. 27, 2021 [2]
Number of shares committed to purchase | shares 1,500,000 [2]
Purchase Price Commitment | $ $ 15,000 [2]
FinAccel [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date Aug. 02, 2021
Number of shares committed to purchase | shares 1,000,000
Purchase Price Commitment | $ $ 10,000
Energy Vault [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date Sep. 08, 2021 [2]
Number of shares committed to purchase | shares 850 [2]
Purchase Price Commitment | $ $ 8,500 [2]
Electric vehicle charging company [Member]  
Commitments and Contingencies [Line Items]  
Investment Agreement Date Sep. 10, 2021 [2]
Number of shares committed to purchase | shares 2,000,000 [2]
Purchase Price Commitment | $ $ 20,000 [2]
[1] The Company’s investment closed after September 30, 2021. See further discussion in Note 14. Subsequent Events.
[2] Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Additional Information (Detail) - USD ($)
shares in Thousands, $ in Thousands
1 Months Ended 9 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Sep. 30, 2021
Dec. 31, 2020
Loss Contingencies [Line Items]        
Letter of credit outstanding amount     $ 88,100 $ 116,800
Purchase Price Commitment     $ 226,500  
Number of shares committed to purchase     22,650  
Investment Commitments [Member] | Investment Agreement [Member]        
Loss Contingencies [Line Items]        
Purchase Price Commitment     $ 226,500  
Number of shares committed to purchase     22,700  
Purchase Commitment One [Member]        
Loss Contingencies [Line Items]        
Minimum annual commitment   $ 1,490,000    
Long-term Purchase Commitment, Description   If the spend does not meet the minimum annual commitment each year or at the end of the term, the Company is obligated to make a return payment. If the difference is greater than $30.0 million for each of the first three contract years or $50.0 million for each of the contract years thereafter (“relief amounts”), the Company has the option to pay the respective relief amount for that year for services to be utilized in the future and the excess amount of the difference above the relief amount would be added to the minimum annual commitment of the following year through the end of the contract.    
Purchase Commitment For Contract Year One     $ 34,000  
Purchase Commitment For Contract Year two     167,000  
Purchase Commitment Two [Member]        
Loss Contingencies [Line Items]        
Minimum annual commitment $ 45,000      
Satisfied purchase commitment     $ 8,000  
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail) - shares
Sep. 30, 2021
Dec. 31, 2020
Class of Stock [Line Items]    
Common stock, shares authorized 22,701,005,000 22,701,005,000
Common stock, shares issued 1,991,118,000 1,792,140,000
Common stock, shares outstanding 1,991,118,000 1,792,140,000
Common Class A [Member]    
Class of Stock [Line Items]    
Common stock, shares authorized 20,000,000,000 20,000,000,000
Common stock, shares issued 1,900,441,000 1,542,058,000
Common stock, shares outstanding 1,900,441,000 1,542,058,000
Common Class B [Member]    
Class of Stock [Line Items]    
Common stock, shares authorized 2,700,000,000 2,700,000,000
Common stock, shares issued 89,672,000 249,077,000
Common stock, shares outstanding 89,672,000 249,077,000
Common Class F [Member]    
Class of Stock [Line Items]    
Common stock, shares authorized 1,005,000 1,005,000
Common stock, shares issued 1,005,000 1,005,000
Common stock, shares outstanding 1,005,000 1,005,000
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity - Additional Information (Detail) - USD ($)
$ in Thousands
Sep. 30, 2020
Sep. 30, 2021
Minimum ownership threshold   100,000,000
Dividends declared   $ 0
Common Class B [Member]    
Number of shares exchanged 1,005,000  
Common Class F [Member]    
Voting power   50.00%
Redeemable Convertible Preferred Stock [Member] | Common Class B [Member]    
Number of shares issued for conversion 4,017,378  
Convertible preferred stock [Member] | Common Class B [Member]    
Number of shares issued for conversion 793,725,807  
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2021
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Common shares issuable upon full vesting of the growth units 1,500,000      
Unrecognized share based compensation expense   $ 940,000,000    
Unrecognized share based compensation expense, period for recognition   8 years    
Stock-based compensation   $ 611,308 $ 1,028,914  
Restricted Stock Units (RSUs) [Member]        
Unrecognized share based compensation expense   $ 985,100    
Unrecognized share based compensation expense, period for recognition   3 years    
Outstanding RSUs unvested   166,033,000   184,870,000
Growth units [Member]        
Stock-based compensation $ 1,200      
Outstanding RSUs unvested 3,600,000      
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Summary of Stock Option Activity (Detail)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]    
Beginning Balance of Options Outstanding | shares 535,767,000  
Options exercised | shares (155,720,000)  
Options canceled and forfeited | shares (5,518,000)  
Ending Balance of Options Outstanding | shares 374,529,000 535,767,000
Options vested and exercisable as of September 30, 2021 | shares 182,617,000  
Beginning Balance of Weighted-Average Exercise Price Per Share | $ / shares $ 6.12  
Options exercised | $ / shares 3.05  
Options canceled and forfeited | $ / shares 5.26  
Ending Balance of Weighted-Average Exercise Price Per Share | $ / shares 7.40 $ 6.12
Options vested and exercisable as of September 30, 2021 | $ / shares $ 4.48  
Weighted- Average Remaining Contractual Life (years) 8 years 9 months 25 days 7 years 11 months 26 days
Options vested and exercisable as of September 30, 2021 7 years 29 days  
Aggregate Intrinsic Value | $ $ 6,230,308 $ 9,340,245
Options vested and exercisable as of September 30, 2021 | $ $ 3,571,719  
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Summary of RSU Activity (Detail) - Restricted Stock Units
9 Months Ended
Sep. 30, 2021
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unvested and Outstanding Beginning Balance | shares 184,870,000
RSUs granted | shares 25,093,000
RSUs vested | shares (37,123,000)
RSUs canceled | shares (6,807,000)
Unvested and Outstanding Ending Balance | shares 166,033,000
Weighted Average Grant Date Fair Value per Share Beginning Balance | $ / shares $ 6.97
RSUs granted | $ / shares 24.01
RSUs vested | $ / shares 8.17
RSUs canceled | $ / shares 8.18
Weighted Average Grant Date Fair Value per Share Ending Balance | $ / shares $ 9.22
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense [1] $ 184,835 $ 846,959 $ 611,308 $ 1,028,914
Cost of revenue [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense 14,860 94,385 54,866 120,285
Sales and marketing [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense 57,124 263,958 186,418 322,353
Research and development [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense 34,472 256,769 122,976 309,698
General and administrative [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense $ 78,379 $ 231,847 $ 247,048 $ 276,578
[1] On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date.
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Summary of Stock Based Compensation Expense (Parenthetical) (Detail)
$ in Millions
9 Months Ended
Sep. 30, 2021
USD ($)
Restricted Stock Units (RSUs) [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Payment Arrangement, Accelerated Cost $ 769.5
Growth units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Payment Arrangement, Accelerated Cost $ 8.4
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Provision (benefit) for income taxes $ 1,438 $ (8,543) $ (1,121) $ (5,043)
Minimum [Member]        
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent 19.00%      
Maximum [Member]        
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent 25.00%      
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.21.2
Net Loss Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Numerator        
Net loss attributable to common stockholders $ (102,137) $ (853,319) $ (364,191) $ (1,018,048)
Less: Change in fair value attributable to participating securities 0 0 0 (5,483)
Net loss attributable to common stockholders, for diluted net loss per share $ (102,137) $ (853,319) $ (364,191) $ (1,023,531)
Denominator        
Weighted-average shares used in computing net loss per share, basic 1,964,395 905,462 1,893,911 713,879
Weighted-average shares used in computing net loss per share, diluted 1,964,395 905,462 1,893,911 716,027
Net loss per share        
Net loss per share attributable to common stockholders, basic $ (0.05) $ (0.94) $ (0.19) $ (1.43)
Net loss per share attributable to common stockholders, diluted $ (0.05) $ (0.94) $ (0.19) $ (1.43)
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.21.2
Net Loss Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail) - shares
shares in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 553,630 810,283
Warrants to purchase redeemable convertible and convertible preferred stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount   19,068
Warrants to purchase common stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 13,042  
Options and Stock Appreciation Rights issued and outstanding [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 374,555 587,977
RSUs outstanding [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 166,033 199,655
Growth units outstanding [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount   3,583
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.21.2
Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail) - Operating Segments [Member] - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Segment Reporting Information [Line Items]        
Revenues $ 392,146 $ 289,366 $ 1,109,022 $ 770,582
Contribution 223,883 163,458 646,546 395,094
Government [Member]        
Segment Reporting Information [Line Items]        
Revenues 217,836 162,561 658,375 420,257
Contribution 125,706 93,962 400,705 226,186
Commercial [Member]        
Segment Reporting Information [Line Items]        
Revenues 174,310 126,805 450,647 350,325
Contribution $ 98,177 $ 69,496 $ 245,841 $ 168,908
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.21.2
Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Segment Reporting Information [Line Items]        
Loss from operations $ (91,941) $ (847,777) $ (352,103) $ (1,017,107)
Stock-based compensation expense [1] 184,835 846,959 611,308 1,028,914
Reconciling items        
Segment Reporting Information [Line Items]        
Research and development expenses 59,844 57,146 180,335 156,832
General and administrative expenses 71,145 107,130 207,006 226,455
Stock-based compensation expense 184,835 846,959 611,308 1,028,914
Operating Segments        
Segment Reporting Information [Line Items]        
Contribution $ 223,883 $ 163,458 $ 646,546 $ 395,094
[1] On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date.
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.21.2
Segment and Geographic Information - Summary of Revenue by Geography (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Disaggregation of Revenue [Line Items]        
Revenues $ 392,146 $ 289,366 $ 1,109,022 $ 770,582
Geographic Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Revenues $ 392,146 $ 289,366 $ 1,109,022 $ 770,582
Concentration risk, percentage 100.00% 100.00% 100.00% 100.00%
United States [Member] | Geographic Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Revenues $ 227,285 $ 156,336 $ 625,662 $ 391,106
Concentration risk, percentage 58.00% 54.00% 56.00% 51.00%
United Kingdom [Member] | Geographic Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Revenues $ 47,914 $ 35,432 $ 122,234 $ 94,440
Concentration risk, percentage 12.00% 12.00% 11.00% 12.00%
France [Member] | Geographic Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Revenues     $ 61,558 $ 78,572
Concentration risk, percentage     6.00% 10.00%
Rest of world [Member] | Geographic Concentration Risk [Member]        
Disaggregation of Revenue [Line Items]        
Revenues $ 116,947 [1] $ 97,598 [1] $ 299,568 [2] $ 206,464 [2]
Concentration risk, percentage 30.00% [1] 34.00% [1] 27.00% [2] 27.00% [2]
[1] No other country represents 10% or more of total revenue for the three months ended September 30, 2021 or 2020.
[2] No other country represents 10% or more of total revenue for the nine months ended September 30, 2021 or 2020.
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.21.2
Segment and Geographic Information - Summary of Revenue by Geography (Parenthetical) (Detail)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue Benchmark [Member] | Minimum [Member]        
Disaggregation of Revenue [Line Items]        
Concentration risk, percentage 10.00% 10.00% 10.00% 10.00%
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events - Additional Information (Detail) - USD ($)
$ in Thousands
9 Months Ended
Oct. 01, 2021
Sep. 30, 2021
Dec. 31, 2021
Subsequent Event [Line Items]      
Number of shares committed to purchase   22,650,000  
Additional purchase price commitment   $ 226,500  
Investment Owned, Shares [1]   19,020  
Aggregate purchase price [1]   $ 153,000  
Investment Agreement [Member] | Forecast [Member]      
Subsequent Event [Line Items]      
Investment Owned, Shares     5,500,000
Aggregate purchase price     $ 55,000
Investment Agreement [Member] | Commercial Contract [Member] | Maximum [Member]      
Subsequent Event [Line Items]      
Subscription contract term   10 years  
Investment Agreement [Member] | Commercial Contract [Member] | Minimum [Member]      
Subsequent Event [Line Items]      
Subscription contract term   3 years  
Subsequent Event [Member] | Equity Investment [Member]      
Subsequent Event [Line Items]      
Number of shares committed to purchase 2,600,000    
Additional purchase price commitment $ 26,000    
Subsequent Event [Member] | Investment Agreement [Member] | Commercial Contract [Member] | Maximum [Member]      
Subsequent Event [Line Items]      
Enterprise Subscription Contract Value $ 26,000    
Subsequent Event [Member] | Additional Investment Agreement [Member] | Maximum [Member]      
Subsequent Event [Line Items]      
Subscription contract term 4 years    
Subsequent Event [Member] | Additional Investment Agreement [Member] | Minimum [Member]      
Subsequent Event [Line Items]      
Subscription contract term 3 years    
[1] Investments are in publicly-traded marketable securities, unless otherwise noted.
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events - Summary of Additional Investment Commitments (Detail)
$ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
shares
Additional Investment Commitments [Line Items]  
Committed share amount | shares 2,600,000
Committed investment amount | $ $ 26,000
Telecommunications company [Member]  
Additional Investment Commitments [Line Items]  
Investment Agreement Date Oct. 06, 2021 [1]
Committed share amount | shares 1,600 [1]
Committed investment amount | $ $ 16,000 [1]
Rigetti & Co, Inc. [Member]  
Additional Investment Commitments [Line Items]  
Investment Agreement Date Oct. 06, 2021 [1]
Committed share amount | shares 1,000 [1]
Committed investment amount | $ $ 10,000 [1]
[1] Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Event - Summary of Investment Commitments (Detail) - USD ($)
$ in Thousands
Dec. 31, 2021
Sep. 30, 2021
Subsequent Event [Line Items]    
Share Amount [1]   19,020
Investment Amount [1]   $ 153,000
Investment Agreement [Member] | Forecast [Member]    
Subsequent Event [Line Items]    
Share Amount 5,500,000  
Investment Amount $ 55,000  
Babylon Health [Member] | Forecast [Member]    
Subsequent Event [Line Items]    
Share Amount [2] 3,500,000  
Investment Amount [2] $ 35,000  
Mobility Company [Member] | Forecast [Member]    
Subsequent Event [Line Items]    
Share Amount [2] 2,000,000  
Investment Amount [2] $ 20,000  
[1] Investments are in publicly-traded marketable securities, unless otherwise noted.
[2] Reflected as commitments in Note 8. Commitments and Contingencies - Investment Commitments as of September 30, 2021.
EXCEL 72 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 73 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 74 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 75 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 236 341 1 true 93 0 false 6 false false R1.htm 1001 - Document - Cover Page Sheet http://www.palantir.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.palantir.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://www.palantir.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 1006 - Statement - Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders' Equity (Deficit) Sheet http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders' Equity (Deficit) Statements 6 false false R7.htm 1007 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 1008 - Disclosure - Organization Sheet http://www.palantir.com/role/Organization Organization Notes 8 false false R9.htm 1009 - Disclosure - Significant Accounting Policies Sheet http://www.palantir.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 9 false false R10.htm 1010 - Disclosure - Contract Liabilities and Remaining Performance Obligations Sheet http://www.palantir.com/role/ContractLiabilitiesAndRemainingPerformanceObligations Contract Liabilities and Remaining Performance Obligations Notes 10 false false R11.htm 1011 - Disclosure - Investments and Fair Value Measurements Sheet http://www.palantir.com/role/InvestmentsAndFairValueMeasurements Investments and Fair Value Measurements Notes 11 false false R12.htm 1012 - Disclosure - Balance Sheet Components Sheet http://www.palantir.com/role/BalanceSheetComponents Balance Sheet Components Notes 12 false false R13.htm 1013 - Disclosure - Equity Method Investments Sheet http://www.palantir.com/role/EquityMethodInvestments Equity Method Investments Notes 13 false false R14.htm 1014 - Disclosure - Debt Sheet http://www.palantir.com/role/Debt Debt Notes 14 false false R15.htm 1015 - Disclosure - Commitments and Contingencies Sheet http://www.palantir.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 1016 - Disclosure - Stockholders' Equity Sheet http://www.palantir.com/role/StockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 1017 - Disclosure - Stock-Based Compensation Sheet http://www.palantir.com/role/StockBasedCompensation Stock-Based Compensation Notes 17 false false R18.htm 1018 - Disclosure - Income Taxes Sheet http://www.palantir.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 1019 - Disclosure - Net Loss Per Share Attributable to Common Stockholders Sheet http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholders Net Loss Per Share Attributable to Common Stockholders Notes 19 false false R20.htm 1020 - Disclosure - Segment and Geographic Information Sheet http://www.palantir.com/role/SegmentAndGeographicInformation Segment and Geographic Information Notes 20 false false R21.htm 1021 - Disclosure - Subsequent Events Sheet http://www.palantir.com/role/SubsequentEvents Subsequent Events Notes 21 false false R22.htm 1022 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.palantir.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.palantir.com/role/SignificantAccountingPolicies 22 false false R23.htm 1023 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.palantir.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.palantir.com/role/SignificantAccountingPolicies 23 false false R24.htm 1024 - Disclosure - Investments and Fair Value Measurements (Tables) Sheet http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsTables Investments and Fair Value Measurements (Tables) Tables http://www.palantir.com/role/InvestmentsAndFairValueMeasurements 24 false false R25.htm 1025 - Disclosure - Balance Sheet Components (Tables) Sheet http://www.palantir.com/role/BalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://www.palantir.com/role/BalanceSheetComponents 25 false false R26.htm 1026 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.palantir.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.palantir.com/role/CommitmentsAndContingencies 26 false false R27.htm 1027 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.palantir.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.palantir.com/role/StockholdersEquity 27 false false R28.htm 1028 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.palantir.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.palantir.com/role/StockBasedCompensation 28 false false R29.htm 1029 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables) Sheet http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersTables Net Loss Per Share Attributable to Common Stockholders (Tables) Tables http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholders 29 false false R30.htm 1030 - Disclosure - Segment and Geographic Information (Tables) Sheet http://www.palantir.com/role/SegmentAndGeographicInformationTables Segment and Geographic Information (Tables) Tables http://www.palantir.com/role/SegmentAndGeographicInformation 30 false false R31.htm 1031 - Disclosure - Subsequent Events (Tables) Sheet http://www.palantir.com/role/SubsequentEventsTables Subsequent Events (Tables) Tables http://www.palantir.com/role/SubsequentEvents 31 false false R32.htm 1032 - Disclosure - Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail) Sheet http://www.palantir.com/role/SignificantAccountingPoliciesScheduleOfCashAndCashEquivalentsDetail Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail) Details 32 false false R33.htm 1033 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail Significant Accounting Policies - Additional Information (Detail) Details 33 false false R34.htm 1034 - Disclosure - Contract Liabilities and Remaining Performance Obligations - Additional information (Detail) Sheet http://www.palantir.com/role/ContractLiabilitiesAndRemainingPerformanceObligationsAdditionalInformationDetail Contract Liabilities and Remaining Performance Obligations - Additional information (Detail) Details 34 false false R35.htm 1035 - Disclosure - Investments and Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail) Sheet http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail Investments and Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail) Details 35 false false R36.htm 1036 - Disclosure - Investments and Fair Value Measurements - Summary Of The Investments Purchased Under Such Investment Agreements (Detail) Sheet http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail Investments and Fair Value Measurements - Summary Of The Investments Purchased Under Such Investment Agreements (Detail) Details 36 false false R37.htm 1037 - Disclosure - Investments and Fair Value Measurements - Additional Information (Detail) Sheet http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail Investments and Fair Value Measurements - Additional Information (Detail) Details 37 false false R38.htm 1038 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) Sheet http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) Details 38 false false R39.htm 1039 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Detail) Sheet http://www.palantir.com/role/BalanceSheetComponentsScheduleOfAccruedLiabilitiesDetail Balance Sheet Components - Schedule of Accrued Liabilities (Detail) Details 39 false false R40.htm 1040 - Disclosure - Balance Sheet Components - Additional information (Detail) Sheet http://www.palantir.com/role/BalanceSheetComponentsAdditionalInformationDetail Balance Sheet Components - Additional information (Detail) Details 40 false false R41.htm 1041 - Disclosure - Equity Method Investments - Additional information (Detail) Sheet http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail Equity Method Investments - Additional information (Detail) Details 41 false false R42.htm 1042 - Disclosure - Debt - Additional Information (Detail) Sheet http://www.palantir.com/role/DebtAdditionalInformationDetail Debt - Additional Information (Detail) Details 42 false false R43.htm 1043 - Disclosure - Commitments and Contingencies - Summary of Investment commitments (Detail) Sheet http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail Commitments and Contingencies - Summary of Investment commitments (Detail) Details 43 false false R44.htm 1044 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 44 false false R45.htm 1045 - Disclosure - Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail) Sheet http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail) Details 45 false false R46.htm 1046 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 46 false false R47.htm 1047 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail Stock-Based Compensation - Additional Information (Detail) Details 47 false false R48.htm 1048 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail Stock-Based Compensation - Summary of Stock Option Activity (Detail) Details 48 false false R49.htm 1049 - Disclosure - Stock-Based Compensation - Summary of RSU Activity (Detail) Sheet http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail Stock-Based Compensation - Summary of RSU Activity (Detail) Details 49 false false R50.htm 1050 - Disclosure - Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) Sheet http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) Details 50 false false R51.htm 1051 - Disclosure - Stock-Based Compensation - Summary of Stock Based Compensation Expense (Parenthetical) (Detail) Sheet http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseParentheticalDetail Stock-Based Compensation - Summary of Stock Based Compensation Expense (Parenthetical) (Detail) Details 51 false false R52.htm 1052 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 52 false false R53.htm 1053 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail) Sheet http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail Net Loss Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail) Details 53 false false R54.htm 1054 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail) Sheet http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail Net Loss Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail) Details 54 false false R55.htm 1055 - Disclosure - Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail) Sheet http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail) Details 55 false false R56.htm 1056 - Disclosure - Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail) Sheet http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail) Details 56 false false R57.htm 1057 - Disclosure - Segment and Geographic Information - Summary of Revenue by Geography (Detail) Sheet http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail Segment and Geographic Information - Summary of Revenue by Geography (Detail) Details 57 false false R58.htm 1058 - Disclosure - Segment and Geographic Information - Summary of Revenue by Geography (Parenthetical) (Detail) Sheet http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyParentheticalDetail Segment and Geographic Information - Summary of Revenue by Geography (Parenthetical) (Detail) Details 58 false false R59.htm 1059 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail Subsequent Events - Additional Information (Detail) Details 59 false false R60.htm 1060 - Disclosure - Subsequent Events - Summary of Additional Investment Commitments (Detail) Sheet http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail Subsequent Events - Summary of Additional Investment Commitments (Detail) Details 60 false false R61.htm 1061 - Disclosure - Subsequent Event - Summary of Investment Commitments (Detail) Sheet http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail Subsequent Event - Summary of Investment Commitments (Detail) Details 61 false false All Reports Book All Reports d178745d10q.htm d178745dex311.htm d178745dex312.htm d178745dex321.htm pltr-20210930.xsd pltr-20210930_cal.xml pltr-20210930_def.xml pltr-20210930_lab.xml pltr-20210930_pre.xml http://xbrl.sec.gov/dei/2021 http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/country/2021 http://fasb.org/us-gaap/2021-01-31 true true JSON 78 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d178745d10q.htm": { "axisCustom": 5, "axisStandard": 26, "contextCount": 236, "dts": { "calculationLink": { "local": [ "pltr-20210930_cal.xml" ] }, "definitionLink": { "local": [ "pltr-20210930_def.xml" ] }, "inline": { "local": [ "d178745d10q.htm" ] }, "labelLink": { "local": [ "pltr-20210930_lab.xml" ] }, "presentationLink": { "local": [ "pltr-20210930_pre.xml" ] }, "schema": { "local": [ "pltr-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 530, "entityCount": 1, "hidden": { "http://www.palantir.com/20210930": 2, "http://xbrl.sec.gov/dei/2021": 4, "total": 6 }, "keyCustom": 44, "keyStandard": 297, "memberCustom": 52, "memberStandard": 36, "nsprefix": "pltr", "nsuri": "http://www.palantir.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://www.palantir.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Contract Liabilities and Remaining Performance Obligations", "role": "http://www.palantir.com/role/ContractLiabilitiesAndRemainingPerformanceObligations", "shortName": "Contract Liabilities and Remaining Performance Obligations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "pltr:InvestmentsAndFairValueMeasurementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Investments and Fair Value Measurements", "role": "http://www.palantir.com/role/InvestmentsAndFairValueMeasurements", "shortName": "Investments and Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "pltr:InvestmentsAndFairValueMeasurementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Balance Sheet Components", "role": "http://www.palantir.com/role/BalanceSheetComponents", "shortName": "Balance Sheet Components", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Equity Method Investments", "role": "http://www.palantir.com/role/EquityMethodInvestments", "shortName": "Equity Method Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Debt", "role": "http://www.palantir.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Commitments and Contingencies", "role": "http://www.palantir.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Stockholders' Equity", "role": "http://www.palantir.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Stock-Based Compensation", "role": "http://www.palantir.com/role/StockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Income Taxes", "role": "http://www.palantir.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Net Loss Per Share Attributable to Common Stockholders", "role": "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholders", "shortName": "Net Loss Per Share Attributable to Common Stockholders", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "lang": null, "name": "us-gaap:MarketableSecuritiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Segment and Geographic Information", "role": "http://www.palantir.com/role/SegmentAndGeographicInformation", "shortName": "Segment and Geographic Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Subsequent Events", "role": "http://www.palantir.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://www.palantir.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Significant Accounting Policies (Tables)", "role": "http://www.palantir.com/role/SignificantAccountingPoliciesTables", "shortName": "Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "pltr:InvestmentsAndFairValueMeasurementsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Investments and Fair Value Measurements (Tables)", "role": "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsTables", "shortName": "Investments and Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "pltr:InvestmentsAndFairValueMeasurementsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Balance Sheet Components (Tables)", "role": "http://www.palantir.com/role/BalanceSheetComponentsTables", "shortName": "Balance Sheet Components (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "pltr:ScheduleOfInvestmentCommitmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://www.palantir.com/role/CommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "pltr:ScheduleOfInvestmentCommitmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Stockholders' Equity (Tables)", "role": "http://www.palantir.com/role/StockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://www.palantir.com/role/StockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)", "role": "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersTables", "shortName": "Net Loss Per Share Attributable to Common Stockholders (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Segment and Geographic Information (Tables)", "role": "http://www.palantir.com/role/SegmentAndGeographicInformationTables", "shortName": "Segment and Geographic Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "pltr:AdditionalInvestmentCommitmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Subsequent Events (Tables)", "role": "http://www.palantir.com/role/SubsequentEventsTables", "shortName": "Subsequent Events (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "pltr:AdditionalInvestmentCommitmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail)", "role": "http://www.palantir.com/role/SignificantAccountingPoliciesScheduleOfCashAndCashEquivalentsDetail", "shortName": "Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2020", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Significant Accounting Policies - Additional Information (Detail)", "role": "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "0", "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Contract Liabilities and Remaining Performance Obligations - Additional information (Detail)", "role": "http://www.palantir.com/role/ContractLiabilitiesAndRemainingPerformanceObligationsAdditionalInformationDetail", "shortName": "Contract Liabilities and Remaining Performance Obligations - Additional information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "pltr:InvestmentsAndFairValueMeasurementsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MoneyMarketFundsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - Investments and Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail)", "role": "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail", "shortName": "Investments and Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "pltr:InvestmentsAndFairValueMeasurementsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MoneyMarketFundsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "pltr:InvestmentAgreementsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - Investments and Fair Value Measurements - Summary Of The Investments Purchased Under Such Investment Agreements (Detail)", "role": "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail", "shortName": "Investments and Fair Value Measurements - Summary Of The Investments Purchased Under Such Investment Agreements (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "pltr:InvestmentAgreementsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021_CelularityMemberPLTRInvestmentNameAxis", "decimals": "-3", "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - Investments and Fair Value Measurements - Additional Information (Detail)", "role": "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "shortName": "Investments and Fair Value Measurements - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:MarketableSecuritiesUnrealizedGainLoss", "div", "div", "pltr:InvestmentsAndFairValueMeasurementsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-5", "lang": null, "name": "us-gaap:MarketableSecuritiesUnrealizedGainLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Detail)", "role": "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail", "shortName": "Balance Sheet Components - Schedule of Property and Equipment, Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Detail)", "role": "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfAccruedLiabilitiesDetail", "shortName": "Balance Sheet Components - Schedule of Accrued Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Condensed Consolidated Statements of Operations", "role": "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - Balance Sheet Components - Additional information (Detail)", "role": "http://www.palantir.com/role/BalanceSheetComponentsAdditionalInformationDetail", "shortName": "Balance Sheet Components - Additional information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1041 - Disclosure - Equity Method Investments - Additional information (Detail)", "role": "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail", "shortName": "Equity Method Investments - Additional information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P11_01_2019To11_30_2019_PalantirTechnologiesJapanKKMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "decimals": "0", "lang": null, "name": "us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "us-gaap:DebtInstrumentDescriptionOfVariableRateBasis", "div", "div", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021_TwoThousandAndFourteenRevolvingCreditFacilityMemberusgaapCreditFacilityAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentDescriptionOfVariableRateBasis", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1042 - Disclosure - Debt - Additional Information (Detail)", "role": "http://www.palantir.com/role/DebtAdditionalInformationDetail", "shortName": "Debt - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtInstrumentDescriptionOfVariableRateBasis", "div", "div", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021_TwoThousandAndFourteenRevolvingCreditFacilityMemberusgaapCreditFacilityAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentDescriptionOfVariableRateBasis", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "pltr:ScheduleOfInvestmentCommitmentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "pltr:NumberOfSharesCommittedToPurchase", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1043 - Disclosure - Commitments and Contingencies - Summary of Investment commitments (Detail)", "role": "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail", "shortName": "Commitments and Contingencies - Summary of Investment commitments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "pltr:ScheduleOfInvestmentCommitmentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021_MobilityCompanyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": null, "lang": "en-US", "name": "pltr:SubscriptionAgreementDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1044 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "role": "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfStockByClassTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1045 - Disclosure - Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail)", "role": "http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail", "shortName": "Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R46": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-6", "first": true, "lang": null, "name": "pltr:MinimumOwnershipThreshold", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1046 - Disclosure - Stockholders' Equity - Additional Information (Detail)", "role": "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail", "shortName": "Stockholders' Equity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-6", "first": true, "lang": null, "name": "pltr:MinimumOwnershipThreshold", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To03_31_2021", "decimals": "-5", "first": true, "lang": null, "name": "pltr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesIssuableUponVesting", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1047 - Disclosure - Stock-Based Compensation - Additional Information (Detail)", "role": "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "shortName": "Stock-Based Compensation - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To03_31_2021", "decimals": "-5", "first": true, "lang": null, "name": "pltr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesIssuableUponVesting", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1048 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail)", "role": "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail", "shortName": "Stock-Based Compensation - Summary of Stock Option Activity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn12_31_2020_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1049 - Disclosure - Stock-Based Compensation - Summary of RSU Activity (Detail)", "role": "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail", "shortName": "Stock-Based Compensation - Summary of RSU Activity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Condensed Consolidated Statements of Comprehensive Loss", "role": "http://www.palantir.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss", "shortName": "Condensed Consolidated Statements of Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1050 - Disclosure - Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail)", "role": "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "shortName": "Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021_CostOfSalesMemberusgaapIncomeStatementLocationAxis", "decimals": "-3", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1051 - Disclosure - Stock-Based Compensation - Summary of Stock Based Compensation Expense (Parenthetical) (Detail)", "role": "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseParentheticalDetail", "shortName": "Stock-Based Compensation - Summary of Stock Based Compensation Expense (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1052 - Disclosure - Income Taxes - Additional Information (Detail)", "role": "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail", "shortName": "Income Taxes - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021_MinimumMembersrtRangeAxis", "decimals": "2", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1053 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail)", "role": "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail", "shortName": "Net Loss Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1054 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail)", "role": "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail", "shortName": "Net Loss Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021_OperatingSegmentsMembersrtConsolidationItemsAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1055 - Disclosure - Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail)", "role": "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail", "shortName": "Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021_OperatingSegmentsMembersrtConsolidationItemsAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1056 - Disclosure - Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail)", "role": "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail", "shortName": "Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021_MaterialReconcilingItemsMembersrtConsolidationItemsAxis", "decimals": "-3", "lang": null, "name": "pltr:ResearchAndDevelopmentExpenseExcludingStockbasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1057 - Disclosure - Segment and Geographic Information - Summary of Revenue by Geography (Detail)", "role": "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail", "shortName": "Segment and Geographic Information - Summary of Revenue by Geography (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021_GeographicConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskPercentage1", "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P07_01_2021To09_30_2021_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1058 - Disclosure - Segment and Geographic Information - Summary of Revenue by Geography (Parenthetical) (Detail)", "role": "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyParentheticalDetail", "shortName": "Segment and Geographic Information - Summary of Revenue by Geography (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "pltr:ScheduleOfInvestmentCommitmentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "pltr:NumberOfSharesCommittedToPurchase", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1059 - Disclosure - Subsequent Events - Additional Information (Detail)", "role": "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail", "shortName": "Subsequent Events - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P10_01_2021To10_01_2021_EquityInvestmentMemberusgaapInvestmentTypeAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "-5", "lang": null, "name": "pltr:NumberOfSharesCommittedToPurchase", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn12_31_2019_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders' Equity (Deficit)", "role": "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit", "shortName": "Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn12_31_2019_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "pltr:AdditionalInvestmentCommitmentsTableTextBlock", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "pltr:CommittedShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1060 - Disclosure - Subsequent Events - Summary of Additional Investment Commitments (Detail)", "role": "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail", "shortName": "Subsequent Events - Summary of Additional Investment Commitments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "pltr:AdditionalInvestmentCommitmentsTableTextBlock", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "pltr:CommittedShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "pltr:InvestmentAgreementsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedBalanceShares", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1061 - Disclosure - Subsequent Event - Summary of Investment Commitments (Detail)", "role": "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "shortName": "Subsequent Event - Summary of Investment Commitments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "PAsOn12_31_2021_BabylonHealthMemberPLTRInvestmentNameAxis_ScenarioForecastMembersrtStatementScenarioAxis", "decimals": "-3", "lang": null, "name": "us-gaap:InvestmentOwnedBalanceShares", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Organization", "role": "http://www.palantir.com/role/Organization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Significant Accounting Policies", "role": "http://www.palantir.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d178745d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 93, "tag": { "country_FR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FRANCE", "terseLabel": "France [Member]" } } }, "localname": "FR", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM", "terseLabel": "United Kingdom [Member]" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r602" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.palantir.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "pltr_AdditionalInvestmentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional Investment Agreement [Member]" } } }, "localname": "AdditionalInvestmentAgreementMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_AdditionalInvestmentCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional Investment Commitments [Line Items]" } } }, "localname": "AdditionalInvestmentCommitmentsLineItems", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "stringItemType" }, "pltr_AdditionalInvestmentCommitmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional investment commitments [Table text block].", "label": "Additional Investment Commitments [Table Text Block]", "terseLabel": "Summary of Additional Investment Commitments" } } }, "localname": "AdditionalInvestmentCommitmentsTableTextBlock", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SubsequentEventsTables" ], "xbrltype": "textBlockItemType" }, "pltr_AdtheorentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AdTheorent [Member]" } } }, "localname": "AdtheorentMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_AlternativeInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alternative investment.", "label": "Alternative Investment [Member]" } } }, "localname": "AlternativeInvestmentMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_AmendedTwoThousandAndFourteenRevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended Two Thousand And Fourteen Revolving Credit Facility [Member]", "label": "Amended Two Thousand And Fourteen Revolving Credit Facility [Member]", "verboseLabel": "Amended 2014 Revolving Credit Facility [Member]" } } }, "localname": "AmendedTwoThousandAndFourteenRevolvingCreditFacilityMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_AstrocastMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Astrocast [Member]", "terseLabel": "Astrocast [Member]" } } }, "localname": "AstrocastMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail" ], "xbrltype": "domainItemType" }, "pltr_AutonomousAerialVehicleCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Autonomous Aerial Vehicle Company [Member]", "terseLabel": "Autonomous aerial vehicle company [Member]" } } }, "localname": "AutonomousAerialVehicleCompanyMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail" ], "xbrltype": "domainItemType" }, "pltr_AutonomousVehicleCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Autonomous Vehicle Company [Member]", "label": "Autonomous Vehicle Company [Member]" } } }, "localname": "AutonomousVehicleCompanyMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_BabylonHealthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Babylon health.", "label": "Babylon Health [Member]" } } }, "localname": "BabylonHealthMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_BlackSkyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Black Sky [Member]", "terseLabel": "BlackSky [Member]" } } }, "localname": "BlackSkyMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail" ], "xbrltype": "domainItemType" }, "pltr_BoxedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Boxed [Member]" } } }, "localname": "BoxedMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_CashlessNetExerciseOfWarrantsForConvertiblePreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cashless net exercise of warrants for convertible preferred stock", "label": "Cashless net exercise of warrants for convertible preferred stock", "terseLabel": "Cashless net exercise of warrants for convertible preferred stock" } } }, "localname": "CashlessNetExerciseOfWarrantsForConvertiblePreferredStock", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "pltr_CelularityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Celularity [Member]" } } }, "localname": "CelularityMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail" ], "xbrltype": "domainItemType" }, "pltr_CommercialContractMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commercial Contract [Member]" } } }, "localname": "CommercialContractMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_CommercialMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commercial", "label": "Commercial [Member]", "terseLabel": "Commercial [Member]" } } }, "localname": "CommercialMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail" ], "xbrltype": "domainItemType" }, "pltr_CommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and Contingencies [Line Items]", "label": "Commitments and Contingencies [Line Items]" } } }, "localname": "CommitmentsAndContingenciesLineItems", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "stringItemType" }, "pltr_CommittedInvestmentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Committed investment amount.", "label": "Committed Investment Amount", "terseLabel": "Committed investment amount" } } }, "localname": "CommittedInvestmentAmount", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "monetaryItemType" }, "pltr_CommittedShareAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Committed share amount.", "label": "Committed Share Amount", "terseLabel": "Committed share amount" } } }, "localname": "CommittedShareAmount", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "sharesItemType" }, "pltr_CommonClassFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Class F [Member]", "terseLabel": "Common Class F [Member]", "verboseLabel": "Class F Common Stock [Member]" } } }, "localname": "CommonClassFMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/CoverPage", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail" ], "xbrltype": "domainItemType" }, "pltr_ContractualOptionAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contractual option amount.", "label": "Contractual Option Amount", "terseLabel": "Contractual option amounts" } } }, "localname": "ContractualOptionAmount", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "pltr_Contribution": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contribution.", "label": "Contribution", "verboseLabel": "Contribution" } } }, "localname": "Contribution", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail" ], "xbrltype": "monetaryItemType" }, "pltr_ControlOfTotalVotingPower": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Voting power", "documentation": "Control of total voting power.", "label": "Control Of Total Voting Power" } } }, "localname": "ControlOfTotalVotingPower", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "pltr_ConversionOfConvertiblePreferredStockWarrantsIntoCommonStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion Of Convertible Preferred Stock Warrants Into Common Stock Warrants.", "label": "Conversion Of Convertible Preferred Stock Warrants Into Common Stock Warrants [Member]" } } }, "localname": "ConversionOfConvertiblePreferredStockWarrantsIntoCommonStockWarrantsMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "domainItemType" }, "pltr_ConversionOfRedeemableConvertiblePreferredStockToCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of redeemable convertible preferred stock to common stock.", "label": "Conversion of Redeemable Convertible Preferred Stock to Common Stock", "verboseLabel": "Conversion of redeemable convertible preferred stock to common stock" } } }, "localname": "ConversionOfRedeemableConvertiblePreferredStockToCommonStock", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "pltr_ConversionOfRedeemableConvertiblePreferredStockToCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of redeemable convertible preferred stock to common stock [Member].", "label": "Conversion of Redeemable Convertible Preferred Stock to Common Stock [Member]" } } }, "localname": "ConversionOfRedeemableConvertiblePreferredStockToCommonStockMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "domainItemType" }, "pltr_ConversionOfRedeemableSharesConvertiblePreferredStockToCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of redeemable shares convertible preferred stock to common stock.", "label": "Conversion of Redeemable Shares Convertible Preferred Stock to Common Stock", "terseLabel": "Conversion of redeemable convertible preferred stock to common stock, Shares" } } }, "localname": "ConversionOfRedeemableSharesConvertiblePreferredStockToCommonStock", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "pltr_CreditFacilityAmendmentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Facility Amendment [Axis]" } } }, "localname": "CreditFacilityAmendmentAxis", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "pltr_CreditFacilityAmendmentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Facility Amendment [Domain]" } } }, "localname": "CreditFacilityAmendmentDomain", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_CustomerAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer A [Member]", "label": "Customer A [Member]" } } }, "localname": "CustomerAMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_CustomerDepositCurrent": { "auth_ref": [], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Customer deposit current.", "label": "Customer Deposit Current", "terseLabel": "Customer deposits" } } }, "localname": "CustomerDepositCurrent", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "pltr_CustomerDepositNoncurrent": { "auth_ref": [], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Customer deposit noncurrent.", "label": "Customer Deposit Noncurrent", "terseLabel": "Customer deposits, noncurrent" } } }, "localname": "CustomerDepositNoncurrent", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "pltr_CustomerFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer F [Member]" } } }, "localname": "CustomerFMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_CustomerGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer G.", "label": "Customer G [Member]" } } }, "localname": "CustomerGMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_CustomerHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer H [Member]" } } }, "localname": "CustomerHMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_DisclosureOfFutureAnnualMinimumPaymentsUnderNoncancelableOperatingLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of future annual minimum payments under noncancelable operating leases", "label": "Disclosure Of Future Annual Minimum Payments Under Noncancelable Operating Leases [Abstract]", "verboseLabel": "Disclosure Of Future Annual Minimum Payments Under Noncancelable Operating Leases [Abstract]" } } }, "localname": "DisclosureOfFutureAnnualMinimumPaymentsUnderNoncancelableOperatingLeasesAbstract", "nsuri": "http://www.palantir.com/20210930", "xbrltype": "stringItemType" }, "pltr_DisclosureOfNumberOfSharesAuthorizedIssuedAndOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Number of Shares Authorized Issued and Outstanding [Abstract]", "verboseLabel": "Disclosure of Number of Shares Authorized Issued and Outstanding [Abstract]" } } }, "localname": "DisclosureOfNumberOfSharesAuthorizedIssuedAndOutstandingAbstract", "nsuri": "http://www.palantir.com/20210930", "xbrltype": "stringItemType" }, "pltr_ElectricvehiclechargingcompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Electric vehicle charging company [Member]" } } }, "localname": "ElectricvehiclechargingcompanyMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_EnergyVaultMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy vault.", "label": "Energy Vault [Member]" } } }, "localname": "EnergyVaultMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_EnterpriseSubscriptionContractValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Enterprise subscription contract value.", "label": "Enterprise Subscription Contract Value" } } }, "localname": "EnterpriseSubscriptionContractValue", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "pltr_EquityInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity investment.", "label": "Equity Investment [Member]" } } }, "localname": "EquityInvestmentMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_EventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Event [Axis]", "terseLabel": "Event [Axis]", "verboseLabel": "Event [Axis]" } } }, "localname": "EventAxis", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "pltr_EventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Event [Domain]", "terseLabel": "Event [Domain]", "verboseLabel": "Event [Domain]" } } }, "localname": "EventDomain", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_FaradayFutureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Faraday Future [Member]" } } }, "localname": "FaradayFutureMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail" ], "xbrltype": "domainItemType" }, "pltr_FastRadiusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fast Radius [Member]" } } }, "localname": "FastRadiusMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_FinaccelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FinAccel [Member]" } } }, "localname": "FinaccelMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_GeneralAndAdministrativeExpenseExcludingStockbasedCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "General and administrative expense excluding stock-based compensation expense.", "label": "General and Administrative Expense Excluding Stockbased Compensation Expense", "verboseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpenseExcludingStockbasedCompensationExpense", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail" ], "xbrltype": "monetaryItemType" }, "pltr_GrowthUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Growth units [Member]", "terseLabel": "Growth units [Member]" } } }, "localname": "GrowthUnitsMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseParentheticalDetail" ], "xbrltype": "domainItemType" }, "pltr_GrowthUnitsOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Growth units outstanding", "label": "Growth Units Outstanding [Member]", "terseLabel": "Growth units outstanding [Member]" } } }, "localname": "GrowthUnitsOutstandingMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail" ], "xbrltype": "domainItemType" }, "pltr_IncreaseDecreaseInOperatingLeaseLiabilityCurrentAndNoncurrent": { "auth_ref": [], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase Decrease In Operating lease liability current and noncurrent", "label": "Increase Decrease In Operating lease liability current and noncurrent", "terseLabel": "Operating lease liabilities, current and noncurrent" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiabilityCurrentAndNoncurrent", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "pltr_IncrementalCreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incremental Credit Facility [Axis]" } } }, "localname": "IncrementalCreditFacilityAxis", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "pltr_IncrementalCreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incremental Credit Facility [Domain]" } } }, "localname": "IncrementalCreditFacilityDomain", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_IncrementalCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incremental Credit Facility [Member]" } } }, "localname": "IncrementalCreditFacilityMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_InvestmentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Agreement [Member]" } } }, "localname": "InvestmentAgreementMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_InvestmentAgreementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Agreements [Abstract]" } } }, "localname": "InvestmentAgreementsAbstract", "nsuri": "http://www.palantir.com/20210930", "xbrltype": "stringItemType" }, "pltr_InvestmentAgreementsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment agreements.", "label": "Investment Agreements [Table Text Block]", "terseLabel": "Summary of Investments Under Investment Agreements" } } }, "localname": "InvestmentAgreementsTableTextBlock", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "pltr_InvestmentCommitmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment commitments.", "label": "Investment Commitments [Member]", "terseLabel": "Investment Commitments [Member]" } } }, "localname": "InvestmentCommitmentsMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_InvestmentHoldingsScheduleOfAdditionalInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Holdings Schedule Of Additional Investments [Abstract]" } } }, "localname": "InvestmentHoldingsScheduleOfAdditionalInvestmentsAbstract", "nsuri": "http://www.palantir.com/20210930", "xbrltype": "stringItemType" }, "pltr_InvestmentHoldingsScheduleOfAdditionalInvestmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Holdings Schedule Of Additional Investments [Table]" } } }, "localname": "InvestmentHoldingsScheduleOfAdditionalInvestmentsTable", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "stringItemType" }, "pltr_InvestmentInNumberOfOunceOfGoldBars": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment in number of ounce of gold bars.", "label": "Investment In Number Of Ounce Of Gold Bars", "verboseLabel": "Weight of commodities purchased" } } }, "localname": "InvestmentInNumberOfOunceOfGoldBars", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "pltr_InvestmentNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment name.", "label": "Investment Name [Axis]" } } }, "localname": "InvestmentNameAxis", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail", "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "stringItemType" }, "pltr_InvestmentNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Name", "label": "Investment Name [Domain]" } } }, "localname": "InvestmentNameDomain", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail", "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_InvestmentPurchasePriceCommitment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment purchase price commitment.", "label": "Investment Purchase Price Commitment", "terseLabel": "Additional purchase price commitment", "verboseLabel": "Purchase Price Commitment" } } }, "localname": "InvestmentPurchasePriceCommitment", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "pltr_InvestmentsAndFairValueMeasurementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments and fair value measurements.", "label": "Investments and Fair Value Measurements [Text Block]", "verboseLabel": "Investments and Fair Value Measurements" } } }, "localname": "InvestmentsAndFairValueMeasurementsTextBlock", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "pltr_IssuanceOfCommonStockUponNetExerciseOfCommonStockWarrantsAndOtherShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon net exercise of common stock warrants and other shares", "label": "Issuance Of Common Stock Upon Net Exercise Of Common Stock Warrants and Other Shares", "verboseLabel": "Issuance of common stock upon net exercise of common stock warrants and other, Shares" } } }, "localname": "IssuanceOfCommonStockUponNetExerciseOfCommonStockWarrantsAndOtherShares", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "pltr_IssuanceOfCommonStockUponNetExerciseOfCommonStockWarrantsAndOtherValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon net exercise of common stock warrants and other value.", "label": "Issuance Of Common Stock Upon Net Exercise Of Common Stock Warrants and Other Value", "verboseLabel": "Issuance of common stock upon net exercise of common stock warrants and other" } } }, "localname": "IssuanceOfCommonStockUponNetExerciseOfCommonStockWarrantsAndOtherValue", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "pltr_IssuanceOfCommonStockUponNetExerciseOfCommonStockWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon net exercise of common stock warrants shares.", "label": "Issuance Of Common Stock Upon Net Exercise Of Common Stock Warrants Shares", "terseLabel": "Issuance of common stock upon net exercise of common stock warrants, Shares" } } }, "localname": "IssuanceOfCommonStockUponNetExerciseOfCommonStockWarrantsShares", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "pltr_IssuanceOfCommonStockUponNetExerciseOfCommonStockWarrantsValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock upon net exercise of common stock warrants value.", "label": "Issuance Of Common Stock Upon Net Exercise Of Common Stock Warrants Value", "terseLabel": "Issuance of common stock upon net exercise of common stock warrants" } } }, "localname": "IssuanceOfCommonStockUponNetExerciseOfCommonStockWarrantsValue", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "pltr_LiliumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lilium [Member]", "terseLabel": "Lilium [Member]" } } }, "localname": "LiliumMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail" ], "xbrltype": "domainItemType" }, "pltr_LineOfCreditMinimumLiquidityToBeMaintained": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of credit minimum liquidity to be maintained", "label": "Line of credit minimum liquidity to be maintained", "verboseLabel": "Line of credit minimum liquidity to be maintained" } } }, "localname": "LineOfCreditMinimumLiquidityToBeMaintained", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "pltr_MaximumContractValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum contract value.", "label": "Maximum Contract Value", "terseLabel": "Maximum contract value" } } }, "localname": "MaximumContractValue", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "pltr_MinimumOwnershipThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum ownership threshold.", "label": "Minimum Ownership Threshold", "verboseLabel": "Minimum ownership threshold" } } }, "localname": "MinimumOwnershipThreshold", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "pltr_MobilityCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mobility Company [Member]" } } }, "localname": "MobilityCompanyMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_NoncashOperatingLeaseCost": { "auth_ref": [], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noncash operating lease cost.", "label": "Noncash Operating Lease Cost", "terseLabel": "Non-cash operating lease expense" } } }, "localname": "NoncashOperatingLeaseCost", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "pltr_NumberOfSharesCommittedToPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares committed to purchase.", "label": "Number Of Shares Committed To Purchase", "terseLabel": "Number of shares committed to purchase" } } }, "localname": "NumberOfSharesCommittedToPurchase", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "pltr_NumberOfSharesExchanged": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares exchanged.", "label": "Number Of Shares Exchanged", "terseLabel": "Number of shares exchanged" } } }, "localname": "NumberOfSharesExchanged", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "pltr_OptionsAndSarsIssuedAndOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options and SARs issued and outstanding", "label": "Options And SARs Issued And Outstanding [Member]", "terseLabel": "Options and Stock Appreciation Rights issued and outstanding [Member]" } } }, "localname": "OptionsAndSarsIssuedAndOutstandingMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail" ], "xbrltype": "domainItemType" }, "pltr_PalantirTechnologiesJapanKKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Palantir Technologies Japan, K.K.", "label": "Palantir Technologies Japan KK [Member]", "terseLabel": "Palantir Technologies Japan, K.K. [Member]" } } }, "localname": "PalantirTechnologiesJapanKKMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_PearTherapeuticsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pear Therapeutics [Member]" } } }, "localname": "PearTherapeuticsMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_PurchaseCommitmentForContractYearOne": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase commitment for contract year one.", "label": "Purchase Commitment For Contract Year One", "verboseLabel": "Purchase Commitment For Contract Year One" } } }, "localname": "PurchaseCommitmentForContractYearOne", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "pltr_PurchaseCommitmentForContractYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase commitment for contract year two.", "label": "Purchase Commitment For Contract Year Two", "terseLabel": "Purchase Commitment For Contract Year two" } } }, "localname": "PurchaseCommitmentForContractYearTwo", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "pltr_PurchaseCommitmentOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase commitment one", "label": "Purchase Commitment One [Member]", "verboseLabel": "Purchase Commitment One [Member]" } } }, "localname": "PurchaseCommitmentOneMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_PurchaseCommitmentTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase commitment two", "label": "Purchase Commitment Two [Member]", "verboseLabel": "Purchase Commitment Two [Member]" } } }, "localname": "PurchaseCommitmentTwoMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_PurchasesOfAlternativeInvestments": { "auth_ref": [], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 29.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchases of alternative investments.", "label": "Purchases Of Alternative Investments", "negatedLabel": "Purchases of alternative investments" } } }, "localname": "PurchasesOfAlternativeInvestments", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "pltr_ReceivableFromTheExerciseOfStockOption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receivable from the exercise of stock option.", "label": "Receivable From The Exercise Of Stock Option", "terseLabel": "Receivable from the exercise of common stock options included in prepaid expenses and other current assets" } } }, "localname": "ReceivableFromTheExerciseOfStockOption", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "pltr_ResearchAndDevelopmentExpenseExcludingStockbasedCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Research and development expenses", "documentation": "Research and development expense excluding stock-based compensation expense.", "label": "Research and Development Expense Excluding Stockbased Compensation Expense" } } }, "localname": "ResearchAndDevelopmentExpenseExcludingStockbasedCompensationExpense", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail" ], "xbrltype": "monetaryItemType" }, "pltr_RestOfWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rest of world.", "label": "Rest Of World [Member]", "terseLabel": "Rest of world [Member]" } } }, "localname": "RestOfWorldMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail" ], "xbrltype": "domainItemType" }, "pltr_RestrictedCashAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Cash.", "label": "Restricted Cash [Axis]", "terseLabel": "Restricted Cash [Axis]" } } }, "localname": "RestrictedCashAxis", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "stringItemType" }, "pltr_RestrictedCashDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Cash [Domain]", "terseLabel": "Restricted Cash [Member]" } } }, "localname": "RestrictedCashDomain", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "domainItemType" }, "pltr_RigettiCoInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rigetti & co, iInc.", "label": "Rigetti Co, Inc. [Member]", "terseLabel": "Rigetti & Co, Inc. [Member]" } } }, "localname": "RigettiCoInc.Member", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_RoivantSciencesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Roivant Sciences [Member]", "terseLabel": "Roivant Sciences [Member]" } } }, "localname": "RoivantSciencesMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail" ], "xbrltype": "domainItemType" }, "pltr_SarcosRoboticsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sarcos robotics.", "label": "Sarcos Robotics [Member]", "terseLabel": "Sarcos Robotics [Member]" } } }, "localname": "SarcosRoboticsMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail" ], "xbrltype": "domainItemType" }, "pltr_SatisfiedPurchaseCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Satisfied purchase commitment", "label": "Satisfied Purchase Commitment", "terseLabel": "Satisfied purchase commitment" } } }, "localname": "SatisfiedPurchaseCommitment", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "pltr_ScheduleOfInvestmentCommitmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of investment commitments.", "label": "Schedule Of Investment Commitments [Table Text Block]", "terseLabel": "Summary of Investment commitments" } } }, "localname": "ScheduleOfInvestmentCommitmentsTableTextBlock", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "pltr_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Abstract]", "verboseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Abstract]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardAbstract", "nsuri": "http://www.palantir.com/20210930", "xbrltype": "stringItemType" }, "pltr_SeriesDConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series D Convertible Preferred Stock [Member]", "terseLabel": "Series D Convertible Preferred Stock [Member]" } } }, "localname": "SeriesDConvertiblePreferredStockMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "pltr_SeriesHOneConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H One Convertible Preferred Stock [Member].", "label": "Series H One Convertible Preferred Stock [Member]", "terseLabel": "Series H-1 Convertible Preferred Stock [Member]" } } }, "localname": "SeriesHOneConvertiblePreferredStockMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "pltr_SeriesKConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series K Convertible Preferred Stock [Member].", "label": "Series K Convertible Preferred Stock [Member]", "terseLabel": "Series K Convertible Preferred Stock [Member]" } } }, "localname": "SeriesKConvertiblePreferredStockMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "pltr_SettlementOfEmployeeLoanStockOptionModificationValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Settlement of employee loan stock option modification,value.", "label": "Settlement Of Employee Loan Stock Option Modification Value", "terseLabel": "Settlement of employee loan accounted for as a modification to stock option (Value)" } } }, "localname": "SettlementOfEmployeeLoanStockOptionModificationValue", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "pltr_SettlementOfEmployeeLoanStockOptionModificationshares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Settlement of employee loan stock option modification,shares.", "label": "Settlement Of Employee Loan Stock Option ModificationShares", "verboseLabel": "Settlement of employee loan accounted for as a modification to stock option (Shares)" } } }, "localname": "SettlementOfEmployeeLoanStockOptionModificationshares", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "pltr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesIssuableUponVesting": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options shares issuable upon vesting.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Shares Issuable Upon Vesting", "verboseLabel": "Common shares issuable upon full vesting of the growth units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesIssuableUponVesting", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "pltr_SompoHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SOMPO Holdings, Inc. member.", "label": "SOMPO Holdings Inc [Member]", "verboseLabel": "SOMPO [Member]" } } }, "localname": "SompoHoldingsIncMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_StockIssuedDuringPeriodSharesGrowthUnitsVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to growth units.", "label": "Stock Issued During Period Shares Growth Units Vested", "terseLabel": "Issuance of common stock upon vesting of growth units, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesGrowthUnitsVested", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "pltr_StockIssuedDuringPeriodValueGrowthUnitsVested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to gowth issued during the period..", "label": "Stock Issued During Period Value Growth Units Vested", "terseLabel": "Issuance of common stock upon vesting of growth units" } } }, "localname": "StockIssuedDuringPeriodValueGrowthUnitsVested", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "pltr_SubscriptionAgreementDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subscription agreement date.", "label": "Subscription Agreement Date", "terseLabel": "Investment Agreement Date" } } }, "localname": "SubscriptionAgreementDate", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "dateItemType" }, "pltr_SubscriptionContractTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subscription contract term.", "label": "Subscription Contract Term", "terseLabel": "Subscription contract term" } } }, "localname": "SubscriptionContractTerm", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "pltr_TelecommunicationsCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Telecommunications Company.", "label": "Telecommunications Company [Member]", "terseLabel": "Telecommunications company [Member]" } } }, "localname": "TelecommunicationsCompanyMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_TemporaryEquityStockIssuedExerciseOfWarrantsDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity stock issued exercise of warrants during period shares new issues.", "label": "Temporary Equity Stock Issued Exercise Of Warrants During Period Shares New Issues", "terseLabel": "Issuance of preferred stock upon net exercise of preferred stock warrants, Shares" } } }, "localname": "TemporaryEquityStockIssuedExerciseOfWarrantsDuringPeriodSharesNewIssues", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "pltr_TemporaryEquityStockIssuedExerciseOfWarrantsDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Temporary equity stock issued exercise of warrants during period value new issues.", "label": "Temporary Equity Stock Issued Exercise Of Warrants During Period Value New Issues", "verboseLabel": "Issuance of preferred stock upon net exercise of preferred stock warrants" } } }, "localname": "TemporaryEquityStockIssuedExerciseOfWarrantsDuringPeriodValueNewIssues", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "pltr_TemporaryEquityTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity Type [Axis].", "label": "Temporary Equity Type [Axis]" } } }, "localname": "TemporaryEquityTypeAxis", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "pltr_TemporaryEquityTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity Type [Domain].", "label": "Temporary Equity Type [Domain]" } } }, "localname": "TemporaryEquityTypeDomain", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "pltr_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Term Loan [Member]", "terseLabel": "Term Loan [Member]" } } }, "localname": "TermLoanMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_TritiumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tritium [Member]" } } }, "localname": "TritiumMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "pltr_TwoThousandAndFourteenRevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand And Fourteen Revolving Credit Facility Member", "label": "Two Thousand And Fourteen Revolving Credit Facility [Member]", "terseLabel": "2014 Revolving Credit Facility [Member]" } } }, "localname": "TwoThousandAndFourteenRevolvingCreditFacilityMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_TypeOfContractAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Type of Contract [Axis]" } } }, "localname": "TypeOfContractAxis", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "pltr_TypeOfContractDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Type of Contract [Domain]" } } }, "localname": "TypeOfContractDomain", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_TypesOfOptionsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Types of options [Axis]" } } }, "localname": "TypesOfOptionsAxis", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "pltr_TypesOfOptionsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Types of options [Domain]" } } }, "localname": "TypesOfOptionsDomain", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "pltr_WarrantsToPurchaseRedeemableConvertibleAndConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants to purchase redeemable convertible and convertible preferred stock", "label": "Warrants To Purchase Redeemable Convertible And Convertible Preferred Stock [Member]", "terseLabel": "Warrants to purchase redeemable convertible and convertible preferred stock [Member]" } } }, "localname": "WarrantsToPurchaseRedeemableConvertibleAndConvertiblePreferredStockMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail" ], "xbrltype": "domainItemType" }, "pltr_WejoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Wejo [Member]" } } }, "localname": "WejoMember", "nsuri": "http://www.palantir.com/20210930", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r117", "r179", "r187", "r188", "r189", "r190", "r192", "r194", "r198", "r253", "r254", "r255", "r256", "r257", "r258", "r260", "r261", "r263", "r265", "r266" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r117", "r179", "r187", "r188", "r189", "r190", "r192", "r194", "r198", "r253", "r254", "r255", "r256", "r257", "r258", "r260", "r261", "r263", "r265", "r266" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r2", "r122", "r129", "r135", "r227", "r399", "r400", "r401", "r416", "r417", "r440", "r443", "r445", "r446", "r611" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r2", "r122", "r129", "r135", "r227", "r399", "r400", "r401", "r416", "r417", "r440", "r443", "r445", "r446", "r611" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]", "verboseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r204", "r346", "r352", "r553" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r271", "r308", "r368", "r370", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r550", "r554", "r599", "r600" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r271", "r308", "r368", "r370", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r550", "r554", "r599", "r600" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail", "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyParentheticalDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r204", "r346", "r352", "r553" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r200", "r346", "r350", "r502", "r549", "r551" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r200", "r346", "r350", "r502", "r549", "r551" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r271", "r308", "r358", "r368", "r370", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r550", "r554", "r599", "r600" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/DebtAdditionalInformationDetail", "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyParentheticalDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r271", "r308", "r358", "r368", "r370", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r550", "r554", "r599", "r600" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/DebtAdditionalInformationDetail", "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyParentheticalDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r130", "r369" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r130", "r135", "r369" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]", "verboseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r201", "r202", "r346", "r351", "r552", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r201", "r202", "r346", "r351", "r552", "r586", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r130", "r135", "r243", "r369", "r488" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r206", "r481" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "verboseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "verboseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "Information by legal entity of counterparty. A counterparty is the other party that participates in a financial transaction.", "label": "Legal Entity of Counterparty, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r44", "r485" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r7", "r28", "r207", "r208" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfAccruedLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities", "totalLabel": "Total accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfAccruedLiabilitiesDetail", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r42", "r235" ], "calculation": { "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r31", "r63", "r64", "r65", "r539", "r562", "r566" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r62", "r65", "r72", "r73", "r74", "r119", "r120", "r121", "r432", "r557", "r558", "r613" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r29", "r402", "r485" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r119", "r120", "r121", "r399", "r400", "r401", "r445" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r123", "r124", "r125", "r126", "r135", "r217", "r218", "r224", "r225", "r226", "r227", "r228", "r229", "r252", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r414", "r415", "r416", "r417", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r478", "r503", "r504", "r505", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r609", "r610", "r611", "r612", "r613" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments to Additional Paid in Capital, Other", "terseLabel": "Conversion of preferred stock warrants to common stock warrants" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r371", "r373", "r404", "r405" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r373", "r391", "r403" ], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Stock-based compensation expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Total stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r35", "r213", "r230" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts on trade receivables" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "verboseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r114", "r184", "r189", "r196", "r222", "r253", "r254", "r255", "r257", "r258", "r259", "r260", "r262", "r264", "r266", "r267", "r429", "r433", "r456", "r483", "r485", "r519", "r536" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [abstract]", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r9", "r10", "r59", "r114", "r222", "r253", "r254", "r255", "r257", "r258", "r259", "r260", "r262", "r264", "r266", "r267", "r429", "r433", "r456", "r483", "r485" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "verboseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r448" ], "calculation": { "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r374", "r393" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "verboseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r435", "r436" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Balance Sheet Related Disclosures [Abstract]" } } }, "localname": "BalanceSheetRelatedDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation and Consolidation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r6", "r39", "r102" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.palantir.com/role/SignificantAccountingPoliciesScheduleOfCashAndCashEquivalentsDetail": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets", "http://www.palantir.com/role/SignificantAccountingPoliciesScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r15", "r103" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash, Cash Equivalents, and Restricted Cash" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r96", "r102", "r108" ], "calculation": { "http://www.palantir.com/role/SignificantAccountingPoliciesScheduleOfCashAndCashEquivalentsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash - end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash - beginning of period", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.palantir.com/role/SignificantAccountingPoliciesScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r96", "r465" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental disclosures of non-cash investing and financing information:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CertificatesOfDepositAtCarryingValue": { "auth_ref": [ "r39" ], "calculation": { "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A savings certificate entitling the Entity (that is, bearer) to receive interest at an established maturity date, based upon a fixed interest rate. A certificate of deposit may be issued in any denomination. Certificates of deposit are generally issued by commercial banks and, therefore, insured by the FDIC (up to the prescribed limit). Certificates of deposit generally restrict holders from withdrawing funds on demand without the incurrence of penalties. Generally, only certificates of deposit with original maturities of three months or less qualify as cash equivalents. Original maturity means original maturity to the entity holding the investment. As a related example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Certificates of Deposit, at Carrying Value", "terseLabel": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r111", "r114", "r139", "r140", "r145", "r148", "r150", "r159", "r160", "r161", "r222", "r253", "r258", "r259", "r260", "r266", "r267", "r306", "r307", "r311", "r315", "r456", "r607" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.palantir.com/role/CoverPage", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "verboseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CollateralAxis": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "Information by category of collateral or no collateral, from lender's perspective.", "label": "Collateral Held [Axis]", "verboseLabel": "Collateral Held [Axis]" } } }, "localname": "CollateralAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CollateralDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of collateral or no collateral, from lender's perspective.", "label": "Collateral Held [Domain]", "verboseLabel": "Collateral Held [Domain]" } } }, "localname": "CollateralDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r53", "r242", "r525", "r543" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies (Note 8)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "verboseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r239", "r240", "r241", "r249", "r589" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Common Class A [Member]", "verboseLabel": "Class A Common Stock [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/CoverPage", "http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Common Class B [Member]", "verboseLabel": "Class B Common Stock [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/CoverPage", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r119", "r120", "r445" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r27", "r322" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r27", "r485" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r68", "r70", "r71", "r78", "r529", "r545" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment, software, and other [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r169", "r170", "r204", "r454", "r455", "r588" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyParentheticalDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r169", "r170", "r204", "r454", "r455", "r567", "r588" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyParentheticalDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r169", "r170", "r204", "r454", "r455", "r567", "r588" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r165", "r534" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentrations of Credit Risk and Other Concentrations" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r169", "r170", "r204", "r454", "r455" ], "lang": { "en-us": { "role": { "definitionGuidance": "Concentration risk, percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "presentationGuidance": "Concentration risk, percentage", "verboseLabel": "Percentage Concentration" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyParentheticalDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r169", "r170", "r204", "r454", "r455", "r588" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in progress [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r333", "r334", "r347" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Contract with customer, liability" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/ContractLiabilitiesAndRemainingPerformanceObligationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r348" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized from contract liability balances" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/ContractLiabilitiesAndRemainingPerformanceObligationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockAmountConverted1": { "auth_ref": [ "r105", "r106", "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Amount Converted", "verboseLabel": "Conversion of stock" } } }, "localname": "ConversionOfStockAmountConverted1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockByUniqueDescriptionAxis": { "auth_ref": [ "r105", "r106", "r107" ], "lang": { "en-us": { "role": { "documentation": "Information by description of stock conversions.", "label": "Stock Conversion Description [Axis]", "verboseLabel": "Stock Conversion Description [Axis]" } } }, "localname": "ConversionOfStockByUniqueDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConversionOfStockNameDomain": { "auth_ref": [ "r105", "r106", "r107" ], "lang": { "en-us": { "role": { "documentation": "The unique name of a noncash or part noncash stock conversion.", "label": "Conversion of Stock, Name [Domain]", "verboseLabel": "Conversion of Stock, Name [Domain]" } } }, "localname": "ConversionOfStockNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r105", "r106", "r107" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Converted", "verboseLabel": "Number of shares issued for conversion" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [ "r306", "r307", "r311" ], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]", "terseLabel": "Convertible preferred stock [Member]" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r83", "r114", "r222", "r253", "r254", "r255", "r258", "r259", "r260", "r262", "r264", "r266", "r267", "r456" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of revenue [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r110", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r285", "r292", "r293", "r294", "r300" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r19", "r20", "r21", "r113", "r117", "r268", "r269", "r270", "r271", "r272", "r273", "r275", "r281", "r282", "r283", "r284", "r286", "r287", "r288", "r289", "r290", "r291", "r296", "r297", "r298", "r299", "r475", "r520", "r522", "r535" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "verboseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "verboseLabel": "Line of credit facility variable interest rate spread" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r21", "r295", "r522", "r535" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Debt instrument carrying amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of reference rate used for variable rate of debt instrument.", "label": "Debt Instrument, Description of Variable Rate Basis", "verboseLabel": "Line of credit facility variable interest rate description" } } }, "localname": "DebtInstrumentDescriptionOfVariableRateBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r51", "r113", "r117", "r268", "r269", "r270", "r271", "r272", "r273", "r275", "r281", "r282", "r283", "r284", "r286", "r287", "r288", "r289", "r290", "r291", "r296", "r297", "r298", "r299", "r475" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "verboseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "auth_ref": [ "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to principal.", "label": "Debt Instrument, Periodic Payment, Principal", "terseLabel": "Debt Instrument, periodic payment, principal" } } }, "localname": "DebtInstrumentPeriodicPaymentPrincipal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r36" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Revenue, Noncurrent", "terseLabel": "Deferred revenue, noncurrent" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r100", "r233" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "verboseLabel": "Depreciation and amortisation expense excluding the impact of foreign exchange fluctuations" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r100", "r182" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DilutiveSecurities": { "auth_ref": [ "r152" ], "calculation": { "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.", "label": "Dilutive Securities, Effect on Basic Earnings Per Share", "terseLabel": "Less: Change in fair value attributable to participating securities" } } }, "localname": "DilutiveSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r346", "r350", "r351", "r352", "r353", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Summary of Revenue by Geography" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "verboseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r20", "r22", "r521", "r537" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable", "terseLabel": "Dividends declared" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r79", "r127", "r128", "r129", "r130", "r131", "r136", "r139", "r148", "r149", "r150", "r155", "r156", "r446", "r447", "r530", "r546" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net loss per share attributable to common stockholders, basic", "verboseLabel": "Net loss per share attributable to common stockholders, basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Net loss per share" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r79", "r127", "r128", "r129", "r130", "r131", "r139", "r148", "r149", "r150", "r155", "r156", "r446", "r447", "r530", "r546" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net loss per share attributable to common stockholders, diluted", "verboseLabel": "Net loss per share attributable to common stockholders, diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r151", "r153", "r154", "r157" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss Per Share Attributable to Common Stockholders" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholders" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r465" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of foreign exchange on cash, cash equivalents, and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r409", "r420" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfAccruedLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "verboseLabel": "Accrued payroll and related expenses" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r392" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized share based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized share based compensation expense, period for recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r72", "r73", "r74", "r119", "r120", "r121", "r124", "r132", "r134", "r158", "r227", "r322", "r329", "r399", "r400", "r401", "r416", "r417", "r445", "r466", "r467", "r468", "r469", "r470", "r471", "r557", "r558", "r559", "r613" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "verboseLabel": "Equity method investment ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "verboseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/EquityMethodInvestments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r100", "r301" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrants" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r448", "r449", "r450", "r453" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r448", "r449", "r450", "r452", "r453" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "verboseLabel": "Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r448", "r453" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r283", "r296", "r297", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r367", "r449", "r490", "r491", "r492" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r283", "r359", "r360", "r365", "r367", "r449", "r490" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r283", "r296", "r297", "r359", "r360", "r365", "r367", "r449", "r491" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r283", "r296", "r297", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r367", "r490", "r491", "r492" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r84" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative [Member]" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r168", "r588" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration Risk [Member]" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GovernmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization that is the governing authority of a community.", "label": "Government [Member]", "terseLabel": "Government [Member]" } } }, "localname": "GovernmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r82", "r114", "r184", "r188", "r192", "r195", "r198", "r222", "r253", "r254", "r255", "r258", "r259", "r260", "r262", "r264", "r266", "r267", "r456" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r76", "r184", "r188", "r192", "r195", "r198", "r518", "r527", "r532", "r547" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before provision (benefit) for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Consolidated Statements of Operations [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r237", "r238" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "verboseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "verboseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority, Name [Domain]" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r115", "r410", "r412", "r413", "r418", "r421", "r423", "r424", "r425" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r116", "r133", "r134", "r183", "r408", "r419", "r422", "r548" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "verboseLabel": "Provision (benefit) for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r99" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r99" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r99" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r99", "r500" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Customer deposits, current and noncurrent" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r99" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue, current and noncurrent" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "auth_ref": [ "r99" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.", "label": "Increase (Decrease) in Other Noncurrent Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other noncurrent liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r99" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r75", "r181", "r473", "r474", "r531" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r95", "r97", "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentInPhysicalCommodities": { "auth_ref": [ "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments held in physical commodities, such as gold, silver, platinum, crude oil, coal, sugar, rice, wheat.", "label": "Investment in Physical Commodities", "terseLabel": "Investment in Physical Commodities" } } }, "localname": "InvestmentInPhysicalCommodities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r85", "r180" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtCost": { "auth_ref": [ "r568" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of the investment.", "label": "Investment Owned, at Cost", "terseLabel": "Investment\u00a0Amount", "verboseLabel": "Aggregate purchase price" } } }, "localname": "InvestmentOwnedAtCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail", "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r569", "r573" ], "lang": { "en-us": { "role": { "documentation": "Balance held at close of period in number of shares.", "label": "Investment Owned, Balance, Shares", "terseLabel": "Share Amount", "verboseLabel": "Investment Owned, Shares" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail", "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r570", "r571", "r572", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r570", "r571", "r572", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "verboseLabel": "Leasehold improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LegalEntityTypeOfCounterpartyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nature of the other party participating in a financial transaction.", "label": "Legal Entity Type of Counterparty [Domain]" } } }, "localname": "LegalEntityTypeOfCounterpartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letter of credit outstanding amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r47", "r114", "r190", "r222", "r253", "r254", "r255", "r258", "r259", "r260", "r262", "r264", "r266", "r267", "r430", "r433", "r434", "r456", "r483", "r484" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r34", "r114", "r222", "r456", "r485", "r524", "r541" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "verboseLabel": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r50", "r114", "r222", "r253", "r254", "r255", "r258", "r259", "r260", "r262", "r264", "r266", "r267", "r430", "r433", "r434", "r456", "r483", "r484", "r485" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "verboseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "verboseLabel": "Line of credit facility commitment fee percentage" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.", "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Line of credit maturity date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "auth_ref": [ "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of the credit facility.", "label": "Line of Credit Facility, Increase (Decrease), Net", "terseLabel": "Increase in borrowing capacity" } } }, "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Debt instrument maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Undrawn revolving credit facility amount" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r51" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Debt, noncurrent, net" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermPurchaseCommitmentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.", "label": "Long-term Purchase Commitment, Amount", "terseLabel": "Minimum annual commitment" } } }, "localname": "LongTermPurchaseCommitmentAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermPurchaseCommitmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Describes the terms of a significant arrangement with a supplier (excluding an unconditional purchase obligation) to acquire goods or services over a period of time beyond one year or the normal operating cycle, if longer, which may include identification of the goods or services to be purchased, pricing, effects on pricing of failing to reach minimum quantities required to be purchased, cancellation rights, and termination provisions.", "label": "Long-term Purchase Commitment, Description", "terseLabel": "Long-term Purchase Commitment, Description" } } }, "localname": "LongTermPurchaseCommitmentDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r250", "r251" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "verboseLabel": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "verboseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r250", "r251" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "verboseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r250", "r251" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecurities": { "auth_ref": [ "r526" ], "calculation": { "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security.", "label": "Marketable Securities", "terseLabel": "Marketable Securities" } } }, "localname": "MarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [ "r8", "r48" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable Securities, Current", "terseLabel": "Marketable securities" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r81" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Marketable Securities, Unrealized Gain (Loss)", "negatedLabel": "Unrealized loss from marketable securities" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Reconciling items" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "auth_ref": [], "calculation": { "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail": { "order": 3.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Money Market Funds, at Carrying Value", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r162", "r174" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Organization" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r96" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r96" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r96", "r98", "r101" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r5", "r66", "r69", "r74", "r77", "r101", "r114", "r123", "r127", "r128", "r129", "r130", "r133", "r134", "r146", "r184", "r188", "r192", "r195", "r198", "r222", "r253", "r254", "r255", "r258", "r259", "r260", "r262", "r264", "r266", "r267", "r447", "r456", "r528", "r544" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.palantir.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.palantir.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss", "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r127", "r128", "r129", "r130", "r136", "r137", "r147", "r150", "r184", "r188", "r192", "r195", "r198" ], "calculation": { "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "verboseLabel": "Net loss attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r138", "r141", "r142", "r143", "r144", "r147", "r150" ], "calculation": { "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net loss attributable to common stockholders, for diluted net loss per share" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]", "terseLabel": "Numerator" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonredeemableConvertiblePreferredStockMember": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Capital stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity and may be exchanged into common shares or other types of securities at the owner's option as long as it is in accordance with the issuer's terms. This security does not have redemption requirements.", "label": "Nonredeemable Convertible Preferred Stock [Member]", "terseLabel": "Nonredeemable Convertible Preferred Stock [Member]" } } }, "localname": "NonredeemableConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r184", "r188", "r192", "r195", "r198" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r477" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r477" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, noncurrent" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r476" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease\u00a0right-of-use\u00a0assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Commitments [Abstract]" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r187", "r188", "r189", "r190", "r192", "r198" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "verboseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r12", "r13", "r14", "r49" ], "calculation": { "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfAccruedLiabilitiesDetail": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Accrued other liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]", "verboseLabel": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]", "verboseLabel": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r61" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r67", "r70", "r427", "r428", "r431" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r52" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other noncurrent liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r86" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "auth_ref": [], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).", "label": "Other Operating Activities, Cash Flow Statement", "terseLabel": "Other operating activities" } } }, "localname": "OtherOperatingActivitiesCashFlowStatement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r92" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r87" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedTerseLabel": "Other investing activities", "verboseLabel": "Payments made to acquire equity method investments" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r219" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchases of marketable securities" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r88" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r374", "r393" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "verboseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "verboseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r26", "r306" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r26", "r306" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r26", "r485" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, par value $0.001: 2,000,000 shares authorized and 0 issued and outstanding as of September 30, 2021 and December 31, 2020" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r9", "r37", "r38" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [ "r90" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.", "label": "Proceeds from Debt, Net of Issuance Costs", "terseLabel": "Proceeds from issuance of debt, net of issuance costs" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r89" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from the issuance of common stock, net of issuance costs" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r91", "r94" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r89", "r394" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from the exercise of common stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r42", "r236" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r41", "r234" ], "calculation": { "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Total property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r16", "r17", "r236", "r485", "r533", "r542" ], "calculation": { "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Total property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r16", "r236" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r16", "r234" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis": { "auth_ref": [ "r23", "r523", "r538" ], "lang": { "en-us": { "role": { "documentation": "Information by arrangement, in which the entity has agreed to expend funds to procure goods or services from one or more suppliers.", "label": "Purchase Commitment, Excluding Long-term Commitment [Axis]", "verboseLabel": "Purchase Commitment, Excluding Long-term Commitment [Axis]" } } }, "localname": "PurchaseCommitmentExcludingLongtermCommitmentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain": { "auth_ref": [ "r23", "r523", "r538" ], "lang": { "en-us": { "role": { "documentation": "This item is intended to be populated, by the entity, with Members identifying each purchase commitment about which information required or determined to be disclosed is being provided. If only one such commitment exists, this item may be used to capture such information; if multiple commitments exist, this item is the dimensional default, which will aggregate such information, as appropriate.", "label": "Purchase Commitment, Excluding Long-term Commitment [Domain]", "verboseLabel": "Purchase Commitment, Excluding Long-term Commitment [Domain]" } } }, "localname": "PurchaseCommitmentExcludingLongtermCommitmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r190", "r192" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.", "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]", "terseLabel": "Summary of Reconciliation of Segment Financial Information to Loss from Operations" } } }, "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.", "label": "Redeemable Convertible Preferred Stock [Member]", "terseLabel": "Redeemable Convertible Preferred Stock [Member]" } } }, "localname": "RedeemableConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r366", "r479", "r480" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r366", "r479", "r480", "r482" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r366", "r479", "r482", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r93" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Principal payments on borrowings" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r407", "r501", "r601" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnARecurringAndNonrecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r6", "r15", "r108" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.palantir.com/role/SignificantAccountingPoliciesScheduleOfCashAndCashEquivalentsDetail": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets", "http://www.palantir.com/role/SignificantAccountingPoliciesScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r11", "r18", "r108", "r587" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.palantir.com/role/SignificantAccountingPoliciesScheduleOfCashAndCashEquivalentsDetail": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Noncurrent", "terseLabel": "Restricted cash, noncurrent" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets", "http://www.palantir.com/role/SignificantAccountingPoliciesScheduleOfCashAndCashEquivalentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Restricted Stock Units", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs) [Member]", "verboseLabel": "RSUs outstanding [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r30", "r329", "r402", "r485", "r540", "r561", "r566" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r119", "r120", "r121", "r124", "r132", "r134", "r227", "r399", "r400", "r401", "r416", "r417", "r445", "r557", "r559" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r178", "r179", "r187", "r193", "r194", "r200", "r201", "r204", "r345", "r346", "r502" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenues", "verboseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r178", "r179", "r187", "r193", "r194", "r200", "r201", "r204", "r345", "r346", "r502" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Revenues" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r335", "r336", "r337", "r338", "r339", "r340", "r343", "r344", "r349", "r357" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Contract Liabilities and Remaining Performance Obligations" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/ContractLiabilitiesAndRemainingPerformanceObligations" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r341" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "verboseLabel": "Performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/ContractLiabilitiesAndRemainingPerformanceObligationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Performance obligation percentage to be recognised as revenue in the next twelve months" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/ContractLiabilitiesAndRemainingPerformanceObligationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r169", "r204" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfRevenueByGeographyParentheticalDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Summary of Antidilutive Securities" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Capitalization, Long-term Debt [Line Items]", "terseLabel": "Long-term Debt [Line Items]" } } }, "localname": "ScheduleOfCapitalizationLongtermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Cash and Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Calculation of Basic and Diluted Net Loss Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r373", "r390", "r403" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Summary of Stock-Based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r5", "r114", "r221", "r222", "r456" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r184", "r185", "r191", "r232" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r184", "r185", "r191", "r232" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Summary of Financial Information for Each Reportable Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r374", "r393" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "verboseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Summary of RSU Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r376", "r386", "r387" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Summary of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r54", "r111", "r159", "r160", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r315", "r320", "r323", "r324", "r325", "r326", "r327", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "verboseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r25", "r26", "r27", "r303", "r304", "r305", "r323", "r324", "r325", "r326", "r327", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule of Stock by Class [Table Text Block]", "terseLabel": "Summary of Total Authorized, Issued, And Outstanding Shares" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r175", "r176", "r177", "r184", "r186", "r192", "r196", "r197", "r198", "r199", "r200", "r203", "r204", "r205" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment and Geographic Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfFinancialInformationForEachReportableSegmentDetail", "http://www.palantir.com/role/SegmentAndGeographicInformationSummaryOfReconciliationOfSegmentFinancialInformationToLossFromOperationsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and marketing [Member]" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r99" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.", "label": "Share-based Payment Arrangement, Accelerated Cost" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "RSUs canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "verboseLabel": "RSUs canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "verboseLabel": "RSUs granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "RSUs granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Unvested and Outstanding Ending Balance", "periodStartLabel": "Unvested and Outstanding Beginning Balance", "verboseLabel": "Outstanding RSUs unvested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted Average Grant Date Fair Value per Share Ending Balance", "periodStartLabel": "Weighted Average Grant Date Fair Value per Share Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "RSUs vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "RSUs vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Options canceled and forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "verboseLabel": "Options canceled and forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r393" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r378", "r393" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Ending Balance of Options Outstanding", "periodStartLabel": "Beginning Balance of Options Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Ending Balance of Weighted-Average Exercise Price Per Share", "periodStartLabel": "Beginning Balance of Weighted-Average Exercise Price Per Share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r389" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value", "terseLabel": "Options vested and exercisable as of September 30, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "terseLabel": "Options vested and exercisable as of September 30, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options vested and exercisable as of September 30, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r372", "r375" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "verboseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfRsuActivityDetail", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "verboseLabel": "Options exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted- Average Remaining Contractual Life (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Options vested and exercisable as of September 30, 2021" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance at end of period, Shares", "periodStartLabel": "Balance at beginning period, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r109", "r118" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r25", "r26", "r27", "r111", "r114", "r139", "r140", "r145", "r148", "r150", "r159", "r160", "r161", "r222", "r253", "r258", "r259", "r260", "r266", "r267", "r306", "r307", "r311", "r315", "r322", "r456", "r607" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.palantir.com/role/CoverPage", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquitySummaryOfTotalAuthorizedIssuedAndOutstandingSharesDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r57", "r72", "r73", "r74", "r119", "r120", "r121", "r124", "r132", "r134", "r158", "r227", "r322", "r329", "r399", "r400", "r401", "r416", "r417", "r445", "r466", "r467", "r468", "r469", "r470", "r471", "r557", "r558", "r559", "r613" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]", "verboseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail", "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]", "terseLabel": "Consolidated Balance Sheets [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "verboseLabel": "Consolidated Statements of Comprehensive Loss" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r119", "r120", "r121", "r158", "r502" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "verboseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets", "http://www.palantir.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.palantir.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsSummaryOfTheInvestmentsPurchasedUnderSuchInvestmentAgreementsDetail", "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail", "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail", "http://www.palantir.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r56", "r286", "r322", "r323", "r329" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Conversion of convertible preferred stock to common stock, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r26", "r27", "r322", "r329" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Issuance of common stock upon vesting of RSUs, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r26", "r27", "r322", "r329", "r379" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Options exercised", "terseLabel": "Issuance of common stock from the exercise of stock options, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.palantir.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r57", "r322", "r329" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "verboseLabel": "Conversion of convertible preferred stock to common stock" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r322", "r329" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Issuance of common stock upon vesting of RSUs" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r57", "r322", "r329" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Issuance of common stock from the exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r27", "r32", "r33", "r114", "r215", "r222", "r456", "r485" ], "calculation": { "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning period", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets", "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Stockholders' equity (deficit):" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]", "verboseLabel": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r112", "r307", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r321", "r329", "r332" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity Note Disclosure" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r472", "r487" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r472", "r487" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r472", "r487" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r472", "r487" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventsSummaryOfAdditionalInvestmentCommitmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r486", "r489" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cumulative number of shares issued or sold by the subsidiary or equity method investee on all stock transactions.", "label": "Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions", "verboseLabel": "Number of shares purchased" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/EquityMethodInvestmentsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "verboseLabel": "Balance Sheet Components" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/BalanceSheetComponents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r253", "r258", "r259", "r260", "r266", "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "periodStartLabel": "Temporary equity, beginning period" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "periodStartLabel": "Temporary equity, beginning period, Shares" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r209", "r210", "r211", "r212", "r214", "r216" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable and Allowance for Credit Losses" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]", "terseLabel": "Summary of Investment Commitments" } } }, "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SubsequentEventsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r55", "r331" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockRetiredCostMethodAmount": { "auth_ref": [ "r27", "r322", "r330" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.", "label": "Treasury Stock, Retired, Cost Method, Amount", "negatedLabel": "Retirement of treasury stock" } } }, "localname": "TreasuryStockRetiredCostMethodAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r27", "r322", "r329" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Repurchase of common stock, held in treasury, Shares" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesRetired": { "auth_ref": [ "r27", "r322", "r329" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common and preferred stock retired from treasury during the period.", "label": "Treasury Stock, Shares, Retired", "negatedLabel": "Retirement of treasury stock, Shares" } } }, "localname": "TreasuryStockSharesRetired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r322", "r329", "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Repurchase of common stock, held in treasury" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfRedeemableConvertibleAndConvertiblePreferredStockAndStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r123", "r124", "r125", "r126", "r135", "r217", "r218", "r224", "r225", "r226", "r227", "r228", "r229", "r252", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r414", "r415", "r416", "r417", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r478", "r503", "r504", "r505", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r609", "r610", "r611", "r612", "r613" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "verboseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.palantir.com/role/InvestmentsAndFairValueMeasurementsAdditionalInformationDetail", "http://www.palantir.com/role/SubsequentEventSummaryOfInvestmentCommitmentsDetail", "http://www.palantir.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r163", "r164", "r166", "r167", "r171", "r172", "r173" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/DebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "verboseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "verboseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.palantir.com/role/StockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants to purchase common stock [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfAntidilutiveSecuritiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r138", "r150" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, diluted", "verboseLabel": "Weighted-average shares used in computing net loss per share, diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r136", "r150" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted-average shares used in computing net loss per share, basic", "verboseLabel": "Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "terseLabel": "Denominator" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.palantir.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCalculationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "stringItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r118": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r157": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r174": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r205": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r223": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r241": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r249": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S65", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r332": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r357": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r406": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r425": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498348-110258" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.2)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r489": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(17))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.4)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r602": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r603": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r604": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r605": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r606": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r607": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r608": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" } }, "version": "2.1" } ZIP 79 0001193125-21-323920-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-323920-xbrl.zip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

S M[YK]80O,9NYD)* D]\06F,[_?<+@70YU&N+IWFPU];) M0_%<:L1_&+LR?;@&?X"[,GBH0?@XN](2E,G]C"I)=??V<-TC3\I7E72\?F^X MF8(U&+QP'Y)0A5WYS'>:^_*9WU)RTEHE:1Q%*H1OIAEW!YR.-K+M@/TX22O, MN:%A\0EZ85+O7P@C;VWVIW[@W]7FQ)9 82IQOGS]O7A&Y]7!H[ U,-<@]NT\ M*4[NFL?G46"2I.;Y*H??!Q?JYAGD:WPG3YSW 8R2.;]P7A9M8JJNWZA+E<"\ M/.!#3/F"+R]2E>&YEKE?N#7#D]ZLNC65Z0>)_QH'N7+F89S[SC+FS+ BLPNS MD)X/^KWIUD& 06'3?%Z!K]9A?,4YA#1-?+_,)LM34 5Q7HM A47^&(RV3F#! M44;[=EW.V.%S^6<@AW-+5;L'FU=2+0?C%P]A9UMKM 8N>:?6_K(M/$2$5YM; M.7VU6 3S0$7P?V*N-%^OXX3>,](5SN R6SI>1H.;3$F+P%-7RR-\*XB ;C/Z M,8Y'F9*P CB[58KL'*0L"X'5*LSJE9O*^W0KAMS";#WGXYUIQ?3P-MWS,W""1T?[@2DYE03/SB5X3J>2 MX"D)GI+@*0F>QWDFDN I^5J2X"D)GH>UR9+@V;($SSNG>4JRYV'',K]ZH7:% MP%2_*S2CGSJDN9<&09.!>SHX/>Q$B'ULW&0T=?L'@R;XF F?L[$[F(Y>/7K4 MMOWAXI>#Z[J0H7QN@UM_/:7>MGM7Y:)>/F$*/F=;)J#\<[_97 M012D64*Q\X.]I,:3L=N?''@YU]YV;P)7?'\DV?7W%,3CF7MZ(G=4X_W]4,WG MMG?4T:*RMZ KBBSS^)8I9"[+/()E"IG+,H]@F4+FLLQ.+_/IL\M:YI=J;V.^ MN,ARU_4::9=Z] W[I^YP=BB.IAULR*0_<:?CA[JB#V9#7@Y/I^YH.NB"-V@W M??=>#L7'L^<+M@V]3F2=Q[A.H719YW&L4RA=UGDZ MZX"3DN!"13C;&[&3L+'>K+:SCJC;2BU>Z]5ZZ!,K0"X)7&2R&\97J@%EB7!68]66H527:O7GVU^T@.:/><(9O5Z;:FYXT MS%;_^(U=N^I0\2I,U'.6B5K\_=E?0"X]^^]OQ&= [._@6>2.O_W5NR6IU%0R MO=Y9;Q( H=C/8W"GF&/"L_'R+*Y%?^A'SW:FZ-R%PQY5SZD4X[POBW&.7MG9 M5J6T3>,93$=-*L]HTE&59WIGE6IYM:JSN;. MFV$;.A"G-VLYR3;R+U0=K=&D6:'DW!:G[E!L1+M*Y&VE2J0]TG-[)X-_RB 'VN]WRLJ1%.0_:X4%<6@ M9"C$XBO0%,I]M_%>-[$V@5D1PL\WTH]@+)T_ ?-]X:L]KVWW1G#$][$[DRMIS:8'H-RO!#+HU>D]$A M2**5QS^A5:'@*T7<%=P/;;:' P*VA2*$%AY("_T#IX6C MO2FVG1^#M-[^= 7OYC#P;@IKEUT'#TR,VRFFQCX &0?N8'C21-\/G/&3 8_L M!2?5'0V&LDDW08BY@]EDMZ5*N\O,._S&7C7!56_&5XO(/F8 8]-+C5VS_)R" M9^@7_KWWM0?_U?-/O QCA5'Y$SCI"(9G5SUVR_+2I4M_.NK//+CP0NZ7A9$= M?"$)YN@;Q@>D8=2=W;RZ7Y3X>;OGYQV)GU?\O.+G%3_OL1SM7?V\INH[V^!9 M8W\.>A.M0S;L\_C94SY^]!),');BO!9:$.>U7'_BO!;G]74^()V==^C>ZY<( M-=Y]L.R];,U@Z(Z&._;''LC>(.K:=&_^?'%:WU]@U;S6I[W1DWFMKT^[9S\V M#KC(J;)$9Q1CNC+^-,ZS-/,BU&-@C+,,KL'0B^8P8([Y[_1,JN9Q5,]C'XC' M^K8>:S;^,8#PT0L2YU]>F%.Z^!]>DGA8$20>[$/S8)_NS\W<_J&/WO\C'FSQ M8!_:T8H'^Y@DF'@MQ8,MM" >;+G^Q(,M'NP&ZBEM^@7:]!?&IK_4-OVA>[3_ MZR^SX6#82/*2;%QNTVS0H!W(%E4" +!'DHW]5'+L?>GFO;7'F0!&G.=UM"GG MW LT3@G^?GZ#A-P*$)/9[FQXH?HZ_A9N.)6$5SAQPOWH.?=8QJ""DQ+%%5=X M&'AG01AD5\X\]-(T6 0PCIFY0#:V&++Q5" ;#PBRJ9<=B1Y]11AE$FY>Z MY.&5"YO1A/*D*RS1269N"'_L,@=PMU+OM MSY>#@3L\/7FUA\4_6:"@_;M^US_AC 8SB>+LZEBP[&,RF+S:_(V$@MHGT'4P M1[=-&=81X)\4HX>G1KCMH!*$L $^ >SD4?%/#$REO! *3Z$C'P[243]TD"I+ MO"CUK"89ULMAG*;*O$U0[1;^1@#YXMWNG'?[1+S;XMT6[[9XMX_E:,6[+1Y0\6[+V8IW^U#/5KS; MQ^G=KMBEVB="C=O$MWU_/[<[& [$S=TZ-_?+B=L?CP[J8-I\)"/W=-B TK_3 MJ(+XO6\OZO_@OJ()-SL]VR;XN<'G1EO6![F^;_K<1@_JNWY.HP-I-_=6;" ] MBU0W(-W62_42E(2%%X;L(^>&K%B8X;'C7%=G_/Z_CJ\6BAKAPE(<+TT5MKU. M"4X_S4,"'_*L A']%IS!.D94?7J-_J(BCR#R+32BQJ:ZQ82:L8I,4]M+V$98 MK*,6"S6GOK&PJK>P):$)\N'C(]=J\5IM#)O$Y38APC]!_T<>M]YUXK5*>"^Z M' !X'*[[)?@S#WRLL,&C>^>M,4+@?%$I;.N\T?W_1.VX_R< ?DA0 &-KY4N[ ME_$Y=>I&^HS4.?J <.%N"FG^^ M9(KVN%H#'\8N$K!C9:#)U7V:D3F ..=*^<6'=?MCE '(?X7OY NXR1[#02ZHL'#&(QB^A=(BRP!&9,C^YX!/5F'!;)O%>A( M7WDV\$:J]P-/A1>))6-4KV:_@V/LI3WY',DGQ*M=<\8:>&99_WRE=S;(S-?8 MP1H+VN(<"#'F)9BVZHT-I@__[G]+M];6 D$D'6^NVXSC-:20?$N0/+Q0X9+6 MX']GIH,Z'CR^"D03S8,U=J_74@T^%A:"CPH/GP]KKU-C\VV,YF+,.LQ3NKK@ M$BW:OM?[R7!O]UE-7>F!H-W&PIJN+4HW$X$Y^6H=I[#PRR!;PNJC[ZG-84$$ MM)'E>B; @NI*Q\6=11[Y0%Q?:K/;8*>TNFQ4>6&KN X*@0>7M<)9TQ )+E[K82MX-:/JU1A+ M39,@SE-D*OCJM<'\1V007>%*RHK1:13A.0;Z(K'*5TFTA;''2MGS8;]?4R1[ MS@V4#V,O/;]>%FOHG@IP2?8.^X.Q\X[W^2,P76AN=,]Y/M[X+.J+<7A!LI[? M613O7'@!B32=?^$GWB5,\R,@99?X6&6M: M23U/XLMLJ2]/746/MFY&BI9N?D;2ME YC?D6)#01^%*D4OZI-0(HKR2@^6J- ML3$;/V.4&+

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

38<>)633E=@6_JB"=XL(VTPG.4[H1H$5??!& 939 M_.MZLV'#E]^F>1'$_T^T/TTWYOVMF@'4WVIDUCBSBGI%2GK"& CGP/5KIGZ7 M_9NITV>#QD/P]7+#0!EMH_)>WO5!DV7AP ,*$+WD&HPP!M+E("4++D@L(R#C MQ-+],TZ)__7BE;KR3MG,7B93[,)#C8Q5(+3CIW3"T@F0'&]S0\ M9&SYF](B4C:7&B' ,L49G@/$YC.,3D9J.K3SJ"F$!3Z1 M4J% <22E@L <6T >'LYH8 C<=TF@MGI=N:1=D@C-L[^CQN)5G=?9"REZ;H8Q MY(7OXMOG-*'&$+M,!C26"OGZXRE(B*!!#IWK.K,]KKJ>G/6JE,/Q29L,_)*4 M[9"$TRSB6$3N3/5U(Z"QK0[GJO]<,8?_P>4$M4N/<8#:D]AV?EK]0#@]N4F6 M<8"JZG7M^:FJRV>#Q?F.9D]LM,\ MTL,"VX@;&=I&T,QXZR=,,[;[$H?,HE#7:7I(BNS5FC]BX02^ V360GN5IL6V M$CMH2M*,5,S*%2V4!0"J!'U3R %QJ@M##G";>VD@OGN3W6;I2Y2$9OO0L6 L M$&2Y;6N$!C@U#Y8=S*67!#S]]]_@]J3GP#NS&RPI]6M.B-DP\*;LKQ;6--.;AS3^\\2GB3/:1?5$5AC=08 MDWI'6MML*,*T;#+DY(N8".6^ULZ!L;^Z? M*2URY&<$AN!/6WC; 7P8)J5[BD!'B&$FNN<'C@:A>7-@M(B.U5+'2XH"9^6[ M".:!QX#HE:%HHHD8 ZI7AD*)+1!,$R=_^W UX/V]99[$X 6ZJ&7=!Q_9"5!LB$E M@V%M F41$^K49OZG2D-,J_&%8=^6?#&(8V%N1H1E)V;83#]OM9[F&RB>>-V/ MQ'HAD2#L@%)<(%9)H'[.76+"@:DLNP&UJR9K=U'NVZY#+78+W']:"+HUX#& M78,<0.R?T2UE,FSNZ M-#E1?:=/& (AYKAR$_DL]O@U>^;;?C6L< B&NMS%)1KXJ05)3(N/:7>U]28N+: M#) ^KLWH ,3US9X_]QXE3UZ&JKY1N$%JS&M,A[Q(=S0[H^)L1P]R(S78JTPZ:>4E;$E(*DH< M# ^4>5-2HL#5 13=5X[F1\2FJL\A4@$G[V42EJ0_M'L;=A65'>A&WK&8%U(Z M'MBUE%9RQ;*$TQ+5]AAM1>4MO6$J@0E)^0A=!J@"N^C 2T(SVA6K0C/448-8 M7L$KY*"58[ */=9J0W0H1Z>6%9QR#TIA8#A-GAYHMCNCC\4UT]".8PT#))9U M,LN769.G=\S[[P@G7?'"./%!I#_6(.AX $54J3D-EC(><0(U6BI MVG<;NHW"J/@>]6C"_[1X4>?#;'5UV!UBG@YY4SS3C%]#S.@S3?+HA?(K6#MZ ME>;Y-2UNM@_!5_.6Q*\EV(V*IY:*#4#= A%-D$X;I&R$?,>;^7Y%6$L\;Y:U MA;:WF5#A5"@<=A2.4YQR+B.!J]A=#$$MH(7>T2*($KHY#[*$+63REL1GI0,T M&*4+,Z =.NG21V+-1&HN\ET;G!7C]SB&-DBCMOC5)(9I2NX(ZUN/.[P #:95 M3N^7(#Z8\LUE4D!C4,BI>?B^JG8HJ%;D,L\/=(.U;G.7.NT;ZCDD>JB4'7?V8\2*M2[X.,O'!B\G^^_^']^P]_(C^MWK]_S_]'\K+8;G HGM,L^CMCXKG<[TDD MU!3_2(^%:TF0\QW0/0,SY<6\R!_?KP@'A2 \HV'UVP_BM^\QC&,J6S^",U_G&\F^3UB7P[(KN4TWE],!80+$/.Z+VZOM7Q M6"?UFEPAI]I#0Q;"OW!IQCUACJ08SMEI3;4;J& M=4&7^\S'[*U+?>@'[:[B2S>=A!*YXE!F(>?P1GSYWMY;Q)FEUUDE\AGEN+-) M'*OPL ,7W(\6>B]>DCU/-I,(7A_/MG3NM5 P_>+31+PDS_(AKVJG20]%DM_3*6H%;L6&ZGH2XY MQ9%N:WYWVZD9F""W:";9I;V,.*'O9'-B@W^ _$?$+R6WTPX@:>=E10_P46A4 M\+ ,7]J>I@G?$M(D-%>#,'(!'Y#JI5>=.E;48GO2H<:C:EU$ZD10$#2\:ARM,%QZ5X714,/CE)[)9&2;DF%4%PEKR4.!#UJCK$1'FHPXQ<]J6_S MW]&01B\\QG--#;>+W=@0"D5HY->673C2KTBP9>L$LH[C](L(8VSYPQQL;Q05 MA&>5XE^ '*1AUM OH;:$"5^Z"A,F<&&Y?5=WC^?F[>X=Z4ZL1)CE=)^5U)]<5B!,W;&*N@S:*=%?.12HV$64K(\^S MKV,<K#>/W/@AH^V.&DEQ$L90QJOY#RW6%3^UK[G+G'BD,/Q8S?B"2R1Z M5*RH,7@?X$G1>!_409_3EB;M?D0KTT.?SBHD5A]LUM/+(LYDG:7&GS:,N%"> MO.I @98E?A<]/1LLZK6 +?;[(W_/DFVOCRL/,!AK6,<[/: 4]#F7MS!OSE>LS>%F(QL M.(5N5/*;B]Z4'"O2XL%+YO37HJJK4-5.2/5*(!7&T0+*4"1'BR:T.B*E1&6] M#?,IAI8)K:I(3W9K<9&2?D'%19P5Z-I"I%0 K^Z'"D/F\A\J "&;@-O,8.5$ M-@:S9]59!/H,,4:51/-^+ XY9F0DAGB]$W@&8X M!IVL]L-X29J1DKL\J".,O[2K)9C2(.7Z%:V68T@V_)GMR08^S(V)=06FY<#< MCFB7+NJ=".;*RUOVI:VY+)"Q[CK05EN2).NF#IX/WMMW+D6 CT M753HPC_0JH!J C*2K&8@PPC'% 8LI9RX<4S#8YW1-9$%KJ!&J;6DM9,'V@QF MLZ!5DVI[Y#29V!B1=^U&?ZS;M&//*B,46>+\"F(190\T?$[2.'V*:/[? M@WV0_.4OGT09?<6 NS)"U8MWT4%::U4\I,U$!!?YRU_(;R7C])5$[#7D)]9F M1?[RPU]^T"H$5EC>&6B= O.P*',J-#_+^"!5G2]?H1-[UYU;>2 M!Z"GUTO= M[_?JZ<2&=,X:04[K97?13]D:((VCC9BN&@;Q\$F5;,\(#/I SF$6&/4G,@N& M,.[3')]C-&!?28UQ=Z8CK?ZB2>?A4.1;,D:1^:\)AQ5)&V@OX@J,# OMQ1<9 M$Z!A\[RXV=I#&CTZT%!X5T+9W>7B65O4:(:KD L(92A'7 Y2*X8;='G!NIWF M177!WKBLZ%&"+B?Z4LK+B)*BKNXP'3I_+D5,Z!.?Y^VK!V=)J5I2V%6!)GY=C02U;J85,]J%@@XP@(#_ M2!,F3+Q.-NO-+DHB+D@1O5"[G[9R H+?KD4?0Q6'N$;4Y9G>L_O8P3A-@@X/ MIE$XXJIO&HZ@PIP1?&8"W!G R?/CW/USD;6\\)=*SGY1OM[9QV.\[T5CUN@3 M,Z:R2-Q1&@.&34R0[WV99)?>_2J)A0MLR'']N)_\05Q55-O5Q*CO3EEQ([T_ M904-;,$/RC3F):C.V'XW3L6E6COR+7RPI3^,&BAJ: CZZM'KA@/7!$9IL3ER M()8$JNEF_L/7:$[T^\&/;F^U9%!_8;WVNNWJW!&@__EKV@5BW0*HF2-D& MQZ)\,79%JI9Q)I[IM'T75-K6-V:W)&SEKK=OT))#SGJ'&2HCV!_$ C2A!8GY M>1;;"Y0MD*#W&&V[M>K]SA79S-1YCD_7S-=]+EVD51_2M0WT"GUG-] E +J_ M\R#CC]WF]46%DR"/0H.3T] #NC*=Q'T,UG3'&S(K(FAQ?)*KV-<#?<;C+*HY M>@P4Y2#]@=%,^E9OM!%$VZ[ MJ\EC+!VAR0,,GD;,<]\NF/#E2[P'9A_'1-43NDTS6M(]!%]I?OZUR((T8RO@ M('N]+.A.%%9GG*QC8I%.5V:%&$ ]ZU?!TYGGZCU-2G29%%HF71X_V4XM?A0? MK9-(Q6?+&M/'SY#Z.SC6"]MQ(DFUZA3F$UZBG'V!?/=($\JL[GOQ &=4=E;! M/X6?D#VK0:J3NF>U1OP(H;1[MVV=/=O!CPYJ-1P9&YQG%SXNN.6M*TYD<)Y= M_IB@ZNB.OI+,8X.R5WZVS>QTM"B1[U*T$('$/;7M'"Z]-6C X1X7T)5N*6[ MFE_WII/; ._E;!?IN\_.$]E^CXOGT MP-8P.YJ=?PWC Y_=^+LE[/\VS/2-V5@#6@/-T1JBK9SS)%HY;KYY.^0+:XC4 M+:U(TQ:I&^-3&-:$-:GB6)EI$ZJ ZAA&V)RW7IL%R4XBY'S4B1UZ-FF$ _5'N=)LW= MAU(B>PJSC1'ZZ5J3#NK78-L5[]#>JW%"E?._6 M"BG(6RUUL9";;2D*?VHZW>TS^LPDBEZJL++#Q5WOEB#OOWAK*5TJ:2K=I%O2 M8:WM:L8[OXYKR?%:&FKC='6^0M["#82M=--F&&9AZW;WI6$[TYNM>;MGY(*M MTVV07E'(6C:K,@(C'H;D,&2J1H&D!MZ[# MK%;HXZC&FR#.7OR^E:C"7[(N7OUVX"9^G'VW42/C;KO-^4^DY%U(?5:O$3-L M/NW#A0'#4A)N66G"78KE600+'P;L-!I(=U]*3!WI%O @M,H:"%E&@+(2U-= M,:PO'6CH(2],:22V06813QX8NUNZ:F/J:T",K#>;B$_!07P;1&PO<1KLHR*( MM8\D./(!8L:F01\[1WK"&=Y%;+U;LB ]CP"H"*0Y."&K;Q9.L (TCP>^I3YD MKV*)8#4*)36@*:BEE6K1553ET@X9]).*# EO S+ZH#; C2EK6!3#-W4ESRM M:-8Q@":F:626\Y=*0M):@&7N5/D:KEK.WAN,784K>Z)06]+[0!-W[-O'ZAU2S\Q#WV1Z# MG(K,%":V"%C?4;9]SZ."WM/L)0II>1)W1\/T*1&MB+* QNWSW)\&W8'/WH^2 M)=U>GE8O8K\3K3+G\"I"UFM>?O&)EN=2]=FHN%LFGKEIM8VURP?O+#'!5=T4 MMAK$C0[ V)X<8( Q/*P817G_EBW,H\Q8'LO$A!6QZ,MNC@)4YI^O2,6!50?7 M2X?R+_7A6E%KE+'^CF[)"Q/6EII<(T3]/D MA7EH9JDWV_+G(F(KRWL:,LHB,KZ&,;)=T-.W<3V@G#Q(V2 I6R1EDZNR*O6* M')LM4Y6;ALFQ9;RL[&F[HZMKV-*5+6NW-&.PKZIF].I>X)YF3F 5\FGG!":Q MD.2T)J,NS40^2FOC^9"6V\Z!66A.+2\DWYX:7 MXMZFWO?4@0>4C<]XGP:Z[UE"4&,: _'R#4O< ;G$/L4B;N3!1=7&PDX@:LWD M-+J&EV.WEU5'CEEUJ_+,;KG'!CH-N[;;M]?Z^:V^X2[B72YOR Z)]W?P"CEO M>[S(A?OFELM#2?6DV**:W%3VPL.>)_8UK8/ )T$L5NQ!06BR$:;1F=]GDOZ^ M"+)B8OD?Z5.4\!0LBPJ@DZ[KRU)+>#O*.)??T;S(HI _<\7)Q$96!#0NTFQ+ MH^*0#5]%N[6]E(6T8T\,64L?FZXRR:IX014[;'U@@2OJ@?VB#1H<]NQ'7L*+ M]Q3[X]W]9VV88#$+:1\S\5I+^]B(B\_8QT4F','[G__X7K@!_IN_UJ/!%^Q- M7N!G-A+L6_7VOO.W^JG/4DJ%!YBF60#CGTA_+;YO1 6C8Y8H;U58=MVN1%&W M/==<;+3YN;M#:>Z\5'P[1JA)4K4/YQLEZ0\IIJANN MK]9WUDIM]]AXQ,X"JGH9G'VBY %/M)BW>]IVT0]<*$U#%]U D<*9WE$_,ATRCC M&:EY\8D6SZES6'2O-4Z^/+>&SRC>K>5=E2G?)OHCL3W?5[NB>"?02#6I!HS RUP! _UB,$G"CIP]06?BS'J.F _,^2I,X .-=E M *#&:;QT'I',L<#HC!W8/JF=HY,>-/N->UH4<560Z7RWC]-72J_2(&E][U.Z MB;916#Z[:(RY#&P,:CU#W!4!!+&X2A",:S6)^<#3LKGCVZ)!C(YB<_@;P@ M2_-326=82SAF=<6?P8(BR7 Z[A;BT[5KA;KX\MW%UQ=L+_[R?-TS65(>>C;SQ"8U27;>G/8T M:WJ>CUT-S,\K#^_&).A-DWV@*^\ZHJV%YAYH:XH.23THPY((OG!ZI@4=]2PW-I\ MG3'\&M+;NYFF=VT+,HIY[Z7-B <#WJ=2W0-O#6^9-02PW?45&EK=%E8C MA[.$9I-&G]'R>12V7'X2PU=M#JM](,^]+_>"/\SL4LK=[%B?HFT%V:GHM?/P M*E64:]%NQ5W107X%/8(U#+TN#@8"NF,\C/O(7A_X T/"QY2(U?F4CO=IC?)4 MKD9].-$N&#CM>:5?R[BGEIZ]X'QV63DIS"-,N_,"Z))A9U?H_FTZDW$XU$2S MEQ%'FW.!I'*5".><@W>QZZ1\8VZ>0%>O]<4'O/J],4?@*TCJAPSG"8&Y)'_, MWT$C@A^\@U)5U=CEA\64UC1->&P^4YHW3 :*F&D#9Z-UGJG(7;_Y-^-69RUZ M=_2KB+>U ;IH"CM!7Z).;%K3NM@W5R(/%CS5,G>>#+T'UL#Z:^2:<7?7@+MN.!2X7Y0(/2,><4$)S3SJ=_&>4B[-RP_L%! M&TW__V79C@%:,6"?X(I"A4, A:"'-YA[Q+ *VUVG26:_;JEU'L.: :Q+X*F? ME(+29E^@3UF,FI"5#(9@ME_:8 A@ (Q;'YR]LEC>%]%L$4$O'"@>V M!I; UEGF2D@;"VMSW+]# @IM;7RY&B1-+!\*WECB.4-\H("P,#>J+WRD6U+S(CI'WR&JT>0[/L@HT_IC'^:%($WK@QRQANBC_(?* M!V]3^;4!=9F#HBJ'RY3EX_)]'?#O2,YF$6F>9-_R8 <>:A ME_KF9.N"18L%:>.#HQ6D*?GBL&]6OB#$-+'K8*?/UG+BPC2DCO3F:TGWY54T MSH&VH8+2 ]589$19[4.&$U(I7_/!]!0MOX6ROMJ0\!3%??'/A:<#R&0U;K'. MDP%0,NS.\.0I*6U-M?K5]P\(_.'](YRO$4QO:;%9<+< M'KU*<_9[O@>_S=*7:$,W;,N0T\UE_XQ[X7RQ@>\ZD_2!Y?R7?\FR1*OB?-9\GQNX; M$,SI/TXG9DTG\GMT,?L(_RW_.>3]MV_WWZ'NO[3IOZ#YY)\PMS5S&FQ_/S2G MM0+ZN#/*%G5A)&8*]G-,19PCX:\8,8?]=^4,TNIQ-W9 '^2H3]\S%/KEA.\>.26Y#5[%<Q$'$BERS<>?SQ/E7W@QP161_=?CJLE(G M;)&BG@09\2.= 1G! YG]30O'.%7:T+EDA UT]L;GU*>MS8J7M)B7HJI.:E5RQ_K MY<>U)3W8[%:D1QJJ_=QF=!]$F[,J5%QM*^H*46OAX;PLRJU!5!MSU-G1ZJK6 MZAU9J[!%(RDXES0)&A1J)%\KY8E22KXTS$YJ:$ ;S\Y[+L M1P,YN_UH\(8;_N#SWG73TT,W8*9F<$,@)OU<@R!BD71L9(D[,R\]2X6.]K7< MK9H=G@Z!#RLVEV2! _9JFA:69'>^NS')Y):V"7/5KU1DB1LK(^Z\K6J!6Z<[ M&M+H9?#NJ3DVY*18HT&FU6 9VRD9;NX[*AEK8QZPT(?^ MK_B_ZPGP];0RW61SM&.%J4S1*-AC%2-UUYI5W2"Y;!^*Q>)7]>KIU7'[,N\: M<99^T*G,%E%+VK1-A__NVQ*+ ;_;BQ)+-P+4Y<%IFHASSU^CXOGTD!?ICF9- MCWBM%"PMH2X:;%HZKA_J9L@7U@ZI&UHU.^#7I>Q_??6M:*;*XCDY04!-.CC#;>XK^ M3LB>]APX5:>B@DW;5LQTIF08P#A-MT. T^_\D)%CW=KZ%&2_TT*\D$J9TQ.+ MNL\)\Q1Q]'>Z^1A$";^;89@971L G!"==>H/T)&1'#E7Y,A+.'-U70IK*SU8 MNY8:XLH2-T&R.ZJ<-\UA3GM^@.S/=GYH!+0S$3%3I,'618F:.D4&4_-H ]#: M?#13!TA5Z=VK8_DITK2 L]X:.Y]RWA(8_B7 M+LRZ>EZ^:!I;TKW?210_:K8,LQR.7,=K& ZP!334ZFY<_I"NP[\=HHPR<9E+ M*5YOV2CQN!1_#V]OF1-]&@$T3"_=I&3-BIE?*J_82@YX,FJZY7?F!:/0B^KT@K1&?WCVK= ?FXN<)B>9'A(YW90BBK_[3'W:)C G/KU>+M->]21NR4Y: M_'/-> \NJ\\12I8;0A=C&SU4CI4ZIQBQ7;"A?-B":MAH.6R[331?>;-=Q0;-$O#A@GFQ=&:$.*EUTT$/G9DM:7!#SJ?'H\%+J(D2,*)@L+&QO!WOV9=/7?!36-O("CL MI_A1LT7O@QV0Z[@?=H MZ$NL^VHU<+,]HX\F,Y1)0=]5E>247Q>M2;A#Y$18 M:TX'86^SB(%@'\3D*'1"'M,L2[\P;*":@ X3\A.G:D @;,0NTHQ)4TV(O&)T M4PS:81=F8D;8@AEUT>Z_MFE&CFSB/:E6M6KLW9>73ETUVC7\E[#ELD--M]^R MXPS2Q*IXD9A^5#"14;:?CPS6J8.MRL:$7=-RM2/IRY&#LR0L]D1T;<(=D1 M7URRW=3-MC9RGO!MC*\[,"-9DE87,_8XVTJ\(<& U\Q7IRK7#6]. W5J3U$; MH=^BIR8S"DTV988@DE&U5J7BD%01EW"T,*>6D,S-34LS3K]K;[*^K\IEJ")R M^)8X3-U2H^W"(G$#P6HR1 ^D+C)8/DF0?*'!\6F"XHM*#7/7TO".T=+,TA^M MPP/CRS'&88^F#6D,WSC]WNH:\);$4D^N_!2_6=@MH^'('?ZJ!.+)57WWJ;KE M>TPS338*3W(6Y6&,.ICM^*8A7S ?WP]2O8;Z*N#Q[:36W9UDHSZ./C:- M;M\S],G]8;^/Q1V[(":;AD.<-2;U-?^HTTO'F3M*V,YA)S) 4)^ZF,IFI.?7 M)S*8,:\QL^_&-,^9[ZK#5C?;^HU6MM[7/B*K2T(;T2#86\LC=%;9/&]+Q&#: M4L/E@0W&OG=1Z,7 7NW-Z*7.OR0JZ#6.]E"M_6. M%SFL5*>;#Z9ECIT7XQ5"SWEP1I>T('"% MUH@9_UC'DX?V'I[IT0FT#K%TT[LK-]1<[JR-G"U3,Q+.21AK<]3*$]#;A[ ( M<_04>CF?OK*%=A@?-N4-R_V2W^ 9@.#.-(T 7Z;;A;H\S5E9[>P]8;WDN MCUL[A\B"T""\,6 M,RG? D6E^ 7G02[7JL&%HB*K!A2@,&8#0O/"!<,]2E ]Z64T5M25,@]_\K7 M6ZTGBT6YPYIH!?22N!O4;:KU<5[2XV)<"1H9X$K$ *+[?+NE87&S97 0CS[? M!06]27B'\O_Q>_LO04S%VPML(HE"M@/D?U@GF^XO6I0&"YGE:X!6-D]O]>%< M?H6O5NKO$/XA?LV(,U<%'UMMK,BQ^?*/?,/4_UV+ <>0H7N/.0,:/25L,U+U M(NO 4'2@6 72=@?R#LN.'<8),/W'C&;9]T$SVB3PF?)@>6]I%O'")/WZ[]4, MV>Z9LKG\#[K4@I#%&\YK BC4@][UM*A9.EAM[S/%4H MJGLK>C-N%,6*]/CQ/AS@Y'/*. M4'Y>L"6EM#-UPGT19,6RN^&1/D5)PJ>R^3IC_OE+T0T/_*/_*2:A6>84C%<= MLJ<@B?XN8M*G:9*G<;0I ]3)YI8-5GTZ=;.MTLZ"N"F-[Y*O/5'[D*]!3-0C M4G)SJ]T5Z;0L+*/=-O<+3>O'UR-,:=Z@KR],"1KI988I$0-YS2$H#AF]V58! M6B:YP2Q4Q)#7%%2R2GL+0<2A>"0COSW0KP4Y8;K\CG73P$7V-HA0;Q!H02'= M$- B A##U8.^;&5RR\PN=+N28V("Q+11=LVSS'P)5E,OQ+?:AZ"/''O_0R9T M1$])M(U"_CR )!?W'<)UF/(Y'!N 3.=PU4E*>#@R$B7BT)WI7*JA)FYX05#* MV_#"'VA=P1>:'$02F.K]4P='[=P":!5"5ZWD]#;!6>:VJ1_Z78A+]QPYN2B@ MU[ M!Y(N[MZ]B>6 TN07G5")[O9'*-CH5#^X'%5YP'=T%T0BJ'5+,Y'GQNO- MW#S&T5. 7LC)%ZF>-H@Y+UP$4?9+$!_H\1*@RZK=S 9H;!;YI>K&C)P(^M;U MV*4LWEW&H@\MEX$8<:>C5?&FJG?3BS# M:N(&]A%8[2;F]=:6BT^ >J)=V1@"T,[%#31T.EW?F'CTMGST7L3H[5I-8-W? M. EB/LW?/U-:W-&8%S#VFX9<&P"11?H#T: M8.IHB@:, EHAK_'L561.QP!H75J9^X#BA&[UW2 19>[R/GK,_8V&%!?GK.5 MPXK)^TA@68 []9-^.:"V^D0+-$ K4>UV4;,XXN<.4?)$D]"[^*9?.Z 5JOPT ME ^C&GZQ NFT %0^T[EV%;JJL'6N!F!7KGDU +A+,U"7Z'.T3HW#8 H9 N8EK9[3>,-&N]S;7*>%RQ1I8X0,\]ITD *[+89_ M(M5.E?,L8-8#408T@NN$,"EFZP0O=$/QF[0\VD W'S?WK0??HJ:IN55J(2,4S12B#1%-D3M0':.*-\SNGX.,/@8YW=1/*[E$OD8V#!GU&-L' M$J(Y\3M!32IRLN85II_$(=D")L$%J0P:=YD$[5)X9A*H+]'H3]H".P4QQ[:\ M1+/7]H*W$:#/TS/HS">W=X*#&Z.NJE=PULB%46G5*1IY M++FZO-"CPSAH"YHN(JRHD,9E.C"SX4+)G.*JQ!*Z^QZLQD+*^'ILFER@ YE_ M$V3\(A&OL2544%*1\LM21! OQ'O:^EY*(;%T/")LG+*T M]#R(P#&F(BF0@^XK?10HTW-YY<*K-&^KL2Z*+'H\%.+)BB+E*US^'DD[HK,D MR[!G5]FP!1GPI4]\@7Q']VDFWA%T.!/1LD"&<_5R2YNCDI0TM OQJ+:NER*8 MEGY'1(WG 8$+-R*6'"/F$JP6M4H=IQ0_I/Y(TZ3'G/ZMP,3[/S%,:2O9P&]5).2DG8!#Q7-(CSL?2$S;N2[06;0 M($+>[>J=E@<1].9+=1)P\&>$,?(O">T.5^$L> '$^T,6;.@ZV=SPYQ"KRE'Y M\0D^44'JU8!]1WY .W#52%-;+R>M!PA_*ZD)NG%,J11?/*WC./TB[IGR)XY. M,[J)RGTM;A#0"XU]L_*"(NS+S"'EQ7?$.5"4_UYV-__)8%A&+MC7F W2*\HL M':D))UK5Z"K_41G48@QKA'KB N#8"6ZG#422[5P1@Y[(ZLRS.I\=IU:HI7">G'@MJX-4A\ MT"C7(/&!(J"1?>;/,I_G1;0+"FHJ -XG!#0:2<8^?#Z7[T,W),NS#&\5,*&N MQD0?TFI 0-:OIU]:]I2E"?LQ+*M+^M+I^AQIY'E6\JI56?=1J^P,A+-7B'XA?X*>]^!VLWJ-DSB;JR _\5)>+ M1LI'AL7:1GY.<&&&.$9%U:MCBE?&L!]49X_D-]$.OAG"J(L:21\$6BF\/@BQ&*6O MUWE.Q9WD5E'RJL+JYB9ABY=#EO%,BF1SG299_4^QBW2VWSD^AE%F>\J^,A3G M;A>XY>]C5NT(4VDW#.$5'.]I@731_6&W"[)7 W69HN M9(OMHEVU^28AZU:'KOL=*N181!7TRP"RJC;4*Y =LO^V-H&R] M'70S0;%B[ZPDEV)G-X(AMU-$TCOW; MZEZW'95G(U";*U_=M#[QIKTQZ:)O"9NNT7JJ]E\D/+: MMT:A,[.S@L/FDZ; ML,D@RL8N4HX=UN;LJ)FX67KR>AH'N=O]!!LGRL)1IX5I1 0/>7PE@@O=68Q0 MZN@A'E+^LM'Z4#RG6?1WNEF1RSP_\/_R$.G-H<@+MDWC$5)Q&W>9:Y6I&R0@;QJ M<8G&/&%W'.V]]&%E XWV"S'JD;9@L/N1AK @UW#,7!'B?TZB(E]_";+-Y'[" M^TL+3M05HI1*5-\8^\08Z'XZ69[1\/T*>%KQEN:16E97-#/\4S^3107-'W/ M>3NC\Z_\0^RO94[5/F*+^G(UO][QC-P%>B. 7NNM>A0E0.N.6X:OFLD$]5YK M)OO#\5^]NE$\325D>]BS*#XP!SQ@6>39(H[O\=3:%-Z0:Z2M1%I4*+Q*U>(2 M/ M,G$*>/XUC \;NKE@7<9]V:&H'-B0:H=S? SGL'RZOC*>-[<^0X[?(?6'" \( M_:MVE^$N!N'?$&89 GY P^?[(S9*<50Y)5&/Y3YB6Z9M% 9<\.KO3/2"[G+N MQ2JQ\X?T6&>"+;$9>^NDE5(!O^1:==CE6SO8.W M:8R6@3D(IYT,3#R0.F5@3@A6=0)F#=:"@_51@!4K)Y.7'&5+AV-PA%<;H&P; M&"75G\H;OBZ3]("V@*OJ^FHJ3=[TL6B%TU:DXEPU]]"*U\[?+WYY=WV)[INF M[ )U9CBR7QJ-9E4EWD%0]C;=G(8_/*4O/VYH5%HM^T$8JS!3]H^_7K&51WR> M% Q;ZZ^1JK:AD@K M-32]1$C*$A)0G[C1,#PGTQ,""@;1KP&J6&X9X!?^9&S M=,>PK\%>EP0(>#VYI->ZJH$L"1 0-TX^**BI1K>-,]708E8>/WD]H4GXS*:@ MWS7.T)T5LP:YK(>]$#EI6!#]D^_(6&MS:X8%%62U0%JOY\Z*"C))#S^0(?HF MW[&QPTP],( PDQ]T^$1WCS0SP$O/ @@K@]Q.+Y"4U*@HLG5]'SVV?H?, PAB MFE4*"#AIO4N6L"A;&3M\E:@0UPJ:D9: AZHEZLJM!C! MUZ,!@E]?LOZ 5G]'FHRGD! *=,HQ;L-..EP8*>#W)I&$M_XX_ MK*H>[ RKJOL MP2_T%P\3VZ.?W6H )?_7>GZ@US]=:[UDV/!Z3$R0B[J%2/= M7\HKAAD>BM8X68\.'H[:"%@SV'.MK_P@.5A.!%B:(W#*(0>$9GD:_XD6S^GF M>%)]\R5ARX_G:']+,QX@#)ZH ;8>;0!"VD .U;F#B^TAEJ.JIXO2=8T MAII(- B^TBG"$.QBGGL>/<8'GS//#AOF>6=7?I>7O?&G.D\ECG_M/M$]N?@; MNHT2D<;Z\1!M.(KG&HE,C(1^3AZMRK[U&#.V,JAGYPK[MIZ;*XQ[]@C6?Z39 MZ2$OTAV;F@PG12I"L%B60D8)&=7?D8]D]/W9#6KI.G/FX;X.=O1FV_F\-IQ@ MH0<:?)/$>@P@GY!8N[D-!FL?C[CF5#?X9VV(6DT&=55)ED\[IG]&C56;>K-S MW4;3E1.,X87;&%Y@C>&%?0POEC.&%PYC>#'Y&*[=QG"--89K^QBNES.&:X[2">#VT0UN'['@]M'>-Q^7 [>/#G";HRN]X.;2I8M[,/#D]8%] MW'+&ZL2]A"<#.]I(-Y_2Y.G=5?1"-^2!_3[B6;OB>ML"3D ]QL?Y23UY<)8 M."Z3]1S5B7L)@.MHXP&X!9QN>HR0^RN.TO! GL7P< #EQ9+2@H(<8JG&7#BE4@PYYOT%=,/I8F3P_>3W25)7+RP+XC>3)AAL< M#UI8'>@\GX.\73%/?YF C)P9LQR-0>]SS&@7TG60&8T"T)6TMALR.D;C TVR*"WSH(F)F3@ M:_VS#CPH]V(@-, V /.<88<0Y YG\Q^',OLMOTBS:_JE2K.)DB>V)4O8CV$Y MC]EV0'[M0.Z0/#749)N)1SCY:YQLVL[)YSTO#+H _SMH_*2=S)#!@RRUQKYP MLUUO4O%AST!+@XF;V'>6=Q^%+,U$. MF>E[\QA'92%2IP1V[Y9 2W?[:JFYB<\?4JS:(*U&R+&561/]'*MLCU6VK5G: ML+12S7BA[$>107L7V6Q@B@AQ3,E"2]!6'RA\0LENS0IGI'+: _" MN5PB>Q#(83-MBRP(BU^CXKD^\[J*@LAM M3:NFY/JQG05:F(NNM2)90U2^_!#6?=#8'GDL]Z"H<]@P_'I9I1:\2UN2CEV( M+F_Y.6[163ZO$4:M#!(NZ"*+LER ^T+*2]#K9U 8?T;RJ M_+.Y2>YX">J,W_!/-M=IDM7_Y,]IEJ7H#58WX3< +7/*GNF#F[=-1./<@"L. M4;V]W415L1TU;C$Y/OJ&,3DXWICQ7$4)%4\FS6Q K>^\,2-J]Y#)D,I/""MJ M?:0N7[;AMWL-MB8^17[C'RL?3D,ZR_F6>NRM.2K)%N=P5I(A0FYS:5:(%]L* MFM]LS^@^S:-B79P&6?;*Y!.JF3:W3NR06UHW?:2-;(N-/R%2,:Y(4)":M[01 MI-WK-&IM2D;4?:D'X*3=J ?:($]YA>DWGN LRL,XY89O.M'5\T">WAHDE\[3 M!.V*'*<+(/Y^/20 M =UJ) -X*=!!O#3 M0@S@IP$&\-,"#4"OATUF; /XR=\ ?O(W $WAGCN:%UD4%G1S&N3/FEV)EA*J M?(]22CEUIR8BG IE:S&UM& EA_0XZ%0=FAD$3H6'AG2O=P$B)W/1;C4,M#@F MHUU72S!$V26,DAB[6I<)$P;CP7MUFUM-(F3@%6Q>@MCA[J2)"?)@VB2[=&[+ MX<'WB.*'%OT"8C3V09".;:TC )HPW/'!DECJWUH7RN.:!4TO'J6_!U(7$-J8 M8K#EO-WQ(XT3T!<'RJ=QD-MUSDC[F-!-/A8C]';\&DH11'(DE<%L1][CVY)_$2VR=LM^,:%^ FYT; M,I:DR\GQ,F*;=7SO:OV4T:JNPV,N+E'IMEMF'JAMET7R/@:/Y.1(SWQOQ8&W MJ7$9@<[FQJ7[ ?UO]\6T35//)LB,*5=F-D _:)'?@"-!OR(5QXJ4/%C7U$;K M,9/X3G%F3^'%'S37 B$G$A?L]R<#%^#CF>^Z.$USTT."&GH\@VTDMB.<)X\Q MVD5 W$'L?_R'#__\_E]P+[^Z2KU^8G/1$Z]5M&>2/ -D!QANX= $;7;IX(C>M#D28IF]+R-Q61_0C7G6B<:'.,C$.^3&=YTD.K"'G60)Y>N;-0G^@.LZM/NTDZ8W M1PSD19 %F^#UXE <,FH>2R4IU'"JY90STP05*6>:I/!C8E2?+)D?B* G66F4!,N(E#/>;=.4(]X".0=A7%T6%GAEF7!@IC M/J$>Z 2C6\8_+ITN@E2(K[,**\U)\96AIBL(PZC:Q2 M@EI)1VI"3-A-+C-<5IT)&=VT.A,L1F#SGHF;YG?I8UI$H06::EHH9&HDEOFK**;*L9W$@?A[_>_6_:.?2HHHY&D MDQYTX02$46 :BIN4)B'!;$,]W!VK4(_U"(@]O/(G'>KZNJ9S#!4E%-244DJE M=1@1KR[55(-&/LC0=VUG2/7].MFPFD\'U+0X0ZL-6\N#BWT\8.IBPP!/EN)U MFNYV- NC(*Z;MH08M?1@H4:]Q')%]YJT->+8_MG6X]T8I*6[)SGZNTRN#[S1 MF^T-?[[I9OLQC39P&&U@A3\8-.EA.,"Z3$C)1VZV1'#R'S@OX4(Z$&]10I(2;VR@ MQ(-I_(GRJ$-3]X3$/LT@T77_L M@68[;1Q72P\6R]5++(7M6J3'?08GQHCH#I2[>?BI4,@-%]>UX*0;VX4 B5M\ M=XI.G\K6/@5?H]UA5\NAJP)KH(6R,8VDN$F>HNF&LI(8.>DI2JD*=X+J&;<$^:Z,MY9S('2N M@G".QKCH3H TU(&8E][#&0;X:8MYF(]Z#0R(93RT^%+5\, _[;7VNJUZ!UJM MK:,L?+JQ+(M4Q"BG/BU9#0 1>2#XD[Z^B_6G(/W^14/$:5#0IS2+_BZV\]89 MWH49#3$:7?0(6D:I*O/)-!IC;D3%!Y'65B ;LI991;NHYT MI"8M%X,^\SCT?O>>$E#7.T4!AP]!U)!C)5+PV[\')A OF+DW0M[* 5G25RNU M(JM.4)*&%/D=@@&BTYIT1?)T6WP),KH2^Y!4[#V6\$:!!49276(SA@#Q?T6# MG#ZG\>9RM\_2EW*/8[4!(Q>@'9BEEQ^UJ*A)FWP^>W#LM&Z2"_:U9YYE.52;[!.1QRW3](NT3CTV3=MLKTK1> M'D:TVE^1^@OL)_Z-'9C+C8+'*!;7 M2DX/66:>6VV,@%9BU:$/K?* O>(@+985J9AP;,1;D5J%,FH7'UDP+<,-4GW+ M<,,3H&6<[_9Q^DKI'173GY=Q./ "VH>+)GUDU3SOLI()QDH*!C/ID@%:1$^^/E;:?\;"N(>( MK1U)7OZB C3[;Q@?-E'R1)AWY=%M?E,@W9)MFM'HB=.%SSSIBFSC [_^)C*N M,*U !9P^X%6H <3V??A,-X>8WFSYXHT7QRV>TTTK->*!/U%E0+UK X#VX*R3 M=)VK8N2@*EE)R4LZN2*"'35@YC=J?E( 8!GD5&Q9.9EP8A4E8FJ:K8-K9-AZ%P8#/'6V^KC^.H^% M'A8-2HF=((&8;^;4XPIDZ+L;](UDL2Z\#;+BM958;4EH-7*!OG!LDEY^E+U< MT MRTJ)?0+*KPSC(KQ-;!P$?2-8'82U\^^B$#G!:0_>HT'HZ0FLH[.4U> MMM64_%M*#>^#C6\2: HG)LWM#E&];+LA''TPQJ23.%';97/5,8 MX"(CCZM1TS++H% ML.;'A%OYJV'86'%P_$!V@AKKLHXULGD5)?2RH#M3L,"GD25%M=NZ#8QL\R:( M:&/9X6UI&+U#W-(80J+T\)A'FRC(7F\RU<1T6B:I12^TKDA<'NKE( MLW48) _:&ZMC@SH_);I/P8/X,D M['/ML IXK7' ?CMV0UYV VI9\KD-2_(N,UD5RDQY_YQFHK[E&7TLW$][56PH MLZ%2?M/\)QC>\2*=A+,LZSQ7/QKZ*4X_%(" ^B7((O[INZ"PE1>120&!HY"S M#Y::A'":!9RUZ+JVCPA=OR*AP'J4HB)&0H(V]M'#P@(.2O1=;,(#VH'M59IL M^ TMYF\?@^3WF^V69G3#1;JZ/+FYL]\D=^.'O%/NJ)%T$4?PD8:15)PEM+X3 MS-\CWRK$T0WT#KH/'J7;Z#Y@1%G-G0;[J CBZ@83D_>IJ!8&?J$/IW90UGMN M&IH6@-T65H2WT5X/&J(@,%8X5ED/A7!6N1XHU2][/2 *FBS^6%R*J\D\SG1& MF_])5K!RUD? MI:DP.OYX&YLAHH)L@Y!?9'@E+[6&$9]&:%Z0C*NZ.;:/F[+N#U\YI=T?NY K M4C8PS'N(8;FH1H6_016)R/ %I;>4 2HI@B=3),2K%3TC);_O4@SYM.B='--37>; M_9M"GLLM>CI/Z'4[Y+NZI>]7A+6!%'<:KVFC4)20QS3+TB_\IF@8[%ESQ>O2 MYF\7N+I,XBY81;;,\Z_[*"L+[;!5_P=/8Y2XD>U/UL;9Y(ZLA/,NQ]+<=:IG MAJ X9'Q"V"CTP#8M#=Y!K*BA9Q--R5"]M;N<&(X:0^:8C1I :&8@(D7W>S;!;6Z2=@C)-)FX-X%F M'D:]K)%3P4U*=L+FE$[H=!E!4R\%/0.FN6AV.79F!ZG9YNP(1;._5;1B7\+<-4:U?:W:OE9MKU,- MS]1L>#0;F@V,R-NEZBWDDWH+>UKM8#WW3?IFD#=0!OV<=U+U>]%-(^14L\_' MVU1YZ-E?2^XJ]98?QK"!U67394,JLCW>41[O9'*-M4A30\@V:=31V2J;5A9M MEUZZ?DXV6? E(1E]2>,788F]U2G^=F\8:%TLTXY8R&1!LN&OX+#1*2A-[FK'W%M3&*_?#VH**LU@F)Y2O?DO*:F;(6O^AE/5 M$&E:ZD_@2*GG$RK]T_L/_]< _<#R#D9 N). @(U?ITP$/!R7C?GF)NB>O66* M;NAF0N\SID6P1W/':"T5*R\;(XOR22[I4+/TPM*=U'C =Q\B7@;:W=XI7C+J M1_BPWFJ="\;[0K.'LK- >2&SW+9U&\ ME6I! G%3Y3X,+K"8;H-%L]U5&B26O5./"FQ;U)=.6BGR+!).@;J/&2\EW&Y$ M.=[=C89RL$=@3*0KBGDX=HKGN3!!(= FNS(AM:27)WC<&L;.C@,%35-, #>W9R' XWB$PV0VF_8)ZRK&SH(-%.%T:08$\@CL/A!A*T MV@E7:9Z?IDG!]F$T"2-J??%(QP!:@D0CLYQ?F^>D0ZDK=S5W0&5&T6'+AYC0 M(M<+,4%ES":NN;O)7V7I?.+*4.?#@Q=L2^>FB?R>?<,F'M;I >4*M^*%]QAU M-WK0 ^04' ,=J#&5N ^/3<&!]5-&Q6S#KW/H[,' %:/VR"SJF1I4S&C(4:X M4>0M^;'\KD5NN/+<-JQT*W2# ,6M2/=0P 1-Q_.K6]YUNC4VURUS6II\03PZ,4#;HHH.F#.Y-4PVX82,/*:D9$ZY! N9>N7/T>$G_%#] I.J^#1T7/C1BJ3^EC75=J'R26 MF*R&&&KX=++V![*F(Q4A_I@:>[DSNL8N'C'.O]+_2,V#VZ: &M&.5/UAY'_$ M'SJYXSKC)??:&+\9/+[&:?)G&L3%L\5_JDC!_*A23LF?EE2D),,?24/O=AWL MS%WK-,7[=?&S()MJ^KZE0?;P3+-@3P]%%.9F).JHH<"HE59:6S-"TJ;$AZ2Y MISNH-'?SF%SI0Y$FZ2X]Y+_0YRB,J=-2P,8%EO-LDU[:H30,I.)8SC+!;2BZ MF;IPX^"6C3OS>(P ^D64!&%(8S.P^U100):DZW<4(UAS GR8JCNR TMU+XX8 MO/.8A@7;KKZ4&&'[U^PI2IY"%U_EQ@LUT(Z:](>_9B,5'ZD92;@4]^4S1AVT M^ S0& <0Y,5=L(D.EA6-3 ?F!&0))3? 2$A)@S_BNA[M^@)-=X[)>LZB(CKL M+$G/72*PG.>>;%(RW3M"R>:*C!Q%N5AG.:'C-YL+PX%^^\Z20Y!7-5,KVJ#Y9^3 M#\0FSR=,7++>?KQ[S(@E![(CK]=Z! /T,/276OFD_P M%(KR(Z3\"JD^4Y?8RXGX$.E\B32?(N6WR&_UUW N#']C?0;FKN:RQHZW6[0I M.CE+6'BE6[(MX164\*K?@]C7\#H(>"4=>*4-O&+Q+:0G(NK3[.-!]OG7,#YL M>!]4+\4=_V0I)C6@+<"[ $,TU>:*'"EYN?JJF=8#B:UGH-17V.9VL\O4&O(& MPF!D]R\G#(;U4LW86@%L4&M+-67MQ<)!L-9<.%RD.8-HOEB3-A=?&P'Q,<>\ MTE=O$FHYZS6Q@!WX&N5V@!=A]+@UBN95 >[XVHZ@[ADV$'R\T-+"3'%*%1!-44*0Q13G@<] 4W0:@Y8I M%E]2K&<-^[>%3UZO^4-;O"YS\VM;Y6.?1C!OK)MTLUP%?R4E*_(6%% EU!ON M5A1:;[U;(8AF9)5@UIVCD0O-C/K2VT"V:E"V@$V/PT"8@:403;KGOD@S;J#\D.W?:9#=)-H*"&Z\>+MPI28N>UG&2&I.PEEYH&DA^_)Y ME4+MQ9]FRSPRZ@7MWOW%J;>*W;)S">IQ>^3BEB7]YA,D6BLD3KZ0JZV>? M(:VLH(M&JQ[Z]YV59S.H,Z2_-G5^394/@5N'P!==\B+2#5J+,)0SVI0P&F0M M'?Y%F$Q7(T^[:3$OS7CFTFL9)J7 H;M=*4 XILX=FTOS;40W\H=T:TTC"UBM M.Z/<4O&RFEH%&(QZ=P.EW\N+%+RJ=W;D=.O> <'&K?+=/ ,PY^[OX4LZ>/!>S^RLU&;91>NB>JP'9ZZPJ%;)*R]G[M5#GM_>;&G+3[/TLXV3<^[%QPMK[ MW13/-#LJE5M.;]7D@ M6C;S]?A=D+>/(D<]B)Q8;G M.@9$8&L/314804Z.G4%T3(";SWC-4)FDJ&FK==O#(086^$*F*KD-M1D[.,![ M$FM6^1$*?FK1HRGU.2]T/(M\>@[!<565SW'QMEL)>7THGM,L^CO=7.;Y@?*W M-]N'=1X7;8>UBW&Q=F /F&_M'8M%5U7)C^V2LF'Q$D.KZ27=FUU^EZ!1\^T\TA9@+?%VGX^\GK:1SDUG>:C%R *T^S]%+$JJ(66.7T MY/&5" [LEYOFU@-R3>J J/["U %.@"8A/EZ)LF5H5D3,O&Y9NS3+Z$8(I=VR.7-"@MZJA?Q> M5L-!&I8:4"B[N&ETV3>ZY$9=0 W##6.2B;@!;++WE,Z_AL^L6^E&M_?1DN.\ MG=26U_IB4D.,_DJ2@]C']W>H3FRPS8$%(X97D.8!R("WCX;U.-913FGV.=.N MFA[K!YR$-Z";#]8YR<@+/BN9-5'[>H!S0!F@]9]%+M*'))K\-7OF>Z?20\3J2ZV3#*U65_S 8D!L[ MH TYZB.'I2HV4O'AK.5&2[^A8NB\\@8#% M:6$W4<=/=IE_T1[T&!KB7T/4R*U9CG);OHP0U M*:\2&CS15U=+UER#; MV YYI_T&6,;[M#VC/6FI@RI$<)/V)TC[&^3DM4-8?8>(#V$?!7\KG067S3^# MW773_VOE-[3["4*J5J'ZU0DO="-D#87/K7]]],T+Z[3XM]I M<4?#]"GAA^2&W>J,WP3BO"&V6]YBG=! MCFWC7BJ%[++/2=;\N8QAD;+_PK8OHU_YSRAWU,$LL+^YG]W\O@7W=4NS*-U< MI%GU*TYG"F%#"_(M.#I='\_H_H>+U,V&I5;,%S<1WAX3E(;L2][;P\2>'Y MD3QJ_'F?)K\PI=EF6KMEQ1 %;&>+TL]*[VG9QYFW<:4XI"4/*>_2<(E()5)] MVED+1;A4I!(+9Z^\B.[G=PI81[1.447O''CO; ]Q3%Y*5A%^>J;D*4N_%,_D MP,P]Q]LUXWF([N;ZC;L'MSO[B\#IO6[^#UINXO&ULTZHGCHB@7 3M'034.%,/G2>;-]D_YU4WJ3L']"(,],0@7:N!GA5& M;"L_BI7K9[YP-5\<5Q!";\&CZ9K&#;!BT".HMZ[? #KOCN M&/2S*"RJJPE" I66_/6/@ 5U8V#?I(.=)7UV4$!_F.3]7?(]^=>2.Z."7Z M3*L3UD+26WJ^X&M71%_"!28G(^_/N$X6/MQ3Y5G1\E+L7WT/Q7[UUX>HX D% MEZPK7Z+-(8@U=;$,M ">R"1I'Q^"CH>XCI1(-;'FD1H"UE9DU%"VP@(:OK]& MQ?,=C<7:5:2_IN=)P9:GVLI8@UK!@KQ5.R=8(571@M<(S53<4&@T(C<(0MX; MHH_%<9-G*9^H(H:\$Z225;I#PXA:\3;DPHD3B@QZ]4>+"NFBCQ82:""^#G;V M%^?T+&B [LAMP0A_:FZG?V@.!]X3*H '=AD]9LC+T &],QVSN81FV@6^CA#T M-G1/1OF NR8@?Z;Q!MEC3R0N[$5F%0KD6\LJ"*" U>J=95(4P&J=F80!9#\\ MH<@XP#5[7!T< ,%[RSJ3NWJ+G^V2 8*V)Y]4R)W]JYIQ4;WK2#$AP:D:\3XP M5<.- $JK/^T3(@!3ZYA:8X[L12<0%0.@9M^I'GI D%XF8;JC]P5SX'R]?,4_ MQ8^@S8[4R 4(7[/T;6 !+T#FOH6X E?'.PNG +'[Y) M:+VF 4[(#G]^319@&N;IP0E6;R&3MLI*^J6\(Y-LSK_N*3^$?4CYK\Z_TBR, M0V=5BHF/39&@K)@,W-? M(O^!_/']BG#3?Y-)F9/ZF,DR-2=U,&_(U;+#G%[<\,TW MY*!-/3>G[VU]=T6:+Q/QZ;?I3GUZ M;+[K7?IOO4V/->=U+;6GFNE*UOQW;#PZKWMEAJ_9ZH5=B_M-7L3RZ 3I7I5C M/[Q1ASW3S2&;PWF;#AHI;. LP=MTYHB!@(Z+A][KXS@^S]Y6NL.ZC7?JGN(% MDLKN_R;F2\\>DV?1P=WU1N<4C,B'IX]\0_//19IM:50<^.N1(K 3967J^&52 MUG::<>9Q^/8;FG-<>G+.V:;U_3KV7$M HJ0J*S>=R_RY[-5$Q!MF=YA#.K=> M5H?<4\95Y'A;-H3[[@68T4[M!YTM]@UY0'M4>_;(B;L(;\@?>O3K,D[C9@K" M+.3035\4YW\=K]E,'OX@;;GQ#&V%^$JW>D'<3 ESA34F%F1)GG7J/A[B7W-7 M!]L(SG060U^22QV[Z$8*'(^4:TD. M=^810-_VOUV'##PR_XEC!AAQU4E<"+0K?[3K^SA5!MT=Y5G24?(D7H +PN(0 MQ \TVYG>^5B2D-!.?B%J+R2B(3G]1F32DIEPH1'#'DL=L[<:&%E*?^IGC(5( M^.:F#_TQI$[+GV:<)P9)\X8FA&&]C9=0\JTY]VGZOTF/L/335;2EY+M7&F3Y M]V_9A8_P$5/[ZA$.X@V%9^PS4I.6#W:)9(1,;R@L,Z;GE[% =[ZP\:V<0KH/ MR%M=?6-Z$OAS2HL;@73C$SQR_M6L/;[RE0=S>UQ4GN:VIS>PNKRJLHH9=L4C.5+IJB\;>PSFOWQ>0+-O(; M;YZ(]O$\SMOKFC>QHI*L:+*ED61";\&I6)_:^LB:*'2G;N*/9VR1=Q%$V6Q; MU^EE? LN;H:1P7MDLI35F'8@2 @7F7"99]KMHK]%.7[4Q'-%3YSRC>8=S.5S MX-X?'.APOHD)H=SZ+WM"\);QFY@0_$<&;T*H(J'_:T*88-3$A*!^KOC;F \& MNARX^6"@O_DFYH-6IMXR)P,_ ;^)F_N3(1XSO[/]GR&GOU_$UYR(OZ M@A"JDU1(\4WX257OHJ]EOVUOZ=+E_WD6I)A>4VO4WX3CO$Z3>#V[$1(LFS%\I[*(D8I(RY5XHOZZ2Y/03M=3M=.0'=$ZN&O7!7O&):U)=3E*QDM]*YNE3 MG9VNEDVA6-!53*<0I'%[(;!OF5[P S2K.YI3U@_/3+ S^D+C=,_-W]6HG+@! M3QJ0W96R 6S70]IH5NR")PU3 LQG2'J!'%576_7*+,$DW%%F+0D=(07H+&< MIGEQLQ4=;;4.!2V@.:@D[0.&TXB+G@(XN'CWD3=CWC,Y+&-II45$'\U:. #" M=QV+UNE&O=NJK,N :=<& ('NK),IS-&$+X[[S54]$>#8PV"U'M*";43R(@U_ MKY0+VS$<.I-2&[IE>P/^B8^':,,#Q;.,F:=:D)[ S[CZ[L'/LMY"@'<=\C/W MC.O4YN1^<(Y@KO%S;R%P:^XO;^_5:H[P-MYD<-$!0Y,%$AT !&AVEPGS;_0A M^+H^%,]I%A6OZZ^1J=J"C@$0^EJ9^^ M"0FC) TI^8T3HZ[ES'W>!YJYPU&A M8*E94.'2R.T&F))\89#I]KT=--V.!X3-^79+0Q[(;62Z8[[OCG+- MHS@2SN\BS6CTE'0HSB+&F#&O&072Z+9Z9IKF >$X47](3Z'6S9(6B#D?Z38M M9L-'4A>DWH-I45.[?)HN,%IJBD^SXH6F-B_^D!B MO_KK?<&\(=_4?*3I4Q;LGZ,PB#6.R$(/ !V;Q/)!^Y$$T>$X=70-#J=>GAL5 M]*G_=:U?L=!#H<(@L1D5B+[#J:L[N+#U,^#TE?$A/ MT]TN343H]3F--S3+SZ+XP/-0'W-1%MTP-XUH$W#B&J-Y'XNLK7H%_QUO[GO2 M-,C+:Y=-DG:;*U*URAQ:U2[2(=RD_7#8\6!:*CU5##F'CX9T?X(?C>=%VO-) MD$?A)%9\B;;7R*U/.N0NUUZ.F$\ZQTT^L_+Q]\HEUI,VN^&N@9%,M*Y*:DU_K MROGAU]NPZ1[41\_%"'8MOAR]T'L:'K*HB*@I'J@B!K1,I:Q]%-9$Y$BU(F70 MEC 0"O])SH.,7QG,>;"ZO":$LYYUTNB*YOF?R.DS/Q_F5Y&V_!KDB[@&V;>T M?9 541CM Y%;F3>M8IJ3'F%]>]'#"_+4J8(&0T9]#!^%/"/:>4OIW +DV9&S M5M+QD&0JU>*R3.E?R,9PN'[7BYI[/-$G'4[Y00_0K'I7@]GF^Y%FU8LD[1?N M*DG/HCQDHW+(RD<"'*QNJ@\ &N5D?6*]1%\VW;R9D[>?P.P=\Z*;\FR]#M>;;=_G MN;\^-LV'4)X@FZB/3*]KM3_16DR3^B.$0YNT/L.9Y-7"LI[8FA);^G>VI@06 MY.V+<6)?.3RY-=TG(&]P3-?_S']\+Z/#?_+6J";9.-O=!EE_F M^4&\'-^*W&CK.GCR X#(5Z,^DBI6PLC)_?HN)R6W^'<[@HE3&6(J[?@YBC@, M)NO]/J-A%8>]XX&\G$2ERIPH=5 9PHP& ;6V)3R4;M)0%. 3W3OW>'*TJH>N M/6(C',7'+/U2/'].HB)W=@YF'BB'8)%LNT?0YR>D4UTC.BHC]R-Q)ZU^W MK$6:970CI@"S_4[X 2ACG[)/I&/.JFWRD)*Z=7)LGK1:%$N&]K^;3U13+Z(S M >DBGAQ4=U%V[**PU25\GFK_>]]T46[L(C!G-;E]=3S;,HW+R0V^$03YNMFI M4D]*#:SU\'ITD(D@/0DU8X!< <]1RBY2VKF_BZB'IT2#E$6A@@)*,D1U_^Z. M[M.,)W5>)MLTVPEO MX-'?2%#2=]Y%20LUR[(M2C-W=PN.&CN8W T&(M0ZLG1$*&-E"DQ M@5R)TM;=9ER@1;]N]KQP()N>JW6U_:DU+0?@^E,OM9S(6%'6IV0SOKWF6%%N MC/"8:T8+5/KK0@M. #'^*6"K^RB(F^(0;-?(CBK05B#@EI@VX0:EO"FXX&K$;,KYV6UX[XH;($U<>W1\BG*YIJ+W7-/W@ M_?!STS(Y-DW:;<_VO*'32X!07=-^/KIZ(Q#%6*4O2>YNLNTE"$[;JB)F>Z\V.608O <1ON$WB"B=J'.QNRD1](3\ (-H5 MH]YM>0$.T24"!M$Q0;=CT-WAI(;1O46S.*MPNVZ#!H(YW>)DE73SX.DIHT_5 M!?4JQF]+SC6S@5;7-?M0\$/IRN' [F[:SX ML+HR',@;H'6UC,-XU\%QQ)@T,MXXRVGXPU/Z\J-(:,U>2YA5_Q ($]BJ?O'7 MCR<*]+3_"("/CBQ]!'R^OGPX/R-_N;S^>';S"3;H8A:,;1S9O/,7-A%MTAUJ M-I0\F#7:Y)&<&4\7=P8\\3\"XDG(TA^VB[OU]>DY#H[4 F4\[K (_!P'KX^? MX\B-"[,5-]M?TRS>F%,U%82 (3!)1L7&O2 W6R*H,/,UG85E\^87H["0<24U M!OI1HAD!X!KS\>O;<9L-/R_+/J[WLOR/@%Y6R**9M>\?U@_G]SC.5BU7.6F+ M)R[U1SF0/OQQ'P+W&*9A'-R(4)HX[TSC!:P'4SAW&P DD>!,CK9I)MMKF"#O-5S>,SIWP[\ MK/+%I3B$DASRUHY:7BDWIR$C@FX)86935TMW< S]C(<.EW"RG@4/):;PL8R4 MA42-;7UO@]3"4:T<(G'X'0"*- CXQ12&3U">7N$PGJ$Q/N74V7 K#<;D0\6 MQ)?)"\T+KM3Z*:/46.' G17*&MSTD.IU-USDR$8:/OSPHMQSC.O8'348$MX MG;32FE 0MMMRSNZ.&$O):MCBKXQ^]#VD29%%JN)6M MH06Z@JN35"Y/6OX9^2*VL6/;]VV-O3KWZ%>?_)SD>QI&VXANC/>P#?10*#!( MK$<"\O5K:S=W\&#K8R!,7*09#8-)@\;,&A0W#=C((KU14="-^0%S M RUDL5Z%I*J*K8*L?" ^USQ[1[14^T**+3]#()?[#<,E21@MTS5,HI73 KJ5@GB4K>/Z!> M-O22^!^#W?Y?['+#W3O4XZ)[\W!F4+C=/1S0U2'KZHC3M[JX_(GMXWXO_\5^ MX,52_NO_#U!+ P04 " @2&E3 ^94SP)> #W* 8 %0 '!L='(M,C R M,3 Y,S!?<')E+GAM;.V]Z7+KQK(N^+\C^AW_>]< DB!8(U!@%FA'['.\)%45ZLLO:\K*ROSO M__-S'OWP@=(L3.)__CC\>?#C#RCVDR",I__\L_CA?UT^W?]P%V>Y%_OHA^O$+^8HSG_XZ8=9GB_^ M\9O M*/WI:' T_.'_'AS] __OZ.S_^>'_'7_]_W[ZB?0B"N/?W[P,_8!['6?__+'R MG<^W-/HY2:>_' T&Q[^L"O[(2O[C,PNW2G\_7I4=_O*_OMX_^S,T]WX*2RCK M6J097KWA:#3ZA?X5%\W"?V2T_GWB>SF5H[)?/PA+D)]^6A7[B?SJI^'13\?# MGS^SX$[K9ZNO B+\[#E))$"OQ2J?!+VT_' 8HS%.!_8&T( M Z)'E^2#/GJ>(91G^GU2M]1Y9Q^]%"OZ#.6A[T7V>EYKM@L8SSG^_V249I/W MR8*,9S(N6T$0-=EU]Z^2^2)%,UPF_$#W268/!:?EKL$\H0#A*>0M0K@$'G5Y MB/\YCH/*3X^X;92FI%[B_X[_1O\[2Z( SZ8W?Q1AOKQ&[Z$?YM8$8;E7G6N$ ME\UNH^2[14W8M-BR\Y-TZL7AGW1PZ'9ONT[+#CR'TSC$1.!OC'T_*?"GXNDC M!NV'2%M@BD;:$YRGGI_?A]Y;&(4Y;A,KU!/6P# FWT'I>Y+.R7PY>8O"J?'< MU:3QEI#N\$#)KRQ&9!9/8I(>B MVBT[Q6:1KRB?)4%%"+J]$E9OV:UK]*8]T[*RK8?'?!ZN%8#H,]9;O%LW&+_2 M)MI.,#L3O_:LPJEIHS.7'IW:YPL\QQM-O*+:K2<#_ 7TXGWJ$[95I>7G'U!. M-C-XIGN>X9WF.,_3\*W(R?+^DA#-2.(J$[I=-&ZV+;5H2A08Z^\7E$Q3;S$+ M_;N83MY&'*N::=O-XBU#?Q3X$S1/ERCW NU#716 M/M4EW'$0A(1O+ZJ0;Q&CM'V(L[T%P/:_V_UFX;F8S[UT.7D?9QFBQ2J]?YEY M^3A=E0_&^;J)23Q^0GZ1IA@7KO.0Q.GJ1SQQAX:C ;Z?>Q3TRPQ5BC\6J3\C M2]VW&*\(SX4_V_QQ/$T1J]R=.-OTIGNA61B4;;_2R:9W,\,_ILD"I?D2]XW, M\ O2(;R+,,/8\B,=0\23?UJ@ZGBUBT[+&@O M_#S\H)?@[1'IM-\ML*>LZ 00I]T],+3SYYM/\D]DGRO5EP#!;CD=[0\Y][/V M[M>L'%+T6MNO[7,MW2LO\HN(]F3R3L[-/EY]KL.HR%%0:],,]QX[!"2Z,08< MD(Z%'^B9F!X:'("Z^7:W1N=U)V[#&)]UPBUUODW2&\^?/:%%DE(896.&4T*' M/=B3<)Z0G^"N16&IRF4]7H]?$J(#MVDRWS@^=B,O2YW:FP@_4%R@R^6JF.EN MH?5WP("V64[M?M3R;9"-?;I)DY:[OYF *Q]M?$L\*$7 M_Y*2>8][OX4+?>8H#E"P0D:^I?T*@3X!2?RM!B/RZ"))MR5%VLMP@_1I18;\ MGZ?)QR\!"G\ATB/_H&*D(L0_O-(OC-\R>E&T:BGRWE!$VW_=*?-Z?GH\&!R7 M@+OHTNHQ3?V65] [47'6T5,.,^-TN]->ZJ_:QO_&57J:H_C&7^D311FK.X6I&(Z!YF -=@1TBG'PZ3SI(9V7)G1>5L4 M-/G:H+..@T_G:>=T[FYGR6^J/;T5TB,HR3 !3Z#:W*A \(DYV^\X:[15Q=M^ M=(=7$=[N1E6%">NB-YL;;3Q\.L]=I?,%MZB@CQ1A\$9.T;4K>S%E6QCX%%V8 M4I2C-$/W'?,TQKT/J TP\J8"HK;*4)3#0>^8XH/@4S5R=30]HC1,@ILXN,:[ M:\6PVBK+ ][QYHQ"6:O?/Z?A9?B#T9+=G>H8+-6FD$_ MZ2V7(C@")HW-+GME\B7UXHS>G&A162_.P /:N]ON1D5X!&0:&UWV0N9-G(_T5+* M8*TL@^W6(5Z?0A$8 8?&%IF]<'A5I.G6ODU^^! 59^#[=[Y7XA&0:6R/V>> M9)C8TD BZ++(,/),/LUNE620^V<FF8QX=: *V73;_C(, 4Y%=X7].TI?D M.\\53E*:0#_KK1%(#$? 9/?N-FU(I'HY21_3Y"-D\?&53-:J,$WN.9TB3 ). MW;0+E8_.EL.CMY/@@!%RY:=)9:=S-IS_SXBF2W'[PBC+0_=NK2K$("'39=%-YP\L">50B M>\A-KI**3"!]->QH(1,X^[MLYR$&JX="X&K,*_8Z' S.1R?]6PW%0 2T[?F! ME>&^M/P/03[4V916RS/HI_U;(C40"_ Z1;T4)4$33*ICCH?G:[=-$'"BZ K\@LR<"[3_ M;R39[=&C0/5WL(7M9^]G4+Y2"IX4I JA_!UFX0SJ-EB?)#ZY$C@]#[.PELAZ MZ=<9KEO[A#,H/XUVXW070\]#+)3Y(-2;@^V";+$"#JT@885/HP"#I; *'RA] M2]H:0MLR67IB:A-:*\]D O0:0$&3C%,1#$N!&8"IY>ZLF M?,O1N!,8HL54SO)]94_(1UB?\?[D >5JFF75F'R K+-MV-8"92G$!"CI7[WT M=U0&4UX%FU9S+JGU.AP>#4M)CI@@LVAR!:6]N^Z^W8F N"(A8VF=2X*:R$M2,H?N#'- MTL4]DAN#6LXXZ6 65V,"H^\##V%TUD^>?^&5R4B*@G/TGJOYZ/1,51@HD9DZ\%Q M*'Q&"\8WFPVM$ 6W_HV'N!(3#_!,;DMB*] VDVQ686("G>@W6Y/91 2:'8GFT(KJ6HER+:WX= M*IH3X'N/-G0K8#D4_Z,YX]=E3\L$:FJZ^16H4$Z![2:-N59@@@T)(LH)461Y M,D?I-5H0_T8Q<9+2%.%9WT:H#B"'0H'8LH:LY+14CU%Y169 #9E-QZKFM@< MB@YB<_-MM.EFHP'X2JHQT1(\M@*&@!ZY:XN.EO5+6(>)QIVM=9MSE1HD;' 1 MO059RJ>\ L5Y[LZRW(1,380.11QI,4TG\?0%I?-K]":G75Z!"07XGL*6;42. MT*'@)=:W9WK7&*JZ;"-S&(8R?; .Q41I>:55$9W^O1:W$ALT[FS76VF"&J5# ML5*L;-SU=NP,/O"EB'V[^!J6K5 JH#OV2G9WX@:?Q&1.0[$O9UE2BXKGXC!V M[3HP;<5@ 1W;C2Y'Y6(=#8#]Q2WI@ 9*6V%;@&_$'E>=I9!5SX(XI9E @#?[ M&GSQB98!LA6_!7205\*Z*=]\U8HR08 _NFW(K!"-K8 OT%?901 R#(]>&-S% M5]XBS#U>_%!%#288X&UY8YI5H&P%BX&^S2[F143"Q="#!XD7GZ(9BK/P Y$@ MXW-TGV39 \HG[R_>I_R.VZ0E)D9P%Z>FNM$0K$!G^F7+>T*Y%\8HN/'2&&]@ MLXHPKM%[Z(=R=W-5928L8+-.8\TPP"=0AGY9^'8%9;3%9RZ%AV&YD: 34&UN MM'/9 ;:%XRL=$U!)YKNS[@W74:2%5*0*H3R=_RY,^A70&J2!#83 M,9R>QY]CUB"*;_P5">+GB@M3,1P#&SDE[,A,8%PYV@"\-&'ULBH- M8 -G&U;K.(##THG\R38=OA6R)"C)H &?/+4I4H$XC-AR3X@:2O#!(5^^I%Z< MD:S.^'AQN:S^1;$ETF_D]>+X>'CBRG989X_4 )NE&'-0RVL5EW+3M%N8B0%X M&]R -37]-7R60LT9TRR8F1]+>\$+\F=Q$B73$&7_X2V\^-__ED_4RHH,,? V M6$($9][6QW0(L>-L!&2&RG76[N"ZB\%67#BHV7?;B0&K^R2E: -Z\?V(4IK0 M3=NM0]0 -?><@E\4"VG4\?!08CN(P'#;F%DZOW&1SY(T_'-C/E8J0KTB$Y(K ML?6;*8 0D[5 R^?#^*][][-BWL[KSFBX M5@EJL*!A Y [!JHLMUC]R*,\TIG?PGRV"LUP\^E'!9D92%13_+] [@C?H#46 M1@O8_5%%B^A*HCE:2_Y:X*X"63YY5\^O6^685(%GUV:,\W%8\LT"72N_I$F6 M/:;)N_0%0Z44TV1@LV4S%GDH+'EB@3JIKP-IE,E:=-))"NLPR0";JYKQJ\9D MR5$+]JX111%97.* I6G:X)7=.0HK,=D NVVIF1-<0ZIA6?+B@DYQ@K! 29;% M:[P&10G-Y*)F75J/20AX.6Y*O!XR2QYBL LTBK&((@QT',S#."3BR<,/I&9? M49-)"=@VV91_76R'D&UT1T8FRSJ3!+!ELBG+8C2VLHPZL6W;/)[68793FDD# MV [9L .P@]L MLR%9V??#N,"0-]=-E^@]2)\IN/K$0,=HP]M(EO;$C 4S)S4!"S1-: MBW]G7V5A%GMIL-V'5*PYL$$>)=8"*(?D)3X>RRWZ@AI,++VT_JH0V?)0 [YZ M>T"YUGEQJQP3 K"1MQFM?!S6W,\@1^TJ7M;*F?+2RT)?0BFW/!')Q:"7NTHY MGH/P/JM#O ZC(I=Z& IJ,+'T<8LS3._TYL6+/XW.*SY*+(WRR'D6$ M8[R?"9, _SXE^8NN$?NOCN]5Z\:9K%UY5V1%ERP*Y1#\,F7BN$U2O!C&+/VE M7PVO@AF@/T5,%];&>HU8YMU\D'$"[7Y@3[7,==>"[&SYJ (_PZI+1T,I);68 M=%QYA&5E"M1!:\N#U9WXR=7=[!,*$)J3^#.X!-[HYR'^)\L;M?II^V$Z-]KT M*B(_X$ZX838HC?HLE/8QP!!N'H 9=Q@\\8V):/G#4P#K[PC,6Q%QAR-G0IQL M\Z0@50CE+Q^!&8O!E>@E0I($"ZH83L\C,',7RNVE41G"5[L-)C1@RX6$2S[Y MYO .X7700Q*G%G3#I!DF/V!CA+%Z-$)X"(^)UI,IV_R00T<2D^VW[J+/J\AXLNA+613-H__;$ M=GP&_3I(3H_05") 8NME$&B&2GX:3B6_TGI,HL!GLR9]V*7E7MUXO!X.($:.EL M2Z\V.!=?P61I7MG;XI_J^UK\J]WY&?,P>KR?LX8&@$FR7=JE3$ M%ZY$W)9MG(P1V7H/8\DB:85MX:Y+OS*3#] 5@S&)YCI00VGKJ8NMG=G-!WFK M(3GAK N\GN-]AS,N \HSS6Z_.WLRTEK^\L-+I0C# A3<3R!6D>QK/19(OU\6 MG?8) 8>CI^%;D9/!\I(\4JGK:X6Z+2905TR% M#=7$ *9 ;XQ-4P[HC699>^C8Z4QYMENG$CQV)2!&I[HC "YXA&1L: 0.9[3EO%=FC/6Q@%)I MH#-)+3(W#YUYVZU]U-4 )&"\7\;-+: L+'2)D^1)^XKR6:)-O* Z$W5?YH9& MR 2JT+=HV1RM?T*Y^=@O*]%M66\V% 9X!'3KFT$=I+O$N%%N9M;3)5Y0G5Z! MCGH]]E7(!,J@;]MLJ0R"72/9GGBQCVA8N=7[FF^+)'Y ^6:#4_G;:J\SCIF_ M-E-]T;;14O.OP\'@_ 0ZFK'9QM$Z=($&[2V:=5<:1%?-SA2(MEX*L2]&M$Z0 M"]3'V%+KBOIT-/&4H^[\[/P"^EW%GO2EAEB@)WLRN=K6DFXF%S:TJ,3Z8D&U M"5B@(GMZ<2M0D:KY=Q,(I'KAP'&]?4DJ8$5JTK[EUXO!<#CLE:I8!"U0%UAS M*1]?%XJB*:US?%(XZLL1R!Y<002>OAE$-[$\LY=$\'R=[LHD)V7M-LBA\ORH M+Z>AYO $NM$OTZGLRI+^;4(!9JOU5V9$,VZ+4>)*U&@;M[QRF *-Z9?CJ=1W MPI+*2!IC]LN^S2XM< J4IE_1EJ7XGU"6IZ&?KT+H?O?2@,89ODW2=Q3F!?\D M;:UMYGGARM,M*RIE!%N@8?V*,RB;E;M1,.VFF: /:9DS0BU0+^#WWK+1\R5- MON>S;W&89[]BI-P5K$$KKZ/A<-2;C7$;@ +*@=^ 2Q2Z+>/\1I@\>F77;X9/ MP'>_'&%U3H!4\=\\FC%@3K*Z4C:?T!]%F(4Y>D;I1^@C)K,GY"?3F+8BLO/N MZ]-L,]D7\\W>I2)07UB+\3/*\ZA,$7 S7T3)$J'[Q(LKIX6O21"^AS[+/"V] M<&K4&+&H#\_ZXOIB := #_:6S=&.)D@OE9JTQ>33KWU+&YB"H-K]BN^HE6,J M22F+9@]%6[;,9MV^G;9M@1;H5K^,QDW336(1],V'F@]!P&+/#+DM'P$?#8=] MV1NH80@8;1@4X"8&\X=M_P08"Z0O:[T&#@&Q#5_MUXAU(TG=E9?-;J/D.VBJ MY74GS/+*[50C3%\,AR CIW$Z.7<9Y&K>G_0V>%R^2T._RC0 M-FW?,G4/@HH":\(IQVIB$;VEU'5=:(P0S\J=^"[.$XZ7L;[F MM/L"M4.!IZ]KKT&6I& IQ1W4VF,A\.*%,['X=#87$@P]3U[W@'*RN7Y,DX\0 M'^'P-Y:)Q!C)OC.WC73EH[+(K-* UQ6DI$5XO M3:58 L GBA;$Z9E2&<3#2(]7N:@FM\RQ'T9H"R_>*UF;.KKX'./#2;N?9'+I M5!*'D,#O&N'.^B$E$O\[0I31F#S_QSNS/^GO)9JF4YW)"_@FH%-%X.N>D6P. M(F4@O3VYK/O:J&Z-=BHPH0 [(P$HC$(:L(D#!>?F!RP7+(0UZ'N$^T^BB(B. MP<(*-(', /C:?X^L:TH#-I6@I8GAJY?^CJB_PR:@V\#H>GQ\/A7T>'FHJG==9#-T([49\;CM16-USK[:+*64FG#3PB1Q?0T>P! M=,M<0+92-().65B@)#X6ND;LOQ41EI[%&@L4DVZL;[N8'U.T\,+@N@1Q M\TF."6@5,FN<92B7;:.:-_N8M,!= M#[VW,%+E -&IS@0&[.[0K7Z($,/F]>Q,158K[1/Z0+'TW:NR+A,5L,6G0^40 MP3V(G*.[<*^2F,KIMS"?7>&S*#YUIJN!(7NG8-@2$R/P4Z,.M48//&R:4U&H M5+%4J'%\#>.JW'#%P6;W);IT:-4H,\7W75DLRL%6?E3'YI[:3K[I!D;<#&7F M&-B"O+^C$ ^YK12IT"Y;FD90*^Y]3'A_/=-P PG9RM2:)W@<.*9>=_$'RFQY MD4H:8\)TY;62KJ-7"YRVO7A>* MNU#]1ICP@$W"+3CG*U$#_*TSO+IAX-M!SO,H,-$<7OW2_P!X)]V]ULBQM\[> MVDTFI<&CBB-/*;I9Q 7QI8%V% M&N"WEK_5P2/1;1A[^!QJYT@D:8P*$_K)MJTCD0[.UIE>G3@2I8F/4)#=8E%R M,T?)EBI5728JX&>W+1@6+%':L%LGAW5-0Z[16T[C]*UP$R]\Z6Y&69D)R\U] MKQT=4>!NG336!25Y0HMRXS9Y)W@E*E$OR@0![/MD70&$*%MG>'7DI%-1<--T M-K M>Q-)!3V])N7(47-:T6B)!L.$?G'=Z21C(@38=*][/P%;.?E2*D[=###27(,: MX+>6_!72?'+S_HY\$NC^$T^Z\10]X5EQ$A-1D/\C9L@/+T+T*Z)4YGV<-,$<5BP7(D>=$JVL-=_)ZD<\:D1AQ_O1:8Z)S,^"/1%E-P M!Y%%E[G[OGB?*"-I]O")2NX<7RO,A &=X\>0.#[]$G"P"6VM,8T_CR<['9JW M2E(QG$'?EEOBF(\,-GVMQ8T#$4L9@VSC1!(''(O(=9CY49(5*=*8]]LVS03M M2E!KD^V#%=0'D2UW)T#\>$Z>P9=!WU$PE.F/JBX3%;!]TAK? G72%H*M]+26 MTY)N O,0D_W+#*VN TL\[))0Y%>L5YME 0 ^Q':D"$W$8"M#K=4WO40^$:)Y M,#>]7V5SN$U282((D6XT;I!)&CIU1H?JTEXRG26WW4LNO$DZ]>)5W.J]QZ.L M?'R3BX]%?7ZL )V\ESQ[T29-G\:VRDK[+#O'.<0=II=C+9Z\ER\X,0#97>5. M8=9Q8"N!70H$UY1BZ):2[L&,S>=P&M.,VG%>QD3"$]TCEJ!/KJWWGI-AIPLZ MF16$E5Y)/M&S$8293B;6%\S3923W2-)K@ (\AXY_JY:_P%AGAK'7XVP5_:42 M@($:KDEN+H(:I=0.0GR[WZ)P6D[%^_>KI1&-R*Z6%ZY&8S!JMD!(/3H] AB9 MB@[JC$W=)AA(X .Q*2'\H6H,N=>#M?+PC^S_O3#]U8L*]!5Y9,O/GE3N6V_7 MO=B1M0E M^8V/GF<(Y2212A*##*)J-YY01!R1S8:37@.$M>.U 0SJ>KC:UTHGM7:?!LTP ML,#F&T->U)?'VJA[/C!%$0/V[@[+[P>>(/\C">/\5_R#YA U;(D2>7$,,%8% M'=UHF\Y(U6^$ 07VUVU*#G_ -@#?\^%*'SON/Q_A6VYTU#WVM!";SEG283[G+'%?.^C=;<+#TFN M,SSE%1D_IQ!'0&Z_S(:B=AL,)KB7L!83@D.?,=3^C[C==,![WY&MY4M?FZ\[ M4I[=:<@2FGKWC71U];)89^O9JF'"\?G:Q]%)@5Q6^ZVUE6W7,A,)\"6&)58% M6V-+ NKUO%#QG-_[9+#^MM'V6%*+4G(.,8PYG=(9H[)J# QPQ"H=8?-'EQ:T M7@^=!Y234/N/**6SQ#C/T_"MH+&&7Y)**)5RD[%_TZJ7$A>#30A7W@CM M_WC(^O.$%DE*_8$U#H:"*G2V&T&8:.H],CP,JFLS:-#'0)7 PP@L/5"0_[\(6:(L:OQMD^] M^$;>1MUD>8CW>]*X>=L%F0R +V8;\RS (LA2TBL^RP@M]=!3VL-4B] &#(-$[I*Q;YY5,N@2Y1"JSY-C7K45Z4P@RAX8=PK MI;A*8A^1IP74]AYFOU_A;HL_8\QP0'?"F@QRQ_9'4JD M.W=K+?U4/N,<3U-4&<<&CS=%-6GRU>,AL"FN@388X^O*; /X4!-H,M_K9>3]>21R- WI-L$MEM01YT?@WC<%ZL,T1=%SI.:(8M4?_\ M$Z.[3,$V:*-$FV6_(FB]'9%1(V3S<#2"3DO:5."<_5)#]+T^%.^^) $:@ET^ M:3J!>+^[T2;V?&5Y%7F9GN>-O":#!)[U1TOJJ@5/#K#_(VOGT1+0Z'+ZZ1+( M@\.-"JY?R53[7TT^6X;073;8Q#9MG D&^!K0$K?*.:"MC [K\,07QR9;$!7, MMSC$DO[NI8%UY33\$F,!^#X25%.;"NP0/*4VLKF9+Z)DB= S2C]"DREV)KBM/+Q,6F0B +[O4_*C',Z-(!_6QFF,!W- M\(8?>%KSBY0:4&\^26I8%+ HP/-%L0JKW^1QIOV/T8ES 'S;T5K]K$NCU_9M MQ7-0* .;W4>A%P.(%SB5O7BM;Q4!7R[+/QH>ATQ:9"* -L*I^%$>:!I!/H1E M@VQG8S^,PG)*HB[K%3_-]=^Q4$C&/C*'E0+)R%YPE; %KZU:P?>M?XVQX?#K M98D"=BF.0SA5XS.@-YVF:+H^>]%$!MI;8:WZ5&)#Z.RJS13(#&"OSZ0[+Y:! M=@\6G\$/!R9B&9Y?-T83XG: T]\*X_!/SEM697(W;*DF!3D)LJ#(6X/;[$"=[LZ-Z/G&- ML'RBPWC3 V$=Y$MUG%]Y:;K$/:7>T+('ECKU&3RW7])="(TO9A /81+?W+,1 MT%=%2N0K/71QRC.) !^;&I,NAW0(1Y]MA"2QL2'/FRI,+L#7>9:HYJ ZA)@* M5(NW9[!MW#3=9/47E9**^;]QNU3"([?SD\K7A?;0;<5F2'(O9J>DA4NJL6RW(.NQVH*N1V(S.QV)IJQ79F9*S-*_0B'^J4XA_ M]?KDQ5,T_@QY4^K6WQE(X(A5 KEOD\3OMJ4=TMZY^8KF;RB5L<-*,*! ;J-\ MD0MHJ?77TF9FG\24;TRDU&R586"!SILBP>_2P^^SI0W!7@GR/M4$5!>N2HR^4EBOW9W$M_%ZQ,NE69**%O2G46+6-$EJ(B MN4/Z"N5U,O?"V(CT[:I,1."9UC1YU%4# 4:^&ISW10UV(P4*YVQ5%1H. ]J= M3ILW/NU*;'RZ+_I"][,7H:R\L7] N9)K;GDF#. '4BV)E@/CLSQR>\?U7TEZ M561Y,D=I)CE0[A9DL*'O2'5/EI+^"X[_ Y=Y>_#F:/*^!4JX $O+,RD .4YDO!+HY3"L\&9\>G?;@0-&>;2IJBEC7A=NT>A&&#V@2]RPRW MVP):>F/C$,8"O%R^X(\K3)P:M6E:A;,^C+XFH 3T]\;F(0X%B3^M-'9JU&:2 M GZ/9L*HH4YPD IT LI"8JP3U=B1]V60!^6-8WX#R(\VE:;$_X4^1KQ<;LJ4,:Y82+6U/.* [!&)=48Y>KOX'.," M^G$!5SL$EXU="D&@D-W;M02V1OK$43 S;!>@$*!=D+6F!$&_!:+OWEXE$[UP M2-:+,!A VR"!1$5BK_58(/C>6*3&P7\593JLVR25).93K; F[1#IC<"CEABM MP(W@"92C-_8J,MU/WL$59[* 7B$;L&],4:MQ\1]&",: M=$>VH=HIS"[#@-]2&XUK"0;!8X3>F)Y8//ZO*)\EP2;4Q^1[C-)L%BX>44J\ MUKRI[*&6=AM,:J[,Z+MD\MDWAR=0BKUEO^O*Y7H#=2A1!UDU]@0!.I"4J09H M(1*0;FS? B9]UZ/X >7J JR:DRZKMPXZ)*NA4A >K]>UI/0W=^)U1UO>ZZ3 MXBU_+Z)=]!HZ8-(./1N=]DXI&D$4:(GY$WF@%&PQ?>)L-!?@CAEGAB6ZT)2_EY M0%SO=70\'$#[(MG1#3V6=Q0G&Q:GKCF9>/TU7Y8)ROFYC$ MXR<2I'DMP$*L3FNG]F.=UEU:BU 22;PKI7/&I6G$QB*0^J MB$_6OL'$!'Q3J\4C?WJP+PBW(DV9KSC\"*:*8!_"2E@LQV OZKHC6;#6J,7@ M5JRK!B>;6M#"&E;^;Y4WE6V:9:(%#OVNP;SHF&,!.52<+H&S20V3Q.%GMR3% M-'1E/>EHOE!A[VKS:8]4N2L1KRP#!^E3)!&XDIX:!DMAO4"/EC8?NF"Y7(R MI^!]+?)*(5@*_^6<X&O1KE6ACM56E#0W5.%R2=?JJ\C+5,9(89W7X9 $G7-EG=C?YD,D!K"@ M;=W,I12AS$Z8+8SW5;EH[\OL?S)DA17EBNQSFA=HW0@%K!@ M=@[=ZMUKO *Q^ATZQ1P!.Y'O?<*T*CE; ?] E^&O28R67[WT=Y3?%G%@D/-1 M41./[_-3\/=HW3#/US)M@=B*2@CKOX32G";]RE$V>;]&BR0+A M4N1X_\B>SHCJ,'$>P,VSKH*H)6$KOB-,PDD3+\B7&:H4?RQ2?T8"KGS#GTR? M"W^V^>-XFB)6V=3747"QSFM:XKNHK(/'^.GQ\@RTA!L(E#^. M1&"@' &5>D9"!T,& 2N,22"/DU\HQ0!=N3&H\.7.($6. 2C0I(.762[W 6]X6 M>9&*TY*)BI8R #(Z-*-&"@,JRZ2 G3%>-W'Q3)Q$C%>,P3D%3CG(0?^!#Y[(Q,D\*;(Q2D,O^A7-0C]")-2M%RO6 M(9VZ)?Q>[;'-SWC@PZ*OGO=;$?F"\;Y59+)7EESRY: .9D<0D<3Z%>>!R4T96#IU@I*(ZIILYB(O,UO7O"_,KQ-)"&3E6\) M#5LJ)0B<-U)!+E\C&B.U=)MFWXMF[< EMR\+*Y00@4\ZC7GAF)PUH%JZC;/% M)E'E;/(^6; (YQ)?M=V2):B#>>4IF-*5Z"W=VW5#J=S-C5>V! 9D,%9*6TE. M'86M"SN;_$S>5]%R54-NNR1#=7(P[P150TZ$WM9M73>M&JQPH?4T'Y$B'D/;A<\!RFU%CZ_N)[L^TBPE&< M3G<+D^NEDS/H*[.]'4UE NCB?@U.$ZZ\'$V3-/R3 M@K*Y]]"/Q!W+SM:3:5M3T'/QEOEI2#NTVD.]H'0N=(05E">#/4-Z<2G2Y]Q\^E$1$$%B>>/_!2_>IV0^:M!:N9,_@+L5I5Y9D9) MZV ][3!TM;P M5SC.-!6,0)WT[:DCIDXQFGIY67:?SQ:J*3G(P[DD)FX2S_X,!46$]U*/:;) M:;[$0B5)LQ;T>1[*@5XM5'O[A"(B,;/W"WH-T*A=9\< [MIV*>+X6!X ;SW M-Y0M?_P)<+GU/,"8UM4H>B3#KSJ4+I<:%UH:M9F@@+=S N[X1)N K6RP5CE;C'VQ8T2Z+@;KY(DP_FG*B\OY34 M>KTX&1Y!'^!-".2K@ Y"2P\B@&TY9+-5X$/$6D9*]@4UF$2!]^CMF5>A.X0\ MD;=%&H)3'> 1?4U?PNQF*; M8IQJ^F75F'R =WTVAKX&Q$-(#-DV>@O=/@&/=Z--O@0#U#.)KO?T7U*YY4U> MD9V.7:%XES7#C?LVID/(K3CV_6)>,.,&POWVPS**QR)"E*8X&,^3-"]]O822 MD6B(K4\PN;MB$]#5)>OH6[\.$5MHG9AP'I!,F635J(C.@=' */N9KZ(DB5"9=\J$K\JTE0^CROK,E@.I7+7 M8( _)O6A6C+D QMO)OD,I;NC4*T3\HI,2L!OWZTHA"9.2X9]Z!VAL1HH)-.? MBSRQ!J@A6C+AN[1$NQ3A;Z]K\SG P*L>#R0PJL589X&/UX9RY0\O+JKN%M>] MC"FRDR?Y4O)9$E3#:3HTJ$1=C(/_2,(X_Q7_H#FZ#%NB'%^<01@MU\<.09>5 MKBI:#3" P$&,FY(BL'Z: 7?+QT4KT)L*X>YO$9*D3&O;)!,EM/74C/5MU;$F M 0=WUEH:)0(G=)-15V(R ;*#6B-T5T\T4=O:9MOT;7\LU_X7Y,_B)$JF^'CP M']["B__];_G#;V5%"AO*%&'(+^E43D35YV%_N*3#+< MT@3@R0#(_M&./ 4@2]XKP&:O\K3RZ*7YLA(X3^&^*JG%-!K8X-5JP38!V?.8 MH *(2@=6:3TF'&"#EPYY1K37L$$%^&RQ#WM,DZ#P\TGZC-*/T)?MV'E%&73H ME#1M=^)29&XYL)B02LZS)2)Q]$AI>28$H(.6DADAD1(@4"$^]V6DN=?Q.--N MA.UKH#T';*S;#3"#A1NUI2O%6Q8&H90&4$NM>5=&QYOP ?-QZ])1O'R=C'XDF10-XR M]R?-)ICHH'.JV5(L8]2VHKD"*PP?)DDWEV:S(G])%$'V$\W88BOXUIT!23"O!)3$H7YY*F#4X7[]S&<[KIL:@)S5M\'0X& MY^"A;TTUP@;>P[C;^]5+0[+H/7FY*AY-O2@3L#.'9^.%7(BGYQ=V55S*17RW M,!,#\ %7R(V:RAH*MR[AC,F\3^* /(_'"\B;%_\^><=]1@'!>7]W.7E2QX[1 MJ<^$!7P?+^&03[H9-$OW=G9C?6YO5,FB)$G#JJK"H +?J3>8C[5Q.9:/3]!E M>9(P:26&%"B:DS8-^NS54#F7L \KYWWBB1,(<4HQ,) Y%/5DS3L&\8%8>S.] M;Y]AFKM;XJ"R_CN%>MJ_C2H?!%@*OK942?/"5Q.Q4Z1 &U"^S 6\U/KK6+H] M+6:V,ML+N-DJP] ".NOR)+_+#[_/MM+@64X0XJ MJ[BI0+3U1MX,$Z$SCS-LZXXF^ /)"4=DA&6XM0Z3/&8A=>"[14C+Z]&@%29 M9Q[9M]>>)MAM)85KJCR"[6H52GGPO0__*$+\X_(EN41?\=8NQ_^W<92L[USU M6Z"R.'/F:-E<#YKBMI4USL$)I$R7=YFD:?*=.$!X"_R7?&DX@XB:>3T_.Q^X MX_G7S12B!'\0F>AXR&\^%V'*7*D5NUV-VD3RIT?.//GI1E=$F%MGEW-!1;9W M9U=>FBY)ECY1-DN=:J\71Z>C,V?B!MC>P0K "K2A7SE0>.K_A(C-B>1J;+G@ MB!O"\C\9#)VQJG0SC6C %^A0OU*I;(\6O#T/DR#TRU=OCVD8^^&"H-.<6T0- ME(9,9YXYVYYFU+@%VM*OK"N\D4)-V%Z&KA'[[VV2,FG(H^F;-H4E>7)Q?';@ MNQ<]"0ATJ;V%=R^O!3<& 1)$@F29QK,KPN,%9<_%?$[><+]OWDU62@.])I3T MU^B1H5$[E.R+M;KOUSTVR[9ZIWIVR*]0(@"V:C04NF#$*H#V_!&B( )3=KFL M_J59B#).(Z7<@#>2*D[YFM $9<]?,E:!&04J6U^#$SD 7[,UX4VM 76$CCUO M_)J\K2SQ"R]6^%MP"S-HT/E59"+GV*$52"R]0K1%TF_HOQ(Y,YL2)0A@HXTA M';SN6WKO9XN#2^]M&27QOY 7Y3,Y&9RB)2R' C!JL"+% ?5H3T1/\HD"!2V; M(AC&Z=G)$/ANWI0.7O^AGMN)(DXC+WV9H=1;H"(/?7'>74GI4L?Z18X*"E08 M2]&3]B)/XF2>%-FO:!;Z$=):_^6U2K# ]XV&O.E"$!:*$58O M]SH<'AT-H#W5#3D2@W#NA5L:YJ'D=<=NH1)+OW;/ @2V7K99F^2"?(82@E\Q MK=7*E8CZM846@P![P"::N\+8\WT4*6:NK5(EFG[MGT40P-ZM"0BYB5$Z7?[J M%9%BH.P4Q)A.C\Z@\H TI$6"PM9[-6O,1,C/T]#_8'L3?^:ETS">^CJ;-9VZ MI4XZ9'C3X<\(F&O/UB27#NO+01&E.G69Z"Z AZ29Y;P!.-=>L)$@TRMW^/$T M1?3A%O$R$W$IK%!B!-JB-Z""PZ4&.%N/UJP^#=X. ,[$@&>FE^2Q2/$\DPG9 M5%8L@0-M8.RP:@ 2]IV9\)7IRG%@U>%'O(R@C5Q$["HKEL A7PVW9M< 9(=O MPJ"]3*R$JA;HW\:I8/)^6Y 4I^,X+KRH? BQ"B?_#:-)'Y+8)^F+([)N3A:( MN"W'TWOB]R-+>]O)=XBOTMG1P&0$.N9N0@% O@/OC!+^!;1"#-TEL-ZGB'EHTV M#@TP6G(2 #[7E4\$D^0VG5:B"?#7C%Z7MT MZ.C]C<:]%(TEOR;@$5Z'J!S<_ I,*L"^'%*Z]!BNH;'D^V1Y#\=]!J:*%RBL M\CH<'!]=#($W<0HBI%9;"21;;E)[#SFMRKO(2^?ZX,UE4:K;-/DZ.AX>0=D1 M&\WAUA"[F>M62XE$^*0YV>65F%B K'_6.-U5%4W4!Y+']@5_8?(^3E,2X5K# M2,PM3X5R[*:[A7Q?)X?38=[9?7)<@4?N^AXPFLUOJJ_\E)E]#%MB@@0^Y\LI MYJM%4YRV?.1E MV>3].4_\WQ73O+ .DV4?[_S4D&SYTX&&H*FB4Z?3W2G,A $=[%E)%9]B"1Q8 M5[L6.W?]C$/LJ O\],SX9,;IOXL!VCM(.43Q'@'MF@6B%_!3[[$MYS>KKHUL MHT>4CW@'R1+9[)8L5WO@><]H\"B1V(HZ;NUAX%9?Y1EJ>&5+9)!Y\&3B5K)3 M1V$KL#?4OG)'6^\U\I.(*S$U!W[Q;N=2>!?3H03P1CF9LE=1^29%GN5>'.C$ MV%5591X5KM&_RZ1 !731'48D[B2>DCP]NPXR:C505&6"!!AHVZ+7O5A86?O(0IV,8AV;Y(J#*MKKE\J M.K51P<:\UO;TO$W2U:[T/Y&73F+AHSZ=NJ\7QR=#:-_/9IP:P;,5HKHSZ[[U M)WW$>@8=(:P9L?K8; 6+[MP]NZ:9+]^3QH,6UV7&G(%K%@\[HW8+GX!@6&-5 MQZ^LCT>]7&(-P D>S+3WY]K+ZUMZ13%+(MSIC#F2=,7N V:9=F)CJ%>'%;R4A+:+IJ@?TP'MS:O4RGL@'VE=;ASO1&?87+TFO97E^H4UE YP]3 M,J5]H;Z"8^G!*BRU>(.1Q!3D6.G[MEN8R0+8%T9"D8!3,0Y+#U5=X?32A-/+ MJBR 3T5M.*WCL/1 U>KAI]+=6[DCXFY)!@S8)J%-D J$I<>ASBR0.E? W/), M(LZD^C;="LDQ67KY";SU96I,(=:/#LHIEEN+R0?XKD_.G&RZE6.R]"C4@;6T M@I,=$4W89C6H5,Z +_&L,%W#8^E9J%LL5\[_)E17JC'Y )L@K?#- ]794U(@ MTZ.5>'_6["OUWCTDN4[V2'E%RMUH!&DP4MH/MPI2*_D .INKGDP5UJ%M/(=A M!KQ*8MR##(-8[Q6_Q>$?!:JX=2BL@KI-O)Z?#T[/P36!2Z9H$C5$=AA!]79@ M2Q]8:]1B\@%/$&M(IJ9.<& "Q\"SI 9/*$!H3H8)PYR'^)^/*P04N](NI=T& MDQWP#8(.MWRM,,=Y&";*IGJA)27@NX;FVJ"+#M2DZ>H]XMD >*$PVB*HH1R: M9;3AU>'9 /IZ6,F4R=4AA6/)'.J T:35-=/9 -C<+:'(Y)J)X@ U=W9TS70V M<,@V+25(!<(=,V6&_)^GR<A($$VJ/(A+Y+#[?;MH*_69WA;CZ0,&+7 M=H'7\]'H_ SXVEQK@ CZ#1UO3<: _"U[I0A# [3L"P0KDGZMQP<2"VVM@O<: MG@J[A9G.NN+-9W32VL7@:+0R^I CB4I/^%\3\H;@,?DNV[T)*K#)VY5@1KL$ M<#=Q*BRVPI$%Z#V,Z;W?ER(,2+(E"]R5N9PFWV.\S,W"Q0LNG9$;)!%WP@KD MU=T VOAMQIT:BZT(8Z[==*S>ZU#['0J&DCE56??U_/SXI#?$F\.R%8G,\JR[ M_2KDYM.?DHT0OMIW\:M$;+.PI[MS_'GTLM0<)7,%RC.&#D=)ONL^-.2 MP;7[[4HIJO)?:!X[OW+/24\ W\NJF3*Z#Y0_$JT7T\)Z41&XCTJQNQ6 M.28!]XRRXG'*[SYP@DM;4W#S!6PME3AXQ-LN+<>_+C['& &^5N;KB&#>[U(( MAY&;\PGAW5'HYZ4OU+E1&T)YBG9+/US<]H8#Z'@G.4E_2 MY'L^HQV6^S+L%&2P@%T9]LBU0@H.>A]93@1 D$(_OM+:5?"[[>#+R0ZB_U.T M0"LU7^X";FK]=<>5J/F2^BM>!4AP(_E6O5**31[ D3Z,-NJ\SMMR+P+>$)70 ME!OLK7),",!7P3Q2I/35^M[C!)0O84Z,A'=Q0 SNA1=)5C)N62R$XPLH_S'C M54T. =J7R2:/OX7Y[ E%E EZZ9TH' ,;M,($!V3X4M.I0;\FO@-QLKI&;_E= MC$]:A49&T=W"5!S0(=^-5EL)!F@GJTXHU3)PB:HPT0"?3R2,Z5#,06/++PN8 MZ-416S%JJ\7(_?CP'#IVD\EXY?;^0)RSM W0=6,*$0.PE8C+BYS"6N^AO:NL M>=A%>+. 4N$^F5^0B.'\I ^;9$7_;3E=.4.C1AR([:),%. O^[GLJ*BL(;#E M-@5,YEWL)W.T\3 CGU*'>9'4>KTX.KDX@S;,FXQ6'3"VTDZZR;9R'$OK42&= M Y]L=$@THK^&S59>2VAW LOA9R)^VWD@[6+ 3I]IY M;)+/4/HR\^()!9EM@CT2P7U;)'%ID16ZH>Z_*Z_G9,OKRJ7$KM)P;F4AI60K M\R;PM'0S7T3)$J%GE'Z$/N)+]"&AZ:\0NSS/Z%NRZM^ODBQ_2/+_1/D3\I-I MK(CAV]DWJ?'DR)6K:I4*[T\M#,Q/:(T3(+;)"U_1Z/AD2OF_'9ZV*E\.LP'"_@@<)V(D/Z9R6#LY^$'N:Z&"0I>S5Y7[2J] M42>]SW)V 'BKD)MI! UOUS#1R/.+HSY-2*5*5Z+:=S?QB+[%Q 8\OUABWO)< MI!29I<>."[HIPW-LFL.9U_#LPK)I7!X*;N+<* M_"LS3=&QCGR:-I[\JES>R+5 YWJMVP7"W0@ZLK?3ZFXLR8-("F!OCO@-A=,9 MD> '2KTI6NWQ'M/0EX:7V4\/V-+[M_[;$Z2E)\LN' P;OQ2NG6?6&[VNQH+5 MCC F@1^HP0Z);N1Y&,EW.S\- 2T8K?K%./[[U-"U>"V]R._Y$.K5[NIB 'R1 M[/2P,!6DI: '?X$C-M#(:-L!8DJ]#"6Y:#J(WM2S?C">?)T0< MZ?'O:18 S&KA12\HG1^I1LY^>\.FQ8,_J@ )%3;1D"-CQ'B^$JW5ZMEB/)VF]+Y^;UK?N$]LPCKX[1:H:&U%Z7$IL\?:D?N, M\C6'C]Q2LA+7+TSZD1#AXACXAI"O([8OR36$8"G1RJ$F1+@X@0[7T27Y?'W3 M$XHE%]-V*6>ASY;W.G%@6C?.9 []"GA/JZ=%<1U&LI>]O6)UXJ4QY0XZ@(T] M%;2LXXW%^1?R!6TLNR^XB;S3EUR&76#L09^:^CL8!-+\BWM_*L7&3*>@XV"[ M"XPYZ*"8_1T' FFV=>'L^1M'I=A*1UG@H;#3"\H?>$R@_HX&L4#;NG0>^H!P M]KP G2ZWOX-!)$Y;7IG]=6_6%UW-RXCN.J_Q#'#KA6EG'@06N\?F/^CHA

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end

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